<SEC-DOCUMENT>0001193125-13-210988.txt : 20130509
<SEC-HEADER>0001193125-13-210988.hdr.sgml : 20130509
<ACCEPTANCE-DATETIME>20130509160631
ACCESSION NUMBER:		0001193125-13-210988
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20130509
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130509
DATE AS OF CHANGE:		20130509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		13828684

	BUSINESS ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		FIRST FLOOR, BLOCK 3, THE OVAL,
		STREET 2:		SHELBOURNE ROAD, BALLSBRIDGE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d535033d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>of the Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of Earliest Event Reported): May&nbsp;9</B>, <B>2013 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>Amarin Corporation plc </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>England and Wales</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-21392</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not applicable</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2, Ireland</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not applicable</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: +353 1 6699 020 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Former name or former address, if changed since last report </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;2.02.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Results of Operations and Financial Condition. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On May&nbsp;9, 2013, Amarin Corporation plc issued a press release announcing its financial results for the three months ended March&nbsp;31, 2013 (the &#147;<B><I>Press Release</I></B>&#148;). A copy of
the Press Release is furnished herewith as Exhibit 99.1. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The information set forth under Item&nbsp;2.02 and in Exhibit 99.1 shall not be
deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific
reference in such filing. </I></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:23pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exhibit<BR>No.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:37pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Description</FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release, dated May&nbsp;9, 2013</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*
</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: May&nbsp;9, 2013</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin Corporation plc</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ John Thero</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Thero</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit&nbsp;Index </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:23pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">Exhibit<BR>No.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:37pt"><FONT STYLE="font-family:Times New Roman" SIZE="1">Description</FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release, dated May&nbsp;9, 2013</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d535033dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g535033ex99_1pg1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:14px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Amarin Reports First Quarter 2013 Financial Results </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>and Provides Update on Operations </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">- Conference Call Set for 4:30 p.m. EST Today - </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BEDMINSTER, N.J., and DUBLIN, Ireland,
May&nbsp;9, 2013 &#151; Amarin Corporation plc&nbsp;(Nasdaq: AMRN), a late-stage biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health,&nbsp;today announced financial results for
the quarter ended March&nbsp;31, 2013 and provided an update on company operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Key Amarin accomplishments since the quarter ended
December&nbsp;31, 2012 include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Launched
Vascepa<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> (icosapent ethyl) capsules in the United States on January&nbsp;28, 2013 for the MARINE indication (use
as an adjunct to diet to reduce triglyceride levels in adult patients with severe (<U>&gt;</U>500 mg/dL) hypertriglyceridemia) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Recognized $2.34 million in product revenue from Vascepa sales in Q1 in accordance with GAAP ($5.2 million in net value of Vascepa was sold to
wholesalers in Q1, resulting in $2.9 million of deferred product revenue under GAAP in Q1) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secured formulary access for Vascepa with over 190&nbsp;million lives now covered by payors without restrictions, including 40&nbsp;million converted
to Tier 2 in April and May </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Received Food and Drug Administration (FDA) acceptance for review of supplemental New Drug Application (sNDA) seeking approval for the marketing and
sale of Vascepa for the ANCHOR indication (use as an adjunct to diet in the treatment of adult patients with high triglycerides (TG <U>&gt;</U>200 mg/dL and &lt;500 mg/dL) with mixed dyslipidemia) </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reported statistically significant reductions of apolipoprotein C-III (Apo C-III) of 25.1% and 19.2%, compared to placebo, as demonstrated by Vascepa
in post-hoc analyses of the MARINE and ANCHOR Phase 3 clinical trials, respectively </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Received FDA approval of two additional active pharmaceutical ingredient (API) suppliers, BASF and Chemport, for the manufacture of Vascepa giving
Amarin three qualified API suppliers </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increased patents issued or allowed in the United States to 22 (adding 11 in the first quarter alone, including 3 since our last patent announcement),
all but two of which have patent terms extending into 2030, with more than 30 additional patent applications being prosecuted in the United States alone </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;On January&nbsp;28, 2013 Amarin launched Vascepa for use in its initial indication as an adjunct to diet to reduce triglyceride levels in adult patients with severe (<U>&gt;</U>500 mg/dL)
hypertriglyceridemia, the MARINE indication,&#148; said&nbsp;Joseph Zakrzewski, Chairman and Chief Executive Officer of Amarin. &#147;Since that day, we have seen meaningful progress in multiple areas of our commercialization strategy, including
uptake in Vascepa utilization by physicians in both the specialty and primary care communities, the initial migration of managed care lives from Tier 3 to Tier 2 coverage, the continued expansion of our patent portfolio, the further strengthening of
our supply chain, and the acceptance for review by the FDA of our sNDA for the ANCHOR indication, which, if approved, would enable promotion of Vascepa to a significantly larger patient population.&#148; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operational update </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Commercialization update </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin&#146;s direct sales force, consisting of
approximately 275 sales professionals, made sales calls to clinicians for two months in Q1 2013. Amarin reports that, since launch, access to clinicians has been good, and that it has yet to hear any significant negative reaction to the efficacy or
safety profile of Vascepa. Amarin&#146;s sales professionals are currently targeting the limited group of clinicians who are the highest prescribers of other lipid therapies. Vascepa is being marketed for use as an adjunct to diet to reduce
triglyceride levels in adult patients with severe (<U>&gt;</U>500 mg/dL) hypertriglyceridemia, the initial indication for Vascepa. Amarin believes that Vascepa is well differentiated in this market based on its safety profile, which is similar to
placebo, and its spectrum of demonstrated lipid benefit at 4g/day, including statistically significant reductions in triglycerides, Apo B, VLDL-C, and non-HDL-C, with no increase in LDL-C, also known as bad cholesterol. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g535033ex99_1pg2.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Since launching Vascepa, Amarin has: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Witnessed steady increases in the number of clinicians prescribing Vascepa (now over 4,000), in the number of prescriptions reported (via third-party
sources), in the number of bottles of Vascepa shipped from wholesalers to retail pharmacies and in the number of co-pay cards used by patients </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Witnessed monthly volume (via third-party sources, often underestimated) increase with consistency in the first months post launch with prescriptions
increasing from 3,224 to 7,260 to 11,768 normalized TRx, reported in February, March, and April, respectively (normalized TRx equates to 120 capsules, or one month&#146;s supply) </FONT></P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Focused on clinician education about Vascepa&#146;s clinical results and increased product awareness </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secured early managed care coverage based on the safety and efficacy profile of Vascepa, including initial Tier 2 conversions (without restrictions) in
April and May, noting that it typically takes two-to-three months of time to translate into script data </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Trained clinicians as speakers on behalf of Vascepa and conducted speaker programs for groups of healthcare professionals </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mitigated the Tier 3 vs. Tier 2 co-payment differential for patients with an actively used co-pay discount program (a common program for a new drug
until Tier 2 coverage is secured) </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Received early, but encouraging, feedback from clinicians regarding their patients&#146; initial experiences with Vascepa </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Vascepa additional indication progress </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In parallel with marketing Vascepa for the MARINE indication, Amarin is pursuing approval of Vascepa for the considerably larger ANCHOR indication. In a clinical trial of the use of Vascepa in the ANCHOR
indication, as previously announced, Vascepa demonstrated statistically significant reductions in a broad spectrum of lipid and inflammatory markers, on top of optimized statin therapy, including significant reduction in LDL-C. In April 2013, as
previously announced, the FDA accepted for review Amarin&#146;s sNDA for the ANCHOR indication that, upon approval, would enable Amarin to market and sell Vascepa for use in the ANCHOR indication. The FDA assigned a PDUFA action date of
December&nbsp;20, 2013 for this sNDA, which date is consistent with the standard FDA ten-month review period. The safety results from the ANCHOR trial are included in the current label for Vascepa. At a daily Vascepa dose of 4 grams, all of the
primary and secondary efficacy endpoints of the ANCHOR trial were achieved. As a result, Amarin is optimistic that the FDA will approve Vascepa for this indication. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Vascepa supply update </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the fourth quarter of 2012, Amarin submitted two sNDAs,
one each for two additional active pharmaceutical ingredient (API) suppliers for Vascepa: BASF and Chemport. Both of these sNDA filings were approved in April 2013. Qualification of these suppliers is part of Amarin&#146;s strategy to expand its
supply chain to provide greater capacity to meet anticipated demand, enable supply diversification and flexibility and introduce cost competition among high quality suppliers. With the approval of these suppliers, Amarin now has three qualified API
suppliers for Vascepa, enabling Amarin to potentially reduce supply costs by 50% or more. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Vascepa exclusivity update
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin continues to make significant progress in its effort to expand patent protection for Vascepa and now has 22 patents issued or
allowed in the United States with over 30 additional U.S. patent applications being prosecuted. This patent portfolio includes claims covering Vascepa&#146;s pharmaceutical composition and methods of use for the MARINE indication, ANCHOR indication
and other potential uses of Vascepa. Amarin&nbsp;is also pursuing patent applications related to Vascepa in multiple jurisdictions outside&nbsp;the United States. All but two of the granted patents have expiry dates extending into 2030 and the
majority of patent applications, if and when allowed, are anticipated to have expiry dates in or beyond 2030. Patent protection for Vascepa is augmented by protection provided by trade secrets, manufacturing barriers to entry and three- or five-year
regulatory exclusivity. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>REDUCE-IT and other Vascepa-related clinical development </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin continues to progress patient enrollment in its REDUCE-IT cardiovascular outcomes study with more than 4,000 patients enrolled in the study to
date. Amarin anticipates continuing to enroll patients in this study throughout 2013. Results of the study will not be available until a specified number of cardiovascular events have been observed, the timing of which is not expected in the
near-term. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial update </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin reported cash and cash equivalents of $201.8 million at March&nbsp;31, 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Amarin reported net product revenues for the quarter ended March&nbsp;31, 2013 of $2.34 million under U.S. Generally Accepted Accounting Principles (GAAP). In accordance with GAAP, until Amarin has more
experience in the commercialization of Vascepa, Amarin plans to recognize revenue based on the resale of Vascepa by the wholesalers to which Amarin sells Vascepa, and not based on sales from Amarin to such wholesalers. During the quarter ended
March&nbsp;31, 2013, the net value of Vascepa sold to wholesalers was $5.2 million, which, in accordance with GAAP, resulted in $2.9 million of deferred product revenue from Vascepa sales in the quarter ended March&nbsp;31, 2013. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with industry practice, the net price of Vascepa in the quarter ended March&nbsp;31, 2013 reflects the deduction of one-time discounts paid to
wholesalers to stock Vascepa in advance of the launch of Vascepa on January&nbsp;28, 2013 as well as the costs of Amarin&#146;s 2013 co-payment rebate card program and customary payor rebates and allowances. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of goods sold during the quarter ended March&nbsp;31, 2013 was $1.3 million. All of the API sold during the first quarter of 2013 was sourced from a
single API supplier. As previously commented, Amarin&#146;s purchases of API from that supplier in 2012 and Q1 2013 are at a higher cost/kg than scheduled future purchases from such supplier. The unusually high cost of goods percentage is
attributable to start up costs, geography, special launch related discounts to wholesalers, exchange rate exposure, lower volume, our co-payment rebate card program and less favorable terms than exist with other suppliers. Amarin expects steady
state gross margins to approach the high seventies to eighty percent level. In future periods, Amarin also anticipates purchasing API from BASF and Chemport, the sNDAs for which were approved in April 2013. The API cost/kg from BASF and Chemport are
also significantly lower than the costs incurred for past purchases of API from our single initial supplier. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under GAAP, Amarin reported a
net loss of $62.2 million in the first quarter of 2013, or basic and diluted loss per share of $0.41. This net loss included $4.9 million in non-cash share-based compensation expense, $0.5 million in non-cash warrant compensation income, and a $3.6
million gain on the change in the fair value of derivatives. In the first quarter of 2012, GAAP net loss was $88.3 million, or basic and diluted loss per share of $0.65, and included $3.9 million in non-cash share-based compensation expense, $2.4
million in non-cash warrant compensation expense, and a $66.2 million loss on the change in the fair value of derivatives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excluding non-cash
gains or losses for share-based compensation, warrant compensation and change in value of derivatives, non-GAAP adjusted net loss was $61.4 million for the first quarter of 2013, or non-GAAP adjusted basic and diluted loss per share of $0.41,
compared to non-GAAP adjusted net loss of $15.8 million, or non-GAAP adjusted basic and diluted loss per share of $0.12 for the same period in 2012. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the three months ended<B>&nbsp;</B>March 31, 2013, net cash decreased by
approximately<B>&nbsp;</B>$58.4 million, including approximately $32.0 million paid for sales and marketing related expenses in connection with the initial commercial launch of Vascepa, approximately $13.0 million paid in support of the REDUCE-IT
cardiovascular outcomes study and approximately $11.8 million for Vascepa API purchased in connection with the buildup of our commercial supply and for clinical trial material. During the three months ended March&nbsp;31, 2013, research and
development expense included $3.0 million for API from suppliers which were not approved until April 2013 which, for accounting purposes, was expensed in the period received. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of March&nbsp;31, 2013, Amarin had approximately 150.7&nbsp;million ADSs outstanding as well as approximately 9.9&nbsp;million, 11.3&nbsp;million, and 0.9&nbsp;million equivalent shares underlying
warrants, stock options, and restricted or deferred stock units, respectively, at average exercise prices of $1.44, $7.45 and $8.49, respectively. In addition, our $150 million exchangeable senior notes issued in January 2012 are exchangeable prior
to&nbsp;October 15, 2031 into an aggregate of 17.0&nbsp;million ADSs (based on an initial exchange price of approximately&nbsp;$8.81&nbsp;per ADS), subject to certain specified conditions. The notes accrue interest at an annual rate of 3.5%, payable
semiannually in arrears on January&nbsp;15 and July&nbsp;15, beginning July&nbsp;15, 2012. The notes will mature on January&nbsp;15, 2032, unless earlier repurchased or redeemed by the company or exchanged by the holders. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Amarin&#146;s 2013 operational priorities </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operational priorities in 2013 are: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increasing revenues from sales of Vascepa </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continuing managed care migration from Tier 3 to Tier 2 coverage </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gaining approval of the ANCHOR indication sNDA (PDUFA date of December&nbsp;20, 2013) </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Planning for the commercialization of the ANCHOR indication </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Obtaining additional patent awards from the USPTO </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continuing development of a fixed-dose combination of Vascepa and a leading statin </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitting an sNDA for a fourth API supplier </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Publishing additional data from Amarin&#146;s clinical trials </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Obtaining FDA exclusivity determination </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Conference call and webcast information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin&nbsp;will host a conference call
at&nbsp;4:30 p.m. EST&nbsp;(8:30 p.m. UTC/GMT) today,&nbsp;May 9, 2013. To participate in the call, please dial (877)&nbsp;407-8033 within the United States or (201)&nbsp;689-8033 from outside the United States. A replay of the call will be made
available for a period of two weeks following the conference call. To hear a replay of the call, dial (877)&nbsp;660-6853 (inside the U.S.) or (201)&nbsp;612-7415 (outside the U.S.). A replay of the call will also be available through Amarin&#146;s
website shortly after the call. For both dial-in numbers please use conference ID 411140. The conference call can also be heard live through the investor relations section of Amarin&#146;s website at&nbsp;<U>www.amarincorp.com</U>. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Use of non-GAAP adjusted financial information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Included in this press release and the conference call referenced above are non-GAAP adjusted financial information as defined by U.S. Securities and Exchange Commission Regulation G. The GAAP
</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
financial measure most directly comparable to each non-GAAP adjusted financial measure used or discussed, and a reconciliation of the differences between each non-GAAP adjusted financial measure
and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-GAAP
adjusted net loss was derived by taking GAAP net loss and adjusting it with non-cash gains or losses for share-based compensation, warrant compensation, and change in value of derivative. Management believes that these non-GAAP adjusted measures
provide investors with a better understanding of the company&#146;s historical results from its core business operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">While management
believes that these non-GAAP adjusted financial measures provide useful supplemental information to investors regarding the underlying performance of the company&#146;s business operations, investors are reminded to consider these non-GAAP measures
in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the company&#146;s results of operations
as determined in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the
future. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About Vascepa<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>&nbsp;(icosapent ethyl) capsules </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP>
</FONT>&nbsp;(icosapent ethyl) capsules, known in scientific literature as AMR101, is a highly pure-EPA&nbsp;omega-3 prescription product in a 1 gram capsule. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><U>Indications and Usage </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (<FONT
STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>500 mg/dL) hypertriglyceridemia. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The effect of Vascepa on the risk for pancreatitis and cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been
determined. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Important Safety Information for Vascepa </U></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to Vascepa or any of its components and should be used
with caution in patients with known hypersensitivity to fish and/or shellfish. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The most common reported adverse reaction (incidence &gt;2% and greater than placebo) was arthralgia (2.3% for Vascepa, 1.0% for placebo).
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">FULL VASCEPA PRESCRIBING INFORMATION CAN BE FOUND AT&nbsp;WWW.VASCEPA.COM. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Forward-looking statements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This press
release contains forward-looking statements, including statements about the commercial launch of Vascepa, including the number of total prescriptions to date and sales trends, expectations for revenue growth, product awareness, receptivity of
clinicians to and patient experience with Vascepa; expectations regarding managed care migration from Tier 3 to Tier 2 coverage and continued growth in Tier 2 coverage; the pricing terms of commercial supply for Vascepa; expectations regarding gross
margins and cost of goods sold (COGS); the timing of FDA decisions regarding Amarin&#146;s sNDA for the ANCHOR indication and regulatory exclusivity; the efficacy, safety and therapeutic benefits of Vascepa; the ability of Amarin to develop a
fixed-dose combination of Vascepa and a leading statin; Amarin&#146;s ability to obtain sufficient patent protection and regulatory exclusivity for its product and product candidates, maintain trade secrets, and take advantage of manufacturing
barriers to entry; continued enrollment of patients in Amarin&#146;s REDUCE-IT cardiovascular outcomes study; continued publication of study data; and continued assessment of collaboration prospects for commercialization of Vascepa. These
forward-looking </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
statements are not promises or guarantees and involve substantial risks and uncertainties. In particular, as disclosed in its previous filings with the U.S. Securities and Exchange Commission,
Amarin&#146;s ability to effectively commercialize Vascepa will depend in part on its ability to create market demand for Vascepa through education, marketing and sales activities, to achieve market acceptance of Vascepa, to receive adequate levels
of reimbursement from third-party payers, to develop and maintain a consistent source of commercial supply at a competitive price, and to obtain and maintain patent protection and regulatory exclusivity. Among the factors that could cause actual
results to differ materially from those described or projected herein include the following: uncertainties associated generally with research and development, clinical trials and related regulatory approvals; the risk that Special Protocol
Assessment agreements with the FDA are not a guarantee that FDA will approve a product candidate upon submission; the risk that the FDA may not complete its review of the ANCHOR sNDA by the PDUFA action date or grant new chemical entity regulatory
exclusivity to Vascepa; the risk that historical REDUCE-IT clinical trial enrollment and randomization rates may not be predictive of future results and related cost may increase beyond expectations; the risk that patent applications may not result
in issued patents, trade secrets may not be maintained and that circumstances that create manufacturing barriers to entry may not last; the risk that Amarin may not enter into a collaboration agreement for the commercialization of Vascepa in the
ANCHOR indication under favorable terms or at all or market the ANCHOR indication successfully; and the risk that publications of scientific data may not accept proposals to publish Vascepa data. A further list and description of these risks,
uncertainties and other risks associated with an investment in Amarin can be found in Amarin&#146;s filings with the U.S. Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q. Existing and prospective investors
are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Amarin undertakes no obligation to update or revise the information contained in this press release, whether as a result of new
information, future events or circumstances or otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vascepa has been approved for use by the FDA as an adjunct to diet to reduce
triglyceride levels in adult patients with severe (<U>&gt;</U>500 mg/dL) hypertriglyceridemia. Vascepa is under various stages of development for potential use in other indications that have not been approved by the FDA. Nothing in this press
release should be construed as marketing the use of Vascepa in any indication that has not been approved by the FDA. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important information
regarding prescriptions data and product revenue </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The historical prescription data provided in this press release is based on data
published by a third party as of May&nbsp;5, 2013.&nbsp;Although Amarin believes these data are prepared on a period to period basis in a manner that is generally consistent and that such results are indicative of current prescription trends, these
data are based on estimates and should not be relied upon as definitive. These data may overstate or understate actual prescriptions. Based on other data available to Amarin and the history of such third-party prescription estimates in the early
stages of launch of other new pharmaceutical products, Amarin believes that while the trends provided by this information are useful to gauge current prescription levels, such third-party methods have historically often understated actual
prescriptions. Amarin commenced its commercial launch of Vascepa on January&nbsp;28, 2013. Accordingly, there is a very limited amount of information available at this time to determine the actual number of total prescriptions for Vascepa. Amarin
believes that investors should view these data with caution, as data for this single and limited period may not be representative of a trend consistent with the results presented or otherwise predictive of future results. Seasonal fluctuations in
pharmaceutical sales, for example, may affect future prescription trends of Vascepa as could change in prescriber sentiment and other factors. Amarin believes investors should consider its results during this quarter together with its results over
several future quarters, or longer, before making an assessment about potential future performance. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Amarin Contact Information: </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Joseph Bruno </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, Investor Relations and Corporate Communications </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin Corporation plc </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In U.S.: +1
(908)&nbsp;719-1315 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>investor.relations@amarincorp.com </U></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED BALANCE SHEET DATA </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(U.S. GAAP) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>March&nbsp;31,&nbsp;2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,&nbsp;2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top" COLSPAN="8" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ASSETS</B></FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current Assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">201,780</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">260,242</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Restricted cash</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts receivable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,441</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,435</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,262</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred tax asset</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,051</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Current Assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">242,044</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">285,694</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Property, plant and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">766</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">811</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred tax asset</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,993</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,044</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other non-current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,335</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,951</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible asset, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,193</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">271,331</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">310,855</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="9"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" COLSPAN="8" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>LIABILITIES AND STOCKHOLDERS&#146; EQUITY (DEFICIT)</B></FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,945</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,458</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued interest payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,520</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,865</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,935</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,224</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,391</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,202</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long Term Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant derivative liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exchangeable senior notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,735</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">134,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long term debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long term debt redemption feature</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other long term liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">807</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">816</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">331,417</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">314,852</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders&#146; Deficit:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,846</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,597</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">625,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">619,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Treasury stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(217</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(217</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(809,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(747,643</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholders&#146; deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(60,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,997</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Liabilities and Stockholders&#146; Deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">271,331</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">310,855</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CONSOLIDATED STATEMENTS OF OPERATIONS DATA </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(U.S. GAAP) </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;amounts)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Product Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,341</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating Expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost of goods sold</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,287</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Marketing, general and administrative(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,838</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,756</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,392</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(60,051</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(18,783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gain (loss) on change in fair value of derivative liabilities(2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(66,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8,860</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,951</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other (expense) income, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss from operations before taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(65,415</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(88,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Benefit for income taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,257</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">590</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net and comprehensive loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(62,158</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(88,285</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss per share:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average shares outstanding:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">136,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amarin&#146;s costs include non-cash stock based compensation as well as warrant based compensation to former officers. Excluding non-cash stock and warrant based
compensation, for 2013 and 2012 marketing, general and administrative expenses were $35,658 and $8,571 for 2013 and 2012, respectively, and research and development expenses were $21,024 and $3,964 respectively, for the same periods.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Non-cash charges result from changes in the fair value of the warrant derivative liability. This liability is revalued at each reporting period and, upon exercise of
warrants, is reclassified at fair value from liability to stockholders&#146; equity. These warrants are valued using the Black-Scholes option pricing model, they are classified for accounting purposes as financial derivatives because, under certain
circumstances, the exercise price of the warrants could increase. </FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a reconciliation of the non-GAAP financial measures used by Amarin to describe its
financial results determined in accordance with United States generally accepted accounting principles (GAAP) An explanation of these measures is also included under the heading &#147;Use of non-GAAP adjusted financial information&#148; above.
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RECONCILIATION OF NON-GAAP LIABILITIES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>March&nbsp;31,&nbsp;2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>December&nbsp;31,&nbsp;2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Current Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,945</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,458</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued interest payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,520</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,865</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accrued expenses and other liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,935</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,224</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,391</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,202</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-Term Liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant derivative liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exchangeable senior notes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,735</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">134,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-term debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long term debt redemption feature</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other long-term liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">807</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">816</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities &#150; GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">331,417</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">314,852</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant derivative liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(49,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(54,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total liabilities &#150; non GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">282,406</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">259,998</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RECONCILIATION OF NON-GAAP NET LOSS </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Unaudited </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss for EPS</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#150; GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(62,158</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(88,285</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Share based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3,874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Warrant compensation income (expense)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">451</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2,374</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gain/(loss) on change in fair value of derivatives</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(66,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted net loss for EPS</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#150; non GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(61,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15,828</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Loss per share:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted &#150; non GAAP</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(0.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted average shares outstanding:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">136,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g535033ex99_1pg1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g535033ex99_1pg1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`/0$Q`P$1``(1`0,1`?_$`-\```(#`0$``P$`````
M```````*"`D+`0<"!`8%`0`"`@,!`0``````````````!P4&`00(`P(0```&
M`0,"`P0$!PL&!A,```$"`P0%!@<`$0@2"2$3%#$5%@I!42(788$R0B08&?!Q
MD:&QP7(C,[<YT24G=SAXX5-SMB@Z4F*RTF,T1-0U185F9Y=8:*BX&A$``0$%
M!0,'!P<("`8#`````0(`$0,$!2$Q01(&46%Q@9&Q(A,4%?"AP=$R(P="4G*R
M<S46X6*20[,D-"6"PC-CD]-4-O'2XE.#-T0F%__:``P#`0`"$0,1`#\`?HT,
M,:&&-##=#Q\/KT='1O;!+@\7LM+WL._[C7@5"V/CUQHE*]D[F1),%6#U9$[>
M:I.`"O4!`LW=3H*F;2]X024!1C`@81(ITJO>A(`268>CM"S5<B">J(4BEI-A
M<Y41^`W;\<-K5+4.IX-+A]A*J"YT\H2^_EZ,<`:R_E7>YY;+;E#-7"/D'>Y&
MU63+,[:^16(K7:7PNI><R%(K&E,T5AP^5`#N7MB2$M@;)^!2J-W_`$@'44NK
M'\3=+PY>7AU>1A=G!AI$-83:`!["AO??Q#0VBJP8L1<C,$/4HJ3QQ'*.-HWL
M\;I,]'ETWLQ@20\^0P\S&ALL:&&-##&AAC0PQH88T,,:&&-##&AAC0PQH88T
M,,:&&-##&AAC0PQH88T,,:&&-##&AAC0PQH88T,,:&&-##&AAC0PQH88T,,:
M&&-##&AAC0PW#J$1(=951-%)$AE55E3%(DBDF43J*J'.($(FF0!,81$```\=
M#E$AV)8>GY39`O=7M6+LO\\.66<^.M$?5WCW:\^6B!KEC:-79ZK9;Q%,6:EW
MEXQ^*)8]JXM\R1S.)L$SB9)H](H``4X:ZRTC#F)6A2LA.J!G4PWD/ZP!]D$7
MV"QD/7C#F*E%CRR2(!60_`V^7.T-L(YBOW'C,&,\Z8OE58/(>)[I`7NH229A
M*5.7@'R;Q-LZ*']O'2:)#MG20[E5;K'(("!A#4U49&#49*)(S`!@QDE-N^XM
M&R4U$DII$S#+BA706V(^%G*BB<V>+F&>3V.5D?<&5J;'S;V+37*NM5[4@!H^
MXU!^(&$Q'U8LS1TS/U;"<$@.`=)@UR)5J=&I-1BR$?VH:R!O&!Y0S]I\ZBH2
MB)M/RTO(V$7AI0ZCR"+VW<'X%C6&&-M8>&'L`&_LUEAN[#HWX,-S0PQH88U@
MD!P.+#&LM@$&YC;?0V6-##&AACV:-V]CTL:&&-#%[=V'V:,78L,;#K`4"7"]
MA]C\&Y^[VAK(+RX7L-W8=8"@;06-S<T$@6EC!^#&VLL,;#H>&#9>W=M8>Q>7
M8MS66&/9HO#Q<&R`^YC1@_!AQ+&@6V!@@@/-S&B^YL/M=BYC1O;!(%[&L9A?
MM;.#\&-OX]9-E[8!!M#=V']PAK+BV,R=K<\?J'^#7QF2WTQL/U#_``:SF3M'
M.&RXL:R].)#?+]EI:B7YA3G@\X8<#+'4L?/UR<@.53MQ@C$3&*,)YUJA8FOI
MKS:(Y!,#KBO$U]YZ1L<H=02$@WZ1WU<]#445:M(C3`_<);WD0FP66I2_:?0U
M>U-43(R!AH>)B+U0Z\#$^K:]HO)]B*N2?8AAN#BD-'-^2S2O#R38V91$H.T.
M5#V,&:6B%G9@%8(]S"G+3UOM='I2@I[2AJ2.M8D/6AK"5*[CF[/*3=">[#9?
MM;1.G8:]/F24'S+BM[K<Q%W-8&S=)6+DX.4DH.<8.X>;A9%]$S$5((';OXN6
MC'2K&1C7K=0"J-W;%X@=)0A@`Q#E$!UT<A28L)$6%<7$'`AUAY?0R?B(5!64
M*!>+"^SE9P+Y3ON&_=MF.Z]OW(\\5O2LV*/LAX-&1<]+:)RW$,"FM=38BL<J
M:);U6&/JDDP'[3Z-$I2B=P.ZA^*FGS,2Z:Y`3[V&71'#Y'SCP)OV-?\`1%6[
M.,:;&5U%^SQ&'*+.0-H"CI$@OWAFB"2'FP[-C<UEAJP.=E*[ML];8>:[>F:N
M*=&I#&DF1GZ/GJAS\[9)Z^)2<DOZR)LL8T?,8Z(=1!VJ!4E2!T+D.<1Z3>%A
MHB],0X916X4=<4J>%PRYPX/#0]136U1`JG+A!&\=+P?,R3>2/F9.\KB3(=ZQ
M9?93`<-=\;VZQ4>W1'W.1#GW=8ZK*N8:9:$<H39D'*:+]H<"J$$2G+L8/`=.
MB3^'.DIR5AS4,1^RB("DG.7$$/!_)>RYCZNU#+1E2ZUHSI44GJIO#_4UA/9]
M^9$Y5\C.<V,^/7-*:Q4?&>:6\G1JG,U2BM:8\@<K/").J0#Z02D7";B-L3IL
MI%^6<``'+M$P#X"`U_5WP[IE-HJIZDI7WB'UE/42](O<#N:6T_JV;G*@):H*
M3D78')`M-WG9YK8?'</8.W[W\^DJEX>#;O9D&]V+F-98:F3OE=S&1[9?#L]_
MQTO7EN0>4+5'T'"L58V1):,0?$$DK;;;)PHK(#(Q-9KJ!P$@F*0SMTW(8?M;
M:MVC-.C457$O&S"30DE9!=P#]K0&HJNJD27:0G=X47)'G\GV,F&'S4O=H\=[
M/@,-O_@G'?1_[:TX_P#\OTM@F,-O7-^++O\`&];OS0W'\UF(.V9G[Y@3N!XA
MQSRC'-/"G'&![9<5D&L;9<32CF]6^I52UJP5Q<Q3.O>N90HNUXIZT9G<N2JB
MJ0%13!/I,9=ZDI^AZ),Q:;V4S$GDI'RCE23<"\A]CCB+=K6^D36I:E!1-+7!
M$N5'!QLW../`LUP(@(B(`(!]0_\`!I8@$6$O:Z-^:N-QJ6/:M.W>^66"IU.J
M\8ZF;':++*,X:!A(IDF*KI_)R;]5!HT;(D#Q,<P>/@&XB`:]84&+'B)@P4J7
M%47``/)/!OB)$1"08D0A*$AY)9+?DC\U?%QO<`PY7./;1M)<$J';S5C.MQE8
M%,]AS%&3KE.'E+M3"/$DY.M5K'I!%_%@'EN9<4U!6*5(Z9`;U.^&2HFGXL>H
M/%66G-"#_P"S(N2<"5>9J!-:S"*HB#)N,D#UK+R^UV-N#.K5^?A+7`PEIK4H
MSFZY98B.GX"9CEB.(^6AIAHE(1<DR<$$2+M7S)<BB9@\#%,&D_$0N#$5!B@B
M(@D$;"+"&8"(B(J!%AD%!`(.XM_6U\N?86^FC=ROA.5E@P^_8<,KSB3'V<@G
MH%U&3V;JU,VJ@*5UN[$UCBWT9`'3E"/I!D(%;KI[^4</'P'4A3ETU,V#54+B
M23B\(+E/=8[@;VU9Q,V8)$BI*9C`JNW[63C[C'>\[UW;.SPWX_9P:<*K'.R]
M*B[[6K9C^@7-_7YNMRSV3BDG1$9BVQDG'/VLG#KIJH+MP#<H&*)B&`=-O3FB
M])ZDDC.RAF4)2O*4J4YQXN++ZJZBU#1YCL)DPB2'O`%HV^8M%SC'\PWWC>9?
M)/#O&;'5_P",F/K7FNYM*3`3LQA47=>AW[QJ]>$=2HFDIJ2%FFFS,`^4DH?J
MV\/;J5JN@=)T:F1:E,HF%IA)>Y*_7E\S:DAJRO5&;3*(5#"EEP>`+R!>X[6O
M0RE5?FI\71+ZQT[,?!CD,$<W5=FJ56HD=6K!))MRBH9O&M[7!5)BX>*E#8J?
MO!,3&V`H[ZHTLOX;3400HT&9@A[BI2BY_(HNY6M$=&K8"<\%4.(1A8>E*>EJ
MK,=_-@<S,"Y)E\4\Z>&]/?S5.FE8*]Q51&R8AR?6GK50".T7%;M*UD@7;DA1
MZTR"+1)8@E,17H,!AM,;X6TN>EA-4&94$K'5S`*22[:+>6YH.'K6=E8W8U*"
MDJ22"X.(=LOZ&;?X$]R;BAW'\;K9`XV7XLG(PQ&Q;WC2QHIPF3,>/7/V2-K/
M63+K']"LH`E0D&BCF/<B&R:PF`Q055<T_4J!',"HIR@^RH6I4_8=NXVM=Z75
M9*JPNTEE7"U)]H>L/Q#>T\JX#E!9<+6")X=W_&.,\\JR$$K6K9F&L2%NHC6-
M;RB"MA:24+%_IJCE_$`HFW5*!@26$#"`AK2IBJ=#FT^*HB1)%UR"`K-MM+;$
MZB<7`=)*0F/F^6'AW,?+!DL^X]WB>^WVQLYQ6"\Z7WB=99.R4QE?JG;*!B0'
MU=L%;>24A#G5(E+NXJ6CGS*4BUD5D5T"^PIB&.4P#IR:<TCHO4DCWR4AS"%)
M44J>LO#K=^&QE]5Z_J*D3'83"H)>'V)?Z!LV-%;!7S'?>KY'YBQM@;$C_C_/
MY*RQ;HNE4V)<8B@XMJ[FI542)"\D7L\FU8,6R*9UEUCCLFDF8=A$``96H?#S
M1]-D8E0F.W["$C,HYS=P;2D]5ZAGIE,K`,$Q%EPZK,X?=3\RZ,`UD`Y5]M\L
M^JW(J[KBF([N"+-8Q`$S4LV2%40<J)F'I$P(E((AX#MI9"8^'XB$=UG2!<K.
M/6]KD(6J<@)B2X7N'_2YEUN8_?I[Y_!3D'=.-.>Y7C9'9$I)(AXZ5KN*8J;K
M\S"6*.1EJ_/P<D27047CI6/6`Y2K)(KI&`Q%$R'*(:85%T-HRNR":E))C&$H
MD6J4%/%XZ?0U3J&IM14V95*S/9"(G\T6V`W\"&\8QK\U[W+J_?Z?,Y.;82R%
MCN/GF#BZTJ*QLUJ4M8ZV58"RL;$V5I)NU8654:F,+=<4E"%6*7K*8G4&MR;^
M%NGHLLM$IVR9DI.4E9(!WAM:!KBJIC),QD,$$/`2YX.\X<&T!.'W+W"'.3`=
M*Y$X!M"%CI%P9E]2S5.BE8*?8D$R>^:;;XPBBBD198%R<4ET3^!@Z54Q.DH0
MYD/5:5.4:=5(3B2(B38ZXC:&9\A/2\_+"9EU/A'#$'9Y6-)T-MPW]F_CM[=M
M1Q%ME_E8V\"4FPE_F\N#+@\[KQ\PYQOIF9\XX=L/"+,F*J/(6RU1E'JF-;J.
M8(?%,<Y=2+-^M'3LFUA[--P->(47Z#1<RJHI*'1(?P+I@T2%H.>BPI.>3.(C
MK"03F&4K/"Y_,U3J2]32J(DQ+F`J"+;NL!Z?.U7O;3[G/S`'=5G+TSP/8^(]
M`I&,O=25XRKD'$L@C6XZ5G$W"T56HQE&R,Q)3DZ[:-5'!T4DB)H(%*954G60
M#V;4FG-"Z81"3-)F5S,6T)2O#;?L=BT/1JOJ:M+/8F&B&ESR4CI<>AK\?N?[
MYW_UB\&__D!<?_/-4?O6BO\`2S?Z8_YFLG8:F_U$#]`M]MWW$N<3=1RFV[,G
M+!X**BJ:*@9FXX)(N034,0BA3FNIC$35`.H-RB(`/B&M9-$HY`)JD(?^.(WH
M:K43=(QOTDM^??=R7G\U0!5#LD<J'!_,*7RQSOQY-X#ON;9I8'2NP;?]AM^'
M6RF@T-9=XM`Y840><MY&KU-SQ(1G_23ZF_..>YMW&.I,K+L;\FS]0""@NL^8
M10`IMP`O3Y:ZQ1+M[1$0VUZ#3E"`^]Y?]!1]+>9J]6*?N^+^F/4]EI!Y%\J>
M[QW;J?RIAN!&2\S8;[?SN&A5^-,)DS'C=K4+[#OY=VW4L.0;$:/I,M*2^1H<
M7RK=J58Z[.)1(`BF43BQNX4O2NEE4Y4[#A34\">UR*>I)PR@O``N.]JJ)N>K
M=9$Y#EU+@RY'4S"_B=^R]FK&_/GN!.4_.#LS<@$3@/B1?DOQG1,)^D##T`>S
M%$Q-_`#;!I7^"T(V&JPK+O<Q+_0UQ\2J92]4E$L/ST^@,EM\R3P,L>#L^X^Y
MLQ>+'V**/S6A$+1D;'2KZ(FQQ%R61BF\GD*ER<W75G$"^7LK=7WBFNU-Z=T]
M0D#)")`#3E^&]?3.R*J/&B9YB5+D'YT/Y)&.[FVLO=84I4"8344)*8<:T@GV
M58C8`^T.VG8R[>.,A7'$>0*1E+'TTZKM[QS:X.ZTZ<9*&2<Q=CKD@WE(MV4Q
M1`1*5RW*!R^PZ8F*("`B&F%-R\.=EURD6V#%04JW@BU.YJE+QE2T414%R@7G
MD+;!?;MYEU'GWP]PQR>JAFK=S>*VDTO4`W5*H>HY+@=HN\UAP0HB9'T,VB=1
MN!MC'9K(J>PX#KDBO4I=%JL6G+>Y*NH_%)M!]!9^4J?%2D8<T/:(`/''D::^
MH=I!OD3\LO\`2#^70PV9W-<""\W.0GS!<;48=26S/QZR/-9RP^9(@*R,@X@,
MPY(6OM.;@42F5^+Z<5PFDF`"8[YLU``UT3"KRZ)3J$5.[E&2E"@;@](<>>]E
M-&I2*C,5%0!,:&HJ`X*+_-:RWT%.3%:F82SUV2=0U@KTI&V"`EV1SH/HF:AW
MB,E%2350-CHNX]^V34(/M*<@:9:X<.8AF$H9H<1!!?<ZZSB^S:U)A*7+QA$!
M<M"O."VOQVL>;$/W`.#F$.1;=RT-<)6O$JN68MJH!C065Z@5.'N3-9(``6Y)
M)VB61;%$/%H\2$/;KDG4M(B46L1I)Q$$*)0^QZ#:.:YGW1J@FIT^',@]8)<=
MKQ>_C>&L,`!$=@#<?J'^#^74!FMR^7(THY]A]G%D7N9BK3NV\S^XUGZ3WL'#
M?M3<4,TX[Q882"\K-QY%.:C82.9QOT?HKPS*QMG3\%`ZQ\B(8;_9.&G313^%
M*3)2"0/$JE,(4O:E#^?9REEO4W5N:FIB(3W66A*RNVBP<Y>3N`(9(A$1%-,3
M#N(IDW$?;OTAO^_[-.^].]S+6(X*+K@6U4_EP0V[-_$7?_B\O[[?3_ILR$'\
MFN6M?G-JN:.+T_42SOTK]R0G;5?6+7B:IK6-J"OF2.0N-L0]LS)&*K97F%XO
M_*:8@\+8=I"X*JO7=N=2;*86MK-HV,5VL:DMF)7"0DV`S]5JD;<%>D;O\/J=
M%F]0PYH+,.7EP5K6YX`=8#Q:MZHFTP*6J#?'B%R0+^(\L6S%LD8WO6(;W;<7
M9/K$O2\@469=URW5.P-3,I>"F&(E*ZCW[8V_0J4#%,&PB0Y#`8HB40'73,K-
MP)R`B:@*2N&JXBT%V+)6+"B0(IAQ@4Q$ESMC:!WRKO<>^_?CQ.\&,GV$'>5>
M-3`DMBQ:2=%&0M."9!Z"*4:B98P*/'.-)QSZ,Q0ZC$C730-MB".D#\3=/F1G
MQ6(`=+QBY;A8F(,>"AYV:^C*MWF5[C%([:$2!O3LY+^'!FT-*T6EKNW0T;]C
M'K;.2^;N_P`13#8?_:G5?[Q,A:Z$^$R@:)&']^?JAE-KS[P0<.R3TJ:JSL;[
M?M<.!6_COG)M_"%3M`@/C]6K/KM_X3G'?]L=(];0>EP^MP7?.'U@VN".WCX?
M@_%[1URD4@D@XDV?D9[/<IYNO9`3YPS#]!K'('B/FF"8QT;?\J8YR)5KZHT2
M32>V%CC>7JAZE,R8D`#.7+%M;'+(%C[F%%-(F^R8;/CX23LRJ3FI6(L]C#B(
M*0^P%3W@;K.EE=KN!"1,08Z7"*M)?O=CY_,U%_97SMD+`?<^X>6''LL^8FO6
M9J?B*Z1+-94C.TT/)DNWJU@A95LGNF^;))R!7B('*/DNVJ2I=C$`=7;6LA+3
MNG9J'&`440RM)/R<N(.UXNV-6=-S4:4JT'LB7&SB^P^;T-KE'\#&#ZA$/X]<
MI"YGN`XAL[GYP+_;NXW!]?%9M_>C=/\`)KH/X3?<L?[970&5&O1^_I/YHZ%-
M3WV1DSJ=VK@25,ACF#/L*H(%#<032A)U10X_]J0@;C^#5IUN"=*SIP$'U-`:
M7/\`.X'TATCU-KE_G"'UC_EVURB'DG8ST(>XF\%D4><.`\5<H_FHJ[@#-M70
MN.+\G80KE>M,$LNNT440'C5;7;*0CWS8Z;F.EX:3;(NV;A,>I%RB0WCL("[Z
M-/S5,^&BIR25DF(4<D'_`,A#N!%A9=5.6@SVK1+QTYH2P`<+##3:-XO9?CNU
M]J',/:VSLM4Y\)&YX$O+U\^P9F@K$4F-GB41!96K686X&:P^0JXBH4CQJ)B@
MZ3`'2`"D<0)?M):JE]2204"$U%'MH%Y_.`Q&]JCJ"A1Z3-92"J743E.[#E;Z
MW::[J^8NUQGM"Z5I21N&#+N\CX_.>&S/!)'6N%1/Y2=CKY5A%O$Y`KB"ICL7
M8`4%R[ME^I(_V<ZMTO):FD5(<$SB?86+WXC>"Q0:Y'H\P""^`3UD[1Y>3FU3
M>./([#O+/#%'S]@:XQUXQGD"*2DX678G*5RS<;`60@)U@)C.(:QP;KJ;O6:P
M%506((#N&PCR_/T^:I<Y$D9Q!1,PRXC;O&T%G7*3<*=ETS$N<T$BS:-H.]O1
M[P4IZ1<B'(4Y3U.R%,0Y0,4Q#0ST#%,4=RF*8!V$!]H:\Y;-WE&6PA:7'?F'
M0WW'M@+N*2@OYBRNWRBK<$N`_(98$2I@OS%NI2*`F4HJD0QSC9,"@<``QB(F
M$P``CL7<=O;IA_%$?SN`+TB500_:\O:I:*!$A%"7`]H.@,UG_!_'I;YAL#77
M+^<635M-D[?99N8>O^X+W[HXSN8D5Q1C([E>C$(*N'2JZC6*(7$`IE8-A.)$
M2E$0*F4``1`--6&BMY0!)TLCC#];+]:Z=F)[S4!P"O4WGKJY=O!H8X+=S?OZ
MH&,!E$VZD9R=34$FX])2>=B!,3>S8!$0W^O6PF'7E6B1I#N,,_UFUNTICOXN
MH?HK]30;YQ<GN)V+L`WV2XZ]RSO26;/LFV:PN,*)F2SY:HE&E)-X^9-II:Q2
M-IIU;,]C(V#6754;-W`.%5#)D*&QA$)RB4VIQZ@E,](TL22>LI2$I40X$ASL
M7NX-HSTW(PY=1EIN=,P;`E3P#MOW,=NZJ\!L(\>ZH3*^<^\IB//=R`MJS#'<
M;<=Y^Q_C<;(\5=%CV[3X;I#\+.M#PJB2*DDLH<SA03F3`"B`:-0QZS.3RE2\
M&FQ)--B%1%)4IW`^SP`;-+A4V7E$JC1)M,RKV@D&_![KVN4XYM.$>5<LX[QI
M1>;W?6&W6VSL6-8;Y&F>2U4J)Y!#S),J5CL=CQ>UKT?#O$V9B*'>N4TA*/1N
M`F#5-J*JS*RRYB++4P0T@ORA!-V`>]^QK!)^'QXZ42\:<[1]F9X'G:\/N:<'
MZMW"N&&8.-$\1FVL,]"C8<66)T0AC5++5726?T>=(J80,@W5D`%D]$!W/'O%
MR?G:J&FZU%H-7@U!#P<P*]A0H]8#A@&L%8IR*G(+E%VQ76/P(%_`W%L@:ZTZ
MT8ZN-KQ_=X=W7;G1;'-U"V0+\@D>0UDK<DYAYJ,<%,!1!1G(LU$Q';8W3N&X
M"`ZZXEX\*<@)F9<@PE@*21O`/_'>R$F(*I>.J"OVDJ<>1FF?E6NX<;`G)N>X
M49$G!;XNY1N"2&/!?N>EC6LZ0C$Y6;9MYFZ;<F1H!`6)P#85'S1H'M,.ZO\`
MBEI]4Y(IJ\ND&;@#K.Q0;SR'TM>-$U<RTT9",KW,0.3L"L/5S-HKCX#M]7@(
M?5^#7/H+V:X>ZV]OD3\LO](/Y=##**=CI,![UG?4`R8&1'(AB'*)`%(04R]>
M1,F<-ND>LN^X#[0WTT=8K/X1I#K`$AVWV`U)T]UJU/%3B\FSBLLK'WV.!RO`
M?N$Y2J->B%([#>8EG&;<*J)HF)'MZQ<9%TM8:BT/XE`:/;BNV14]]RM/3F$`
M`X::6@ZXFNT*'VBGS4$"&O;8+#RV%J1JFF>'5%83_8Q#F3Y;KN1K*?E3^?`X
M+Y76?AG>IKTV-^5#<K^AE>+]#*&SE5F"AXY!N!P$$E+Y6$560@'3YKMHT+XB
M.J]\4:'WVFHK,$/F(%BG8H)M?P-HW/:5T35.PFS(Q3U(MWTL.>[E#-T][CG(
MKP3X#Y-N-3>&#-V6P)@_`L6S`%)=WD._(+1HS$:T*;SUE*K"G<OBB0!V<)HE
M]IPTIM'T85BM0\X?)P'18IP"1;;Q:^Z@G^X4]64NCQ.JC:_$C:X/:&F,>#"?
M`+Y>SD1B.:;`&6;;Q3S+EG.<FL'7(/\`*-\HCR3EF+UR<H+KC5V'IXLO4)MQ
M:&-[3CJ7F*P*WKF#'07RD.90B'N0E5EGYU[1T*GB1TQ&2H>^B0BI7$BP<@<&
MS)DAW2)_0)_W&NEGO>K:'LF(GM*X^EM5/Y<+_!OXB_\`)Y?_`+[<A:Y9U[_N
MJ:XI^HEGAI3[DA<5?6+7B@&_TA^,=OW``:IQ+O+'8UC\N3:RAV-VP]Y_OLV?
M+KL`L?!_M6F+5J&14@NJO?,ZD?*@5^B!B"R?F7N,:O)"?[6["!9`/V5@W:<R
MK\(Z.$I[%7J%JMHA_DN?O:DP75W4"HRK9*6%FPD'UV\`&AA\V7V[C5^UT7N,
M8T@@3AK>,3BKD2E'M@*FTM35$S;'-_?`B4``L]&I##.E3!MY[5IN(F5U._"W
M4)4A5!F2Y:7JA/\`F_*3QQX%HG7%*RJ34X27/#E[C@3Q'+8RJ/"?EID/@WR@
MQ#R?QDNL,_C"S-W\K"E<';M;?3GWZ#<:7)"0P`=A9(%99`=]P36%-4`ZB%'3
M1K]*@5VEQ:?$2"E:7I)P4ZP]%S4BDS\6G3R)E!=E(YL?5RML*X'S7C[DAAG&
M6><53"4]CS+--A+O5))(Q1,:.FF9'/HW9"B/D248X$[5TD/VD7*)R&\2CKDB
M=DH]/G8LC,C+$A*<1PN/`WAGW*S,.;ET3$$O0L/&W?S-ZQK7%KQN/0VR+VSG
M_F]6@(]PK!SD#B87?%.O;D$``">GR3D%(-A]H]>^XZZ!^$GW)&/]]Z`RFUY_
M'P_LD]*FI-[5&:\=\<.XAQ0SMEEW-L<=XOR6:SVEW7("4M,TBR3K4^Q0%A7H
M1N[EI4YGKU(#)H)'.!!$VVP#JYZLDX]1T_,R,J`8\2'8\@"P@VDM6Z!-0I*J
M0IB.2(85:X/-EK/M9)^:8[6-%@99W"36<[Y;&3<YV-%CL,V6JR[]R)!%!)P^
MO`5^-BVRIPV%50XB4/$"&]FD3+?#34DS$"2F$E"E.?G!=B]P9HQ]8T>&G.#$
M*L!E(>[>62KYQ\M^67?6YH1LU1,0RDK)Q\&-+P?@6EO$9EU5:8G(&>N5G4D_
M4BT9:QST@L#F2=;))]8$33*5)(FG+0J33-#THB/$3D)S+B&XD;-P==ZV7=1G
MI[4U0?"02!8E(L<+7#C:S(G8R^7/RUQWS?2^9G.DD%`6[&RYIW#>!X.89V-[
M$VY9FHW97;(\U&&6AT'=>3='4CXMFLX$CSI675#RBI&76MOB'`J$FNC4?,84
M5PB+=>!\W%QQ:WZ:TG%E(R9ZH!Q2.J,7[_(O9T@?ITH!NL9@@O(+9W/S@7^W
M?QM_W5FW]Z-UUT%\)ON6/]LKZH95:]_CD_1']9JC>QG_`(N/!#Z_OJ1_YK6/
M?^'5IUP"=*3I%W9#I#5S3/WW+?:#I+:W/Y_X_P"?7*0L4[:`SW-S);9?_P"N
M#X:_U8U8/_QEN.G%*?\`JN-]H?VI9?Q_]Z(_H_LTLUKRVXEX1YMX)NO'CD!5
M&UJH%S9](&V*C-5>>;D.:%N%4D^@RT/9H!V(+-G!/IW(H!TCG(984RJS=&G4
M3\BHHCI5;L-SP=Q:Z3LC+U"7,K,`&&7\0;'$-E3]T+MD9M[8?(!_BK(R+JR8
MXLBS^4PKF!LQ,W@<CU-NN`%*OY?6VB;G")JIIRD:)Q,DH(*I]2"A#CT]I;4\
MGJ.0$>"H)FD%RD8C:=_$,E:U1)BC310L/@'V58./ER%O>^S7W@LG]KO,I6\F
MI+W?BQD:69$S)BLBYECQ9SBFV#)-#;JG\EC<89N`"LD'2E*-2>0IL<$E$]+6
M.D);4DFOLDY:C!&:&KY2C>Y1Q!;:T]7XM'CB$LDR:KQLW^KF-C:>D!F?&V?.
M-SC-F&+E$7K'-^Q=8++3[5"+E<L9!BYKS]0G478%&KYFN4R3ELJ4BS==,Z:A
M2G*)0YK[K,R513*S2"B,F(D$&QQS#S;V<`CPIB1,Q`(5!5#)!Y"R[?RC74/;
MQS68WB)^7N0#";ZQ&AXW,(_C$=7OXGN\=@NN[HCI4U:T4?W"(K:L=`9J'?2U
M<USS,M5.YYY5MI210:_,*=N&,%!^]15C)+">$0<QBB;I4GNY4#9=\[S&0%\L
M_F`!^HH[^.^F##E:2I-M&GR=RE_\K4M<S-A1_F4L/+BWXQ?D#S@$`%E\POVL
M5!$__E6&\2$#H_-$HHY4./6(^WZ->G=*.F^BU#])?J#?(FYT6^)2I'!WI++C
MYMS-G#N.]S2MXEY(]RSB9\#<-7<Q,T#DU9Z+5J5QWG)Z`D8"9<*0&.G4ZE&9
M#DINTIH,>M5ZHBZ8QYU`$R``!V+(RLK0-.&;I\A,&+,@!4(+*H@!L+WVI<`U
M4F)B-5ZF(,U-0Q"@ORQ"`$EQW;=X9AMAR9Y4OD1'_P#I#[;OFIFV5*VP-A)-
M$@FW$@)^HR*D<2](?5L&J"JFTQ(/\CG[=L11MYFM'?9NQ]4E0!L2&LY[?=LY
M&9)O%BLUK[HO&+G3C"O5XT3.TW!&(<?U>2K=KEU458&;F+53+Q8W#)`S:/=E
M(T70(5R`B8H_U>JQ74T^5@A$&0F)6:?85J4H'<XAINEQ)N)$SKFH,Q"=<@!X
MWV-;9^'Z=5LO!<_?SX<&FR\ORV;"V>+\UOV^4L+<C:?SCQW!"TQ_R7.-;RQZ
M%N!(Z%SA78XAFTNL"1>EL?(E59^:<QMO-?Q[@^XG5'=^?"VO]XDE4B84^/`M
M1O0;^8O\S*O6]*$"9$_#'NHE[OG"_G%O.RH-8LU@I-FKMQJ4L]@;34YR+LM:
MG&"IF[^'G8-\A)Q$FT6((&3<LGS8BA1^LNFM&@0YE"X$8/3$007["'.YFHD&
M*N"L14ERTD<A#:\G:LYSP/</X2X@Y%,UFB-S>17P?F"";&+U5S+%431C[8T,
M@4>I!G++`G),P'VLWJ7X=<F:FHRZ%6(LB01`]I!.*3=S7<C/JC5%-2IR)EXS
M@.5]+\M[6*D_++_2#^74`+6EL+;V4=[%3M)]WC^^PZ1$124RP@4HCL.XI9;R
M4@?\D3!^6D.FEK)+M)T<?FCZ@:CZ='\\GG>775ZVE?\`,Q\#3<M^`LIF"F0?
MO',7$1U(96@Q:H>9)R^,EFJ:&6*XGY29EUR(0K5&823WV\V+V`-SCJ-^'%>-
M*K28$=3I:9!2=F8'JGCARMNZNIJ9ZF*C`?O$)]OYN/KYVS0Z/=;+CFY5'(=(
MEW,#<*18X2WU2=9*F1<Q<_7Y!M+1$@W43$IRF;O&I#>W[0;@/@(ZZ0FI>',P
M%RT8`RT1!2H&[K#H9.R\5<M'$=+\Z%!VUX+/'\4LX3_S!_<YXNY9LE7D(GB[
MV\L*TG*%]JLFV`L'/<J;,@W6>M"M3&69/8Y2YQ1%&74'6:+A!$0#SQ#2/JTB
MG0NGX\L%#Q&=BE*5`W00_H'.]F;(S)U-4X,0I/=H"`5`W9L>+U#B',SAW1_\
M.'G(/M$>+^8]_P`=+E=+G3!S5^4)QF$]+6RM*?29@[(2O,&QUD?[(G]`H_Q`
M&NNQ[/\`19`+M4KCZ6U4_EPAW[-W$7_D\O\`]]N0M<MZ]_W7-<4_42SPTI]R
M0N*OK%O[7?M[@7Z@?`*_S53EDV.<<Z%>88PLDFN"4@PE[%'+DM5V;!^40E&J
MQUW1%?`"/CM0'\K7QHBA*KE<0A0?+02%JXBX<OK;ZU+413Z:HY@F-$&5.T`W
MD;_2YH"=H'G1V=NW=P:Q9@Z0YUX,4RK--SY(SK-I+VERO,97MZ*#R=;*OBU@
M3NVU7;%0BD#"8P&(SZP\3CO.ZKI.JJW68DR).*95'4ABQP0+++<;^5M&B3]'
MITBA"XP$1765U57G"[!IB\GNZIV1>6/'W+O'+*'.3"#ZDY=I,S4)03%M"J\4
MX?-Q&(L,>"E9`J<O6YA-!\T/N'0X;D'V:AJ;IS5M*GH=0EY2*(R%A5Z;=QZU
M@(L:0G:K0IZ55+1HR2%BTY5<ANP;+XOU:C:;>;E4X6V0=^A:Q9YN"AKS65E7
M%>N$5&2*[6-LT,JX1;.!83;)--PF"B9#E!38Q0$-M=/2T5<S+0XD9)$98!<;
M"+'VNL9(S,-,..I,,O`+.A_*<=Q\8Z5N';<RE/;,9@9K*/&AQ).1_J91-,\A
MDW&;,ZP])2.FZ8SL>@40#K(_V#<Q0TE_BIITI`KTLD%:2$Q0-]RN2[FV,QM#
MU<J?3(ZAF%J7^?G'GXL]+M^[^/\`%X:2X(=F%SB?,S(N+L6SJ?F_/\0'`7^Z
MG#_WG9`UT#\)#_)(P_OO0&4NO/X^']FGI4U6'8;:"][N_!M+9(Q4\IRCDY52
M`8IDV]"MRIB["`@)A`OAO].K3KQPTI-JQR!VT=87%H32X?6H`-V=G].]OVK*
M5W$N)=P;4>FUF.Y0XR:.KSA2X-(B.CYN=E(ELLO(8SEY=NW3=NH.[L"G;)IK
M&.FWD/(6#IZ3[H;1NJ9B@U9"XL11DHIR10\D97N?;<[$[&:6H:-#JDDI,)($
MTFU)N?M'JOM;*Z;.K50[4@[9.)ZE7:F3_F-W399Y"6:J6FO2`AYB+A(R#Z*F
MH:4:[;@)5$ED_H$-=0&'`G(&4!*Y1:;K'%)%FWGQ9*$Q9:,56B(E6_\`)ZVT
M]NP1W<VW<AX]KX\RU*M$N7&!8J,C\F(B*:!\F5`13CH#,$6V+TAY\DJ0&LXB
M0.EM)[*`!4G210YFUUI56G9\KEGBFQSU3\U6*>&S=P9RZ;KB*M+9(Q/>X8MW
MC;O(L?SXM?\`CJC"RQK2'DA][9W/S@7^W?QM_P!U9M_>C===!_";[EC_`&RO
MJAE5KW^.3]$?UFJ-[&?^+CP0_P!=27_-:QZM6M[-)SOV0Z0U<TQ]]RWV@]+:
MW7Y_X_Y]<I*#E`_FAGN;F2TS!_UP?#7^K*K?_K+<=.&3_P#5<;[0_M2R_C_[
MT1_1_9I9TKZ/X/Y]*#`C`^H-?W`W[3Z&B-S<X38*Y_<?[;QZSY7B2==GD3O*
M[8V:+<+3CRWHHJIPUUIT@NFH,?,Q*JGB']DY1$Z*Q3)G,&I*C5>>H,^B>IZL
MJDV$8%/S3M)VMI5&0EZE*F6F`]!#@<0<"/3M;*<[C';OSKVU^0LU@W,T>9_%
M._4S6+<G1K99.J93I`N#HLYZ&7.42-I1L7I2DXXQA68.MRFZDS)J'ZBT[J&0
MU+(HG)4DQ_E)?UD$7O\`*ZUDC6:3,4>9["*.H+C@1Y>HVM-7LY=Y:_\`;FFK
M?A_(:LY=N(>76$\RMM-;J'?2V,K7,P[R.;Y(QZT65!(AU5E4RS,<02)R*!04
M*)7"1#&B=6Z.@5XHG)4)35$*20K!:007'SM(T&OQ*:52T8E4FL&S`/#N=FN/
ME(^D>VYE`Y!`Q3\MLEF*?;;K*>G8Z,4VP@!@^R8/`?9[-*?XG]6O(!O3+)',
M5>;8U\T9E\-6I)>GM'#D2EFC]M+7,UQRM"B2[:_;SFGBTA*<'N*4@_=*K.'+
MMQ@;&ZKERNX6,NX775^'?,66664,<YS")C"(B(ZF1J.MY')FYD;BM0]+1QI-
M.)MEX1/T4^IJ">^G-=ICMW\<;75:7PWX9R/,/+T`_K>):<PPKC5S-TI"6:&9
M/\M69BUAO/A(JLLES*QHK>49])>45(#D(L)+OHF!JBOU1$5<S,BF0U!2B5*Z
MSC:D/+CO'(U6U%$HM*DU!$&")U0<`$AZ=_'8WT/EJ.W+P^N/;CB\Y9:PQAG/
M5_S+DJZOY5_D:BU._K4>+ILBI4X2FQY)^,D1@52),5)!RFGY8K&?$,8!*!->
MOQ'U#4X6H.[2T>+"EH<-.7*5)M-I)`+SBQI.DR46F=YC0T1(JEE[W&[8_BS!
M@]N#M\?3P>XFCM]>`,7CM^^`UGZ]44:AKKLR)V8_Q%>MK2:33`?X>#^@GU-[
M3B'CGQ^X_)SR6"<(8GPTG:5&*UE)B^@5BC%L"L81=.-4F2UN-C@DCL".E01%
M;K\L%#=.W4.M*:J$_.J"IN-%B$79E%72]O>!*2TM_#PT(^B`'\S>SAK3L%CS
MF.-_.VQ>6A=W#N+./.9?#+D!@#)2+`D-:L?SLC#3S[R$PIMTK+%Q/4^Y-WK@
M`)'JUZ<8)+**]1`%OYJ9AZ#F`9B@5*8I59@3<L05I6`0_P!H*+B"-GI:/JTG
M#G9"+`C#JY"7EUA%H(].YL;U9([999LH=)15LJJW440.51%11!0R1U$5"CTJ
M)',01*8/`2B`ZZ]A*5%A)4IX64A_%N?8@<M2=[,H?+1]RV(X6\L)3`N8;<UK
M/'GE&#"&=2\X^(SKU$S%&$%*D6A\Y<*$:1<=8VZAX9\X.)$RF5:J*&`B0B"X
M^).G%U6G)GI1&:?@O+@+5(Q&UP<]KEHZLB0G.ZQRZ7B;;@<#Y8-I@(KH*()/
M4UT3LU$2.TW9%DSM3M3$!8KDC@HBB=`R0@8#@;I$OCOMKG)V4B&?[39Y8LWW
M@C,"]&WT\-[)/_+.9/@L@=RSNZV`LU'*2.2;*]NU?9>M0,\FX-+..2#NI6-2
MZS&>LV:<TR\Y1/J*3U*>X[&+IP?$.6BP--TI`#D(2YYN!"!?Q9?Z4C)BU><5
M\M8>+7`A[^>T,ZM(QT?,QS^(EF3:2B99D[C9..>HD<-'\<_;J-'K%TW5*9-9
MLZ:JG34(8!*8IA`=*!,1:'+ANSI+P4E[B&OZTA2<L0=4AQ&U[9$/=PX/2/;^
MYY9LP&WCW9,?NIS[P,*NSI&.65Q7>5EY.M-6JA2%*Y<5QT9Q#K`3<068CO\`
ME!KJW2=;AUJA09Q?M(1V<0/N4+U%^#F1E>IJZ=4U2X'5)>-[[O+BVB'V$.!G
MZAW;VQO!V>()'9FS@5OFW,!E42DD64M:H]LI5JB\4$`4VIE5].V,F;^S>*.!
M#\H=(#6]:\9KL1<,_ND!Z$_-+CUB-Q(X.<S5TS3#3:8E*W",L9E<MPXNOWM*
M?NMKJMNVESJ62/Y9T^,&7=C^'AU5.0*;83?9_),.HO3)!U%*`.">V3<7XMN5
MT'PF9L_5'SAL>@G]F4/#\@NW[P@'\>NNQ@D<"=P#(!3@H^5K:HORZDG&0G9=
MXK34U(L(B&B(W-,G*R\H\;L(N+C6&9LBN'\A)/W2B31DR9-TCJ*JJ'*1,A1$
MP@`#KEK7:5Q-6S(AC,LJ2`!>>JD6"UGAIA2(=#A*4>IUB3@+2;6JJQ"^PY\P
M+WE\FWFZGBLA\&>WE04Z[BK&,P4CR`S5:[3-242[OTM#+&`CRI34W%N'8"9/
M9PQCHQ-0`*HH75IFN^:&TI"AP0856GEDK6+,B0`7`[7>DM"P>[ZEK:UQ0%2<
ML"Y)+\SKK-YM/('O9@%?LZ=J]RF*2O`7C%T"8##Y.,8-N?</9LJW224`/K`!
MV'5&3JW4H``G8XV=9X:S^`T;_30^9OH_L8^U,&^W`;C9X_\`N`R_[_63JW4Q
M#C.QW?2;'@-&/_QH3N#+4_,E=E_CYACC;7.97#S$E2PTTQ%*1U6S=0Z'%^Z:
M]/TVW2J,=`7PK!,3HH3E:LKI%FY4`0]0S>EZO%`-V)\/-93TY/*HM4BJBPXO
M60I1M20+L'/]#4_5VGI:#*)G).&E!07*`WW$=!Y&2XQ#E>]X*RGCW,^+YQS6
MLAXMN$%>J;-ME#D.QGJ\^2?LQ5`ABBLR=^4*#E(1Z5VRJB9MRG$-.:HR<O/R
M<24C@&#$04J?P<_B-K+J4F8LI,(CPBZ(DBT/?T\K;`W;_P"9N/N?7$[$?)S'
M[EH1.[U]NC=:X@X36=47(\4F1C=Z;))E555;K1$V106_F=)EV2B"X!TJE$>2
M*[2(]!JL2GS0((L2<%))L(/E:\8,_*;48=2E434'K`@`@7I-CP1Z=C(Y?-]&
M*/<"P(`&*)B\4H43`!@W*!LG9`Z>HOM*!MAVW]NG;\)1_)8U]D<CCU4W%EMK
MLOGD#Y0AI?9])JS/E_VY''=^X4E.IY0)WNTN""/3]L[?'%Q4*E]H0W%00V\/
M'5EU^I8TI-Y0"C('VVAZASM#:5`\;@/^?Z"VL8(COO\`2`[A]?\`'O[-]<KD
M/#DW[<"+V>65YRJ#CY6AL[SYI#M@EX_9P8<\</UWTV'N1$X:+S"PBVHDCJ+G
M15`SA*<.D@3RF<5E1DV5<&,.Q0F&Z^X@9RF`O_X8:E5.RYH<TI\U!'4>;T;+
M?FV\CF56M*-W>-XA`3[I7M.VX^OG9=[@]S$RGP,Y.8PY.8C=&^(*!,%"=KRC
MA9"*OE(DA(UM]%G2I&`%8VQ1`F3*8P#Z9T5%P0/,2((,*O4>7KU.B4V92%)6
MDE)Q!'LJ!:HTJHQ:7.)FH)<7^;8=S:[O%/D]BGF5Q_QGR0PO-IS5"R=76LRR
M+YJ)I&OR@%\F=J5A02.?T%CK$JFJS>(&V$JJ0B7<ABF'DRJT^;H\_$I\V`(T
M)5I-@(P*=KPSYDIR%.RJ)R!UD*=9B"R('S@73^O?QM`!#?\`56;[AN&X!]Z-
MUV$2^T-]AT]/A*7T:,0;#&59C<&6FO7B>2_Y@N_I-49V,W$>V[N'!%21<D:H
MGS4BW044-T`=^ZK%C;1K8!$!`3NWZB:10_.,<`^G5KUSF_"DYE#QV;CR$6\+
M+6KVF0?&Y<_)$0?D\Y;6Z$#]0B`>(#]0C](_1[=<I*ZUU^7:+&>QN<'V\S)`
M9#R+1K)\X%C5Q#6B%>MJ[$0>-Y9VD_;@S;7R.XUV5H]JI7!E`24F6TB^3:&0
M*(J`[W1V\P!#3FE9>81\*8I6DC,HJ#[.KVCWC:+67D6+`7K1.15@('*$@=-G
M%G?OH'P$/WP$/8/X?W])A*LPS!V0@.XX@LQ%#*7/!_+_`,&YK)NLO\O(-B^Q
MH,=P?M^8&[CW'N>P-G&'`AS`O+8ZR'&M6IKABN[%0$C"TU=ZL03%(80*F_9&
M,"$@T$R2@?DF),T&NS^GY],[)DN-D1+[%)WAHZJ4J7J\J9:/[8%B['\&RG.=
MG!;//;SY!63CYGR!])*QQE)*FW*.0<C4,G4M5<Z47<Z?(+D(#IFY*`$<MQ'U
M$>Z`R"Q0,4!-U+0:](Z@D43DDYX#LOS5.M&YSWO9'U6E3-*F3!F`<C[#@1@Y
MGQOE)4TR=L6YJ%(4#K<J\GBJ?;[1Q)5<>D()A^GI*4`#\&D9\4PZOI!+R)9(
M?P)9GZ++J2?I_P!5+-";Z6#FNF8M5!WDH_-LEQ&0;X*MW-FF6,,E5Q2?EN!.
M.Z/DW-BE4+&SH2#-U7KIE#$ATJ<L\,@+MS&29Y!-8J(`@=$RIB6?2IEDU0F<
M3+*ANL$PHI3SY5]%S0M<$0RB<AB`/MR`G"Q[B#>YUM[GV-G394JG;F#(]S_6
M"SYW=CYC][K_`!R.4.(W'1/(02_CYP6@+IS;5L(O1'?I%<0^QMT^&VN@I&)J
M3NJ?#(-,[L_JY(T1S\'.@=#+":31^V/?%S7:XYD"[EB?E:P7MVU5MUVK]FAG
MGOV>[/5I?&OW'<2N,WP%[T\LGD_$'K^:OP%[\]/T_P!K^E^5MO\`8VU7-11(
MMGXCA4;.X.SQ8F:[=!S-*T5,"WPI<V[Z!=YHC:#W#EOD-KQ<PBWRQ+9BG,BI
M4:/);)?D%7Z-5,UOY3S7(F7R37<:6:Y42(LPHB4%DHV4>MP`"CY@F$P`BJD8
M)J$0RXAB"_JB&5%%PN*@E7.`S)DQ$$`=J5%?YP`-^QYZ7[6DKK3;9;Y%]OT?
MC\`V^GQ\=8+['/\`1RL%SCF]ES(D]PBM<GCUW,Y^5.:?F%F_'@]CMQK,WJ_&
M'B4\P\WIYIM\*"#AYC_ETQ=N\?(QXD*DK*H($49`4SI,AA.4'#IZ))9H7A\*
MC=\</;BQ,[^!@EQX$M1*JA79GOD2<[+=#5LM_6.XX;+&7+"L=F?8/]-W=*VV
M#;IXM<0>G;;PZ=N8>VVVF4(FMW60:<[[:+_D-2RC3#[8DR_[,?YK!JQV9^D>
MK-W=)Z.@>KJXM<0.CH\=^O?F'MM^_K/::VRE\&FN=;[Z)=C^HNVL)1ICY,29
M>_"&'OW>]>UO>-ZQ<?U3K3]V.;_F3_U//A9U[_\`=/%G"/W=_!'IC>O]T>KY
MA^\?A/T'5YWNO]#]/U=7]7OJDQ8D/Q-/:P:#WY]CXRK_`/`:S0D0^YG)$GN[
MV?JU<CG17.:#7$.L<&OO\I'ZD.;^]5^L;N]^"/N+XL\6OCWT_IO\[^5[EYB=
M7N7T?_COJOT+R]O.\-M6&LQ*]W")XU!I/A[@_-&B9;A[/N'7.>YHJF(H_>QX
M?$G.\OPAX[W17^7%M#/M;,<\Q_&^10Y$6CF#;;N.1K"HPD^;=#PMCS,1*X:,
M@PCVC:"P7D?)]55J23D%Q:N',B2147,L"J)"%3,9":@,LJH@R:99,'*'B`I:
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MV1]T=*]@B6`FW#U*)=@W;VD5R`$`2D*EJJECBN+$3$?O`A*',?,U&K:8V2+W
MI4T)%^"20[],#\F]E6@J7:8V-MR`[DFV_P!'#_BOM^+_`*<6VFP8FKLW]C3W
MV_KHKKK?U#4<ITY8]<Q=\P?YC3RJM2Q_^I':?@KD!WT_V?\`\5O_`(O^&N'^
M$OU?OB/J+[Y]Z^[N<7N?W=ZG;U^_^;?5?V_]=OJMS$2+XY^\P:+XUE#LT9>9
MV#O<7\&F8297PP]BN<\/>7N0776O]XZ[:WY_@=4L%??M'_L[^0'>8^_GW0\V
M^XGA_P`:/?'PSU)^O^)?3\XO<?POYG1YGO7]"\SH_/Z=;&H8E2[C_P#8(-)[
MGAVD:([^C[B_8ZUO*D)IW>AX6N9[PXW(#][W1'^0W-HP]O-GFYAQ1QZUY$6/
M/=KRLF\M(S\YR8I>*L?9C=-3V22-#%LU5PO?LF8^CT4(H4B-#-)ERJJU`AUP
M36$Y"\]UDRYJ*S)"$F6?8(9*D78%24J-NU(M9GTWM1*CO!68K_EARMSP">GC
M:TS7X*BP?@W,N1<6;H$#M2)*.BKB@?R3-DUSI('<%4V%,#F*03[`80#QU'#V
MNMM;>MRV>TR"?<?K.<!Q)91[@.;>_J7C:-J0&9)-<7.$2F)B/1EU!K9+`KC_
M`)@IM%(\CSRP8FE2%3,KY8])5>D`<^FHD#O2?!(-'\0=9[Z+G\\#T\6H-90G
MNW\TB3?8/'ZO'DB.\K+&H/&L=FGQ_P!-W=*]OC_T6N(/M_'S#VVTP^TUOGM@
MTY_VT1W[!S4Y*-+/#HDR_P"S'^:UKG;)K$1Z[(7[+G-_?9]+U,?O.^Z?BSPT
M&@^O\C_-?Q%\7\Q`H?Q+Z3^P_P#6/D>S^KU4-1Q)C+#_`!%!H]YRYXT3-=N@
M9G;,'M8J&B5RJ\'B3F7%T.S]JY_%HU<\*QQ+_6(GOVAF;^]5^L?[DA/>?WU<
M6>(GQ-\+>6O\.^Z?*YB>Z?A;I\[TON_]#Z_,Z?M]>I'3\2L^'#\/P:5W+,?8
MC1;['O\`<<-[:-612.\GQ.)-]X=C#/IB^6#>$82K';-^][&_ZO.;^\-]^/Q=
M$?=7]V'%GBI\?_&GJ2^Z/A3W-S#]Y>]?/]GE^'1U=?V.K4E/1-5=P7XA!IGA
M^4Y\T:*YV_W#:DHC3W;H[M$FNV?8Z'CR17MH,]IB,Y2QU?S$')B[<_;DHJ_I
M0TP_._%W&S&LPP:E82X2I*"GQ[R_EA27;KG%$9(TT=DLDJ5($BJ=2HE06IE2
M*LO<$2B+W]@M:QA?G0AVYS\69],$<$]LJ.H.L[1.7;=UE%^W<[%[2)[GY>+A
MN`W*`O,Q51#CN;%\R6[+,6[5U947@^6%45HC5XY9HN<AIVL68PB8K)`>2!(#
M'*F)S!K:>\2\:E?";9S/9>`[',X&QU_*WM6.Z^'1>_?P[L+W[GX_E;+G+4NT
MQT%WY`=R;?8OY?$#BMU_@ZMN<73U?7MX;ZZ91$UC9[F0S._[T7T0',GLNG,]
MBX]Y<Y%GGB=+6\]M2I7CW+<_V8_(#OE_`WO0GQU]U'$#BG]VHV#TY-P<_%_.
M+X'"U>CZ>OR-WWE]'7]GHU3=31!VB/Q'!I'>,IRYXT7,[_`>[8UDHR4Y%>%+
MF\KOF8;O>.\K&C5SQJO&G[^W_P"T/SQWH?U@_AV%\S[\N)?%/XF^$.IW[B]S
M=7-7W9\-^;Y_D^@_1O-\S\_JUOZ=B5?PY/X?@TON.<NRQHGM.M?[A_/BVA5T
MTWO7\S7-=XRXHPW^\Z>1HPX[JO;`^/:7]T^>>[/]Y_Q-"_=[\`<2^,/QQ\8>
MO1]P?"7N'FK[Z^(/>/1Z;TO]?YFW3XZE9F)JSNZN]PJ9W;(<V:+$RY<<SX/.
M]M*630^V3W=<SVN:QR,?\3R+,:V&J]S'X(1][YY^91^&/=H_^C.)7$7XB]!Y
M/CZWW!S5^-?.\K_COZ_\>EM#B47ME9(5#[3-C%B.>_!\%W,UQ6F;[#KKG>P=
M\Q;_`-H]EUFE5[:7WH(>@SSW>_OK^/2>F])Q*XW?>I]Y_O[['E>7S5^+?COX
ME^K]/];_`.$TQS$U1W$=I"I7A_969HJ\F1^'N77W[K[&J(31.\CKS7>GXHM_
M:/\`+:SY_9TB.6T;:<A'Y`9"[H]RI2F.84E1:]P;#O'/&D&TF`G4C+.J@_Q9
MG3+&1I"TGCMRK(339LV*UW,"QE?L:1FJ54]1'=$2"8N>WNZUJP-^:&A(%USS
M<[%F72!%`]XJ.I#K,Z<HP<YZE6WN<[%^#7UZI[3Q?BW0W^C6#<+W/P]+8PW,
MO?\`,<(]NYQPC.ASDD9F(N*LF[)QGD\8PU?L6=V&1#-B`Y=4B"G9ZKLI:GI(
M>6-C0?2+*-4:=`&6(Z]*.KWH#QX5E]$`,.SM0HNANQ>7&W99Z6J^J?"_#SX@
M2%_(<'E[N(L\A:WD/RG*<0EVQ+22)>/GQ`Y497\]P_C48I0QOAV@@B!6;>5F
M4R!Y`%$1!<WVA$/8&X[?Q.[7Q\=HX?NXNM^4JZZS8WCHWL?"3V>;+GQO]E+,
-W?9_=OI:VM;>LW__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g535033ex99_1pg2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g535033ex99_1pg2.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!L@)D`P$1``(1`0,1`?_$`/H``0`!!`(#`0``````
M```````'!@@)"@0%`0,+`@$!```'`0$```````````````(#!`4&!P@)`1``
M``8"`0$#`PD/#PD%!0,-`0(#!`4&``<($1(3"2$4%R+4%1:6UE>76#&SE-56
M=K8WM]<8>!DYFD%1,E)35)4VASC(B0H:2F&ATB,D-'2U=W&1,Y,EL=%"DG-B
M@B>!P6-$-57&1V<HN$DZ$0`"`0,"`P,$"0\*!@$$`@,!`@,`$002!2$3!C$B
M%$%1T0>1,E*2(U.3LQ5A@4)BLM(S<],T5'0V-PAQH;%C@[0U5187\')#)'48
M1.&CE*3!@B:BQ?_:``P#`0`"$0,1`#\`S$^%)X1/AN\@_#BX<;MW1Q.U]L7:
M^SM'U2W[`O5CD;HZGK99Y5-=63G)=P6TID6?OU^IU#`4H"81Z``>3%*R#?D)
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MJ[>^S%*PL?DP>`WY?W\$;\&>D_@V_DR_3=Z'_96Z^T_TN^GOVJ>D+S'VT]Y[
M8_:O_P"G]YV^[\V\G8[7JL4K-_X('YH_P_?Q;*+\X<8I65'%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*UX?\45
M_4\_TF<4J\WP0/S1_A^_BV47YPXQ2LJ.*4Q2F*4Q2H@Y`6S8U"TCM6\:CJT/
M>-E4ZBV.T4VF3[QY'Q5JF8&-7E$:^X>L"G=ME)8C4R")RAY%SDZ^IZY.Q3AC
M+@&XNT>VF>(3.HNT<)D42R`?9&.,LX7[+3;RU-A@?)8P0E?%.CB+4;*9BC<E
M7/V*-+H5V%RJ$L`2+5&6M.65`O?#>N\R73A"+HC_`$H?<%@*1;O"0B4375Y>
MTP_>J=@3KPLDP<L_5=!,HEY>@CF0]8],Y?2_5>9TM$&FR(<KE0\.,HD(\.UE
MOQE5XS87L6L*L/1F[?ZJVC$W&5>1+*"LRGARI(V9)QWK&T;H]M5B5`)`O6/'
M;_BF;@U!Q+XQ;ID=`0T_NOD*WF=H.],PTM/&/3>.51:+W>[7AZN9F=^I8J]K
M%=BH=`Q2MC2SL$@,*9<SG$]6^TS=>Y?2^1G-%L>V01+FY9"E(\J4QXZQH>PQ
MMG.8T+6=HHW-M?"L>AZKS<OH[_46%CK)N6=ERQ[;C\0<A%,TL9DO8QL<.!I9
M#Q1)&0$V-9`=_<PZ#HWB3*\O&T7);#I9:A3[34X:M.X]J]N!M@NX2.IK!I)R
M2J47&I2K^PM2J.ES`BW3,8YNH%Z#@N/TEN^5UG'T(H2/?)<]L3X2X1)%+ZRU
MN.E0C&PXM8`=MZR"#J#;)NE9.L69ALT6W',8@%FY80,%"CB6+$(1;NDDD6!J
MT.K\G_%!H$_1+!R9X4:BE=.W:PURKRJW%/:5SVKMC6"EN?-$(^UW*FS5-AX^
M:J%<36,285AW3H[<W^N()D"F,.9/TSZM,Z63:=GWG+CWI5DT29<"0X<C1*Q*
M<P.7B,Q`$+2HJCLDLQ4''Y]\ZLQ\/Z;;;HI-I&AVACD+YBQ2,H!55!CE>(,#
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M#G'`FS(I(6,D$L49<:;L`R2(P1)$8<269+II)BS76^O&QV70J-L:"XQ>'HC`
M7ZIUJYPZ4CR'W<WDDH:T1+*;8%>MD=4.D47I6+XG>$*JH4I^H`80\N9/O/3?
MJFV+><K9,W<=\.7AY,D$A3&QRNN)RCZ2902+J;$@7\U8YL^_=7[[L^-O>!BX
M(Q,O'2:/7)(K:9$#IJ`#`&Q%P";><U7^_N5W/.+Y0T_BWQATIQDNEP/QLB][
M;$D-Q;/V#3HB*?KVX:9)PE5=UFI3Z\NR0E!`R)UVZ*AT>IC=D0[.6?I_IOHS
M-V;=>I-ZR]PBV;#W:/$@Y44;RR+-#)-&\JLX56TQG4%8@&P%[U<MTWG?,+*V
MG9X(<9M\S]NFR)06;DHV/)%%*J/;41KE71=;L+DZ;6-8<=^9F_6VX-C<>.=F
MH]9:7V74]...1=9M^G+Y,W_4MHT_%2Q:[:5W$I9(6OV."L]2F^GG"#AH5)PW
M5`Z0B!!$]+U#TWTS_IANJ^C,O+RL+&S%Q<F+)B2*9998WE@:((S))'(B,GMM
M2R+8BQ[M3MNX=0#?<39-\Q\=#N*R>&DA<LIDA,?-AEU@%7TR"56`Y>C@6#\*
M\^'AX@LKS1?[@@[MK9OJ>Q5-]`WS5\1Y^^=N-@\;MBHNU]7;/,20;ME$GLL$
M:NF^21`S=!4R92F'M9/ZTZ`_TIM&#N$4YGR&)Q\Y+`#$STC25\<D<?P4JE0U
MGNKZ@+`53;-U4N[;]E[8$"X!#38,O&^5BQSRXLDI'8I6:(]ALR21LMP2:N2Y
MB\E''%G39[_":\GMM7NQ7"GZQUAK:O*)M'5OV/L"72A*Q&OI9<IVL%")+J'<
M/GJP=V@V0./[(0S%.F-AFZHWZ#8X)8L?F+*[S2DB.&&&-I997MQ(15]JO>9B
M`.VXR7<<_&VC:\G><P.V+BQAV2,7DD+2)$D<8["SR2*O'@H):QM8VIZ0YD\K
MJUR"A>.?/'1.I=6SNQ];W;9^J-@Z#V//;$H+Z-UBBP<WVLW!.UU^MV&&L,;'
MR*;Q%5%NJS51]0!A4'R95NW371^3TYN'4'1N?F3MM)A;*AR85B<PY#\J*6$Q
MNZL.:"C(^EN.H6`[V,XN[]28^\[9MF^X<"0[P\L..\,A8IDPQ\YX9E8``&&S
M+(C,@8:23JNL!(^*!RD:0M<Y:6'BS1([PX+7?(ZJ1VQ6VRY!UR*C*;/64M%K
MVZIO7BD,WJ"&OI.S'3="@G)&DD8EP14Z8&`V7W$]7/3KY,'1^=N,\7K)RH5:
M.$1#PB3/&9X\.64GFB=HK1W5"@G8(3:]4VY=4;I#!N.^[7BI/TMM<L@E=GY<
MTD>.W*RIX5(*%(I`Y"N59TC8K<E;W/\`B'>(_5^$=$5-6:-8MQ;?DJZQMT+3
M8.(F356!I3FRQ5:=;!V1=6K,\-5*DT?RA$4@,L+UZY.1-!(P"8Y,8Z`Z#R^M
MNH8=JDECP]N\9#!/-(R@HTI;3'%&2&EG<(X1%!`(+.5`XWOJ#J#'V39'W*)'
MR<V7%R)<6%`29N1"9G=FMIB@B2S2R.1P(1-4C`5-W*K>V\]74;7;;CGH1[O7
M<FV[1&U.M1[UU*06JZ"5Q$.9F3O.X+K'1DJXJ](B$&O=`8B)G3MPJ1-$IC^I
M&T;!LNV[EO4V)NV9'A;3BQ2RR2M8NZQ,HY,*7',R)02(UO8$$M9034Z;=)HN
MGDW>*!Y\V80+'#'Q)DR!W78FVF"(]Z:0\56P`NP(CKAARUV[N+8.^..O);5E
M-U;R/XZA096Y-M6W%]?=5V2I[382\K2YNJ6"6BX:<;.R-H99%\R?MD7"2I0.
M4.[4+TN_5'3&R8>Q875G2V5D9/3V9D9&-;(C6*>.?%$9E!5&9&C82J493YU8
M`CC1;;NF\+O#[%O\$46:<5<J%X7+QR0M(T3`A@'22)U`;4`KA@T98!K1-<_$
M6N%&\4&J\'IK6];)I^TTFLKI[=)+RGMEC=EW*&LTS5JP_AS)>Q!(B;+57""2
M_;[P7`E+TZB`#6=.="XN_P#J_P!TZK6>1=WP<EDCALNB6.**"68ZCWN8D<S/
MI`-U0GSU(ZDZDDV+J+:]J2-7PLO&66=S<-")<J?$B8?8Z#.D*&_&\O#L%_'B
M!^([9>(>]>(&CJ!KJ!V'+<@=K4NL[(?SDG)1Z6MM=W&ZP]#CK.T"-(H#J9D9
MZ242:(+]E)06Y_U`'I'ZLN@L?KJ;=6SYWQL+;]NFF1D"L9,A(99TALWD*0LS
M$<0+=EQ>9UKU#)TOLJ9V)&L^XRNY6-CI`@AY8FF8]ME::)!;B6?L-JOQVSR<
MXY:%D:]$;NWQJ#4<K;%#I5B,V1L6ITQ_8#IJHH'+#L[!*L'$AV5G*9!%(I@[
M1P#YHYA.T;!OF_R/%L>'DYDD0!<0Q/(5!O8MH!M>QM?ML:ONX;C@;5"N1N<T
M6/CN2%:1@BL5%V`+$`D`@D#LN+]M5+>-U:>UFT@Y#8NT]>T1A9T9)Q7']ON-
M?KK*>0AXI2=E5H=W+2#1O(IQ\,B9TL*)C@1N45!]2'7*;'VS<<J66#&QYI)X
M5U2*J,S(NI4NR@74:V5;D#O,!VFIGB\3D19/-C\-,ZI&^H:79E9U5&O9BR(S
M``FZJ2.`-0!LKGEQIIG%S:/+*H;;U=MC6.M(2<='EZ1LRGOX*?L\4S%=E1F5
MI:R#Z&;V:<>*(MFZ!S&5,LN0`((F`!N<G274L&]8?3^9A96/NF=-&D:2PR*Q
M623090A`9DC`=W*_8HW$6O5-A;QLVX8F7GX>7CRXF%#(\K)(K*ACCY@1F!LK
M2$HBZOLI%[;@&!D?$LUZ\LG#Z4:634!='\B-/;4V=?\`;:^PHX:UK9[K*N5N
M4E(8+&5T6MBG&2\RNQD#.UDCMU6_9$`/U`,JG]7F5B[IU%M$PR?&[0D#8R\L
MALL3YOA8V"GO%9$^$C*7U$\+BL<BZOBR]BV'>\-4*[IF20Y*EP?"<K`.9(KD
M<!)$;)('TA1Q[;5,'(;FM2Z1PWV-RSX]V/6F^X*HLF2T$_K=R96"D3CM2T1-
M=?M#V.IN9),%&(OSB8J9A.50@`8``<L.U]);B_6.V=*;_!DX,F?FX\+<R-DD
M6.=PO,57`OP-U\AJ\3[]@2=.;GONT3090V_!RYNXX93)C0O+RW*DZ;E0&\H!
MO:KIJ3LNEWM>;B*_:ZS,VFG%@F]^K<+-L)*6I4M/PS:=CHRQQ[==1[#.7L:Y
M*N@1R1,ZJ`@<H"7RY9=QVS)P"9V23Z.>::.*4J0DA@?ER:6]JQ1K!PI.DFQM
M53MNY19T,:NR+N!Q8)I(@>\BY":XR5]L%<7*,19@"17"3VI3[#KFS;&UU9JS
M?(2"C[@="4KDTSFH-S,TX))M+Q)Y.)6=(><1TO&*M71"F%1%9,Y#`!BB&6_<
ML?-VN$OEQ/'(8!,@=2NI'37&XN`2CK9E8<"IN.%7K:EQ]RW-=N60$C+&/+I(
M+1OJ"NC#R.E^*FQ![15BGAF^(4?G;I9Y/WFBM]1[VJ+1A*7O6"3QT\CAK%I3
M>26O[[3Y!\!74W2[=#(?ZMR`#W+U!=`_0Z?3-D>M/H!.@LH3;7.V9LCAE#L`
M'CR(T5I<>95X(XU*Z=FN)U8>6L!Z%ZO/5?P&=$N/FL.;&%;4LV*TLD*3I>QX
M2121NI%T=?,ZDRAQGYH5O9?%!OR@WO*Z\T?7D+1LJ#GY2;MC>&I4(RI&Q[)1
MX]X\L5I7CT&ZDDWA$U3@H<H`LH)2]0`,LW4G2C;5O&%L^U<[*R<S;L'(50EW
M,F7C13M&BI<L%9RJ\+D`$\:NVR[VVY0[EDY2I%C[?NF?C%K]WE8>3)")7)X*
M65`S?8@FP\E7#U/D)HB^ZV?[DI&Y=86_4L4C).)395:O-;FZ-&H0YSIRRK^T
M1TDXAF9(TZ1@7%18O==/5=,L>?L.^;7G1[9N6'DX^XRE`D4D;I(YD(6,*K`%
MB[$!;`W)`'&KI@;EM^Z1O-ML\61%%JUF-U<+I76VHJ3;2@U&_8O$\*I>,Y=\
M5IIW),(CD?H^3>0UF<TN7;L-HTQT>,MS.)>SSNLO^YF3@TG6L)&N':C502K$
M;('4$H$*(A-EZ:ZBAQTRYL'+7&DA>5&,3A6BC*AY%)6S(A90S"X!8`GB*@CW
M;:YI3!%D0-,#""H=20<C\!<`\.;_`-/W?V-ZZ,W.#AH37:&W#<J^/!=6N;*:
MF-]B#N&@A3%[<5NH[-64K(,][$J3Q6J1E1:@J*_=E$W9Z>7*D]'=6#<8]G.V
M9XW66,R)#R).8T8;275-.HJ&LI8"P)`O>I,>_;)-B3YT67C-A8Q`E<2(4C+6
MTAV!LI:XM>U_)4J7?=NF]::_3VOL/:NNZ/K!9"-=(["M=RK\!2UVTSW7L2NA
M99.0;0ZZ4F"Y!;F(L(*@8!+U#+7%M.Z3[E]#08T[[MK*<D(QEU+?4O+`U76Q
MN+7%N-5JYF(^%]))+&=NY?,YH8<O01</KOITD>6]JMWVYS5UG'\0]Z<I..5Y
MU7R`C=1TRT3K1:G7B*M%0?6"N,2/#P$K.U)Y)@R5[*I!4(4>]*4P#T\H9<FZ
M8WC`WO`V??L7)PGS<K'C'-C:-N7-.D)D0.!JTZC;R7%C4K`W3:]TQ\N?;<B'
M(\+BY$C<MU>SPX\DZHVDG3JT`'RZ22*J&`Y$O1MK5S>K#HJFZP0XRU_>EG6D
M=CBQV757;Y8B\Y,S=6DF[>.C-1148)NDXNZ+_M29DSE``$V5>Y]/X^#+N>)!
MXN7+Q-Z&%"5C!B<$RJJR.#W<F1T7E1*#K4L0;@`VS:=VR]UQ=DR52%3N6UMD
MR(6(D#VA(&.EKRPJ)&$KFQ1M`L=5>RC<]>$>SK3"4;7'+CCA>[G97I(VO56H
M[FU_8;#.2"I#J)L8J(BIYT^?NU")F$$TB&,(`/DR#)Z%ZTP\>3+R]IW&+%B1
MG=VQY55$479F)4`*HXDG@/+4Q>J.FWD2),_#,LDBH@$T=V=S9%4:N+,>"@<2
M>`JOVW)_C<]VVKH-IOO3SK=Z`*"MJ)OL>I+;(2[ID615!2F)RQK`4Z;`X+&*
M+?J5(>T(=/+EMBZ>WZ?:3OT.%E/LBWOD")S"+-H-Y`-'!NZ>/`\.VJ[)W7;,
M/.7;,O(ABW%M-HG=5D.L:ELA(8ZAQ7AQ'$7KF;.Y%:'TU+UFM;4W-JO7%JO+
MCS"C5R]WVL529M\D=0C=!C7HV:DV3V677=JD2*5`AQ$Y@*'E\F2=NV7>MY$W
MT-B9.6V/$TD@BC>30B@DL^@'2H`))-N%3\K-P=N2.;<YH\?%DD"!Y&"*6\H!
M8@$@<2!4#\/N3.Q>5G$I'>C.FTZ#V+,/-K1%=JGLS+>T]>8I-NLU5KA9*9,T
M<2K:/EE(9%1VHFBH9(%3]V4W0`&[=5;##T]F8F-#(\BY&W8>2Q8`%3DPI*Z@
M#R)J(6_$V%[50;%N@W3+W&'(`6#"W;+Q%9.\73'D*(YOPU.`"0#8>2L>LSS#
M\9"`W]0^-DAQ@X!CL;8FN;EL^!6;<@-T*5I.N464@X><2D)$^LDWS>3.\L"'
MFZ1&JA%"`<1.7L]!V!A=+>JG<-JS]YQ]QWOP>W''YNK&@#'Q+R)'H`E(/&-M
M5R+"UKWK&,[>>L-NR\##GQL`R;C+D1Q6DDL&QHDEDU\.Z"DBZ;:KFX-K7K)9
M&<L*#JJ!U=4>9FX>,^C.1UWB61Y'6C;<<.VBWLX\?ECB-Z*>\*5JS6&,6=+I
M))*G9)G.J?L@'7IF"R],S;QN&3_H7&W+<-E@"_"'')D6Z:FYBQ:U7BKZ>]Q5
M;^>K]'N[[9@1S=6R8>%ER-)8"6T;(CD`JTFDDZ"A?A96)`)'&J2WWSYTQH'D
MIQLXVVZU4:+G^02MG6&5L%]K\$%581,8F:L`O$O5R/'KK85A=)QT2("1-=P1
M0A>V?H7)G2W16Z]4X6[YF%',WT7BQOI2-G:66298^2+#@R1ZYG'%M"W`M<U#
MU'U)A=-KMLF64\/N.4\>LNJK%$D+R'(8G@8M:I#?@`\BB_&U2[?N8?$_55[:
MZOV9R5T3K_9#TT<1K0[EM6DURW+GF%2H11"5^6FFLH)I%4X%0#NNJ@B'9Z]0
MRU[5TKU-OD#96S;?FY6,I(+Q0R2*"!<@LJD7`XD5<=RWC:MGT_2N3!C:UU+S
M75+K?3J&HBXOPOV7JC[#R2G8CFYJ_BRUKD*[JU_X^[`W(ZMYGSSV:9R=0MM<
MKS*(9,DR#'+QC]M-G5.J8W>`8A0*`@(Y5;5L$6?TSO&^RNZ9&V2X2*@`L_B7
MF5]1/$%.4+6[;F_95+NNZO@;ILV#"JO%N<F:K-?V@Q8894*6X'692#?L`!';
M5N?++E5S)J/*W6W%KB#J+C[L.?MFD+7N>P2V]]A7>ALHUA6KA#U3S")6I]:L
MQWBZZDP0_941+Y`$>T`!Y;ST=TYTWNFP[KU#U/DYF/@[?DXD(&/&DC,V4DS`
MD.R@!>2>-_+V&J3J/><[;=PVS:=KCCES]Q7+8<PE45<08Y;O+<W;GBPL;V[1
MY??Q^YD\CXS>T]QPYYZAU'IBZKZ@G-]:_O\`IO8\Q=]23FNZ7*,(6_M['+7"
M%K$U5[!4G4JU<*&7;E:+-%A,0_5,PFJ=XZ6Z6R>G)>H^BLS,R(\/+AQ\F+*B
M2*0-DASCR0\MG5T<QO&PN&5P.!#<)>)N?4&-NV)MV_8T"P[AS5QY('9QS8%5
MY(958!@S1MS(V4%+*RL0Q4&\ZL\H.-UT]O7M1WUI^S!J^*CYW9!X'8U3E4Z%
M"RS$TG%RMP592JR==CY&.**Z*KL4B*)`)BB(>7,-S.G]]V['CRL_#RH<::9H
MHV>)U5Y4;2\:$@!G5NZRB[!N!%ZO>+NFVYTXQ</(AER3")M*.K-RCV26!OH-
M_;>U^K7;:BY!:)W_``4E9]&;CUCN"N0SXT9+SFM+Q6[K%1<B5LD\,RD7U>D9
M!NR<@U7(IV%#%-V#`/S,^;OL&^;`R)OF'DX;2*2HFB>/4`;$KK`N`18V[*^8
M&[;7NC,FVY,&0Z6U"-U<C5V7"DD7\GG\E='KCE1QGW!<I_7>J.0.F=E7VJ@[
M&RTRB[*J%IL\$#!Z:.?&E8.%EWLBR*S?D%%45$R@14.R/0?)D>5TWU#A;='O
M&9@Y<6U2A2DSQ.L;!QJ0ARH4AAQ7CQ'97Q=XVE\]MJ7)@.YJ6!B$B\P%#9P4
MOJNI]L+</+7NM_*'C;K[8M?U#>]^:=IVU;6JR1K.N+-L>HPEWGEI%<6L>C$U
MB1EF\R^5?.`[")4T3"H;R%ZCGS;NG=_W?%FSMJPLK)P\<$RO%$[I&`NHZV52
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M-NAS7EDVQ,J4/$5MV\V2'3<OBCAHF-M5S<"I4&=JGS>>\`Q(-Q\/$5>[6;0(
M4G!L(\EV8@Q`GM6Q-Z]RG,WC)(Z4V?ORB[RU#LC7&I82;E;;9:9LRGS5>C'<
M.P4>$AI2PQ\H\BX=_(+`F@D#@Y>JBI0`!Z],D[CTUU)M4L&-G;?F0YF40L"/
M#(C3,S!0L8*@N2Q`LH)N1YZG;7NFS[OD/#AYF,ZP\9F616$*6+,\ECW%5`SD
MM8:5)OP-0;HGG0PY+ZXXB;7U5.Z#1KN_)V3B]AUFR;;:FN]7>M*A)6%6AZ]8
M0[5TUNFT*X\01),1JPM!:LRKK]`[!2CE_4'0,G2_4>Y;#N8S)4Q,!YH988"5
MF9&B3G,&(T8>IG5I@6*L$4W)-L5V?K!-_P"G<3>\$00Y,NX0P3132@&(2"4F
M.ZCCE,JH\,)`YB%FN`HO<Y9>4O&FF[.B=*VW?^FJSN">%F6%U?/;)J$3?94\
MAW_F!&%4?2Z$VY.]\V4[HI41%3L#V0',1P.G.H-TPI=RVW"R\C;X;\R6.)W1
M-(#-J95*BP()N>`(K)L_=MKVN1(=RR(,>64`H)'5"P+:00&(N"P(!'`D6KG;
M-Y(\>]*KNVNX-X:GU<Z8P*5H>-M@;`JU1<-ZVO)DA49U5&>E&*A8E674*V*O
MT[L5Q`G7M>3)&W;-N^[_`.%8N1DVE6/X*-G^$=6=4.D'O,J,P7M(4D<`:GY6
M;B8(4YLL<0:-Y!K8+=(RJNXN1=49T#'L!90>T57U'OE)V;5(6]:YMU;O=*L;
M0'T!;*A-QUBKDTR$YDP=1<S$N'<>^0[PAB]I-0P`8!#YH9)W';=PVC+?;]T@
MEQLZ.VJ.1&1UN`1=6`(N""+CB#>H<'<,'<\9<S;IHI\1B0'C8.I*DJ0&4D7!
M!!\Q%JL_N'(G>=XOO(C6W$^BZMNL_H"LUV&?2^U;78:U5)G>=L")L36@#)5B
M)G';**JVOG0O)=R#=58KU^T;ID#LKF"_8.R;=%L^)OG4$D\.)FYYCB6)59VQ
M(-2960`Q7B)RL,"\%=HYR6L%O39F=*FZG9\%5?+BP#D2EO:H\W##AX<;R*DD
MTA^QB,5A=S:P:L\O_&/M6]=F<>HWC#P#+?-3U.AW.U+N>0&YTX!2&V(>7+`E
MB'R>LE7CM\F$&OYP11LB5+J3H8_:\F>CI;U4_0`ZE^D=[^CCG-B6\-!KYJ11
MS$VYMM.B1;'5?5<6X7K%)MZZPAWJ/86QL#Q\N!XQ?A)-'*Y[X]B=-P_,C;A8
MC38WXVJ6]@\M/$;L'*39_'/C%H;B;:@TQK+3%NV!.;?VULRH*>V7:43,O'45
M7"UJDV%.2B8UY!KD266(W5,GV1,7M#T"U[9TST&W3;]3[UF[G'@2;OE8F.(H
M8G=HX$AD5Y59U"LRRC4%9@#P'#C53F;WU#%N^-T_C08K;NVSPYDX9W$:/)--
M"R1.!J90\)TEE4E2">)L)&XW\Y-M>DK>NB^>.O\`4/'_`&5I'6]>W>]NFN]F
MN+9I64U!87KN)4G'=DM<=79BK25<EF1DWJ<DW;IJ)J`HB)DRF,-%OG2G3\NQ
M0=1=$Y67EXC[B,&6+(A$<RY+IS(1&$9TD69+V"DLKBS`%@!4[?N^^Q=0#8.H
M,>".2?`?,QY('9U:&%UBR!(&`9'BD8$'VKH21[4DW_K;>U4V<:Z:+['HZ3K;
MP&-JML:T0P+['(2*+.'4I"/GG>6=).&.#HQV8+%*W,"@CV1`<PD;/NIGRL;P
MT_B,)&;(70VJ!58(S2BUXP'(0EK=XV[:OXW/;CB09ZSPG"RI%CAD#J4E=U9D
M2-KV=F5690I)(4D<!4/Z"Y!26R;WO73.P(6(JNWM$W-%E+Q$*\<NH>R:WN#<
M\[J[84$=^!7PM)V"$S5^D<!!K+,G*0&$G=B-RW+9(X-AP.H\!GDV_+#Q2:@-
M4.7!83PM;AI8,DT!-F:&1;C4K53Q[D5Z@R]AR0JRQI'D8Y!_#8DHTJY!XAXI
MDE@F`&D/&&4E9%JP#F=RS\4+C--2EGJW'OAG:M)3.W:1JW6DU/[HVI';!DE-
MC6&.JU5?6VOLJ$>$B?\`U9^`O/-GC@$40[104$.SF7]$=.=`]328>S[AF[I#
MU)DB74L<$30*8DEFX.9`Y!BBOQ3VYT]G&K1U3NN_['B9V]84.-+L6%#'(Q=V
M$Q#/#$UD`TDB:7AWAW!<\>%7;:@W_O+7E2L<WXCZ_$CCD_-(NU:&KK_=,Q*5
MR9K4'`*35ID)F5V;!4DS1[")('64(W*LF1H45#F+T'+#O&T].9<L4'0C;IG3
MV)F6:!%*AGCCB*B)Y"=<DF@WMWF11<M:J[;LG?D=WZ@CPX,,F-(FCD8EI6$K
M,AU@`=R/4EC<VDX`+<S#;N8/%&@4JD[(O/)/1M.U_LI!-UKRZ6?:5+@ZQ>&J
MK<SM)U4YJ2F6T?8&RC8@J`HU45()/+UZ9:H.E.I\G=9=CQ]OS9-Y@%Y(%AD,
ML8N!WXPNI>)`[P'$VJK^F]G&WKNQRL?Z+=RBR\Q>6S#5=5>^DD:6N`;BQJ1;
M5N/4E&A:W9+ILZ@5.NW%RBTJ<_8K?`0T+973B,<S+=""E9!^W8RBJ\0S5<D!
M%0XG03,<.I0$<MT>V;C+E28,6/,V;"CO)&$8NBQ_A&9;:E"7&HD=V_&U5:YF
M(^)'GI+&<*5XT20,-#-*;1*K7TDR'@@![Q[*ZO4>_M&[^A)&RZ-W!K/<%>AW
MPQDM-ZUN]<NL7&2((E<"RD'M>D9!NS==P<#]A0Q3"7R].F5.[=/[YL!C7>\/
M)PVE4LG.C>/6`;$KK`N`>!MV53;?O&T[L\D>V9,&1)"0'$;JY0L+J&"DD:AQ
M%^WR59MO[Q&=4TJ3U97=#W_2>\+38N4>L./>T:Y7]DPT[,:V:7U2PH/)22C:
ML_D7K":8+P)B)(NR)I&,!@,("&9+TST)NF[9L(W:#,Q=HR,+,GBG,3!)&Q<9
MYPJ,X"L&*@-8W`-Q5JZFZEQ-CV?.R<:2"7>L*3%5L<N`X$^7#CN64'6N@2ZN
MSVP`/"OS^4"=CSJ6X?%T??5&2%2*X5M1'>N?.26T\XF=)4P*;.39C5E*(?V:
M!H4IK0#3HN:+*@8IS1;;T3'N'14W59S((Y8YETQD2VY81N;JTPL3(DYBAU)J
M@#R:7F5K"ON]]0ML^^8>T^'DDCR0X+J4]N600Z-3K9749#GF:'80,(4D*M;)
M/F`UDU,4K7A_Q17]3S_29Q2KS?!`_-'^'[^+91?G#C%*RHXI3%*8I3%*_)R%
M.4Q#E*<ARB0Y#`!BF*8!`Q3%'J`E,`]!`<^,H92K<5(L:^@E3J'`BM8VQ1%A
MJVR[YX+T8E+!6=T\H8C<=3<H@H#:$X-VYVON3=$2B=`B:",3&7R(=U1-OVB)
M@A+$3'R"!1Z#V"7&WC;-J]:6>4?(Z8P9HLP-;X7,PPL>S:A>]Y5F@D+W9M6(
MS,"+D:TZH&3LV=NVQ8`T)U4T!Q"H_!-F%XMY=0;E^7'!D3,.Y;Q*E+!;U7Z.
MG^4/.SEQR&Y`<7]^ZQT'I;1\+(\$M8#>>/T?OB%O5=@4VCS=,K4&\A;ZA&P,
M4M;U/80[A#SHSI%@=`QBD2$#6V'.V+IGH.'$ZOQ<G/W3J:4[E,L>2<:2.!&>
M+#$CA'<\T\W*",%TNZRB^I2*K)AS,SK*'&Z8DBQ,?I2%,>-FCYT7C)@LF0$C
M8JH?'@7&QF<.X=+I93JKJ-&[)F>,'#CE!P&Y+:@)S'?<,+15JK;Z3$1BC!WL
MGA?M>4;2E?VM6]?I1]QD)%AKJ$>/$_89B995$L6FW3=)K$`^5G4<>V=;[WL7
MK#VR=MGQMSF.++,S&3P>YX2Z(VEFO$;906%^:VEF#O*R,&*U3[)'N/1XWGI;
M((W',3!DW/%C4!#EX^63XJ!$)<+R<@Y"F]P1W54:;U#\QNGBMJ4^LYKPG^?F
MU-H[ILVU-?-V7"KTLVCD;6-BP-HG8F%FZW;*/L(]@MNCJ[K^EOGA@=H.HEO#
MN&Z*3DHJE3*&0;7M'5V[[N-M]9^RXQZ8$4PR-R,4>.V.J([MEIF0Z4R))9%C
MMJYHF5G,8.IC5EW7,Z=P=@FW'I3.GPM],:>%Q09&UREAR,(X3FZ*"61E`1X5
MOK;2@6KWZ9R`U1X=_-OFQ"\N+2QTU0>5VP*9OS2N\;NDK%ZQLAD-=Q-.MVLW
M]Y,12%A;;4G]:!5LS?+-U'K9R)FY3]DV8%%MN;UWZO-IV[IQ!/O>Q/EPSXJD
M<YX<C),\.5&AL90W,:.31J,?+758=F8[EE_0W63[MN*,FT[GMF(BS6+)#/AK
M*DL,S*"(@PD1XF8A7+$<&90:TVESOI7+S0_/B!T)5I*[<?-:\7=A`'*EN]5;
MZUONR']7G0D:%K=!U#)$N;"N1!2KO9QH].Q(X/YL4IA#O!QW/Z'W'IG$V[<>
MHF&)O4^]8B183CX<XXEA8Y,@U7A4R?!QQNFJ0?"`Z;5>]HZDPMRWQMKV?_NL
M9=MR9)LA#\#$_*D5,<-8B29AJ9PI`B"E6.NZKB^X_1_@B):3TJ[N'B=;$K=R
M2UEKMS9ZVEXD^Y8%E!V4E9B%IF%3K;78+-C#M8Z4!1`&*:)$4"$[HI>R4,WE
MU5D>MF+K+<7VC8,?(P%W&?DR-M<$W,C$S<MV=HV,NM;$LQ)>]SVFM3=)8W3#
M]);<NZYLV/N)P(>=&N1)%RY#$O,0(I`CTM<!5`T6L.P&KV-W:EFN4OBC4Q'2
MG+C;G'R,7\.V"ND3L30;RD24C?JG*;B(,.@]>W6NVM@]KSQN[2>I+HH@HHH!
M![?9$<UYTSEMTST!U"V^[9CY61%U1B128V2KJL4O@\C4=*,C+(A5D"W``9@1
MP%9)O*8VY]1],0;1E.N,^P9[Q9,;:W:-<G#``=KAUD#*S,02613<7-X_Y=\1
MI/2E*/HRJ\B-R\@^;_B32T)Q;C]Y;SE8ZP3VO^/T`JI;]H.XJH4V+K$!!T>L
MU=)P>0\S;M3R#QXAWZW:Z&RHZ8ZCBZFW2&%MNP-NZ&V)GWC,A@0Z<B;'&C&6
M5Y6<N\LK1011EM(3F%%-C57O&#+TYMDV]29F9F=29*':]OUN%Y3Y^D2F+0M@
M8TCER9)6#-9%C+*I2NJMNF.6'AQ[WXO<T=^<E=9[LTW3V=6X5[%BM?\`'IEH
M9"@Z/V#(H,:399QW%WBW(S\-0K^VCA*"Z:!&:3Q93O`*)@&[;5U!TMZP6W7H
MG;MNR<3>]^9\V.67+.0'W'&5Y414:)-+Y,;2PZE)9SRTL0!:Q[EL.^=*[-@[
M\,N&;:NFE_`)!RB,*;E093:Q(1:%5BFL5))1M(U.36:+FCS+U!P;T)-;\V[)
MHIP+:0AZY6(I.081Z]NN%E6%O7H!G)2*J4;'HNC%.NY>+G!!FR157/U*3LCI
M'IWIS=NJM^@Z;V=`VZ3LU@UPJ*G&220V)5(QQ;@2395!9E!VCF;AA;=M,^^9
MC-]&8T/,9D&MF!L$6-01K>1B%100.)9BJ*S#&AQIW!QAY87O95NG.9?'C>G-
MO<>EK_K_`%SJ;3NQXNS5CC]KB0KSU]*4/5[4%DY&PRRZR23RS65=))>3<-P*
MD1NR122S8O673?4G3G2V1M&S;5N$/3$#QRYF;-`T<F;*KA(FD!N(<97;1C8]
MS8N))2\[$C%>GNH-IW7J/:MRW[)Q(MR65EQ,5)=8@+@R2DO8<_+,$1$LBJ$5
M(W6%1'<M9*_Y1:ALWA+T3PTX*>+)<YY""HG%1]QE<1<F;:\!<:]>XR/L%KFJ
MF9H608T:*K\0K-A,'`&*D>)%"*F[89G\VR;EO'KGPO6EBQ__`."G-@W5\P,O
M(BACB$LD;R`Z5F613C\HD,9K*!Q%8HV;B;%ZO=\Z1W!F7?XX-QPHH9%)DR9<
MIYDQF1!<R)*DZ3:UNJJ&+$!2:RY>+<R&$\+GD+&NEDNU%4?7$>NMV@(D91GL
M2@-3G`QQ#H0YT_)U_7S4OJYG7,]<W3^3&#IEZ@C8#RV8R$?7XUL+(QWQ.B,_
M%E_"1=/YBG^5<&4'^BIJY5\L]1<6:%JX-\H7ZMZHW`NIK.R;LK3<R%+TRM*U
M=4T=.[)M3.1;2]$B)A;JU9RR**J;5X)3*G1*`'RR[1TSF=6[SG;9MTD*[E%%
M)/'$[%'R=$@#0P<+-,`=0C8KK%U0LW=J'%W5=BZ:P=WDC>7'1<5'T)S#&'0?
M#.G:84(^$8!M`XD6K'%X5'HD@N77*FL<*]HW'?O#&3U]K^WV3;EOFG^RT"<E
M%9%S$OJU5M\6$%K/M!HK2&_G#]-P]D4HEV0J)%$@-V!V3UX=\R/5_BS=<XD.
MW]2P[M)'APHBX[283Q&3(D?%2R(%R.6L<NA3*I)N]KC#]E7;H.O2G361)E[?
M/M`;.9G,PBR(Y43#19FN5,F.TS-`I*II#60DK5`\L=9SVTN;_B$MZ+V1VAK#
MB5Q2WMJ\Z8B+Q"^Z;V!.WN%0;@D/?E&=0B7$<8`_\0CLQ1Z@/3*?HC>X>FN@
M,3?LM2VW0];-'D#AWL7)VI,?*4D\`.1*S_4T`U<NI]G_`-1]>0=-AM,N=T-D
M1QFVHKD+O#2XK@7'>3)CB(/DX\14![KV#!<K*#K+Q`6;%9G"[O\`$B\/S4FH
MC2I03?,]4ZEOJ(2J"!A-W1236WIJ>,H"8#W@LT_*;H&9MTGM$_1?56/T#,P?
M+7:.HL^<KV,9L&:'$^VL,*&*90;6\0>`K'=TW-.J>DM[ZE*VBQMDP\-`3?ES
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M!+F9YF[9.!UMU'N.#.G^I(.BH5RYHB#_`-^#@1YDBNO=+\PN&D3@7NRGL-8$
MV)AY?1N+CPQR)TKD]=QG$C<D7P6\>T2@<"(7MJC0V(B**?**ES:VH-:5G8WC
MDZAU_JZD1%)5XBZ?V$WUO6:A#HUM&])ZFNID;/&5%FS]B8^<`S)-4B[9LFIW
MR150'O`[68)!O&YY?0W3VZ[CE3ODX?68B29Y&+QPR'"EF7F$Z@A+.S7:P5F'
M!.`SX;=@P>L67`PX(D3.Z*R#)&B`+/,DV7#CED`"NXTQI'W;Z@+=XDGV4NL\
M1^36U/!DC*C"ZDV?I1IHO=LJ6N5R-@G.NGNPZE0*`6PHSE98MDH.6DHBUJK*
MOVKMNH'LB0%%BF4+US*]REZEV#J;UA9N0<B#/.'"V/(Q;6,:;=9(XWA8W*QM
M$S)&R$`(2$M6#8/T9G]`]#8"<ME^F.7EQBPODQ;0DLD>0.!:19$C>0/<LRKK
MU#@8NVS6:=K75_CS:ZU_`5ZCT*O;5XZS473JNR:0=9@I.SUC7[N<<1L(Q!&,
MAPE72!%5$T$DDS'\H%\N6_8,_<-VC]76=N<LN1F+U+DP+)(Q=^7'F8[(FHW9
M@K2/:Y)&JU7_`*AQ,/;=WZQQ,"*.#&DZ'CF=44*ID;"S5:0@6&IE103;B%'F
MJYGG5<=@\)]RQO(+44%+R_X<7'./XM*0T$F!$@Y713=!+CY=WYFJ"CDKQ:LS
M4FQ.X-Z@B$:F41`1#I:^EMLQNN8MR]6^=(D1BWGZ1BD?CR\35RMWC4$@:>2L
M>3H6S/)K;R549N:O3.U[+ZQPC2)@;8,/(C7B9EDC$VV]T]TGQW_;L[GA'.L:
M^0'*QK32,-QNX61&D(84E&^N-$24!(2)$2('G+`C4GJ]HLCPI1-VG]CL2SI\
MX.(F,=9P8PB(CUS6'K"Z@/5&];GO8!3&F,G*2]Q'`BZ((A]K%"J(/J+6<^K?
M:9MG7:\/+;7N39,4N0_EDR9IA+._E/>E=R!<V%@.`%8@-&:YN-%X$<`N>VC(
MEY/[*X_:";0VVJ'`E$S_`'QQEF5GB]WI!02$Q7UEH:Z9;'7>V4X@\9JH$_W@
M2CNGU@;KA1>LOJ/I+?B$Z=WD0(TC#\TRTQ8QB9H\NE"QAR!<:L>5B2-`K5?J
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M&NR4C"Z[.W92KR+(+<KHO=JF%8!S%,V+?]MZ-V/`ZW,R]4_ZS@EPTR&8Y4>"
M6QQ,3J)D2*3+[\8<C5[:/N6ME^TR;/E>L&?(Z953BQ])9J9KP!1CF?ER-B(P
M6RMD)C\PLPXK&P1K/JO.?(_CIH&&U_X-&LXK5-"B*+L#D=IU>[UZ,@HZ-:[`
M=*:*EW#IQ=%6:2#JXNI42"5X=^HY.]2.=-83D.8HUF#O>\/ZTNIYGR)6?!VS
M?/#@DE8.4ZF/E(;I&(V1&4*H`9%-K@5BR;?@1^IG:WCC57S<W8!.XX/,)G/-
M$D@[[<SF.#=NQV"V!KO-:\3N+<CXDWB955[H/3[RJU/COQ[E:Y1UZ-7%:56)
MBZTNWA:K#!4HS$:U!6*Q)5MB1Q(MFB+PZ;0A05`O:`<;SNI^I$]1^#GKG98S
MI.H-RC:;FOS3'#%`\<?-OS.6CRR,(]6G4U[7`MF6-L^TR>M?"Q&QH/"G98',
M811&[^-EB#O&`$=A&-"LRD@%['O->S6+WK2-9^'_`.%!7KSK'BE.0DPEM1M`
M;MYM.;*OQJTLVI3Z8A4H:09P3.4;OK[::TY,U@"O^Z;B+11,%"&/VR9K-MV7
MO?K)WG-7+SX-Q.Q8$LB800YV:<G'QGEY&LHMHY%6;(L=14J0"+UB^/)'@=$R
M01X\,V(G56=#&DNH8V-RLK,,3SA`S<L*&BC`4HKL"_8`88X]6^MRNJ_'?;5+
M:6J-I5)[I"AST9<=,:7:\>M66--O2)J'-+T77#9^^9K5UB*(L2SK=11O-J("
MZ*H?O.T-3U=AY<?371[Y^)G8N5'U/&NC+R3E3J)<C&D^%<JIB:6PE&.P!B5@
M+`<`Z=R<:3K[=4PY\.6&3I#-8C&BY42E%RD"`W/B.5<H9[GRQFS(:RKK[/U'
MISE;8MG[S<0Z>HJ3X/VOI[8J4S'MIN/?U1&[`1]&.(-RFNC-%F04!JFT.0Y'
M*BI4Q`>UF#[IC9N7M_5&)MZ,^XR]>XR0JO`\YTRUBLWV)UE;-PT^VN+7JY[)
MV]"/K$<:=(9KLY-@D:'!:1R?(J("S$>0&K2.&>R_#^Y!;D?<H&&QN%M!Y0W2
MK6>D\$.)&LE]4PUETH:9BY1&"EK>E563`EMY!WIX1!=T=0JB5=;F\Q:B)N^5
M-DW66S^L7ISI'*Z5PXMXS(FA,N[9Y,[QR1HNLXV*6)Y>)`I;7(-+9,EW>R*J
MU1;#F=&[YU5@[YN(PL79\7,C7"QW1$=I6D6,Y60`/;RFP@A:XB4J?PK7&.G2
MNO*U/ZOUIK;8W/WC3I/DC';9@WECTE'^'T-DYZU;>T?LTLR]<EO-=NB>Z+2^
MD["8SE2PD:^QCN&<BJ<"LQ$@;*?<C'OV+N_3FR[AN73*8D?)FCW(0;8V)X;E
MR131&,XT"K'KBFCD;4LH))+E2<.W3#D;`WS!WG/Q]OW.;+RU<3X?/R^8\NN"
M;'<L)978<F3'Y/>TV5>QC68:[67@]K3G)SR0\22%U^K;]G5_4R''26W=3"S[
M;8&E6>K64-*4[1"LG&R2)[839*DEYS$0XDFAD'1#E*;M$-FD]MQ^J]T]66W8
M?JZ.1](0;EN+YT6)(5G65YM6)-*5*L85Q%C1)B>2F@AR"&K:&:<'#ZVBSNJ#
M$=H;:<-,269/@4:-G\<KZP8UF>8I(0PUF(J`;`BKQ_`V+$D\-O2Z<"RDHV$1
ML6W48>,F3F/,QD8CM:WIL8Z7,<3'&48M2E2<=H>UWI3=?+EI]<;9,G56/)FR
M12YC;1@%WCMRW<XR%GCM8:&-V6W#21:J;H#P(@W8;8ACVX;_`)XB0@J4CYW<
M4JW>4JM@5;O#L/&JIV@H0/%]XHIB<@*&X:\DC%3$P=LQ2WW6(&,!>O:$H"/E
M'+9TL#_M_P!6'R`[1_>,JKEU5_C_`$G]7-W?^XXU8U5KQX>>K]M>)?6/$NBM
M6DWY?MUW:7I:>YJ>G+W+9G'F2H\7':9A>/KZ:CI%]+'9-1<L46E=4*\0DU"`
M<`5,F(92F%UQNWJ^Z=C]6)RR<?%D7)7%<J\>Z')D:2;)"$$1N.2\<DMXA$C=
MB!KR<J;8\+U@9^7U<(!MTF-AG'DR$U0>#3&59XT+`KS%EYW/1")'=KJ"QX4O
M2(FKZD4\"BV\VH>JUJ>&K;HHSNS[OA(5W+LGSZO-WO'VEV:>G(]PLWM$=%JL
M$XMNY4*NT?EZ%["X&',WS)IMRZRZ^PNC7>7-EVK!94Q&(YV7'D8ZYLD(1AK;
M7SC(R7U(6XE&XZV$,6-T5TQG;K%)'T]C]0YI_P"Y&KD;=+!G-BKD%@0L141%
M%:RBT5P&06LBYW;_`-1;!U]X@->7C^`/%^_M-C;<BT]73FEY[?/B"[DG8L9*
M!DI"5)/$C2:YBKTDBUF8FR0YWZ43'%(M_J$DE#G=$[/NF#A=-9^))O>XXG)A
ME'A\A<7;,)3+SB)95NQEQ7#K/%*JK*Y*7;4BUF6^Y>$>I=XP\Q-NQ6&F(S94
M)R<C(;D1!6@@X1O%+$>7&$)>.VHIJ!9<RO&V:]G>9/AJRBT@A(.9/PHIMX9V
MDZ3=`\[4UJD#N2+$44!P4QOFG`1`1_5S%^I,?PR>L2$*55=[P>!%K7R<T]GD
MJP].3&?9O5]([:F,&Y<;WO;#PQV^6PX5RN8FE+KOGQ6]'4RA<D]O<8IIGPCV
ME-KW32PTX;1+L$-O4UN>OORW6NV>-]AE5EBK&$C<%>]2)T.`=<L7J_W+&VCU
M>]2Y^7A8^?CKN>U*89]?+NT6;9^XRMJ6Q"]X"S&]ZRGK.!\OJGIG#BD>"9X=
MW(E2VM0HP"56]UL]QJN">Z+6XU+\AP1B^.NG^6V\+[O[>/*/>5@XP[.H*.T]
M[SL$\?577C2L3<T%1J=>JD'6ZI`,GDN`.7KA%H#EZ=-/OCF!,N8UO_7+[KM<
M>P[5M^#M6TG,BGE3&5P9IE(2-Y'D=W/+0D1H"%4EF`N;UE73/3;0=28NY;CF
M9.=D0ZD@$I73`LN@RZ%15!:0QK=VU,!W5(7A6,7D7HAA4?!NX/26EZM2M<46
M=E>*UTY97EIJ%ML]K(:[;0"TDM=]P4V+5C9[;]2KEUDF3V1:/'ATRLP.)Q!N
M0Y<W*V]ZOX@\Z#?)V,$#[@F"CR\J*+,>,)"(V:\>.\BB1$ET$B=HWXO8UJOI
M[`$GJ/FRMOA,F[Y.%"96C75/+",Q'G%Q9Y%6/4S1ZN,09``O"NYX3:[U1<=Y
M;TM-5Y_:5Y`P$CP_V10]LU_@=PO-I^H)5&7*\-%SL[;M5V"V4*4VS5U7+I2%
MC3-SV!9)?LID,B8I1MO7&7GXW0\^#N.Q[A@P2;IBR12[CN!R"L\9[W)AF19'
MB>.RY)1N2$XR6-S5RZ9A0];[5EX&Y8<V7CQSDP8N((6>-Q'I&1)&UHE650T`
ME`+2!PG$-:&>#%SUKJ7E3Q`U;JB[\$>>,`,TWH]-M^G-,O='\U^-E>"BR\1-
MVG=,%5F3IA)14?%,4&]A=VMVG).)550GFR#CKUR7J2+=M^V3>]PW2#>-DRGP
M9Y9I?$+D[1ED-%+'#%J.E!-,ML1,8,NG2W,9!IJPHNW;/E;>NWR8>X1?2L83
M&F@,.Y0F225&F4@!W./'*QR3*$4*-.CO@B3*_:O#4HM(YTZU\16HUJ0Y?7'D
MGNZ6GZI/5,RW*3;L%+VD3Z$=\;9<[-K:)DSBH(Q+6`5KCQ--FY0["QTSD5',
M7CAZ\S]MZ3RO5H\YV?$VS#5A!)IAQ\Y'U9ISAJ"H#.6EE;('+>$EA>,UFF:^
MPX?4G4#=:C'"32L87G0M&^W''"01P7!NR_"QE8N_SS[HJ1?II#5.I-G^)S?)
M^\ZL2FG](X(<3I*D0>YXR-MESU^Y>3]N527F499:=:-]AQY8Y%)Q(D45=IN"
M*@1?U9Q-C^7N>[[5T!N[X>6JY+]92QO-B$QQN&P5,@A90A$$C*IT`*K*J76R
MK:C\'MVX]1=-XL^._P!')TA(\<&2`[+IW#EQF526#2*C,+DL1J/V58L-F/-5
M-^(W'AYNF-=S^H$?&?WX.RHV-:R4F=W4_;SM(DX1\Q@Q&4?0R38QCR:*0&%2
M/*N4Q3%$Q1R[I3Q0ZIZ?\$T<>=_MT>4TE@BRB!S"Q+=P:90C*S=U6`9K`7JA
MZN4OT_UM&JR/&>NH!(L=];1&;&$R*%(8EH2ZZ5[[@Z4[S`5>+4FO$[?'++DG
M9>!]1UE;N-ZWA]["IG(>8U%4XP-#WC;QY=&2T_7$8^.BD:):+W68)K(J+"Q2
M579D6(5R)5#)AF);R.KMD]5^=%US)EQ;L^]XDNVKD.QR4Y<,WC)XM3&6.(DP
M#7P5Y%!0DJ2+_M+].9_K'V)>G$@?EXV2N>T(40^&F>`8\&0H`5W=^<Z*P)6+
M6&LK@5'/%6V:4LNI_`?2TY(T)T->V];:SLAM2VT4P4C-M1O&VW%M\9;6D<W:
MJ%NR#CH+_P`Y*+LQO5'$>H#F<=88^\+ZQ.L<C(YO@LCI;-DPW8EHW@,^&`T)
MN5,/,U>T[NJ_EO6O^GO#Q>K39<%PJ;OC=6[;'EH0!*DVG.95G'MN9RBA77QT
M%;<+5#2-L\/NK<3^;&E^7U9HSWQ$K+MODDL_J5HI:C[D_L;9%EN4NMHRR:9>
MN(UW=IJ#5CBP@Q3F"<"Q;$:*]KL]A;K;),7KK<9^EL_U9ODITOCX.VJ##)HA
MQY8]!SQFV(1&YAF>0Y`[R.MB1I`S6>;IC!W[J1NOUA(ER\AP9D++-@/'IQ4Q
M;AK@I\'&L7%9>)`%JOBUSH"N[7\0;B%"\N]>U?:6S=;^%-5I&?BME1,3;V[#
M9;FXP%?M\M)1,JW>1,E,E5.Y1,NHDH!%3G.3H80,%LS]\3;]FZXS>C)FQ]JR
M.J<9(WA)2^.RYDBK&P(9$;0A`!!*@+V7!LN)M^3D)T)M_4B.^2FT;A(T<Q#-
MK3P:IS?(\D:2,K7N-99N)L1=-X245!U.M<TM>U&-C8"D4+GGR"A*C5H5(K:%
MK$6K)1<@I#Q#!,PH1L>D[=*'(W2`B27;$"E`/)F']>Y.5N/3W2VZ[A(\VX3;
M'I>1R6=Q#E9$4>ICQ8JBA=1))`XDGC66[+!CX77/5&!AHD6&F?BN(T`5%>;!
MQY9"%'!=;L6-@!<\!:PJL_#&`[>'YE1TV!PO['GAR*-?!7[7G2KJ0F(R2JBZ
M@''M]PK0W<9W`]`**(%[/DRDZS#GIOI-X_S'_3J!!YF7*REG!^VYP>X/$7XU
M4;4%7K;JD6(=MU@<7N+Q-M^'R66__3*"RVX<"!V&O7I(Y!\5CG&F!RBH3CWQ
M4,8@&`3E*938?9$Q>O:`#=/)U^;D0!_V?0^3_5,_]PQ:EYY'^YV&/+_I/_\`
MZF35FUGX;:TY>>*3SF97N^[XHSZGZ1XNI0KW1^\]@Z>6*I.1%][3J=:T::B4
M+&JT5;$.V!\59-/H8`+T.;,CV3J/<>FO4]CY6W1XCR3=29R'Q&/'D*-.-AD%
M5E#!3Q.HBQ(L+\*MN\8.-NGK/BQ,PR<A.FL:2T<C1.U\_-4@NA#:2!P'8#<@
M7JF_#^::&X+V/F[QCY<`T0V_1*JXV1=N3&Y;3-VJ;Y=<3"(R"4!=9-_<Y&8.
M1+7Y)-2`DH-DNJV0<F(*:1>_`@577V=G=>]([9U#T]&%V<9/AI]MQ8E48>Y2
M6"LBQJK/XX!9(97&H'X,M<`F'IK;5Z3ZVGV_-F>7-R<838>?.YN^)%<RX[,[
M%$;#MKF"V5T/,(TIW8V\+V#:::Y05&3Y$U>[UFM;YU[:&?A5K;6G/9@FJ-!!
M9):SS&A`0=,&A*9M.PUMS'3#5NH=1ZXKB23+O.TU41S(NNI<O<>E,O:,">";
MK+`.,_4/('>RS%"D,<ZN">;%ARAXLP@:3E/X@@JP<V/:3AQ;]B[TD4L7J_RL
MC)3:E8@0XV0\A9W,8%HEW!!KV_4W<@1H1WWTC)/5$S.?&2V\Z@TG(L8W@7K"
M/OKE'_\`9_L^]W%:WM-:.Q\I?9,D(F]4(7R'!`_4?4B&:SQ#(OJ>R^<1X=^J
M(^2/+S%P/^X8#S:6QP3V7%NV]9KO)1NN=D3'MXQ-GSVF\_(;)@$-_.O.672!
MY0Y[+UV/BQJ$3X]:H%0Y"`/,7B64!.8"@)C;EKH%*`F$`$QA^8'ZN4_JI!/K
M'VL#M_[O^X951=?\/5OU`3V>`B_O^'5'>(S0Z/LWDOX8=*V+7(6X5.5Y'["7
MD*O8FB$C!S)XO2UKD&K:4B795&<NQ(Y0(=1LN11!4"]#D,7R94^K/*R</*W[
M*Q&9,A.F,IE8=JD9.'9E/V+*>*L.*M8J00#4OKZ-)NF\#'FXP2]4;:CCR,K1
MYMT/G5K6(\HX'A6)OG-3V-#\1[:@;3Y"\2^&^ISZ%TS7.,\IRGXC4C>&HI:B
M0;)\E>*+JN1MUBJ]'UW-0UT[UP\B6R0OGK91)4.B"0`.Q>@,YMR]7DRIB[CN
M_4;;S/)G1XN9)CY;*Z*N+.[(KS3P\H&.]PL<Q<F[N2,?ZQPAC=0[6L!Q\+98
M]I=(G?'67&2?Q3O+&$[L<4[(8WUFQ:,*H-K"JF:Z%UM-<1_"NTS;]CM^4VE;
M5XBWG4#*3VG;/I.ISE)<1^S+)&5"NZVN4A(RQ=<Q<PT4)&=%CLG<;V"(`+;L
M=:Y]ZW)/6CF;F,-]LW_%Z+S-8;(3*G$L./&(YIW50!D!!%K5UUJR`N-1-6.7
M!QV]6N=`N8F;M>7UA@$&*)L>`1S9.F6''&HAL=V,I5XCRW$C!#PN9HW7J1>@
M\IO%(U?Q!HL3KRVWCPRJ9.0--U!#QU./+WY.;O<)'2,-"P*<?&MK.ZBEE&J*
MZ2*:BBAB]3";RY@^T;N=UZ%Q9^L9ILS9<+K7!YG.9Y=&++"),Q+F[E'2.[(#
MQMW16P)MOQ]LZ]VP[''C8NYY?3&Y6;2JJT\65&N(T@`L1$[\"0;!B/+5J%XO
MOA?VJ#\*NO\`$VMZT:[VH?)KCQ$6UM0*82MW[6C4L*]C+K7.0#DD6QEF,[)V
M5H1%)C.JG?N9-`RR`&*DL?-G8&)ZQ5Z]WG<]WFF?I+*P=TY;M)KQ<A?#R28X
MPP"8V98[/>$#1")%<C4`=6[H_3<'JM&W3QHG54,VW"1'0C*3(7-A7)DE+?"!
M&8RJ7<F-W=`MV*6VT!I]2-(C,#5JX,L,N%@&4&$C!D1GRQ:4&6<%Z+7SD9<L
M(B1F#GM=\#4A4NUW8`7.54RLF-!''(ZQA&0`,0`CMK=;7MI=N\R]C-Q()XUO
M:2&*4ZI55FNAX@'C'JY9X^5-;Z#]CJ;3;4;U'DBIE,4K7A_Q17]3S_29Q2KS
M?!`_-'^'[^+91?G#C%*RHXI3%*8I3%*8I73GKT`I.(V92#ASV1O'JQ*%A/&,
MC3B$4NJ5=:-1EC("_3CUER`<R)5`3,<`$0ZADQ9IE@?&5V&-(060$Z6(%@67
ML)`X`D7`J!HHW=)753+'?22`2M^W2>T7\MNVO;$0D-7V01L#$1D)'`NZ=`PB
M&#6-9`Y>N%';UP#5FDB@"[MTL=54_9[2BAA,81$1'/LLTT[!IW9V"A06))"J
M`%47[`H``'8``!PHD<<98QJ%+,6-@!=CVL?.3Y2>)\M?A.!@DIIQ9$H6)3L3
MM@C%.YY..9DFG46V6.X;QKB4*B#Y9@@NH8Y$3*"F0YA$``1$<<^;D>%UMX4O
MKT7.G7;3JT]FK2`NJU[<+VH8XVE$Y53.J:0UAJ"WU:0>T+JXV[+\>VJ;@=7Z
MTJLNM8*QKNBUR><$<)+S<#4H"'EUTWBA57::TE'Q[=XH1TJ0#*`8X@<P`)NH
MAE1)N6XRX_A)9YFQ1;N%V*=WVO=)MP\G#AY*E^%Q>?XKEQ^)))UZ1JN;W.JU
M[FYN;W-S?MKN;+4:I=(\D3<:Q7K9%)N4WJ<9986-G8\CQ$BJ:3LC*4;.FQ7*
M2:QRE4`O:*4Y@`>@CDB#(GQ91/BN\<X!&I25:QM<7!!L;"X\MA4UT26,Q2`-
M$W:"+@V((N#P-B`>/E`-?IC5*O%U\M3C:W`1U5*U<,BUIC#QS2OE9.S*G=M"
MPS=NG'`U='7.*B?=]@XG,(@/4<3Y.1DS>(R9'DR.'>9BS=VP7O$D]T``<>%A
M;LJ&"&'%3E8R+''WN"@*.\26X"P[Q)+><DW[:H'\'W0O3IZ$=1=.G3IZ-J9T
MZ?K=/87YF5_T[O=[^,RK_C9/OJIOHW;^SD0V_P"1?14A,ZU7(]ZVDF$!",9%
MG$(U]H_9Q3%L]:P+8Y5&\(V=(H$70B$%"`8C8I@1*8`$"@.4+Y63(KK)([+)
M)K<%B0S\1K;CWFL3WC<\3QXU/7'@3041`8T*I8`:5-B57AW5)`)`L#8>:O>X
M@X5Y*1TX[AXMU-0Z3Q")F'$>T7E(M&1(1.01CI!5$SMBD^33*58J1R@J!0`W
M4`#(4FFCC>*-V6*4`.`2`X4W4,!P;23<7O8\1QJ-T20J7`8H25N+Z218E?,2
M.!(XD<.RDU!PEDC'4+8H>+GX=Z4A'L3-1[24C'9$U"*D*Z8/D5VK@I%4RF`#
MD$`,4!^:&?(9I<>9<B!F2=&NK*2&4CL*D6(/U0;U]=$EC:*0!HG4AE(N&![0
M0>!!\H/"NOL=-I]QCD8>W52MVJ);K).6\78X*+G(Y!PB0R:+A%E)M739)9),
MYBE.4H&*41`!Z#D<.5DXTWB,>1X\BQ&I6*M8]HU`@\;<>/'RU"\,4D/AY%5H
M.'=(!7N]G#LX>3AP\E=#7]1ZIJ4FE-U76.O:S,H)JI(2]?I=;AI-%)P04ETT
MG\;&MG2::R8B4X`<`,4>@^3*F;=MUR(F@R,G(>%K75I'938W%P20;$`B_E%Z
MD+@8"2+*D$(E0W5@B@@D$$@VN+@D</(2/+7<$HE(3M![PG3:J2Z*(BW4MY*]
M$%M"C<6Y6@H'L`,PECHBU("79%;L]V`%Z=`Z9(7-S$Q3@I+*,)C<QAF"$WU7
M*7TDZN-[=O'MJ:V/`\PR'1#D`6#$`L+"W!K7'#AV]G"NYEH>)GX]S$3L7'34
M4\*0CR,EF3:1CW14U"+)E<LGB2S9<I%DRG`#%$`,4!#R@&28I9()5GA9DF0W
M5E)#*1Y01Q!^J.-36`92C"Z,""#V$$6((\H(X$=A'"OQ+P<+8(IU!3T1%S<(
M^1*W>P\O'M)**>-RF(<J#J/>)+-'")3IE$"G()0$H#T\F$DDCD$T;,LRFX8$
M@@^<$<0?J]M`JA.6`.7I*V\FDBQ%O,1P([+<*XU=K%9J$82$J5>@JO#I*K+I
MQ%=B8^$C$EW)^\76(PC&[9J15<_JCF`@"8?*/7)N3E969()<N2264"UW8L;#
ML%V)-AYJEPP08ZE<=$12;D*`H)L!<VMQL`+^8#S5R"0,&G*/9Q.&BDYJ29H1
MTC,$CF991_'MA.9LQ>R!40=NF;<RAA(D<YB$$P]`#KDHRR&`XI9O#%M12YTE
MK:=6GLOIX7M>W#LJ/2HF7)`'B%72K?9!;ZM(;M`U=ZP-K\>VNL)2*6G$1D`G
M4*N2"A7[>5AH4D!%%B(F4:.CO6LE&1I6@,V#]L]4,LFLD0BA%3"<!`PB.3SG
M9IR#E&:7Q10J7UMK*E=!75>^DKW2+VT\.SA4I<;&6%L=8T&.Q)*A1I-SJ-UM
M8W;B;CB>/;7KLU$HMR4CEKE3:G:E8A4ZT2K9J]#SBD6LH9(YU8Y259NC,E3F
M0((F2$HB)"C^H&?,7,S,)V?"EEAD8`$HS*2!V`E2+@7-K^>HIX8<F,19*+)$
M"2`P#`$BQ(!N+D<#YQ7<NX6&D'<7(/XF,?/X159Q"OG;!JY=Q"[A`S9PO%N5
MDCK,%5VQA3.9(Q!,F(E$1#R9*266+5RV9=:Z6L2-2W!*M;M%P#8\+@&HFBB=
M51E4HK!E!`(#`$`@>0@$@$<0";=M>H*]`%?2DH6#ARR4XU08S<B$8R!],,FR
M9T6S.4=@AYQ(-6Z*IB$35,<A"F$```$<&64P^'+,<?46TW.G418G3V7(`!-K
MV%JB"J)AD`#Q"KI#?9!;ZK!NT#5WK7M?CVUU</0J-7BQ98"F5.#+!@_"$+#U
MV'C"PX2HE-*!%@R9H!'A)&(`N.Y['?"`=OKTR=+G9LY9III79T56+.QU*INJ
MFYXJIXJ#P!XCC4A,7%C4+''&JK(7`"@`.PTEQ8<&*\"W:1P)M7(<4VH.RSA7
M55K;DMG4;*V4KB#C%BV%5D0B;-2<!1J8)91H1,I4A<=X*8%`"].@9+3)R(Q&
M$D=1$Q9+,1H8D$LO'NL2`218D@>:ICQ1.SLZJ6D30Q(!+)8C0WG6Q(TGA8GA
MQJTB_P#$>T;5Y1ZXW5L3><M8-):<<M;?J_C`EK^IQE<@=O-()[76^R9C834_
MMKL_L>QE'*K*+<I@V9NU05(8>P4N91LO4\&Q[+G8N-AJW4>:CP^-,CZX\670
M984A_!ZY"FDS^WY;,GE)-HWC:'W>3$@,QBV.!XY)<944KD30N[PL[^V6.,LA
MY(!1GB1SQ'"]A5)-9-1%9,BJ*I#I*I*D*HFJFH42'34(<!*<ARB("`@("`YB
M!`(L>RKXK,K!E)#`W!':#7!CHB)AXUM#1,9'1<.S0\U:14<R;,HUJUZ"'FS9
MBV22:H(=##Z@I`+Y?F9-GFFR9#+DNTDK=K,2Q/"W$FY/#AQ\E2H8HL9!'CJL
M<:G@%`4"YN;`6`XF_P#+QKJ0I%,"MJTT*C6`J"Z:J*]4"`B@K:R*ZXN5DE8/
MS3V+436<B*ABBD(&/ZH?+Y<F-EY3S+DO)(<A-.ERQ++IX+9KW&D`!;'A;A18
M8E5T55"2%BP`%F+WUEAY2USJO[:YO>]>6%*IL575*A%U*LQM352<HJU=A`Q3
M.NJHO3G4>)*0C=HG&G2=J*&,J44A!03")NHB.)\O+RIAD9,LDF0+69F+,-/M
M;,22-/DX\/)7R&"'&4ICHL:->X4!0;BQN!:]QP/G'`\*YKFN5YY[#`\@89T%
M<<).J]YS%L5_8)TW0%L@YAN]0-[%N$6QA3(=#L&*0>R`]/)D(R<@2/,)'$T@
M8,VHW8-[8,;W(;[('M\M.1#R5Q]"^'4J0MAI!3VA"]@*_8V'=\EJ_:4!!(24
MG,HPL2C+S3=LTF)5*-9IR4LT9$439M9-\1$'3]NT36.5(BICE3`P@4``1R$R
MRF`8Q9CC!BP2YTAFL&8+V7(`N;7-A>HPJB43@#GA=(;[(`&X`/;:_&W9?CVU
MTC[7>OY2NMJA)4:G2-39K$<-*P^K,*[KK5=,ZJB:[:%<,E(U!8BBQS`8J0&`
MQS#UZB.35S<Q,@922RC*46#AF#@6TV#7N!I[MK]G#LJ#D0<MH="<ER2RV%F)
M;421V$EN\2?LN/;7AMKG7K-NZ:,Z)36K5]#-ZX];-JO"(-WE?:"<6L$Z128E
M3<0S85#"FU.`H$$P]"AU'(I,_.F_"S3-\().+L?A```_$^W`4`-[8``7L!4$
M>+BPL&BCC5A&T8(4`A&)9DX#VC,S,R]A))(N37+D*12Y8KDDK4:Q)D>0Z5>>
M$D("*>E=P"*I5T8-R5RT4!>'27*!RMC=42G`!`O7(!EY2DLLL@9I!(3J/&0=
MCGCQ<7-F]L/(:C$,("J$72D9118=U&`#(OF5@`"HX$`7%4S$Z5TU`R3.8@]3
M:RAIB.6*ZCY2)H=5CI)@X)U`CAF]9Q2+IJL3KY#D,4P?KY5/O.\2(T<F7DM&
MP((,KD$'M!!:Q!\H/`U(&W;>&#""$,I!!T+<$<01PX$'L/DKO_:!0_;2-W"E
M5'VZ]GL#;_:W#>VGL>;>9]@9_P`S]ENSYG_JNG?=.Z]3^Q\F4Z9N;'C'"CFE
M7#:]XPS!#<ZC=0=)NW$\.)X]M39,;&EF&1+&C9"VLQ4%A86%B1<6'`<>`X"N
M7-TZHV5Y$2%CJU<L#^ON@?0+Z;@XR5>0CT#IJ`\B'+]JNM&N@41(;O$3$/U*
M`]?(&00963BESBR/&9$*-I8KJ4]JM8BZFYN#P-^RHYHHLA!%.JO&&U`,`0&[
M+@&XO;R]M=C$PL/`,B1D%$QL+')J+K)Q\2Q:QK)-5TL=PY5(T9I(H%4<.%#*
M',!>ISF$P]1$1R"2664@RLS%5"BY)LJBP`OV`#@!V`<!42HB%B@`+L6:PM=F
MXECYV)XDGB?+12&AUI5K.K1,:K.,FCB/93*C%J>5:,'9TU7;)K(F2%VW:.E$
M2&43(<"',0!$!$`PLLJ1M$C,(GMJ`)`;3<KJ'8=))(OV7-J,B.RLX!9"2I(N
M5+`!BOFN``;=H`!KI)Z@T6U247,V>E5*QR\(8AX65GJY#S$E$&37(Z(:+?2#
M-PZ8&(Z3*H`I&((*%`WS0`<G8V=FX>H8<TL0<6;0[+JM<<=)%^!/;YSYZESX
M^/E*$R8TD07L&4,!>U[`@VO87\]AYJYT]5*O:B,4[/6X"QIQ;Y*3C$YZ'CI@
MD=)(>5"08DD&[@K1\B/[!5/LJ%_4')>/DY&))SL61XYK$:D8J;'M%P0;'RCR
MU%-%%D1&"=5>!B"58`J2.PD&X-KFWFO73/-8ZVD9Y>TR&O:._L[I$[=S8WE3
M@74\X;JM#,%$%Y==@>06148F%$Q3*"44A$@AV?)DR/.S8L<X<4TJXC7N@=@A
MN;FZ@V-SQ/#B:^/!#),N3(BMD);2Q`++I[+,>(MY+'AY*[AC4ZM%K1;B,K5?
MCG$)%#!0J[&&CFBT1"&,F<T-%JMVR9X^*$Z)!%ND)$>I`'L^0,^29F7,9&EE
MD9IB#)=F.LB]B]SWB+FQ-R+FU0IC8T:QI'&BI%?0`H`34`&T`#NW``-K7`%Z
MYIH6&/+I3YXF,//-V*L8A-F8-32Z,:NL1PO'I20I"\38K+IE.9(#@F8Y0$0Z
M@`Y*6:5(FA1F$+D%E!(5BM])(["5N;$]ES;MJ8T<;NLCJID2^DD`E=5M6D]H
MU6%[=MA?LKF.FK5\V<,GK9!XS=H*MG;1TBFX;.6RY#)K-W""I3I+(+)F$IB&
M`2F*(@(=,EU,!*FZFQKB(P\0WB20+>*C4(--C[&)PR+%JE$IQO<^;>QY(XB1
M696/FX]WW0$[OL>IZ=/)D<LLD\AFG9GE8W+,223YR3Q)^K4N&./'01P*$C7L
M"@`#^0"UOK5U56I%,H[1PPI51K%/8NUP<NF=6@(JOM'+DJ94BN'#>):-$5ER
MI%`H',`F`H`'7ID_)SLW-(.9-+,5O;6[-:_;;43:_EMVU+AQ<7&);'CCC+6O
MI4+>U[7L!>US:_9<UQH/7M!K$M(S]:H]/KT[,`L$M-0=9A8F6E`<.`=N`D9)
M@R;O'H+NP[T_>G-VE/5#U'RXDSLV7'7$EFE;$2VE"[%%TBRV4FPL"0+#@#84
M\-C>(.7RT\4U[OI&LZC=KM:YU$`GCQ(XU[92AT>;GHRTS5,JDO9X3NO8:QRE
M=B'\]$=PJ9='V,EW;-608=RL<3E[I0G9,(B'ESY!FYF+&\.-++'#*+.JLRA[
MBQU`$!N'#C?AP[*BE@@G*M.B.4]KJ`.GC?NW[./'AY>-=RG#1",HZG$8J-2F
MWK1NP>S";%JG*.V+0ZBC5FZD"I`[<-&RBQS)IG.)""81``$1R5S91%R`S<@M
MJTW.G5:VJW9JMPOVVX=E1E$:02L`954J&MQ"DZBH/:%)XD=E^/;5JO(+B-6]
MXRW'A^PFF6OV6A=_1^^5(>'J4:\8W:0;0MAB)"$D4B/(M&/&9/8#K.'G=N5#
MF((&3-VQ$,@Z=ZCFV'.ES)$.0)-KRL(*SD!$R8C%=39N$=[A``#V7%6O?=J7
M>=GDVI'Y#R;AB9;2*+L7Q)UGX\5NTF@*7)NO;QM:KG*[4JK4(T\-4JS7ZO$*
M+KNCQ5=AHZ$C3NG/3SER=C&MFS4R[CLAVSB7M'Z>41RQ9.5E9C!\N225PND%
MV+$*/("Q/#B>'95QA@AQR3CHL9)N=("W/G-K7/U:Z^,U[087S,(:CT^)".E'
M<Y'A&5F%8>8S3]$[=],,_-627FTH]04,15P3LJJ$,)3&$!$,C;.SG`#S2D"+
MEB[L;1W!Y?;[2X!T^UN!PJ'PV-=CRTNTHD;NCC(+@2'AQ<`D!CWA<\:]CZA4
M:4L;&X25+J<C;8LJ1(RTOJY#N[''$0[WN2L9MPS4DVA4>_/V035*!>V;I\T<
M^0YN9CPOCX\LJ8\E]:JS*K7`!U*"`UP`#<'@`/)7V7'@G97G1'=+:2P!*V.H
M:21PLQU"WEX]M=U["PXRX3XQ,:,\#`8L)OS%K[+A&"N#D8X)+NO/`8"Y#O.Y
M[?=]OU73KY<E"658FA5F$+,"5N=)(!`)'82`2`3Q`)MVU,9$=UD<`R("%)%R
MH:VH`]H!L+V[;"_97B-A(:%%\,/$1D2,H^7E),8U@T8C(R;GL^<R+X6J27G;
MYQV0[:RG:4/T#J(X>661$CD9FCC%E!)(47)LH\@N2;#A<DU\$:"1I0`)7(+&
MW%B!8%CVFP``OV`6[*M?D^+BC7<&TMO:XV7.ZR?[@KE0]N<1!1;5TU?;,UTX
M20I6QC&7>)-G)3U@5(>=BEVZK>;8D;=I1!1N!SU>=N$^=TG_`*89G22#-.1B
MS*UCC\Q?^XAT6TRPS2+'*48C2XEL3SCINO3F9@;)UGC=4Y^#C;CAC"DP\S%F
M!T9>.Q)B*R*0^-E8W,E\/E1ZF0.HT$1@'\)<<]BL91W/Q?(^YM;"X1:C[,+T
M^E.W+MX_.L6U>SYC1Z2MAA")NEE*S&KJ>:5=PL/=`Y;D1;)89]$;V(N2F[97
M*5BZJ50J'<6E8K:S7`^"!X0\`-2!5&X/]S_5U+)KRN@]E;4G*<I/E1R<B#O8
M4<4@8M"ZM8;A,MWW%!=N1.\L\GA#C3<VLB_?->1&PVQI5%K6)-\C#U9*SOM=
M1Z1U8Z)=VY-@6;>W]D^,*9+0X46=ECSG2*@#DWG@/H;=^2,7Z5S/!!B`G=X(
M0+D'X\D`'(]N4&DC59P_W4Z%,WT@>A>G_I?3S>9JGT'-U'O&'5H^C=+,XVI=
M,`R").9R;XQZN<XJ6BV.1D;=O6<L<LZ8.4)-]):ZUPZ37<,5D3U=G',GL*\1
MAJ:4&Z2T_!HCYG8GB)55!;D.X17FP;?U%C<8-YS8V9E=M`5`9(S>%@J\%"6!
M=1PD8`W4%@T$WK+]6TJB`]!;(^)&#%$LF1ER,N/D*1G+)(SAIIY+LF)E/W\*
M%B@6=DADB[!WQLO[LT2Y5Y#6AX_K3Q&QU12:HU&G6$!=)!)5E:)AM&R$>H`0
MOL<X5)7XM-5%&O*.%!(HY2*W10A3;-_A=YH-WRUG=6N;*=1D/PP<?9Q-:Z1,
M=,;<>_I0+]?UE^K6>)</*Z"V9MON(V5,C*C;P^/QPEC=6^"RD8#QF8$,F:B*
MNF!VFDFK'1''YOIV:V_=YJUN]A;-W;>AMUVN[^*0A%%(F'8)5^@TZ-B6KMZU
MCX2E5=JFW3`AP\Y=JN'(E(*_=DSS/WELO:-OV.!.7M^!"U@3J:6>5M>1D.=*
M]Z5@H5`-,<21QK?26;0(P5.^9V^R6Y^4R+&@!TX^-$MHL:/4S$JK&25W8ZY)
M979_):>)2&B)M!)K-14;+M4';5^BVE&+6001?,5BN&3U)%VDJFF[9KD`Z2@`
M!TS@`E$!#KEHBEE@D$T+,DJWLRD@BX(-B.(N"0?J$BJQT26-HI0&B8692+@B
MX-B#P(N`>/E`/DH\AHB1=1KZ0BHU^^AG"CN'>/&+5TZBG2R)VRSF-<+I'68N
M%6ZADS'2$AC$,)1'H/3/D<LL6KE,RZU*M8D74V)4V[5)`)!X<!YJ.B2*%D`9
M0P8`BX#"]F%^QA<V/:+FW;74VFCTN\-FK.ZU"KW!FR7,Z9-+3`1-@;-')DS(
MF<M4)9H[2;KF2,)1.0`,)1$.O3)F-E96'(9<222*4BVI&*FUP;74@VN`;=EP
M/-4,L44\?*G57BN#9@"+@$`V/"X!(!\Q/GKL'%=K[LD.FZ@X=RG7G"#N`(XC
M&2Q(-TU0,U:N8<JB!BQCALU.9-,Z/8,1,1*`@`],^#)R!*\XD?G2!@S:CJ8/
M[8,;W(;[('VWEO7SD0\E<;0OAU*D+8:1H]I9>P:?L;#N^2U>Q.$A4I=Q8$HB
M+3GG;)&-=3:;!H27<QS=0RS=@XDBI`\69(+',<B1CB0IA$0`!'(1+*(C`&;D
MEM16YTE@+!B.RX'"_;;A4;(C.LK`&15*J2.(!()`/:`2`2!P)`)JGD-:ZZ:N
MWC]K0:4V?2,PUL4@]0JL$B[?6!D9P9E.O'";`JSJ8:&=JBDZ.)ETQ5/V3!VA
MZSQGYRQQQ+-*(HE94&MK(&%F"B]E##@P%@1P/"I3XV-*[R2QHTDEM9*@EK$,
M-1(NUF`(O>Q`(X@56N4E3Z8I3%*UX?\`%%?U//\`29Q2KS?!`_-'^'[^+91?
MG#C%*RHXI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I6-OG+1K+L#<G#*+I
M%LD:;>X*Z;=O%$EFC]VUC5+?4=;'D(F*M#)LJF2:J,^0RL=)M5`,!F3M0Q.R
MH4ARYOT1N"[7]+YLD*9..NTE9(F`(>.3*Q8I`"?:R!7+1..,<JH]B%TFS=28
ML>=M6-@R2-!S=XQ@)5OJB=<?-DCD`!&K1(BLT9.F5`T;=UC5BNN.3%JO6]]_
M)5NWS6C?2YRXT%H_;M@=(1SFQ:3G('C#*RMKIT`K<(R6J$7/SEZJR$/'23QB
MY:.DI%)PB@JHLD&9[+TW@Q=+[.IMEX$>#O>?B?8G,09L(@5PIUC1$\DL\*L)
M%\/+&&4`N,7R-TS8M^W&255BW./#V7&F`NRP--D9$<LJ>0AD=#"[`J.;$T@+
M*8ZGS36XMZ;@WMJ[4SW?]H1I5<;\J!=W6EP.NFLAO*/T;N&@U"DS\S(25-G(
M=)![%2[IK*JP*+-L^6!0Z`MS"7N\<W+`VC;NE\_J?P$0W'Z,VV=<=VFY>-+F
M)G"6R\P2E6$4<T*2N63N79TN'JY\C.&9B['!F2/C'=LC'.0!&97CBPH<GE%M
M')YD$SM!*Z1C5H8%4>]K?X3<'+N3H<;='?+>YE=V#A#NWE0X8LZ)J!&/C;KJ
M>WM6E,@H4%J(NNE2Y&&=@WL#=PHX<OU2]ZU<L>O9"_9NV],;=E28J[7#(,;=
M-DQ@7DGNXW%#XOF6D%Q<$XVC08KC7S@*K&Q]SSMSC1<Z6''S-SW7#THD7P*8
MLDBXTD19&/,31\-S.8LH)`$9%ZY6X>8.TY+;%60K&S[>XU]<;Q:M([!@IY34
M%5UV$N'&"W7F5K&OJ0,0\WG.2D//`Q=JVA:78QY552M$V:R8E5-1P])[6FR[
MC#E8\9E&W9N5C/\`#ODD8V>L*2NZLN-"@6.2/DLDDD@#REDX`4.-O6XOF;7F
MQRNL\>5M"9*#E+!JS%C+1%74RRR2+.)U,3JD8$2AG(E4T+HW=\_":3FZ_'[6
MN-0V(YJO"FEZ,@-:JZHA+?LZ_7+BQ5Y(L);+'?Z#=C2%3BEUE)>6DW!!5BHM
MJH<%@3*5(^1]4[*,W?\`X''AD1]VWPSM,)F@QL>#*CU9!CBDC(:->XBJ1SY7
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MJK"]NTU:`L*$B\AR;#FI:W3$Z\>Q\DVDTXM2)9`AYFH8%5`JND]LVO!W+;1@
MX398R\#?)7R)`XDQVAQMT@2/0K<N/E0Q1-,DBLYDR%<,@Y8-'U1GY^9T]NT<
MV0D"XV+M#*L15DR?$9&W322"0@EHS*[Q1&(K;D.'+%F`GGE]6B6;E]7N^XK5
M?EPE7>*5DL"6O[-9*C"J12Z&RD`&1KC*Z1DE%2D_+II^9ID*+8WE`#*@4<Q'
MI++\#TWN>1X^7;O^]PE,L:.[$&+,)0Z"K!3;6>V^@#23:LNW_'\7E;3B\F/(
MUMG_``<C*B7`P`')8%;IJ*CA<!RUP`U[+$>36R=!\4./-NT?L^.*3:%MWBPF
M-((0KB_$XUZHE[*^EI:<=-PB%+1&O^%"*I&,JU>&2B51,9H#<2@W$<]EZ>P-
M]ZS;9=^#/B1[9@<S=`1'XB8!!#D`N>6T>\,?#1L^J4,R3$AHYA6&QYV=MVP9
M.\;5$T.YKO&0(=H`5V4O&XDQ&"<0</EON+<G1&T8>*,E)H6K*_R=G'J6CM+T
MR,M[ZU0NY=H:8U1:-@IK1Q'=CH]K5%Y8IA5Y!)1T4@2[QD4+58[1)-`R4B8J
M9"E,7IK79,2+(ZSD\5C+CC%7,R1C'5I67%BDEBA[Y+DQRJC68DL(B&N"0<LG
MS)<?HV7/PLHSS^&QPF2-(+">>"%IAILJDQRN4*V,;%67O**M"'>_*2<Y#7YK
M4Y6OT6CZ<Y&U33#2D6O:NHJ=0I+7!VU.!56:H<W0)';LM<;=$V)TM7G,9/M&
MSIVFT12;*%(N"F1;?M?3YZ<P]PW<//E[GB9<\KI!/--')$^4H$+1RI"IB,,<
MLZ31R-RVD9BBNA6V[K/ND&Z9>V[3IBQ=M7$$7PD44;K+#CR7GYJ.3"[R-C(T
M;1Z&7@7D5E,`V3G?O6MWR]6;7M_MUWH]HTER3N-)8[)1T\@@$QJ_9%+J#6WT
MO55(ATMD4VG49M(R@B-FEY!>=19G7.@T[!B!>=JZ+V?.VF/`W:.'&S1-LW,E
MCYQ>*'/+ZWGG=O#,TJO$RQQ1@8Q:-6D>Y!D;IO6;A[RV7@/)+C))ND0A;EB.
M6;#PY)E@ACTKD:H9H#')*SA9=4NE=)B<3KLZK6^4WEPZH,#SDN6P7D[M>SS+
MJS,4M+N]D42(D..MY=OFD<O6*BA4C1-Q48^=18R]?>G9D!;L*.`$ADK9M$V+
M&V\Y,^RQXT&/M$Z:;SA)67.P-"R\QRQDB+WE,3Q%E9!I3B6@SY)Y]BP7\?S)
M\K/VUR+1@IS/%EIH0`&6-[<M%D$J@H22S7`G.C<D=QQ'`WD!MUPJ7:>T]$S?
M)RGU^2>13)H\MY=*W^X5*L3=GC*\W8QBDL,1!HN)3S)NU07525,FBB!P(7'-
MXVC;)M]V.*$+A86\8NU2S`,=$!S1")VC:4L512[NG,9@@L&8J+UD^V/DQ3[U
MAR,^4VVY&8L`8`22B+&&3#"^@*&=G80@HJLPTV76>-M37?/+BH4^;+,[1A35
MR^/..L>WO\MM#1^WM@ZICMM;/C:?<=FP\9K'75+J\7K@*M(]J(=3C21;M)7L
MJ*+.&Y#IYE[[!TME[OC[>,>1'AS<M"B0Y$`E&/A9&1'BS2SRR7RI,B&./X)8
MV:.0JL8D*-6(P[YO4.QS]0!DD=]K3(1'>-EU/D8T;3PQ1JDW(ABGDEEC9Y"H
MA6\G%ZJ&@<CMO5?D-%ZNEN1BVS];Q'-F2TN\M]BB]<LW3JFFXFK[&CJ799^M
M5V#A59]G?S%.9VV29+N5B@B!"DZI#3+L>U;EL4.YMMRXNXS=/;AD\M#-9IL?
M=DQXYHT=V8*,;4--V6P9S>UQ5Y>=G;=N&?AQ9;SX\&?LBJS",E(\R`MD*Q10
M"&D*]X@%20H([*M[VISNVU*:NVS)4+>EP/=Z)9.:-UK*].#1E2HJ.M=,[3=T
MNGRMVONRJW/-+!!0:ID(YO`P;`TQ-KJ@=5^AT*<]7M'2>#!]$YNX8</A)L'9
M1D<X9#DSYY=G$<$#I)S9DC8\QG2''16.AB0*K-TW"7(W+<=FQ)Y4F7<\F*#D
M\L,$Q\/':4\Z5'B2."6;F,2LDDC%%4&(.1RZ]N7>&OXO;<E1KU:K!/\`(?G1
M1JA.2,C:=<55MKR"N'&^DWA-W19ZSTB7K-/7M<PDC$QCB8:RK,Q>Z2224>*`
MHI5OL>TY<NW;)E0I%A[=MF[R@Z9&DFDQ-SGC6&4!PTED+9$J1Z)2%<@I%P6P
MKO.X"*?J17$F7E8G3Z%181*F9`4ER4X'3ID`B5V+1+)*I<-ITF8[AMSF'#:T
MJ;R9VO'*MJA-;L6MK#3FXN--CY%2=6IK^I*5NP2YKA3(K56P'&O(V2D$[5!P
M[2N.G*JK`2NFRAS)J6>+"Z1^D3D'&;1)B8I#28V8N#'))+,CL425LI8YE2(0
MR\R0(Z9("2=P)=3)O[8JX<4RG)&X%=)G@&5-&<42B".0QB!)4D;79X[R0-$2
M4L[23ORWG5=M<=>&E\K^Q;S5XZT\C^)]F7M4+'1%+EI.,L,RT.9U.PM@BK*T
M@F[E1Z58S01,FFJ)2"HJ3]G0=-87T)ZQ<S;\C'A8PX>ZH(69I4!7$F94#*49
MS9>7?@Q#-W5>Q7[N>6VZ>K;*RHI93(^/CDRZ1')W<O'5W*C4B=A<VN@`N#H[
M:0K/(C;KS9=2N"^XC/G]HYK;#XPR_&48:JA#0&M*FZN,?&6MN@C"$V8A>"PU
M78V5U)KR!XE5A*@0K1-$R*HQ8FQ[7)MT6(^*&CGZ<.Y-F:G#1Y("L85.KDB&
M.0G">-T,IF4MK5NX*G>,W(Q=PS7ARBIV_<,;&B@LI&5',N.69^[K:619I,B)
MXF6-8XM)1U#O4H<V*G,I;KX.W_TE7UK%)<M-?U-OK2.E645K]X:4H^S7C^;G
MV#./2F+--=8Y(C8KIZ=DU(!A(W[PPJ9:>@LF)<W<MO;'ADDEV'<I.:ZEI(^7
M`H"Q<=*!BQ+MI+FP`95N#<NIH#/M`R%DECC@R,&Z(;+*[;GB`/(;:CH0LBQA
MEC.HLZNP0K"UAJ6M;OR[,VX[]NS;BUQO-'8O(GD=:K.BL_I*32#448\4*(_+
MYD[L2=ECCH1[JOM2*1=?BE5%7:AI!1),;C@YN[[?T++GY_P73S;7F08>+&A)
MS\AQ(/&RKQ!3&F;F>(>Q>:*.+'70CLM#GQ;5G]2+M;DOO/B<&625F[FW8ZO"
MY6,\-,N1`CVQU+&3GR2Y)"%5>B>)J-;C;MP5NE0DV[O=&Z(WD$YY3/$+(YD;
M1:_8^(E9677V2T\Y47=KTK92+)@P,^2*>*$X,T13(<4S7[?Q(%W_`&E5_P#\
M4P]KV]\,:1RDD,N,L4L1M;F9$+Y#2.IU3#6[ZM-UL^(7>/%W3*L.JI.H,F&7
MO=_E#QO-QSVD00)%"T41(CC*1:>)`:XU;:UOG-M\@K5<N3[KC_`\?]O0M$K^
MJ74-KE_5[Q2C4"NV;V:L$98X@E^L$[L&1L;M&(/$2[(J9X]--)!PH"I38?%B
M8F)TQA9$.WC<,O<,?,>1QS>9CO#+-&D<7+8(K11Q)DR\U)`\<UCH2SC(LN3(
MR.H\C:TR?"XV+%M[1MW`LIR=#R&4R`W1G)Q$"F,JX9KLQ45C_8\S^0#Y783*
M%Y$66KUFYZWXJ;)HE^VX7C])V*K0^W^2D)0K!=$Z31J^WC];5>>I$P)6<)87
MLV_:)&17.Z*H)R9L2+HO9QDXN!GX4;9>+O4V)D18YR+NJ;7DSB!LB1BD\_.@
M5N;!'%&'+1@.EJQ9NH,P39.XX609=NGVC<LB`R*BIKQGBY<L40`FCBC,S1GG
MLQD6-&98VU@W&6W;/)A!/8^L-=[VD-FQ6JN0+>J)6]E;=`Z]W_M.H2&D66Q)
M.D4&SW&F*:4L-YUO;Y(0D4@A6BCJ(0%$RC==-18<7@PMA>#"W[<\`8AR,#+9
MHE3(EQXG@SEQX\N:$2C(\,\.M&"S+_W.F1;H1&;YD/G8R9.W8.8,B99,)A)*
MT2,IFCG:3"658^4)Y>5%D0EXF*X\K1D7TS+QFW.BTKZSY07=+<#MC%TW@O0M
MK:NE;_4Z=1K&.PG*6W(:=M:M:+[)QSQX\L=:CTE&[=S(Q/?E(#8136#MS=QZ
M/AB?&BBQ$.3+U9!C.L+RRH,2>/;Y4B!8*ZAEFF(,BI,H+!B"AM]V3=FGW+&Q
M\B60XB[1N#R\U8T8SX>3)&Q8QED9HU4`F)M$G!U7O@5"%>WKOIOL.T:[H$K,
ML%-R\@]AS]GN<3?-<Z[GCS%5X^Z%FF-2K=EVK2[_`$:+<2BTZZD5V!(E1TY;
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MR@9(Y04((]!#KFG-P2?!$RZ=4T0>P!U!BEQ8$7#`D6!6X/DK.-LFAW"/'F#$
M0S+&UR-)"N%-RI]J;&Y![*P13'+7?D%IV$VS$<@BVRX[FXX\H=BV?705RCJ1
MG'JUZLK3V7K;JHQ[&!3L40TI=@3"`ED+0XE"OGY.T(H*=4<W$_36S+N<NQ+B
MCP.'D;08\PM)JRQFY>-%(CG7R6CR8I7D@6%4DC11WWL6K&L+.R<C-&=+/:9]
MPSL4X=AI6/'3*T2*+<X30^'B>9W<QOSO:1@QUD>N5MV1HOA->=FL;M8=L;(K
M^IY+83*QWZ,@'*OLT\@D)0P&AJ+7JLP-7(%54ZR+8$3+`W3["KA3RJ9AN;A[
M9G];Q;&L<>#M1W*/$9E9B5B\0(C*[2LP,N@W9NY'J%]"BXJJZ3FR\CIN#=<R
M1\K-FV_Q14A0#(<;FB)!&H(C9QI5;L]FMK)M5A>QMZ;ZILDKJ/6_+!YLIM9)
M_AC(H[L<5C6,W.4]??&RIBJW6GMO:W665(<15@JT0E*PB+EHI(L$G@&,NY3[
M!QS+:]CV7<-PBDW3:CAP8V=N>.T`>56R(L3;6RD9F<EN=#/9)9(PL;"RF-&!
MOC>1N^XXG34VZXV6L^=D;+'EV*H4QI7RL:$-&JA2()EEE$<4S.X>"1A(P)"\
M.[<A^3]2V3,\78'8%MN[5GR-GM?M-QRMCTWK39HU]#C]3MP0U-<W.>UG)ZG3
ML+NP3[HB*@UHKI[&-^X2("Q3+Y)VC9MAWG;8.ILC'AQG&W9,K01K/)#(\&YG
M"U\KG<\JL!#RJDP`<"0E4NIN6\Y6X[-EOM>+,\ZS38*AY3&LD*Y.)DRO9PBQ
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MJC/@(,?)RNGILQY4>:T,L&Y1XJO$KR.!&8"QG20R:GNR/&`%K[%B;C!NLN/)
MG3/C8N?M84,L5Y(L\QQS0RD(+Z7EUX\B<MH]*HXE!),:[#Y8<B*3IIO8Z1R6
M)?[3M[B0SWM(RSJK4"2:Z%V*MM#4=99MJQ'04"S;-:/+H["DXTL58C2$@9S"
MB*;SO"KE"^8?26PY74AV.?",>W8/4&%AK*'<-FP9`RN:)&)*&0ICQY$3P*@1
M)#J5T*-5GBW?-&V_3?BD?-R,+<I#BZ1H@;$@:2.1`/A56&33CY`F9A(\D94Q
MLK*U1;M>[9;\@]>:+LW(C:-BKNNN37#[8,;='R6M(:UHFVA6MV,K#69Q]"Z_
MC*Z\J`/Z@B>/248)N4A=*IJ.'`BD*<GIA=HGQY-_Q]OQHISC;WB<H&9HW2'#
MQ)XV(:4MSKRNCLK`,EM*(P+&FWH[A%M7@)<N:09.!MV6SVC5XY!NT,$C1E4`
M6(JR,5<.%=%)8JS*?9HR6VI2XG4#_P!,]IG*/R"YV<I-`V75,G&T]>F15&FK
M?R"DTI"`D#5XUV0N\=+50B@.EI9Q'G05.CYB4H%,%'/C[7NF)C[3DX<?B(>A
ML7-&0"XEYT,&%I``;EF%HY"C*T9<MW^;>PJ[Y4F;@[IO&\XD[I)!U;%`([*8
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MCE4&[TR8D"W=%;7M6Z89PY\99-WR<N2*)IA.('`@C9(HIH#:#)1V>1VFCEC9
M#"&$2ZG-?U7DY^((I\*8Q8T6#+-*B&+GW21B<A4F&F;'1%$9B1HY-8ELSLR*
MD<MN8FRPH^E$W.T&"=]N7B&[ITI,0RK"LI3[W653F-YJPE47@S1A7,>,;!5F
M(4%SW*3TZ29#G5-WIA/.?IG$[LD<!...AVSF<%BGBU@AO-J!MPF9P4!T7NNG
MA809N[R0IN<@DTB/?\''@N`"(<E\,Z`"";21R2$,UR`UPW!34*0G*#D-6..-
M=V(WY8);9NFV.#.VMX6.0=5W5QX'1M]H9*5[6[="1U9KL8=E7/.+4[CY1A-*
M/RN7\:8Z)T0(LD&3;ETUL,G4>1L:;<,/`PMZVF!)"\VK)3,F9)XF9V*GF(G-
MQVC5&C0G67U*:BQ,W(7<X\HS\[G;AN<)Q>[H6+%\08Y$TJ)5Y!BCCF+NRR'(
M3VK`:JJV=>;][8JMJ:1Y"RF^:\TW)P)V$WV45*C,I2HVK9U_M$9/4Y![086$
M@7D#(LJ\UFXAF[;.'39J[["ZKI(Z9AD;9@X,F<V;!MPVW(ADWS$1#S&,T46U
M-*LCB5FO-`\ICE=-",=`"*RM6.Y>=DKTE)-/E'-\7LN-E2J=`$3^/Q5!0Q*I
M2')#.B(Y+@X\C*Y#$+,.M=D;-Y-OMG:'O]J<H-N..K+_`$7D)*(Q\5$.)S>9
MK5)--4VU%XUC4U(;S.H5(MO:C'&;`DN]:',42=DF8QO&/M^Q=/CKO:D$;YIQ
MY,!+LRPO#%S-Q3B;N(<@KA.LH99(VD%CQ-9=@2SY/4L?1F49)1%/D^*92NN;
M!R;18"-I"\N3*Q9S,'3ENLD+*I!4FK\>(NR+#N#B]H+:%M%(]GO.J*58I]=N
M0R;=Y+OX1HH_D&Q#%()6TDX[2Z8=`]0H&6CKS:\39>LMRVS`4IA193A$/:BD
MZA&?JQWT'ZJU+Z4R<G*V&!\N5,C)0R1-*OM9C#*\/.'U)0G,'D[W#A5Q68E6
M0TQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2M>'_%%?U//])G%*O-\$#\T?X?OXME%^
M<.,4K*CBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE=8[A8=^_BY5]$QCV
M4@SNU(62=L&KA_#G?M_-'QXMXLD=Q'G>M?\`5K"D8@J)^I-U#R9,266,,L;,
MJNNE@"1J6X;2UNT:E5K'A<`]H%0NBR`*X#!6#"_&S`$!AYF`9@#V@,1V$U2,
MQJ75=B96Z-L&L]?3L=L!TQ?7R/F*97)-E=GT8BV;1KRW-7L:NA9'4>W9HIH*
M/2K'2(D0I1`"E`)\>X9\/)Y4\R^&9FAL[#E,Y)<QV/<+$DL5L6))-ZA:*)VD
M=U4O+&(W)`)>-00J,?LD`)`4W`!-AQ-=K#4*BUWV!&OTNIP0U:#6K-8]AJY#
MQGM<K;A1JJXKT#YDS0]B(-=5BB8[1OW:!C(D$2")"]&3GYV89FRYI96R2#*7
M=FYI6^DR:B=974UBUR-1MVFI4.%AXT44&/%%'!`28U5558RPLQ0``)J'`Z;7
M'`UZ$]<:\2:IL4J'3$V*-<D*<DS3J\&1JE49=0JTK5DVY6((DKDFL0#N&(`#
M98P`)R"(8?/SI&+R32LQ>-R2[$EXOP3&YXM'_P!-NU/L2*GA$5E90`RN[@VX
MAY"2[CS,Y)+L.+$FY-4\MHO23BPO+<OIW5:]KD08%D+.MKVI*6%\$4T%A%@\
MFCQ!I)R$:Q,*+?MJF[E(>P3H7R9-&[[L,<X@RL@8I9R4YCZ"9+ZR5U6N^HZS
M:[7-[W-4_@<+F)-R8N=&B(K:%NJ1LKHJFUPJ,JLBC@K*I`!`-=9/<<>/-J:M
M6-GT-IBQL60L#,F<]JZCS#5H,7$HP,8+5O(0;A%N,=!MTV2'8`.Y:$*B3HF4
M"A-BW[?()3/#FY:3$N2RS2!B9&#R7(:_?8!G]TP!:Y`-0R;?@2QB&6"%H1IL
MI12.[K*\"+=WF/I\VM[>V-_VYXZ\?7K"GQ3S16FW<9KU1=:@1SG6-)784=5R
M_3E7*M/9JPAV]94<2B)')S,BH"=P4%!ZG`!R-.H=_CR9<V/.S%S)D59)!-('
MD55*JKL&U,JJ2JAB0%)`X&H/HK;/"#`\-!X$.SB/EIRP[7+.$MIU,2=36N;F
MYXFN\FM-ZALEM9WZQ:KUO/WN.0CVL?=9JCUB4MK%K$O2R46V9V-]%KS#5"-D
M2`X;D(L4J*X`<@`8.N4^+NVZX,#XV%DY$.-(Q+(DCHK%ET,652`2R$H21<J=
M)X<*G9.%AY@5<N&*54%EUJK:1J#674#;O*&X?9`'M`JM1A8<9@MA&)C!GRQP
MPY9P6#49@L09R#PT663[KST(XSP`5%#M]T*@=KL]KRY1B658FA5F$+,&*W.D
ME00I(["5#,`3Q`8V[34]D5F5V`+)JTD]JZM.JWFU:5U6[=*W[!5*1^JM71,O
M/V"*UO08R>M:<JE:)N/I]>9R]D2G5$%IM*?DFT<F]F$YA5JD9T5P=0'!DRBI
MVA*'2>^X9\N(F!)/,V#&%"QEV,:A2Y4*A.D!3)(5```+N1[8WE+C8R97CDC0
M9NK5S`H#ZBJ(6UVU7*1QK>]]*(O8J@4_LG2M+V+JY75(LTJI`M$X):I*U5HS
MBCT:8J+]E+TZ7K+-NBFQ8GK<I&-U$4"I@W.D04#E%(YRC48F[Y^)O$6^"1GW
M".766<ZS)J!657+7+"6-GC<GCI<D$-8B'P6$<"3:VB3Z-DB,;1J`JZ3V:=-M
M+(P#QL!=)%5QQ45V:NG=6O[A"[*G=<Z]G]J0;%HR8[/DJ+5EKXV*U;+M@%A9
MSQ9YJ,2$CM<"I(+D33*L<I0`IA`?B[ON$$$V%@SSP;9.S%X4E<1L"1P9=5GX
M*HNP).D7[!4!P8)EA.<J3Y$*C2[HI8$6.I>'<)8:N[8`\17KB-):8K\Q*6&`
MU'K"#GYQU+OIJ<B*#5(V8EWM@0%K//)2391*+V0=3;8PINU%3G.Y3'LJ"8/)
MD#[IN<F(,"3)G;!5`@C,CF,("&"A"=(4,JL%M8%0;7`J9X7%&7X\1Q^.+A^9
MI',UJK*&UVU:@KLH:]PK,`;$W\U'2>F=?D:)T/4>L:21A,/+"Q)4:%5:V1G/
MR$;[#OYQH6&BF0-YA]$?[*LY)T65;?ZHQA)ZG(\G>=XS?SS+R9;1<KORNWP6
MH/R^\Q^#U@/H]KJ`:UQ>H$P,&(LT<$*EI`[611=UU:7-AQ8:FLQXC4UCQ-5K
M$URO0+)U&P<%#0T<^?2DH^81,6QCF3R3FW:S^:D735F@B@X?2[YRHLZ6.45'
M"JACJ"8QA$:&:67(54R&:1$C6-0Q+!8U%E0`WLBC@JC@!P`M52JJDC2H`)7?
M6Q'`LU@-3'M+6`%SQL!QX50U9T;I2E0EDK--T]JVI5RY%4);Z_6=?5.!A+41
M9N9HL2R145$-&$X55H<4C`Z35`R8B4?(/3*W+WC=MPY7C\K)GY'X/F2N_+X@
M]S4QT<0#W;<0#VU*AQ<;&G?)QXXX\F3V[JH5FN23J8`%KDD\2>)/G-172^'6
MB*<EMV$'7](G]?;;M];N#S54U0J8XUO6G=7J4#5(YG7ZB$($*DU*2`([`5$3
M'(Y4,8H@'3I=,KJS>\O'V]9)YO'[?XC1D<V3GMXB:29KR%M0T\PH-)'<X&_&
MK=!L>WX^?FYD,:+#G18Z/"$416QXQ&.Z!8Z[!FU7&KLM4DN^/NA7Z$*U?:1U
M$];5IS+/:XW=ZVICA"`>3_7V==PJ*T*=.*<S74?.U$`3.YZ_ZP39;1O>\K(T
MJY>4)7C$;'FO=D%[(QU7*"YLIX"YL*K?H_`Y8AY$/*619`NA;"10%5P+6#J`
M`K>V```-@*[![I33<DRL4;(ZEUD_CK?&PD-;6#VAU5TRM$16B))UR*L35>*4
M0FXV`30(5D@Y*JDU`A02*4`#(/I;==2/XG(UQSM,IYCW69Q9Y5-^$CC@SCO,
M.!)%1)A8<9U)%$K<@07"J/@1<B'L_!#4UH_:"YX<3772/'S0DQ6JU2Y?2&H9
M2G4M=1U3JG(ZUICZM5-TJ;MJN:U!.856+@EU#CU,=JDD81\HCDU=]WQ<YMS7
M,RQN3KI:432<UE%K!I-6HCNKP)MP'F%2SMNW'$.`<>`X);48]"\O58C5HMIU
M69A>U[,?.:KFQTRGW&!4JMNJE:M-75%D*M;L<%%SD"J,<NBYCQ4AY-JZCSBP
M<MTU$>J8]T<A3%Z"4!"BBR\J#*7.@ED3-1]:R*Q#A_=!P=0;B>\#?ZM5!@@;
M&;"9$.&\9C:.PT-&18H5]J4(X%2+6X6KJ6NK=9,;NYV8RUS1&>R'L<G$/-@-
M:C7V]W=Q*2"#5*+<VM*/)/+QR;9JDF5`S@4@(F4H%Z%``FC<MQ&$VVC(G^CG
M?6T6MN6SWOK*7TEKDG41>_&]ZEMA8;Y$>6\41RH4T1N54NB>Y1K75>)[H('U
M*J64@(*</%*3<+$S"D%*H3L(I*1S.0/#3;5%PV;3,4=VBL:/E6S=XJFFX1["
MQ"*G*!@`Q@&FBFFQW,D#,DC(R$J2"4<6="1VJPX,O8P[0:GNJR(8Y`&C)4D'
MB+JP=3;LNK*K*?(P!'$"HN3XX\>4KEZ1DM#:83V%[-C9?;VGJZCDN7MC,;MF
MG_;06#";]FQ/Y1==_P!_U\O:RY1;]OL&']'09N6FWB,Q\I9I!'H:]TT!M.@W
M-UM8W-QQJDFVW;LG(.7D8\,F4S!B[(K.6%K$L022+"QO<6%NRJP@=9:WJUEL
M5TK&OJ17+C;S@I;;9`U2!B++:#@H"H'L4['L&\I-G!4.UU<JJCVO+\W*5]PS
MY,)-MDGF;;HVND1=C&IX\50G2IXGB`#Q/GJ<<7&.6<\QQ^.*!#)I',*"UE+V
MU:1866]N`X<!7&E=3:KGKG%;'G-9Z_F=AP3;S.$ODK3*Y(W.':"FY2%K%6AY
M&K3D>V%)ZL7L(KD+V53ATZ&-U^P;EN.-BRX.-D31X,X^%C5V5).SVZ`A7[![
M8'L'FI/BXN4\<F3''))";H64,4-PUT)!*G4`;BW$`]HJ'+YP\T';Z8I2876U
M!UW&NK33;+)JT;7U)A5)=.I;`K^PUX*41;P9&SZ&L\M7DTY%)0A@7(H8P^KZ
M&"YX'4^\8>X8^?-/-D#'#A8Y9'9.]!-CKP+<.6LS,EK:6[.!-4\^VX<T&5%'
M&D4^7%*CRHJB2\RA9'U6N78`:B;ZK#5>PJ2'>@-$/Z.PUB^TIJ1YK6*>C(QF
MO7>MZ<XH\;(&.NJ9^PJ:T,>!9O3*N5#"JFW*<3*&'KU,/6B;>]Y?.&Z/EY1W
M(+I$QE<RA;:=/,U:[:>%KVMP[*CBV[;X<1L"&"%,%VU-&J*(V;5JU,@&DMJ[
MUR+ZN/;7)L.CM*6Y2NJVO3^K;.K4(I>"J:EAU_4YI2L0CEL#-S#UT\E$N30L
M4X:!W1V[84D3I^I$HE\F?(=YW?'DFF@R\E)LA@TK+*X,C*=0:0A@7(8Z@6N0
M>(XU]\!@F"/&,,7AH?P::%TIP`[BVLO``=T#@!7LL&D],VV#>UBU:CUC9JU)
M3#>Q2->L%"JLU!O[`T8IQ;2=>Q,E%.6#J8:QJ)&Z;I1,RY$"@F!@(`!D,.[;
MICY"9>/DY$>5&&".LCJZ!V+N%8$%0[DNP!`9B6-R;U'X/$Y;Q<J/E2(B,-*V
M9(P!&K"UBJ``(IX*`-(%?B4T?I6<=T]_-:@U=,/M>-VC2@/937]3D'=&:L#I
MJ,6U/<.XE9:LMV2B)#)$9"@5,2`)0#H&1Q;UO,$TV1#EY*3Y!^%997#2WO?F
M$-=^T^V)[3YS4J3;=NFQTQ)<>%L2(DHA12B$VN54BRDV%[`7L/-7?U*AURDN
M+:[@&IFSB[VN0NEA4,*?^USTDW9M'#@"))(ID+YJP2('D$YNQU.8QA$PTLV7
M//CP8LAO!CHRQCS*\CRL./G>1CYA>P`%5/)C&5+F`6FFY>OZO*B2%?\`_2-0
M?.;FNF9Z7T['O[G*L-3ZT8RFQT'+78<DSHE7;/[XV>"<SMO<WB,41Q:$'1E3
M"H1\9<IQ,/:`>HY-.Z;F<6'".1/X+'</%'S'T1.INKQI?2C*>(90"#V&H/"X
MPS&W$1I](/'H:72.8R6`T%[:BM@!I)M8`6J0@9,P9^QP-&P1X-O,@8@@EYF#
M/NNX\T\U['<>;=QZCN^SV.QY.G3*.1WF=I)26=B2Q)N23Q))/:3Y2>VIL*)C
MHD>.`D:`!0HTA0O`!0+6`L+`=GDJ/*[I;3E/A_:]4M3:SJ\![86MM]@Z[1*M
M"0_MK8J)+,K-[&1D4V9>V%FL@0R3WL><IF(42G`0#+A/O&[Y,D<V3E9,DT4;
M1HS2NQ1&!#(A+$JC!F#*+`AB"+$U2IMVWQB=8X(57);5-9%'-;@=4G#OFX!N
MUSP'F%<FSZBU1=HZ<A[GK'7ENB+/*L9VRQ=GI=;GXZPS<6U;LHR8G&,K&NVT
MM*QS)HDB@X<%46122(0A@*4`"3C;CN&&T3XD\T3P:^64=E,?,)+Z"I&C622^
MFVHDDWO4^2&&;F<Y%;FHJ/<`ZT7VJM?VRK]BIN!Y!7>)4FFH5J/I:%2K"-.B
M48IO%5-*!BDZU&(03AJ[A$(^"(T"+9HP[MDBJU*FD4K=1$ADP*)"B$,F=G2Y
MIW*6:5MQ+%N:78R:F!!;63JU$$@F]R"0>!-0Q8N+!CG$ACC3$*LI15`0AKZ@
M5`M9KG4+6-S?MH%)IA72;XM1K!7R5B6MZ3P(&*!TG;'$>K$.+0FX!IWQ+$O%
M+G:G>@/G)FYS)B<2")<A7,RU4(LL@41-$`&:PC9M;1CC[1F[S)[4MQ(OQJ8T
M<;EBZJ2Y0M<`ZC&08R?.4(!2_M2!IM:J7B](Z8@VMK8PNHM80[*]OD)2\,XN
M@U2/:W*3;.COFTC:V[2)12L+YN]4,L19X"RA%3"<!`PB.5#;ONS#'5LK(*XA
MO`#(_P`";`?!=[X/@`.Y;@`/(*D^"P^?-D\F+Q.2NF5]*ZI5XC3(UKN+,PLQ
M([Q\YKMY_66MK6:1-:=?4>RFEQ@C2QI^IP,P:4-5G2KZLC(C(L'(O1KKU<ZS
M#O>UYHJ<QTNP81')6/GY^(4;%GFB:.1I$*.RZ790C.MB-+LH"LPL2H`)L+5]
MEQ<6>-HIXXWB:'E,&4$&(L&,1!%C&6`;0>[J`-KBN8C0J*W1BFS>EU-!O!3[
MNUP:"-<ATD8:T2!Y!1_9(I(C,I(Z?>J2SHRSQ$".%!<JB8X]X?K#XW,#:^=+
MKY/)OJ:_)L!RKW_!V51H]K90+<!49@A(92BE7D$C<!WI%(*NWG<$`ACW@0"#
MPKJ7VI-4REYC]GR6LM>R.RHE$C>+V&^I=;=WF-;II*()H1]M<1JD^S1(@L<@
M%3<%*!#B`!T$<F8^Y[EBXLF%BY$\>'-?7&DC*CW%CK4$*UP`#<'APJ#(Q,3+
MDCFRHHY)8?P;.H8I8ZAH)!*V8EN%N)OVUYL6I-56^TP-XMFLM?6BZU7N_:O<
M+%3*Y-VFM]TL9RE[`V"2C7,M#]VX.90OFZR?0XB8/*/7/N)N>Y8$<D6!D3P1
M3"TBQR,@<6(LX4@,+$BQOP)'837S*P\3."+FQ1S+&;IK57TDD$E=0.DDJIN+
M<5!\@KJ)'1.F9&Q2]V/JK6R-_FQ*J^V`E1*K[=UGZ#!:,8R:MH-$C-+R$<R7
M,F@J=8QTB")2B!1$,A.Y;H-N;:8\K(3;BCKRUD<1@27UV0'3WR;MP[QXF]1M
MC8DF4N9/#%)DKH[S*K-9""@U$7LI4%1?NV%K6%09`<'=,57C=/<=:S$QE>3M
MNKXW5]QV;!5.HQ&PKBRBH@L.UG+3)1T,W2GY@B`&,!G152%,<W0``1#,CW'K
M/=MSW^+>\DDPP9R94>,7<P(Z.CE50L0JN4`;38D'MJGP-NQ=OR)\V)5.X9#3
M%YM($I$SR/I+@:B(S(0@)-K"IZJ^D]14R`0K-7UAKN!AT9QG:S1\-1ZO$L%K
MBQ[H[>XK,(Z+;,SVA-=`JI7W8\Y*H4!`X"`99<_?-XW#(\5-E9!F5'2,F1VY
M:/J#1IJ8E8R&8%!W2"018FJ?;=DVW;,'P$,,1B9$$IT*#,4"@/+8`.W<4W:Y
MN!;L%1;`<9D8C7^Y:L[V#//KCORR2=@V9L]I"UV$L<JE)1\35BQ<>PCF18B*
M1C=>PJ$,U6(F99$`,Z[0N3"<:K(WN*9MOA&,@VC;@=&.7=D=FE>>5I"3J(FG
M<M(H(!C`A%D`JJAQ9(LW+W+FM](Y**BR`*K0)'%RL<1V%B8"3*A<-JE9B]U.
MFKC*_`Q%6@H:LU]@VBH*O1;"%AHQFD5%I'Q<6U29,&39(@`1-!LU1*0H`'0`
M#+3FYF3N&9+GYCF3+FD9W8]K,Q+,3]4DDU%@X6-MN%%M^$@3$@C5$4=BJH`4
M?6`KM\IJJJ8I3%*8I3%*8I3%*8I3%*8I3%*8I6O#_BBOZGG^DSBE7F^"!^:/
M\/W\6RB_.'&*5E1Q2F*4Q2F*4Q2K!^:G.4G$-WJZ)9Z5V%M9]L:]T&K2DW"H
MFA-?:ZA;Q>(FC-K#<KN[9/62;Y23E`(RBFR2[UV<O4P(H]5@S3H;H\]9[P-L
M;+@PXM,G><ZI)'2&281PQ`@R,5B9F-U1$4DMJTJV/]6[[_I;IN??Q!)DO#8\
MM.`"\R*-GE?B(D4S(H)#,[LJJI&MDAKE)XDUZX[;R6HL3Q.NVP-*T>UZ.I>Y
MM[K7",I;6O6'D#.MX*DQFK*=,PJ[W=3R-6>)'ER1CM#V/[?9/ZH,NO1706'U
M9B1OD[G%A[AF2946%#RS*TTF'"9YC/I8'%ATC3'+(I#D,5&E;FGZIZAGZ>C:
M7%Q6RX\;#&7E-K6)886FY**K.+2Y#D,5@4ZB#&`=3@"?>9G+:X<<":@ING])
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M'5,Y<K$;K=K7K'5ZKW#(V_%Q\+`+]:9,F:G@6E50C;>W+RM4^DKI$C(L-EU2
M:P2JGA55;'\7E"O7YD?7''>>V5QXJ4-QMF]_[V'8E8K"^IVO*D(M36*<1KUT
MSD):_N&C68;J3!6[IJ$>!^@B;IU&':O5.^1D2;=O&X18>[2[EG;?A1\IY%R<
MK;U+3AG!7D1$Z5BD8-S"W!>R\C-Z[0;=#N&RXKY>G:XMRRT+K&V-A2N5#<;B
M68".9S$I`"Q^WX\,S1#E4*4Y#`8AR@<A@'J!BF`!*8!_5`0'-0$%25;@P-9Y
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M3I`>8C07,0"59^L-FWS>\K$.U28J[;B+S!#.)&CER[DK/,B$:N1<+`I8HEC*
M$$K%J[#=O'7FUR!EXK;U7M6DM5;XXS<F=J/.,<E=:3:)>A6W0=IIZ5'69[/A
MHRRN)\T^Y\]>.&[U@LU37,V;J=PDFH8N4.R[MTIL<"P3)ESX.\["<7=$1T$D
M4C9/.1L5BFE6410DI('`UR*6)`JMWG;MQW@-C,T2_1^;AYF"Y#:6R4QBF2)@
M""8',\L8*Z772"+D!JMIG_"!WW1]8ZKKG&[?VKH"\K<:=E<6>1T[LO7TU+Q%
MSI>Y;O);%O-NU\W@)%LZA;G$6*>>H1`/059^9F)WY1,7H&5/ZS.F]TWG.CWW
M`RCTG-F;;D010RJ)HVVJ(08Z,S@HT<T0)R%'$.28V\M66/IK?</%Q-[PLC&/
M7^-+GR-*Z-X5VW)Q+.-"G6!#*D?(;M94^$7B0:JV-X1VT5;@>EZ=W1KVN<6=
MKP7%"#Y'5*W4>5D-HR!.)189"L.]7ST9()P$:O>FD$B69"114`@]10$HB(BV
MOUK;8<QMXZ@PII=VQ-VW'<L'E2`1K/N*$/%D!AJ:&%@C1%+-PLP(X&ER^ALO
M&VR/`Z?R8XY9]FAVK->5"VO%B=SS854V3(=9IT*M>/O*;W%QG=33(DFFDF4"
MII$*F0H?,*0A0*4H?Y`*&:29F=B[<6)N?Y36Q88H\>%((A:)%"J/,`+`?6`J
MV;DS0*7.5!*R2];BW\\A<-1PJ4LN@/GY(F2VW38^0CBN2&(J#-ZQD7"*I.O0
MZ:QRCU`PAETVG)GCGY2.1'HD-O)<1L0?Y00#4$Z(5U$<;C^D56_X/&C_`(+J
M=_!*.4_TEG_&O[-1<F+W(KQ^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=
M_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*.
M/I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/
M^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V
M:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+
MW(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^
M#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_
MX+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=
M_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*.
M/I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/
M^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V
M:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+
MW(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^
M#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_
MX+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=
M_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*.
M/I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/
M^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V
M:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+W(I^#QH_X+J=_!*./I+/^-?V:<F+
MW(I^#QH_X+J=_!*./I+/^-?V:<F+W(J$IB1\/^O2LE`S]PXPP<Y#/7,;+PTQ
ML#7T9*Q4BS5,B[CY*.>SR#QB]:K$$BB2I"J$,`@8`'+5)U?APR-#-N4"2J2"
MIF0$$=H(+7!'E!K*\;U?=99N.F9A[)NDN)*@9'3#R&1U87#*RQD,I'$$$@CL
MKK?;3X=/PB<3_C.UI[X\@_UGM_\`F>-\O']]4_\`VUZ[_P`@W?\`_"R?R5/;
M3X=/PB<3_C.UI[X\?ZSV_P#S/&^7C^^I_MKUW_D&[_\`X63^2KS[:?#I^$3B
MA\9NM/?'C_6FW_YIC?+Q_?4_VTZ\_P`@WC_\+)_)5X]M/AT_")Q/^,[6GOCQ
M_K/;_P#,\;Y>/[ZG^VO7?^0;O_\`A9/Y*GMI\.GX1.)_QG:T]\>/]9[?_F>-
M\O']]3_;7KO_`"#=_P#\+)_)4]M/AT_")Q/^,[6GOCQ_K/;_`/,\;Y>/[ZG^
MVO7?^0;O_P#A9/Y*I$HU*X@[/1D7&M6FD]AH0ZK="77HTS6;:C%+NR**M$9%
M2`D9`C%5TFB<R951*)RE$0Z@`Y6XG41SPQP<Q9@I%^7(KVOV7TDVOY+U9-VZ
M9WG861-]P,K">4$H)X9(2X%@2HD5=0!(N1>UQ>J[_!XT?\%U._@E'*OZ2S_C
M7]FK1R8O<BGX/&C_`(+J=_!*./I+/^-?V:<F+W(I^#QH_P""ZG?P2CCZ2S_C
M7]FG)B]R*?@\:/\`@NIW\$HX^DL_XU_9IR8O<BO/X/&CPZ#Z+J?U`>H?^DH_
M-#YF/I+/^.?V:<F+W(J7V[=%J@@U;)$1;MD4VZ"*8=E-)%$A4TDB%#]B1,A0
M``_4`,HB23<]IJ;7NSY2F*4Q2F*4Q2F*4Q2M>'_%%?U//])G%*O-\$#\T?X?
MOXME%^<.,4K*CBE,4IBE,4IBE,4IBE,4IBE,4IBE0GR$^UK_`"AZ6^[/0,K]
ML_._[*7YIZE3>T^NOW0J;,H*FTQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*
M4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*
M4Q2F*4Q2OFU\^VS<W.7E^8R")C#R/VX(B*1!$1&XRG41$2]1$<XAZP`_U9N?
M#_YTWW9KW&]3SN/5-TT`3;Z#P_+_`%*U:1YJV_>Z'_DI_P"CF.V'F%;'YDGN
MC[)KSYJU_>Z'_DI_Z.?"!;@!>OH>2_%C;^4U1$7$6)_-'EYTS:*C69W",778
M\$%BN$Q$4ROIAWV![Y10GJB)$Z%)^KY<W9U1N_JHV#HQ>D.A<0[MU%F1Q29N
M[Y<;1F)A9SC;?!<<M%;NR327:2UAW3QY\Z/V7UU]2]>OUQZQLX;+TM@R31;?
MLF%*LJS(;HN7N>38\UW7OQ01Z4CO=N\.%;>:MOWNA_Y*?^CFE+#S"N@N9)[H
M^R:>:MOWNA_Y*?\`HXL/,*<R3W1]DT\U;?O=#_R4_P#1Q8>84YDGNC[)K;/_
M`+-"DFG0^7@)ID3ZWG4W7L$*3KTK=MZ=>R`=>F=$>HP`8FY6^-A^Y>O.C^.I
MF;>.F]1)_P"TR_G8:V?,WQ7!-,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE:\/\`
MBBOZGG^DSBE7F^"!^:/\/W\6RB_.'&*5E1Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2H3Y"?:U_E#TM]V>@97[9^=_V4OS3U*F]I]=?NA4V905-IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE:$-VX\4KD;XF7,JN[+W74-#:ZJV]MJVB
MXW2U&*HZ<Q@[(6B4H"I1QEFY)2T2[MZ1)!,3^I[7;`BHE!,W+&-TQM_4O7NZ
MKNF7'BX,.X<5/X7(:;(Y:P0"X^$?O=[CIX$*U[5Z[X/76\="^HGI;*Z>VG)W
MC?,K9\>.&*/@D93$$AFR&L=,*`7;LOV%E'>$<\O^->@Z/XESKA[INTC4=519
M:.>^WR;LC6UL]0U]Q`M96^W*X2\Y+1B2AX5)45O8P'!7(G,5%),3B4@YAC>H
M+<\A]YZGW_(@Z>]7V'DE,.7+)YF<=,(6#"C8\R<M-(8S,;HA8`EM)%:LZ6_B
MZ;(Z5VC:L3`R^K?6WFE_$XNW0A(\.,R.L4N:Z*T>.&505C%Y'`+6`L:]7B?\
M6-(<4=]T.H:(5G7]4LNBZ';EYZ>FY*67LKZ7!VL:PHMGQ^ZB4I='L+`V1(1-
M+M]DH`'DS5_7DDFS]09O0V$O+Z>P,B.:&-U4S))/CQF423%1*_$#NL=*F^E5
M[*W)_#_OFZ==;#D^L'J@#_5DV3-A2<LLL*PXTSF.-80QBU(693*%YD@`ULUK
MFO/#[K7A[[3/4M+[^T9R/VCR(V!L96#J[W5-I+"U,E<?I,`C@D4?;Q7#-CP_
M=/'+UP+<X%;@`@8PE[.9#T-M?0W4;X6PY&'GR]1R%^;(LFF%5#,W,)Y@TI'#
MIU]V]P;!BP!H?73NGKIZ67-ZNZ5W?8\#H7"PE=DRH>9D&47#!?@)-1D8HL:Z
MQQ/&PN:GV"X4\*=H<W.3,/1'&P([AUP^UXM:-C-8B<D[1;]B6FO+KQDQ6Z7/
M.'3F0%M-3B2C9N9-4BRAT`!`2@J!PH]CV+I3/EWSJJ9,N7HC;9%CQHHB3-E2
MR`11JKW#6DE#21"X+K)"K,HUBL>W;UF^M;I[U<=-8VX>!/K4ZGRM$;R(D4&'
M"1S>9/&`%!BB9>9=2J=\L&*@&BYCA9PWVOSAXLZFT'LNS5C4&_X=O,7C7EPD
M!],&FIB,BG$L\H%C2FSKOXV>MB+0$V8.3+'356'NA5*"8FJ]FZ+Z>W/UE?0,
M.3S^G'P6RPD;'FHR8[2/@NW`\Y64%A[=4+69B%JK/K8]9G3?J7WOJOJO;X9.
MK=IRN1#/&O\`V>9'),L29L6BRM#%J+-ILK!`6T78#L?$`X;\3:+QLB>1W&:L
M[FU$$+ORS:#LFO-WK2*LK<G<$,L5:YU4LU*24@$.@K$"*2B1^Y<-EP,8B9R^
MJL?7&Q[-MNU[-U'L*SP8.ZM/&<:>_/C,)E^&8$EE4\O05)([\)%BS`U'J:]9
M'K"W?KC/Z`Z]GVW<IX=IQ\^/+P0O*19Q"1CR%$1"]I;G@&5T=1J6Q&1K^S2?
MQ$Y=_7QJ?[&[;FR_4;^:;E^-A^Y>M#_QT_XOTW^J9?SL-;/.;XK@NF*4Q2F*
M4Q2F*4Q2F*4Q2F*4Q2F*4Q2M>'_%%?U//])G%*O-\$#\T?X?OXME%^<.,4K*
MCBE,4IBE,4IBE,4IBE,4IBE,4IBE0GR$^UK_`"AZ6^[/0,K]L_._[*7YIZE3
M>T^NOW0J;,H*FTQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5Z'+ILS
M1,X=N$&K<@D`Z[E5-!$@J*%23`RJIBD**BIRE+U'RF$`#RCD2JSG2@);S#C7
MPD*+L0!7SD^9)G8>))R(*5N@9D'+*_**.C+"#E%V79:H(II-^P(&(=,3"8_:
M`2].G0>N<LXT&SMZQ#D33S+OR]40+'"(P8GA.1\)(TNJZNK!0J:"&!)U"U>R
MO0F1OJ^J78L6#'@;IMNC0TTYE(F2<8RB*)(-)#QNI=FD+@H5`TF]ZG;QEJA5
MJGXB.WTJS7H>`3G(S7%FF2Q+%!H$I8IBMLG,I-OA2*'G$D_7#MJJFZF,;RCY
M<MG7F_[YO7K*R\;=\S)RL;`W1(<9)9&=8(0N.PCB4FR)J9C90.)-ZQG^$O9=
MGVKU&8&;MF+!!FYWB9,B1$57G<2R*&E8`,Y"@*-1-@.%39XJ>O[-M;EAQ'UE
M3&[1W;K[QAT!5JVU?OD8UDXF)6*!NR1=2+C_`&=D@=4>AE#^I*'E'*KUA[1G
M;_Z\-WV7;%5MPR<G'2,$Z06\.#Q)[.`/]%4/\/N_[9TKZF-TZEWEG3:<'==R
MFF95+L$6<W*H.+'Z@XUY\.O5E@XQ;9YY['V(RCF>Q^&&A=BQ#0K)RG,M(/9\
MVL6K(/8Z2;@#9T#(JJG85('JNH].GE')73:2=/\`0G5G5"`'<<:&/;EMVQME
M2%)71P>W2A4>0\#Q`L8_71NV)U_'T)TOMC,^Q=3;K!F,&&GFX<*<Y5=3Q4L2
MMU/9Y:[_`,#W:TM#[#Y2:ZKUCJ<)NK<NDGJ^EG=W,T-$3&VX-Z]DHMDLG)E5
M8/'`OWZ;HB*A%!4[HP]DP%$,OOJOS]Q'26]=,=-O"G5'P65B<PKWVA4HP0,"
MNM.ZX)!"DAR-*,1:_P"+#8L')'3/4V]094W1N!NACW$0:M4>',$#&Z6<!@K1
MD@C@;`AB+WY[>2U](\W?#&A^;TQJQ[R?C:1<1Y"2D*_@8ZJDOS=LY=:90M[N
M`"/8MUPLB2'<$'N`'J3L`")@ZY7CML<GK<C8/CCJ&/IX:C>T1W4)V2:;7E$9
M<J`;GX,`>T6M0[,>H(/4EUM/ZM8MP7H"3=X?H]'5VR/H]G09IA$FJZ&,MK/>
M%M>J\@8U$7BO16VF_"]LYYUS6LI7E(GR8F?P>_:&YBD95+0KP9(RB<K'0Q&K
M96'\T0$0640%P50&Q%UCK@?K@?K.CR8]BV#_`%.T3>L;5,,KEE;>&O,5NH[J
MKS.5H*A22".)62LU_ASR.G9/6?FKZHH\Z/U5'8H/%>(#E3N0,5S&TFIM>DFZ
MZBOX5D58VC%3%_9I/XB<N_KXU/\`8W;<R[U&_FFY?C8?N7K#?XZ?\7Z;_5,O
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M9<QL4@=RN1N10R+<AE#@!`$<GQ8N3-%)/#&[01`%V"DJ@8Z5+$"R@L0`3:YX
M#C4MYHHW6)V42.2%!(!8@7-AVFPXFW8.-6`[IX.7+E)R+8W'D5N:2F>+&MGU
M4L>H^+E!++4^%L%[ATT'SRY;YL;20)(7X8J?;E5B(M$4(Y`G0RI3G`W>9QM'
M66)TWL)Q=AQ%3J7(#K/F2Z9&6-N`CQD(M%J4V=S=CY"!V8YG]/S;ON8FW.<M
MM$15HX$NH9QQ+3$&[V/M5%@/+Q[=)#GP(EYR<O1)Z@2<CMM=CL>H['9N,GV.
MQV>G8['0.G3YG3/.3J\E>K=R920PSIC?RWUGC?SU[U>I\`^J;IH'B/H/#^96
MK473MX^6,Y?/';YR8"E.Y?.EWCDY2!V2%.X<J*K&*0OD`!-Y`^9F.EF+:R27
M)O>_&_GOVWK8D<<<2".)52,=@4!0/Y``!57TFY!6+Y3KG8(M6]M*E.Q$R>N2
M\_,L$9A"'<D=MX=699+'E8QB=5(H"+<Q3`0!*7IURZ;-NGT5O$&\2Q#)D@E$
M@5V<!G3BA=E(<A6"L0"-0&FX!-6??-G.[;#F;)AR^";+@>/FQQQL8^8-+.(V
M&AFL3;4#Q-^T5R=B[,M>S;_?]C3[]5O.;)LLO9[*WBW#MG&KNI=XH\.T\U*N
M(+L6O;`B951/T*4!'RY:^9.P;GR-))([/(3PUNS%F8J++[9B0+=T<!4_:MFV
M_9MKP]HPHQX3!QXX8=0#,B1J$6S$7!L.)%KU0:*RS=9)PW66;.$#@J@X;*J-
MW""I>H%5071,15%0O7R&*("&%9D8,A*L.P@D$>3M''LX?R5<G1)%,<@#1D6(
M(!!'U0>!^O7EPX<O%U'3QRY>.UC$.J[>.%G3M4Z8`"9U7+@ZBZATP*'9$3"(
M=`Z9\N=6NYUDWOY;^>_;?ZO;1$2-!'&JK&!8````>8`<`/J6KW/9"1DE"+2<
MC(R:R2?=)+23]W(*I)";M"DDH\66.DD)O+V2B!>OEZ9]9F=M<A+/:UR23;S7
M/&W$^R?/4$4,,"Z($2-";V50HOY[*`+_`%:VO_[-)_$3EW]?&I_L;MN=#>HW
M\TW+\;#]R]>=W\=/^+]-_JF7\[#6SSF^*X+IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4K7A_P`45_4\_P!)G%*O-\$#\T?X?OXME%^<.,4K*CBE,4IBE,4IBE<-
M_(Q\6@#J3?,XYJ*S=N#E^Z0:("X=K$;-4`6<'33%9RX5*FF7KVCG,!0`1$`R
M.-'E<11`M(U[`"Y-@2;`<38`D_4!/DJ%V6-&ED(6-1<D\`!<"Y/8.)`X^4@5
MPG=BK["5803Z=AF4W*E.>+AW<FR;2LD1/M=X=A'K+D=O"D[`]13(8`Z#U^9D
M<>//*C21([1H+L0"0H\[$"P'\M?))8XM/-95UMI6Y`U'S"_:>(X#CQKW3$W#
M5Y@K*3\O&0<8@9,JTC,/VD8P1,J<$TBJO'JJ#=,RBA@*4!,'41Z!D$<<DT@B
MA5GE;L`!)/\`(!Q-1,0JEV-D47)/8!YR?(/JUQ)&TUB(;1SV6L<#%LYA1!&)
M=R,O'LFTHLY("K9*.7<N$DGJCA,P&(5(3"<H]0ZADQ,7*EF./''(V0M[J%)8
M6-C=0+BQX'AP/;4ILB!<?Q3.@Q;`ZR1HL>(.J]K$<1QX^2O:]L5?C9*.A9&=
MAF$Q,=L(F)>R;)K)2@I^13V.8KKINGO8'YO=$-T_5SY'CSS*SPH[H@NQ`)"C
MSL0.`X=IJ.26.'29650[:5N0-3<.`OVGB.`X\17<Y)J.H3Y"?:U_E#TM]V>@
M97[9^=_V4OS3U*F]I]=?NA4V905-IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4K'7RVYJ7[66PZYQCXM:2F]_\`*Z[P[.QM(J1:RL!IC4](>2"T;Z1]S;$!
M%%G'P23INH1&-8*JRCTY1*0I.I.WGO2_2&%N.!)U%U)F)@],PN4+`JV1-(!?
ME8\7:6L1=V`1?+?C;&=YWW)Q<E=JVB!LG>)`&L;B*-2;:Y7\@\RCO&KZ64`G
M*-J=,7:$JTA>*XR3=)R;2-([0@+%(1`1UC<5![*I+2T6S>E660`X'(NHT-V%
M1'J8!PMYS&TL6&\JX<AM8FQ9`UT#A>Z2.!\P;B*R!8]81YU0SJ.T#L8BS:2>
M(!XCSV[:JO*:IU?-QY]?SY.7WXQVW/LQD\XBZP_:S<OUZ;[LU[A^I[]T_37_
M`(/#^96K2LQVMCTQ2F*4Q2F*4Q2MLK^S2?Q$Y=_7QJ?[&[;G0_J-_--R_&P_
M<O7G3_'3_B_3?ZIE_.PUL\YOBN"Z8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*UX
M?\45_4\_TF<4J\WP0/S1_A^_BV47YPXQ2LJ.*4Q2F*4Q2F*5AG\8S4,)8]<:
M6V[-6B[^<Z\Y(<98RM4IK:7D9KLTK8-[T]J^M$]6&8H-K-8"1BPM6IGQET6A
M1[:*951$^;5]3&YS87K`PL&".$MF+E(TC(&D5$P,N0I$Q_!ZW12[*`Q"Z=6D
ML#A/K0Q8\SU9[RTK.J8N/%*`K%5=VS<*)>:![=8U>30A[NM]1!94*XO>=(47
M\/'D,6\E'\-T^_\`@3^3[%P6T^W'T5!+5OTJ^B(S7_80K8*>RWMJ[C_5=.WW
M_E[.;"]4_CO],;/]%V^A!F[Y].^TT^'\.?"^+U<=&BWA;\-=M/&]6/UC>%\;
MNOTQ?PWT#@_0WM_\2YTG-Y&C_P"1XKDZ[]_EZ;?!U?%XGFV.*>T[9Q93W[<J
M-<>%.L^2NVM8<NTY=U+O=;53<%;U3*'I52VT6**"+92*M#Y,6Z3KJD624;]!
M[?9S`/5]MF_X,FYY>U131]0YW3$D^S,`!+*QRX5:3$)[93"DP!7O:!)I\M9#
MU;DNVUX>"7N8-ZP3NB*>"8DN/,\9E':('R#`S7[I&C5PO6&6UAKH.//'`><Y
M7(ZX'PZ.2)>%?I#+=13#D";<]C'1X5;YHAN#T9##^UWM_P"U>Q78[OU/7-T9
M'TZ>J=Y'1UO]P?I7IWQ/)Y?,Y/A5^DNS_H^*_/;?]75KK!\,[#X3:SN6G_9S
MQ&_>VU<CE<U?`Z[][1X7Q/A;]W1;E_8U)6]`:ALN6+R-!\/B$&I'A=_@*#.%
MN([`\]*%0].GHL,4.Y"1"8\^]N?=B`]>UW_ZF1=/_P",_P#^(<O_`$O_`*KW
M_P"F-'+Y7T?RCX7Q'D\+HYGA/L+]G&K7G\P=-)_J[F<G_1V']&:^9K^E.=)?
M1;O>,YO@]>KX2UO)6Z&AWO<H]_V>_P"Z3[[L?L.][`=YV?\`[/;Z]/\`)G($
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MR<D^U*BT9M42_-.<P!^I\T0R?BX>/FY"8F'XF7*D8*J+$K,Q/8`!)<FI4T_A
MXFGG,:0H+EF:P`'E)(X5'R%ZY";HH^LMAZ$G./9:59)2J7E*VM;E;;I#;#UB
MY24=NX>!64UG$A%#9FJZ1D)0O?&;E+U*D?M>2O.)MFT9N1@;W%E>+C5X]!"Q
MM%,.`9N^U]!O=.%_.*IA-/G8\63MTD7(8J^H=X/'VD#@+:O(W&WFJ80D]^`8
M3!1-0`8P`!C!M*X=H0+U[("/H@ZB!>T/3];KEIT[?V<R>WXM?RE5MYO,OLGT
M5Y]E=_?4+J'XT[C]Z#&C;OC)ODU_*5]O-YE]D^BGLKO[ZAM0_&E<?O0XT;=\
M9-\FOY2OEYO,OLGT5\\?G0>14YJ<L5)=NR:2I^0FU32+6-=KR$>V>FMLD+E%
MD^<LXYP\:IJ]0(J=NB<Y0`1(4?)G"_66G_5VYZ+E/'36OP-M9[1<V]DU[D>I
MV_\`M-TU?M^@\/YE:M6S&ZV/3%*8I3%*8I3%*VE_[.@[V$VH_*T*/`TZ:2/=
M-6C(FM5KFJTH@J%=M0-RLB1-.M17:9R=H3F.9$2"```&Z]0Z.]0ZXQP]S\0S
MJ>=#;2H;[%^V[+;^>O.?^.LO],=-Z`"/"9?:;?\`5A^H:V2O97?WU"ZA^-.X
M_>@S?VC;OC)ODU_*5P3>;S+[)]%/97?WU"ZA^-.X_>@QHV[XR;Y-?RE+S>9?
M9/HI[*[^^H74/QIW'[T&-&W?&3?)K^4I>;S+[)]%/97?WU"ZA^-.X_>@QHV[
MXR;Y-?RE+S>9?9/HKR$KO[J'6C:BZ=?+TVE<1'I^KT#T0AUQHV[XR;Y-?RE+
MS>9?9/HJ7&XKF01,Z(DDY%),7":"IUD$UQ(45B(K*)(**I$4Z@4QB$$P>42A
M\S*,VOP[*F5[<^4IBE,4IBE,4IBE,4K7A_Q17]3S_29Q2KS?!`_-'^'[^+91
M?G#C%*RHXI3%*8I3%*8I7#?1T?*(E;2;!G(MR+H.2H/FJ#M$KEJJ5=LX*DX(
MH0%VZQ`.0_3M$,`"`@(9''(\3B2)BL@["#8BXL;$<>()'\AM4+JLB&-P&C86
M(/$'B#Q'8>(!_E`-<1U7X%])L9M["1#R9BRG)&2[J-9N)..(IVN\(Q?K(G=M
M"G[8]03.4!ZCUR*.>>)&CB=UC<68`D!AYF`X$?RU\>..73S55M#76X!TGSB_
M8>`XCCPJCX/4>MZ\TN#&/J$.JUO]PE+]<D)5`9PEBMLN+;SN7DBS)GP+*IHL
M4$4">1)L@@FDD4A"%*%3)N6=)'C1-*P3#AY4-N[RTU,Y"D6-V9W9F/>9F))-
MZ@\/"9IL@J#-D!!(?=!$6-`1V65$4`=E[FUR2:KD*Q6Y9M'LY6O0<FTB5$5H
MIK(1+!XVC%6Q`3;JQZ#ENHDS403*!2&3`HE`.@=`R0F5DQS'(CDD6=KW8,0Q
MOQ-R#<W/$\>-?6@@:#PK(AQK`:"!IL.`&GLL!P'#AY*]KROP,A(Q\P_A(A]+
M1/;]BI1Y&LW,C&=YY5/8]\LB=RS[8_-[LQ>N0QSSQ*R1.ZHXLP!(##S,!VCC
MV&HI(XY=(E56"-J6X!LW#B+]AX#B./`5V^2JCJ$^0GVM?Y0]+?=GH&5^V?G?
M]E+\T]2IO:?77[H5-F4%3:8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I5![+V-7=3TZ
M1O-J1GW$)&.X1DY2K%;FK9,F7GYR.K[#S:"KS*0E7219"42%<Y$A(W0`ZJ@E
M3(<P5NW;?/N>6N%C%!,P8C6ZHME4L;LQ"C@#:YXFP'$BJ?*RHL.`Y$VHQ@@=
MU2QXD`<`">T\?,.)X5;AR<X1:PY>W#5TAO&?N]EU;K-=_+N./R$V$=J+8]H4
M7:JPL]LZ&9H)/[@E6P0-YK'N''F!CG[2B1P[137_`*=ZPW'I;%R4V9(8]RR`
M%&25O/$ECJ6%CP37?BP&KS$>2V;KL.)O,\+9[2-B17/)O:-V\AD`XMI\@)MY
MQ5WL9%QL)',8>&CV,3$Q;1NPC8N,:(,8Z/8M4BHM6;%DU32;-&K9$@$333*4
MA"@````&8M)))-(TLS%I6))))))/:23Q)/E)J\HB1J$0!4`L`.``\P%<[(*B
MIBE,4KYN//K^?)R^_&.VY]F,GG$76'[6;E^O3?=FO</U/?NGZ:_\'A_,K5I6
M8[6QZ8I3%*8I3%*8I6V5_9I/XB<N_KXU/]C=MSH?U&_FFY?C8?N7KSI_CI_Q
M?IO]4R_G8:V><WQ7!=,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE:\/^**_J>?Z3
M.*5>;X('YH_P_?Q;*+\X<8I65'%*8I3%*8I3%*8I3%*8I3%*8I3%*A/D)]K7
M^4/2WW9Z!E?MGYW_`&4OS3U*F]I]=?NA4V905-IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4JT3F#M3DIKRFUF"XHZ,)N3;^R)]6JPTM8Y=O`ZJU.@5B=XZV#M23[XLH>
MOQZ1!*@S8IJ.GSH2I%[/7RY3TKMO3^?ER3=39OA-JQTULJ+JFF-["*$=FH^5
MFX*.-6;>LO=,:!8]GQQ/FRMI!8VCC^WD/;8>0#B3PJ5>/U2V]1]25&N[YV@R
MW%MMJT<+W:_15894V&E9=\[7>JMH*NL>I(^#BBK@U:`H8[@Z"13*F%03#ELW
MS*VO,W26?9<8XFUD@1Q,YD95``NSGM9NUK<+GAPJKVZ'-Q\-(MPE$^8!WG"A
M023?@H[`.P>6W;4S9::KJ8I3%*8I3%*^;CSZ_GR<OOQCMN?9C)YQ%UA^UFY?
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MC&A!4</9"1?*HMFR*90^:8P=1$`#J(@&5.)AY6?DIA8,;RY<C!51`69B>P`#
MB:E3SPXL+9&0ZI`@N68V``\I)JW336]]8\[M&W&T:EE=H0&N;+(6J@0&QDXB
M8US-6)DT12:'O^KI&5;$D'%=>&=",9*@@0JQDS&(7H'4;]NVR[CT7O,6-NBX
MSY\:I*T6I954GCRI@#8.+=]+\+\:MF#N&)U#M[RX;3+BN60/8H6'9KC)XV/V
M+6JZ.(CPB(J,BBNWS\L9'LH\KZ3<"[DGH,FR;8'<@[,!3.GSD$^VJH(`)U#"
M/ZN8Y+)S96EL%U,38"P%S>P'D`\@\U79%T($N38`7/:;>4_5KL,EU%3%*8I3
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MI?3=RF6\VU@[9!G4=Q\39U*Q(C7K8WC'*HBHW.9RP7,`"=,W9#I?L3=L_I7=
MIING,SX0*\2SQJ5+(W`LFL:D)'8>##R$5;)\'&WK"CCW:#NW5S&QO9AQ`;2;
M-;S<0:N-CHZ/AV#**B6#.+BXUHW81T;'-4&3"/8M$BH-6;)FV(DW:M&R!"D3
M33*4A"`````&6&2225S+*Q:1B223<DGM))XDGRDU<U544(@`0"P`X`#S`5S,
M@J*F*4Q2F*4Q2F*4Q2OFX\^OY\G+[\8[;GV8R><1=8?M9N7Z]-]V:]P_4]^Z
M?IK_`,'A_,K5I68[6QZ8I3%*8I3%*8I6V5_9I/XB<N_KXU/]C=MSH?U&_FFY
M?C8?N7KSI_CI_P`7Z;_5,OYV&MGG-\5P73%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I6O#_BBOZGG^DSBE7F^"!^:/\`#]_%LHOSAQBE94<4IBE,4IBE,4IBE,4I
MBE,4IBE,4J$^0GVM?Y0]+?=GH&5^V?G?]E+\T]2IO:?77[H5-F4%3:8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*A;?,CNT-/7)SQB9:[GMSK,DF5#)LJ6D6-!;2;B0;LGDI/NH)L]D
M'"$&Q47<E;)%`SE9$J(G(!Q,6[[+'L_TK$O41R$V@&\G*4&4@`D!0Q`&HV%S
MV`WL;50[@V?X)SM0B;.M9-9(2][$FUSP%S;RD6X5$?#OC'=..]:N$IMK?-_Y
M$;KVS-LK=M.]VQX=G5T)QJQ,S;P&KZ&V,$+0:/#(*&1;-&Q`46*4%5S"H/0M
MTZKZBP]^R(H]KPH,#9\5"D,:"[Z2;EII#WI9&/$D\!V#A5%LNU3[;$[YF1)D
MY\S!I'8V6X%K1IV(H[`!V]IXU>+F*5>Z8I3%*8I3%*8I3%*8I3%*^;CSZ_GR
M<OOQCMN?9C)YQ%UA^UFY?KTWW9KW#]3W[I^FO_!X?S*U:5F.UL>F*4Q2F*4Q
M2F*5ME?V:3^(G+OZ^-3_`&-VW.A_4;^:;E^-A^Y>O.G^.G_%^F_U3+^=AK9Y
MS?%<%TQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5KP_XHK^IY_I,XI5YO@@?FC_#
M]_%LHOSAQBE94<4IBE,4IBE,4IBE8+.4WBK[AT3SQA^+]9U;IV7IC:S:`J[J
MO6R]SL/R/W&7>,@NR?6OCS2FS(:_8ZOK`"B,XH[5[2/FRI@'U12DW%T!ZN-H
MZLZ9DWG/R<J/*:7.0&&-7Q\+P>.)U?<78ZHURK_`%!WM2CR7.#];]49W2\\4
M>)%`Z#$AR&YS,AR!+E'&Y&&5!$DZ:26#=T'AV`FKUN;_`"?W-I:3T1J'C30]
M<W[D)R*N%D@*0RV[99JKZW@H>CU1_<K9.6=_6F;^?6_]/9%;-$FJ8F,Z7()O
M4`;,(Z1V7;=XR,_*WJ6:'8]JVYLS(,*J\S()8X4CA5R$YC22J;N0H56N;VK(
M=_W)]HVV":%`VX9V?%AXRM<1\Z1))2TI6["..*)V8*"S'2%XFL>,]XOF_KWK
M'5EBXW:%U3-WIMQIV5REY'P>SK_.14-4*;IJ\2>N;Q4-=N*^P<.IFY3%A@'J
M\09\*;/S,J??F`QNH[$?U:=-;7O.=)ON=ECI.',V['@DAB4SR-NL0R,=W5R$
M5(8B1D$=XN"(U\E8Q'U)OV9C8FQX6/C#K_(ESXVB=V\*C;:ZQ3G6HUD32O'R
M5^Q5CS&X$U5.Q?%PVH2W*7?3FF==6#BSJ>"XH3G(ZTW"[2[#:C(G+0L,XK3/
M5L%%L#5^07HC.=1-+C(JD!0P&!`!$!`&V>JK;%S6V?J#-GBW;+W?<=MP>5&#
M&T^W*2\N26.I89F*+$([MQNQ`XBDR^N<S)VQ,_I_&CDEQ]FAW7-25RNC%E9Q
MRH&46>=5AG8LUH^ZHM<V.=]-0BJ::J9@,FJ0JA#!\PQ#E`Q3!_D$HYI)E9&*
M-P8&Q_E%;%AFCR(4GB-XG4,I\X(N#]<&K?\`D?8("/H)(]_.0[!^I?--.B,G
MLHQ:.CM4=R4559R5NX735%NDD@<QC].R4I#"(]`'+AM<<C9.I58KRY>(!^*>
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M%-:><>S3T@T+ZMZA[I8;U[CPV3\6_O3Z*:T\X]FNELNY-24ZO3ELM.S:'`UJ
MM13^<GYN3MD&VCXF(C&RCQ_(/7!WH%2;M6R1CF']8/U\G8VV[AF9"8F+!+)D
MR.%554DLS&P`%N))J5-DX^/$T\[JL**2Q)```XDD_4JSGB7X@U6Y?3VP;)1Z
M,]JG&R!\UCM8;XO]FA*PKN^91=KH3SZEZXD>YM#2C,"IE\UEWHHE?&Z]VD'J
MNSE?5'14G2L,&/FY"2]0O<S8T2E_#K8%1)*.X9#Y46^GRGSV79M^&]22RX\+
MIM:\(YG.GFGRE$/>T#R,>WR"KJ=>-]$:GK"%+UQ(:]J%6;24[,(0</8(E%BE
M)V::?V*>>E(I(JF!:4FY1PY5'KT%14W3H'DS&L^?==SR#EY_-ER2JJ68&]D4
M*H[/(H`'U!5WQH<3#BY&,$2$$FP[+L2Q/UR2:K?T@T+ZMZA[I8;U[E'X;)^+
M?WI]%5&M/./9IZ0:%]6]0]TL-Z]QX;)^+?WI]%-:><>S3T@T+ZMZA[I8;U[C
MPV3\6_O3Z*:T\X]FGI!H7U;U#W2PWKW'ALGXM_>GT4UIYQ[-/2#0OJWJ'NEA
MO7N/#9/Q;^]/HIK3SCV:>D&A?5O4/=+#>O<>&R?BW]Z?136GG'LT](-"^K>H
M>Z6&]>X\-D_%O[T^BFM/./9IZ0:%]6]0]TL-Z]QX;)^+?WI]%-:><>S3T@T+
MZMZA[I8;U[CPV3\6_O3Z*:T\X]FO/I`H7U;U'W20WKW'ALGXM_>GT5\YB><>
MS7SFN>3AN[YN\N731P@Z:N.16V5F[EJLFX;.$5+?)F36071,=)9)0H]2F*(E
M$/*`YPYUB"O5NYAA8C.F^[->XWJ>(/JFZ:([/H/#^96K3\QRMCTQ2F*4Q2F*
M4Q2MK+^S<V*OP5%Y:%FYV&AS.;OJHS<LK*,8\RY4ZY;"J&1*[71%4I#&`!$O
M4`$<Z+]144LF'N7+5F`EA[`3]B_FKSH_CJ95WCIO40/^TR_G8:V8O2#0OJWJ
M'NEAO7N;[\-D_%O[T^BN"M:><>S3T@T+ZMZA[I8;U[CPV3\6_O3Z*:T\X]FG
MI!H7U;U#W2PWKW'ALGXM_>GT4UIYQ[-/2#0OJWJ'NEAO7N/#9/Q;^]/HIK3S
MCV:\^D"A?5O4?=)#>O<^>&R/BW]Z?136GG'LU5::A%2$52.11-0A5$U$S`<B
MA#@!B'(<HB4Q#%'J`AY!#)/9P/;45?O%*8I3%*8I3%*8I3%*UX?\45_4\_TF
M<4J\WP0/S1_A^_BV47YPXQ2LJ.*5CZ\2SD/?N+W'-KMG5UUK=<OT;LFG1E9I
M5DUU:-EI;UD),)1,ND8F'I*+FVQ,Y<2)F6;RC%(YV/F)CJ`"`JF+EO0>TX^^
M]60;1EXTN7B303ZTCE2!XE503E<V3X-1C]I62T;E@&/9>W[S.,39,K-YZXK0
MHC+*R&15;FQA4:,=]Q.Q$%H[R#F:HP645CCTSX@_,'?]SWQ"[NJ\7PLG*=JN
MOK5+B/+P5P4W](>V.XU>/<[K@]FS$'7ZK?74>D^!A"5R#4(D]DI)!G(]A02B
MK>?6MTCTYTEZMI=XZ8S&W;-ESDA.=%(B18PO(!`N.KM*^3,!JB,A$4IA98R+
MN*R#^'?.S.M/75LVQ]48"XVQK#-D/!-`\L6=IQ6D^'F9-&)M\+J6S9PIR,*%
MN8ROW&78-A#K*0L0HX6?N7"D6P.NXE6:4=*+K&:)&56DH]!!L@P?JG$3+(D3
M3(DH(E`I0#H&M("3"A8L6TBY868\.T@``'S@`6/"U0[HL:;ED)"L21">0*L3
MF2)0'-A'(S,SQ@<$<LQ9;,6)-Z[3)M4-,4K#)R'\)!YO3E;-;^9<DI2G42_W
M'25[V7KM75%0M=\/.Z(>M'M6:ZDWI*OD;EIJO2IXY$))E&H*D=]M<#B)5>P7
M:_1GK-3I/8H]JEV]<K*Q)<V3&D$SQ)JSHN5(,N%`5S%0$\I9"`@"A;$:CAO5
M/2;]19TF;!D^'.5A0XF0#&DP,,#.RG&YGYI,P=M<L0U,]I#=E%2'MGAORCY`
MJ+7:1Y)):6W7IGDQLR[<3ME1^J:)=DZ=I"TUA*DDHMUI9I9"(N1)&-</5D7C
MIXG(E[395P0BQ#($L^T]1]/[)#`BX1R8,_8SA[M%S9(Q.[9!FU126O`Z:(/P
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M<5PC$M8*16PG;MA,4!PY:P[=*7,V;.@D`)U,!>O0(=J];$F-D2;CO&WQ9F[1
M;EG;AA2<QXQBY6X*5G+(-7/B!TM%&Q7EE>#=EJ?-Z$0[=#M^S9<F)JVN+;<I
M]"R-DX43E@O&PBF(>9&E4$%9"-'#CF8(0I"E(0H%(0H$*4`Z`4I0`"E`/U``
M`S4))8EFXL36>1QI%&L48"QJ``!V`#@`/Y!5N7)6G5&8HR<Q+U6M2TLC>-.,
M$I.4@HJ0D$V#G<5';N&)'CQHLX*S<(.E2'2[78.10Q1`0,(#<]JGF3(T([A.
M7*;`D"_+?C8>6I<ZJ4N0";C^D5)/H>U'\%NN?<16?I9E+XW-^.E]^WIJ9RHO
M<K[`IZ'M1_!;KGW$5GZ68\;F_'2^_;TTY47N5]@4]#VH_@MUS[B*S]+,>-S?
MCI??MZ:<J+W*^P*>A[4?P6ZY]Q%9^EF/&YOQTOOV]-.5%[E?8%/0]J/X+=<^
MXBL_2S'C<WXZ7W[>FG*B]ROL"GH>U'\%NN?<16?I9CQN;\=+[]O33E1>Y7V!
M3T/:C^"W7/N(K/TLQXW-^.E]^WIIRHO<K[`IZ'M1_!;KGW$5GZ68\;F_'2^_
M;TTY47N5]@4]#VH_@MUS[B*S]+,>-S?CI??MZ:<J+W*^P*>A[4?P6ZY]Q%9^
MEF/&YOQTOOV]-.5%[E?8%/0]J/X+=<^XBL_2S'C<WXZ7W[>FG*B]ROL"GH>U
M'\%NN?<16?I9CQN;\=+[]O33E1>Y7V!3T/:C^"W7/N(K/TLQXW-^.E]^WIIR
MHO<K[`IZ'M1_!;KGW$5GZ68\;F_'2^_;TTY47N5]@4]#VH_@MUS[B*S]+,>-
MS?CI??MZ:<J+W*^P*>A[4?P6ZY]Q%9^EF/&YOQTOOV]-.5%[E?8%/0]J/X+=
M<^XBL_2S'C<WXZ7W[>FG*B]ROL"GH>U'\%NN?<16?I9CQN;\=+[]O33E1>Y7
MV!3T/:C^"W7/N(K/TLQXW-^.E]^WIIRHO<K[`IZ'M1_!;KGW$5GZ68\;F_'2
M^_;TTY47N5]@4]#VH_@MUS[B*S]+,>-S?CI??MZ:<J+W*^P*>A[4?P6ZY]Q%
M9^EF/&YOQTOOV]-.5%[E?8%/0]J/X+=<^XBL_2S'C<WXZ7W[>FG*B]ROL"GH
M>U'\%NN?<16?I9CQN;\=+[]O33E1>Y7V!3T/:C^"W7/N(K/TLQXW-^.E]^WI
MIRHO<K[`IZ'M1_!;KGW$5GZ68\;F_'2^_;TTY47N5]@4]#VH_@MUS[B*S]+,
M>-S?CI??MZ:<J+W*^P*>A[4?P6ZY]Q%9^EF/&YOQTOOV]-.5%[E?8%=$M1N/
MK:Q,:>XI^G$+;)QCN:C:NM7Z2E8I"&CUD6S^68PAVA9-W&,G#A--9PFD9),Y
MRE,8!$`&<)=U:!LI6R#BJP4O=](8\0I;L!(%P";FI9.*)1">7SB"0O#40.T@
M=MAY35-U724$_1N[':FH^/+V,=VN90IK.JT)FY1<ZY42:EAT+LWL42=NO:CG
M[\'A6H"Q$G8[`?LLJ<C<>4T,FUSYBRK&I<N]B)>.HQE#<)V:;][MO4F/'>19
M$S4@:,N0H`N"GD#AA8MVWMPJOD]-:@12212U3K9)%!,B**2=&K!$D44B@1-)
M),L6!4TTR``%*````'0,H6S\YF+--*6)N27:Y/G/&JD0PJ`JHH4=@L.%?OT/
M:C^"W7/N(K/TLSYXW-^.E]^WIK[RHO<K[`IZ'M1_!;KGW$5GZ68\;F_'2^_;
MTTY47N5]@4]#VH_@MUS[B*S]+,>-S?CI??MZ:<J+W*^P*>A[4?P6ZY]Q%9^E
MF/&YOQTOOV]-.5%[E?8%/0]J/X+=<^XBL_2S'C<WXZ7W[>FG*B]ROL"GH>U'
M\%NN?<16?I9CQN;\=+[]O33E1>Y7V!3T/:C^"W7/N(K/TLQXW-^.E]^WIIRH
MO<K[`IZ'M1_!;KGW$5GZ68\;F_'2^_;TTY47N5]@4]#VH_@MUS[B*S]+,>-S
M?CI??MZ:<J+W*^P*>A[4?P6ZY]Q%9^EF/&YOQTOOV]-.5%[E?8%/0]J/X+=<
M^XBL_2S'C<WXZ7W[>FOG*B]ROL"OG7\[F;..YL\M6$>T:Q[!ER'VNU9L6+9%
MFR9MD;?)D1;-&C<B;=LW1(`%(0A2E*`=```SAGK%F;JW<V8DL<Z:Y/:>^:]Q
M_4Z`/5-TT!V#8\/YE:M2S'*V/3%*8I3%*8I3%*VIO[.'3*?;*-RQ4M-3K5E4
M8W;5B;)2?@HN9.T37KEK,L1L>1:N3($5,F43`40`P@`CG1GJ(GGAP]R$+N@,
MT-[$B_=?MM7G1_'6B-O'3>H`_P#:9?:/ZV&ME?T/:C^"W7/N(K/TLS?OC<WX
MZ7W[>FN">5%[E?8%/0]J/X+=<^XBL_2S'C<WXZ7W[>FG*B]ROL"GH>U'\%NN
M?<16?I9CQN;\=+[]O33E1>Y7V!3T/:C^"W7/N(K/TLQXW-^.E]^WIIRHO<K[
M`IZ'M2?!;KGR>7^)%9^EF/&YOQTOOV]-.5'[E?8%2$DDDW2200231013(DBB
MD0J:22290(FDDF0"D333(4`*4````.@93$DFY[:CKV9\I3%*8I3%*8I3%*8I
M6O#_`(HK^IY_I,XI5YO@@?FC_#]_%LHOSAQBE94<4K`WS9Y"\MW_`"DY!4C1
M6Z*WIFD\&N*54Y93$!)ZEJVR@WG/2[^XN5:98I:Q]J3H\`A`TQ=N5Y"&;R)#
MO#&!3H'J=M=';9TWM_2*]6=0X<FX'/WY=J2-9G@,$9BA>693'QDE;GJ$1R8C
MHLZ\;G'=^AW;<]YP.F-ER5PILC;<O+,QC66\L,T<<$;*]U$(9@[LJF0$74DV
M`Z/6UXYQ<H=:W3F#R1CZCH;1%^US4:YQRXQ1<2PGKU(LKC;Z9.(;$V'LU1-T
M6DV6TI,RLX1YVDF%<(Z))+I$41!4^->NC:>C.B^E,OHW:Y7W#JSQZ')R2"L4
M*QNZ+A1#VHE)93)E.&$$H;20MP-H?PI[MU#U;ZV-EWV6$XO3N/C9,BA9+-,X
MPW$N5+"#S,K"CM)*-K0K+N$:QPG62+Y[(0JI(6((NW7:+DBX\JS5U)'F7394
MK1(%&[F75464E5T3@)3N3',9<P"<1$3=<P6`$0H&!#:1P)U$<.PM]D?J^7MK
M']T:-MRR&B=)(C/(0RQB%6&LV980`(E(XB,`!`=(`M:NTR;5#3%*8I3%*8I3
M%*8I4)\A/M:_RAZ6^[/0,K]L_._[*7YIZE3>T^NOW0J;,H*FTQ2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5'K2_5:
MX3>R=>4VXQ1]@Z[0B6%L8HHFD'=(E;C`&G*BYEX]46Z+@'L<<KM-(%>BJ9>R
M)BB(]*YL')Q8<?/RXF\#D%BA[!(L;:7"GC:Q[I-N!JF&1#/)+C0./$Q6##MT
MEA=;CZHXU:-Q.X#5#CO<+1O38E]M?)#ECL%L[87?D5LHJ!)U*O.G:;M.@Z[K
MC,YX36^NX\6Z)4XR/``5%$IE3G[)"DRGJ?K;*W[%CV;`@BV_IB`@QXL7M=0%
MN;*Y[TLIN;NW9>P`XDV;9^G8-LF?<,F1\K>)!9IG[;>X0#@B#AW1]>K^\PBL
MBIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4KYN//K^?)R^_&.VY]F,GG$76'[6;E
M^O3?=FO</U/?NGZ:_P#!X?S*U:5F.UL>F*4Q2F*4Q2F*5ME?V:3^(G+OZ^-3
M_8W;<Z']1OYIN7XV'[EZ\Z?XZ?\`%^F_U3+^=AK9YS?%<%TQ2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*5KP_XHK^IY_I,XI5YO@@?FC_``_?Q;*+\X<8I65'%*P%
M\B.,?$?EYXC'(36.R[9R7U!L"&XP::7OMMUER7<:EU_M/7UJF;U%15$EZ=%M
MD5YH(D6SL[L'BKAJL1V``F7R]K<W2N\=1].>K9=WVZ/`R]L;J&5%@GQ1D/'D
M)C8\GB$9CI2ZE%6P#!D)U=EL4ZDQL/-Z@VW$RI,F#+^C,AXYH9C"5C7)17B8
MCO,7=@_`VLO$&P(D]AP=TGQ6U1LJ4U%R+Y2;5:DU[$TTU$VARAL>X=8U2D,K
M'77#M[(45XZ.G#4:,C(LK::4C$?/B5TSINV*`J=,UUZV.N-_ZGZ3RH=VV_`A
MYF0DTD\.&D,KL"VH3S`<QH'#LV0H)=U%Q<BMR_PQ=-;)LWKCV4X>2[.AF2"*
M6=F(E,+B(8,=Q"-Q#6&W&?\`[>/+,326`O68JM"@-<KXM?8CS882*%O[7R=W
M`]QY@AW/L(GU'NXCN^GFQ?U$>R&8QC:?#QZ=&G0MM'M;6'M?M?-]2U8QO?-&
M\Y8G\1S_`!4NKQ!O/JUM?G'RS7_"'ROJKN\G5;*8I3%*8I3%*8I3%*A/D)]K
M7^4/2WW9Z!E?MGYW_92_-/4J;VGUU^Z%39E!4VF*4Q2F*4Q2F*4Q2F*4Q2F*
M4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2L=_BD\F-G\1^'MQW;J!2NIWB#M>
MO(=B>TPZD[#@SLMOC(63[Z.2?1QU518NS]V;O0[!^@]!Z=,PSK[?<_ISIJ7=
M=MT>+22-1K&I;,X4\+CR'AQK=/\`#_T)L'K(]9>-TKU*)SM,N/DNW*?EOJBA
M9ULQ5K#4!?AQ'"M9*"\>+Q)+1-15;K374$_89U^VBX6#A]0RDA*RTF]5*@SC
MXY@VMRCAX\=+'`B:9"B8YA``#KFCL/UJ=?;CDKA8$<$^8]]*)`S.U@6-E#DF
MP!)MY`37=V=_"/ZB]KPY-QW)]QQ\"%"\DDF:B(BCM9V:$!5'E)-A4^6?Q./'
M!I5?E[9<>."]5JU?9+24]8[!Q;OD3"0T<W#M.'\G)/)Q)JR:(%\IU%#`4H?-
M'*W-]87K0V[&;,W##$&(MKN^*ZJ-1"K=BP`NQ"B_:2!6*;;Z@_X5-XSHMLVG
M>QD[C,VF.*+=8'D<VO946,LQL";`$U:K1O'R\4[:=[B:IK^L:HFC2$BK#Q<0
MPTK.2MMN$N(*)I,ZW!1]L6>*)D4()NV)#"<H=0#IY0V_N^_GICI),+)SH=Z]
M;.Y11308FW1B7&P(6`D)RY06YV0\9MR8K"(^W:XL=3;-ZBND^J^LI]WAV[<.
MGO4;LLD\>7G[MD\C)W"6/5%?#B:-1CXD<HOXB;C,+!%LUQ*.P/&@\5'3=C&N
M[2U_K[6%LE&C64]AKKH*P56=DF)Q,S92`,Y2RM';UN841234`#!U+V0'R=,T
MGE>MCK_$R#@9J0QY:6!C>!@RZ^*]TO<:KW'#CY*WOLW\*_\`#UU#A'<^G\K+
MS=OU%3+!GQ2IJ7M!=(B+J.T$\!79WSQF/%IU;'5R7V9KFGZ]BK>T!_5)*Y\?
M[16V-C9&12<`ZA74K96R,@B+=<A^J8F]08!^8.1[CZT/6%M&2N'NL,6-ELI9
M4EQV1BJFQ(#,"0"0#YB:E;+_``P?PZ=2&9>GLW)SFQVTRB#<(I3&QO8/HB.D
MFQ[?-23\9?Q:X37L3MJ9UO48K5D\X2:0FQY'C[:F=)EG*XN"H(,+*O9"13DZ
MYFJ@$[*@]L2#TZ],BRO6=ZQ,''BR\V".'%G%XW?'=5D'G0E@#]:F)_##_#GN
M&\3=.X&=DS;_`(P)EQDW&)IXP+`EXA$76VI;W'"XO47./[0'XA::"ZA7NC>T
MFBH<O75CT0[12&,'4/;CY0ZAE`?7%UF`3?$[/BC]_5_3^#CU,,X4KNUB1_\`
M+7\C6[K3I1U-U&JS3[NQ>R]<@Y1X*).[1%U(1C5VX[I,3'%-/OE1[)>H]`\G
M7.I\:1I<:.5_;LBD_P`I`)KRIW/'CQ-RR,6*_*CGD1;\396(%SY["JCR?5#3
M%*8I3%*8I3%*8I3%*8I3%*^;CSZ_GR<OOQCMN?9C)YQ%UA^UFY?KTWW9KW#]
M3W[I^FO_``>'\RM6E9CM;'IBE,4IBE,4IBE;97]FD_B)R[^OC4_V-VW.A_4;
M^:;E^-A^Y>O.G^.G_%^F_P!4R_G8:V><WQ7!=,4IBE,4IBE,4IBE,4IBE,4I
MBE,4IBE:\/\`BBOZGG^DSBE7F^"!^:/\/W\6RB_.'&*5E1Q2L0^UO"CTWR7Y
MV[8Y(\I]8:FW7JBPZ/U/K[6M6LWMA=6>JW&GS%L=VR8<-$$HZ(1C9B.F&B:)
MR.UUC&0,!DTP`!-L[8?6+G=+]!_Z?Z?FR<3?VWB7)DE33H;'?'AC2.Y);4LD
M;L1I`L1WB>`QW?=@@W[><'*SDCEVW%P)HF1KW,LDZ2(Z@<+!`ZDD@W;@#VB3
MHGPM.'^EXBT/.*?';5&EMCVYG`UUU>(E*=:N(N$8VV"M!G_FH.Y!&=5A9&#0
M?MXUP";)^Z;)HN3@@8X#A77'6'6_7'3S=/;ON,V1AG(BE"RMW4DC)"RV51K:
M-6<JC=QB;-P)K97J=R.DO5IUW!UA+B,(H,;*C9(41GG2>!XVQN9(U\>/)N(I
M<F&\\,;,\(,@6LD+)%=NS:-W3M20<H-D$7#]5)!!5ZNDD0BSM1!JFDV14<J%
M$XD3(5,HFZ%``Z!ED0,J!6.I@!<\!<^>PX<?J<*Q[)DBFR9)H(Q#`SL5C!9@
MBDDA`S$L0HX`L2QM<DFN3D52*8I3%*8I3%*8I3%*A/D)]K7^4/2WW9Z!E?MG
MYW_92_-/4J;VGUU^Z%39E!4VF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2L-WCS?FX=D_\`4#3GW18/-9^MS]B9_P`=#\XM=-_P
MA_OOP?U+-_NTE:*\)LA]JZWU*TUVSKU6[0\Y'R].E(XQ33$?.1S@KIA)L$Q1
M<`11DX2`X*'(*91#RYH3H[IKKO/CR^J^C\?(&/L\#S3Y:Z4CQTTE6O))9"[*
MQ"QB[M?NJ:]+.N^K?5SMCXG1/763C'(Z@D\+!A/JDERN9P*B*.\G*]W*0L:_
M9.*SD\DN2/+J@<`]<(;HY+[$V+=N<T<^D7]#M2%3\RH.F:I*+>;2,0ZBX)C,
M%?;).[11>`JNHCYJ@`$(0QS".7>L7?=PQNB]EZ)W)GEWW+3Z3S9F:[&&30<+
M%`7X,1K89!(`=FTW/=85SIZL/5QT5NOK\WSJKIK!AQ.D^F8XL'%BB4\M]Q.H
MY.06+%R\:WC56[HXD7-B,<G#7E#L[BILJ;M>EZ/6KCM*]T^1U=37<S%RLS.U
M62MKAJV3F:$QBW3<5+>H<A4$`5(ND<BAB&3,4P@.$=)=0[[LPRMJZ9B4[QNB
M)CI(JZID[VK3""=%V<*Q+*>**>`O?H'UI>K_`*<]8.T8T/6&7/C]-[;EC-G1
M71(9EA5NYE,P/P"@ECI*D$`@@@&L^\V]DMB[[\)/C#RYG(?:?*JG6>Q;-WF\
MD6L0\EX")DXV3L5!US<7<81NP<3Z1F+5=X@0HE[QF500Z*%$^[,+P.Z^MS9<
M*9XLG>=CV"?Q<J\5;-"1LBWMI<Q=Z4G[!W5E`+,!QL(ALOJR]9'770,4VW>K
M[=)H,?;8U+JK()%AR<J%7[RQ2:F6.]CH?1<Z.'4^)5&[SO&@]B1T]OS1G*+6
M<7S(@4;XV@(QZVO_`!3DI.>/%0FNHR2830Q,C7(]BY%F^\^9MG@*J]0[0#ZC
M&-WP-PW=.FH-YR\7==JFZB$<F;%<2)D2L!-A#B5.,O?1'4*X"('`!%KYZD\K
MI39.KFR-MV;=^GM^;I%VQXI74X^Z01QA_&E6C#KD2$+(H1WCM<*1;C/^S-C6
MJY<FO$(X13[DLAQIUYP';O:)KHL<P"$J,I4:U7G$7*,%P1!ZG)'6?E,!C'4+
MVFJ0E`HD`1J>IMXS^IMG]8D.ZL'BVV2)\4!5"P-&FM=``X=\*UNSNVX"X.$]
M);%MW3_2'JT]9FW#3UIN?4YCR\C4W,R4R6EY@<7L4LA7A8_"M?5JN--I4PFC
ME3#Y1,R.81_RB@(C_GS0+]A^O7IHG"4#[8?TU]1S6_VNZ%]9=6_Y&QSO;!_,
MH?Q2?<BO`7?/\:S/UJ7YQJK3*JK73%*8I3%*8I3%*8I3%*8I3%*^;CSZ_GR<
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MEE5^=E0P\UV-VC2%)2S"-7+!+`7:NIX1;IW^[YUV[0]T\0^C<]M8L^-(;.3D
M]::@TY3XNCW%QL&.KB$?;;)JN1FVR$B\B@55CV@O5!<I&6.HDF*29CW/J/:=
MBEZ"R=[@Z=GV3<X-VQ\=&FR,E^;')CS2.$2=4U%61=;!2%&FS7+*+/BYNYX_
M4^V[?],Q;CBY6-E221QQ0ADY)1$9VC+:8F+]UB0QD324*,&K.%FEZV-3%*8I
M3%*8I3%*8I3%*A/D)]K7^4/2WW9Z!E?MGYW_`&4OS3U*F]I]=?NA4V905-IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K!UX^=T
M*RX/6FA>UBWNCS]AUS/A;6<(=>D0Y8/9=40&)G;`"P)Q\W*B^[3-N)#"N5(X
M]0[.8!ZV</7ZN<O.YL0Y>5C)RRUI&UR7U*OE5=/>/DN*Z3_A%R='KZV[%T.=
M>!GMJ`[@TX[<&/D)OP'EL:T8&=7AV<J_FP1.YE9$X@J]>*&<K-VX@`>9LA4\
MC1J`!^Q)TZ_JCG/^\^LWJS>^E=OZ&FF3'Z1V]5TXN.@ACFD!N9\D+;GSM[N0
MFWD`KTJZ?]4?173O6NY>L>""3*ZXW)R6R\IS/+!$188V(7N,;'6W".(+?[(F
ML@7.[E;5^4]DTV[HM:L%-J.G-#TO445$67V*%<CVMM.ZE9-J2(>/FQ(Y^NDF
M<@&,"OJ1$P`(Y9>N]^BZKZQSNH\%)(<#(2%(8GMJC6)64`A;K]D``I(L``!5
M-ZF_5YF^KGI_*VW=YH<K=L[=LG,FDBUZ7,[!@#K"MJ'>N;6X\#5_6L=O\'^!
M&[>-NXIKCML1_;E^*%7L<S3&=@AK!-5G<]HDEC#L22)9[2JU@'4O3"$=1C9J
M9(S5)\104DE``<V'A]0=(="=3YJ+@9'C#MV&BJK`OB23P<S*4NSW2<ZHU)1C
MRU:1>X3I&D][Z3];/KHZ'W+8(]\P1@+U/EJL[1O''DX$%DBQU$4(YD:9&L2-
M(#S&B`U,MZ@C=G-?B<TW7J3DIQ"T-M>@;OIFW5=FW^R[BV')71'8#59!P5S#
M*'=7.VK,EGJCI0AE2$2!)(P`4!`H$S%L?JO9.GNI\#J#H_"EAAQQ-XB.:1F\
M1S;*;OJ=@2IE)8DWD9'*MIXYQL7JJ]86Y]&;MT%ZS]YP,SI[-P$Q\9<+'2$X
MI0W#`"&$,`5C(7C?21<7O56\L_$AT-LK2^QM7<7>.4]I&8Y";2A=Q\@K38[.
MC-$G+A#NB2P-JU'(/I)))@ZF@[TR@>QY"@3U+8#*&[,74/6.WR86'LO1^-)@
M[-B;DV>"[DR^(+$JJV9@L0O>P:RZ52-54&J/U<>I3K#9>I\?J;UC[W#N\FV[
M2VVX,<4101X[*%+.Q5"7"BP%G)N2TAL*D'9OBX:NMNI-CSE3XY2=8YI;STU`
MZ*W!N]>R(N:H\J,8S-'R4O`10.57'LU+-DR?ZLS%IV3G`5'"H-TP/7]6=>[3
MO>T[GB;-M_@L_?GC;<&U7C.C@R0J#[5U+)<A"%:Y#.`U6'I'^''?]BZCVO'W
MC>X\OU:=/9TV7MN$(B)EE<AHUF<@#3&>-P\@.FRH@E?3@C=%`K)P4H=`*U6*
M`?K`"1@`/^[-6/Q4_P`E=;Q_A%_YA_37U&=;_:[H7UEU;_D;'.]\'\RA_%)]
MR*\!M\_QK,_6I?G&JM,JJM=,4IBE,4IBE,4IBE,4IBE,4KYN//K^?)R^_&.V
MY]F,GG$76'[6;E^O3?=FO</U/?NGZ:_\'A_,K5I68[6QZ8I3%*8I3%*8I6V5
M_9I/XB<N_KXU/]C=MSH?U&_FFY?C8?N7KSI_CI_Q?IO]4R_G8:V><WQ7!=,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE:\/^**_J>?Z3.*5>;X('YH_P_?Q;*+\X
M<8I65'%*QZ^)ONISI3C`Z<(U/4ME:[0V!2-*RTKR`BUIK0>O(G9+]>(>;'W/
M%(HJC(Z_K`$`72!S(I+JJI)J+)$,90N5]#;0F^=5XV"\LL.B.?(!BL)Y&Q8F
MG6#&)(`R9BFF(GL[S"Y`4V[>L]MIV+,W1(^<T*1#1<A")<B&!C(0"PB192\F
ME6:RV"FK$O"-Y(TZTW-MI?6VON&[6,F='2>T]J6KAC18JAU>`VM5=IR&LACK
ME%5]S)1**>P*VU;RL$@LZ-(I,6QC*%%-0A\V9ZS-AS3M,V][A-O0AQ\K"CQ8
M]QE:5FBR\,Y,L:%PI,F-.KB9D7E_"!"0Z$5@G3NX8F)O$&V8*[7+-.V='.V&
M@0J,.<"#()6X\//'(L:!CJ,JF1>XY`S[YHBMF4Q2F*5:ILGG!Q/T_N^A<;]E
M;PI]3W9LPS`E.H;\959\^4E5U&T.C)2;&-=P-97FG"1B,4Y1VR.]-Y$`4ZAU
MR39>D.I>HL'*W/9<.7(P<-2TKKILH52[!02#(RH-3)&'95LS``@FT[QONT;`
MV.N\3I`V6^F+5?O78(&-@="%V""1],9:ZZK@@5;R-Y2Z!XD4)/9O(K9<-K&E
MKR[2!9RDHUF95U)3+XJBC>.B8*MQDU8)=UW*)U#E;-5>Z2(90_9(43!0[)L>
MZ]1[BFT[)"V1N#JS!00+*HNS,S%511PNS,%N0+W(!KLW+QMNPI=QS7$>%"!J
M8]@U'2H`'%F8FRJH+-QL#8U$NT?$<X0Z8IVH]@;)Y&42O5#>[-K):GF4PG9U
M.W13LJ!BS"+2N0\N_B85L=R1-R\?I-6K18127434*8H7S!]7W6>Y;YD]-X>W
MS-O6&;31DHO+)-E!=V6,Z^V.SGF#O1ZEXU9INJ^GH.GX^J9<E/H*7VD@#L6(
M!+`1JIE+(%/,71JB(M(%/"J@V'SRX@:HV_KC0M_WW2*_MC;24,O0JH924DO9
MA"QJ@C7%W<Y#QLA6Z\C8E#`$>>3>,RO0,`HB<!`1IMJZ)ZLWO'S,K:\&>6'`
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MR`ZC]L#3@?\`;_\`B+!?-SG/UN?L3/\`CH?G5KL/^$/]]^#^I9O]VDK1-SDN
MO6^F*5^U555SBJNLJNJ($**JZJBR@E3*!$RBHJ8QQ*F0H%*'7H4H``>0,$DF
MY))/:3VG^7SU"JJ@TH`%\P%A[`K\8J*F*4Q2N,\_W1U_PZ_SHV0M[4_R5''^
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M2`L03>7//5IB[7E]5S#>(DFPL?9-QRE1W:,&?&B26#2ZLK+(''P94Z@W%02!
M5CZHR\K`Z;RLK!>2/,#XJ*\8!D02YF/%(Z`@J2(W<V8%;7O8<1;?Q$N^VZQX
MA:?'62T#%\8:=7>)-ALVT:)JW6U=K6@=F[E9[/K$-#;GUU<:_6HWVPLYFE+B
MV3:O%TY&-[M1JY0$R(+&R[>8=IW7U=9_4HSI<_(^E\2/%&3.SY>%$\&0V1B2
M(S6(YRK()D4QS*4D!0LT:XM$V?M.^[5LCXT4&0TV6,B;'B5<?-A3'1L:8$`F
M,JYD#P.0\,NI;NA5VSE9I6MBTQ2F*5J_\I]$<UJ1XC.S[?IVG[EN\-R#VMQ:
MNU0;Q>F]6;'XK3=:H*,57+^QY-WFY-%[1K>5UTPC'3VJ>QIDC$=K@Y*85#E'
M.AO5OO/2<G16+M6_2XD!VW(W1YFEGF@RD3+35#+M@B/PT\A(AR$>_=0(!I8W
MUAU_@;R^^3[MM:Y$JY>UX>/`D,:2H<C&<AX<]9>['AN>7-S$''7(6/,B73=[
MRWVM:;]M71?)#7?&_D%N.L<%N4>[-3;?U93J)#SE^LC^:U,>MQVS-5U5:<4+
M=*BVDK$@F5UWK5PFV66.=(G=B`X3TKM<&%A9N'F9N'CKU3TNZ8LLDA6.%_&H
MW*S&"_`EQC2!B`ZWT"YU5D'4[9.;%C8T$<C9NQ[Q@YV0L8OSHGQ)KKCW(YLD
M!R$DY9TM<'3Q`:L:B7&/E1QRTSJY]8.*6Y=TN]R^'YR.XQ-J)K6N05QE]"[+
MWEN2R[*I\??XT[IL:K4UO7;.W3EI$@*%8.VIT1(;L`4-F9^\=/\`4>\;GT_B
M[MAXTJ;IL&0N;,[1PY";5BKC93++QU2"0:L<=DR@,&'MJQO#&?MN1M_7LVWY
M3[?'D;W(^W(@;)1-SF2;&^!%AQ2-DF4=Z(RE77M4UGLGBAREU\^OG&<_'S:N
MU9_E%4/#9AZCR"J4/"3^L-2O>+Z-58[2;[.N8NR.:4A75H1=:'/W:@2(*`)1
M+U$QIVV=5=,;OO</4";ACX6'L_4^^;E)'*6CDRL;/3X#PZ6^%EETE)HC8IKX
M7'`V>78MZV/9#CS8DN9/N72.+M*1Q!7&+EQO-J,Q)TI`GB$D$RW0F$^5;C:V
M03,DBBD<XJG3233,H;]DH8A`*8YO\IQ#J.<P2,'D9U%@23;S7\E;DQ8G@QHX
M)&+R)&JECVL0`"3_`"]M6Q\G8&WOZ@@_A[\XK\2G<M/M58-.LP,LFJ_5V_2T
MF\H+Z13,[*=HNLDJ"(#W2@H@4WJ3FRZ;3)"L^EXPSZ)..HCARVX6'#CY_JTG
M#%;@V%QY/JBJV]H6W?AY?_%S2/6V4_B,+]''OW]-1:)?=_S"GM"V[\/+_P"+
MBD>M\>(P_P!''OW]--$ON_YA3VA;=^'E_P#%Q2/6^/$8?Z./?OZ::)?=_P`P
MI[0MN_#R_P#BXI'K?'B,/]''OW]--$ON_P"84]H6W?AY?_%Q2/6^/$8?Z./?
MOZ::)?=_S"GM"V[\/+_XN*1ZWQXC#_1Q[]_331+[O^84]H6W?AY?_%Q2/6^/
M$8?Z./?OZ::)?=_S"GM"V[\/+_XN*1ZWQXC#_1Q[]_331+[O^84]H6W?AY?_
M`!<4CUOCQ&'^CCW[^FFB7W?\PI[0MN_#R_\`BXI'K?'B,/\`1Q[]_331+[O^
M84]H6W?AY?\`Q<4CUOCQ&'^CCW[^FFB7W?\`,*>T+;OP\O\`XN*1ZWQXC#_1
MQ[]_331+[O\`F%/:%MWX>7_Q<4CUOCQ&'^CCW[^FFB7W?\PI[0MN_#R_^+BD
M>M\>(P_T<>_?TTT2^[_F%/:%MWX>7_Q<4CUOCQ&'^CCW[^FFB7W?\PI[0MN_
M#R_^+BD>M\>(P_T<>_?TTT2^[_F%/:%MWX>7_P`7%(];X\1A_HX]^_IIHE]W
M_,*>T+;OP\O_`(N*1ZWQXC#_`$<>_?TTT2^[_F%/:%MWX>7_`,7%(];X\1A_
MHX]^_IIHE]W_`#"GM"V[\/+_`.+BD>M\>(P_T<>_?TTT2^[_`)A5G7+/E,QX
M@1U;9W7?=QO6U=@O21&J=!:NU-1;9N79\PL<4B(UFHH%373B6R@=7<FZ%%@T
M(4PG4$P`0V5],=+9?54DCXF-%#MD`U39,TCI!"OV[GAJ/V*"[-Y!Y:LF\;YB
M[*BB=VDRY#:.&-0TLA^U7S>=C8#SU/3O2&PMA/-67^P[HO4#8*2HM:H.""M5
M:)",E;)6UHB2BKA$PJQX:RFCF<BHGW#@7#=%V0%DA[92GRR)ND&`N3@X\,+P
M3=QFN6NJ/J#(S#4ER`;BQ*\#P)%7`XIR3#DRLZR1]X"]K%EL0P!LUK]AN+\1
M4E^T+;OP\O\`XN*1ZWRW^(P_T<>_?TU5Z)?=_P`PK$AXWU5V!$^'ML5Y8MJ.
M[7&%O>HR*0RU,J\.19138$(5%47\8B1XD+=00.`%'H;L]D?((YJ_UPS8S]"Y
M"QPA'YT''4Q_ZJ^0\.-=.?P@K(/7A@EFNO@LWA8?HSUI+9R#7KG3%*8I3%*8
MI3%*X[OIYJYZAU#S=;J'S.H=V;R=?\N0M[4_R5''^$7_`)A_37TLM?T;;"E"
MI"B.]'Z"1ZA63IHAKJDF!(AH5D)4P,9N(B!`'IY<]!<#(P_`P_\`;B_)3[-_
M<BO`'?$E^FLSO_\`RIO(/C&JKO:%MWX>7_Q<4CUOE7XC#_1Q[]_35KT2^[_F
M%/:%MWX>7_Q<4CUOCQ&'^CCW[^FFB7W?\PI[0MN_#R_^+BD>M\>(P_T<>_?T
MTT2^[_F%/:%MWX>7_P`7%(];X\1A_HX]^_IIHE]W_,*>T+;OP\O_`(N*1ZWQ
MXC#_`$<>_?TTT2^[_F%/:%MWX>7_`,7%(];X\1A_HX]^_IIHE]W_`#"GM"V[
M\/+_`.+BD>M\>(P_T<>_?TTT2^[_`)A3VA;=^'E_\7%(];X\1A_HX]^_IIHE
M]W_,*>T+;OP\O_BXI'K?'B,/]''OW]--$ON_YA3VA;=^'A_\7-(];X\1A?HX
M]^_IIHE]W_,*^>?SH0>->:?+%M(R)I=^WY";51>RIV;:/-(N4[;)%6>F8LP!
MHS,X.`F[M+U!.O0/)G"O614]7;F5&E3G36';;OGA>O<?U.@CU2],@]OT'A_,
MK5J^8W6R*8I3%*8I3%*8I6TE_9U*_<9ND<K#5;8#BDIM[IJXKU)"LP,^$@HI
M7;2**IE)E-0[84"E,4"I]`-VNH^7.C_4-+!'A[F)HA(3-#;O$6[K^:O.;^.Q
M7.\=-Z6M_P!IE^2__5AK9&]H6W?AY?\`Q<4CUOF__$8?Z./?OZ:X)T2^[_F%
M/:%MWX>7_P`7%(];X\1A_HX]^_IIHE]W_,*>T+;OP\O_`(N*1ZWQXC#_`$<>
M_?TTT2^[_F%/:%MWX>7_`,7%(];X\1A_HX]^_IIHE]W_`#"GM#VYY/\`\>'_
M`,T/_P"7-(\H?JA_N_ZN/$87Z./?O31+[O\`F%3*W(JDW0377%RNFBD19R*9
M$1<*D(4JBXI)]$TA5.`F[)?4EZ]`\F4)L3<<!4VO=GRE,4IBE,4IBE,4IBE:
M\/\`BBOZGG^DSBE7F^"!^:/\/W\6RB_.'&*5E1Q2L''B#V#>K+<%LK.O*GXO
M<I#66JZS>-+9PE6XY)ZPJSNNN+2I)L*TIM%TG/(6.REE$BV#OT545$VC/S<2
M""G:VOT%#M,NVK+N$G3:2P9DQT[CXGFRK)%"J@\D:3!&5+1<0PD:75==(&,]
M42Y,1B&,N>_,Q70^$T=QN<KAWU]DVE-"D=WE.UQJXCC^&BINY'>EF;[14\7=
M*+7UM*'C4/$`D>-JVJUWR$_7NV>JMM1F"SJ7=!!4>P90!9D9G6[?0YD^MXZ[
M^A#TRQV__27B!E1?X<,OQ6G3)?C-\'R;VYE^]JY>GAJK&]D^D5WG',YW[D$R
M`^(,/(ORV*B33WB>ZQC"<=2DMW0:SGYI"ME4Q2F*4Q2N!'Q47$IN$8J-81B3
MM\]E'24>S;LDW,E).%'DC(N"-DTRK/I!VJ95=8P"HJH83&$3"(Y&\DD@579F
M"(%6Y)TJO!5'F4#L`X#R5\L-1>PU,;D^4D`*"?.0H`X^0`=@%<_(*^TQ2F*5
M"?(3[6O\H>EONST#*_;/SO\`LI?FGJ5-[3ZZ_="ILR@J;3%*8I3%*8I3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I5#7.9N\:E5E*%4HJY>R=O@(VSB_M"5
M;3K]+>KG)/6QBH:-DPG7T*@!3I1Y>Y,[$>R"I.G7*S$BPY#*,V5H=,3%+)KU
M2`=U#Q&D,>!;CI\QJGGDG4(<=`]W`:[:;*>UAP-R/-Y?/75&TOJ8^V2[X5UY
M4UMRDJ"5!1V6O#-%[@UIB#YY)IUMG-+)G=LHOSY^LH9-(2=L53=KJ`],F_2^
MYC;/H43RC:>;S.4&(C,E@-97L+6`%SYJ@\#A^,^D#$GCM&C78:M-R=(/D%R:
MD[+=573%*PW>/-^;AV3_`-0-.?=%@\UGZW/V)G_'0_.+73?\(?[[\']2S?[M
M)6B;G)E>M],4IBE,4IBE,4KC//\`='7_``Z_SHV0M[4_R5''^$7_`)A_37U&
M-;_:[H7UEU;_`)&QSO?!_,H?Q2?<BO`;?/\`&LS]:E^<:JTRJJUTQ2F*4Q2F
M*4Q2F*4Q2F*4Q2OFX\^OY\G+[\8[;GV8R><1=8?M9N7Z]-]V:]P_4]^Z?IK_
M`,'A_,K5I68[6QZ8I3%*8I3%*8I6V5_9I/XB<N_KXU/]C=MSH?U&_FFY?C8?
MN7KSI_CI_P`7Z;_5,OYV&MGG-\5P73%*8I3%*8I3%*8I3%*8I3%*8I3%*8I6
MO#_BBOZGG^DSBE7F^"!^:/\`#]_%LHOSAQBE94<4K';XFFCMG\A-"4S7NO(F
M;M,`??>HYG==&K=_<ZSG[UHZ-F7(7FOQ5M9OHMPS=(*.&D@"173<RY6(D`X"
M(`.9>K_<=LVGJR+/W9ECA&)EI#*T?-7'S)8&CQ<EX^/,CAD)+K9N#:M)TU9^
MI$W"7IK.BVI2^X&.,K&K:&F1)X9,C'60_@VR,=980]Q8O:XO5@'A;\*-G<9N
M5VP'$EH2TZZH]-T[8=83.X+OMLVTH[D):E]J$G*5?]21DM;+59M?QIM?M2H6
M)LMY@@N](V*#<3)`H.Q^N.M<+J+H-5FS8I-RRLK#E7#C@$3XABQ9(\P3R(B)
M+'+.5DQQ=V6[FZKW:PO;NEVVCJZ$8,$AV_'\<6R7EUQRQ3/&V&B1,=4>5`AD
MBDD'<:(.#=I`:V$<T-6S*8I3%*8I3%*8I3%*8I4)\A/M:_RAZ6^[/0,K]L_.
M_P"RE^:>I4WM/KK]T*FS*"IM,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,
M4IBE=//6&`JL6XG+/.0]<A6BC1)U,3TFRAXMLJ_>(1[%-Q(2"[=HBH\?NDD$
M@,<!464*0O4Q@`9L$$^3((<9'DF-[*H+$V!)L!<\`"3Y@":@DECA3F2LJQCR
MD@#B;#B?.>'\M67<RN.G(+E`:D:OH_(-707'J4"4'D"YH#)ZAO:_10@D1A1J
M/=#']C*)7)E$RJ<J^2(>1,F8")=""<#9=TGOVQ=.<[<LS!\=OJV\,)2/#1-Y
M9)(^V1UX:%/=OQ/&U6/>]LW'=N7B09/AMM-^<4!YKCR(C=B*?LC[;S5=5JO6
M--TOKBE:HU[&K0](U_78VKUB-<R,A+N6D1%H%0:IN925<O)*0<"4O:4675.H
MH<1$1\N8UN6XY>[Y\VYYS!\R>0NY`"@L>VP4``>8`6%7?$Q8<+&3$QAI@C4*
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M3%*UX?\`%%?U//\`29Q2KS?!`_-'^'[^+91?G#C%*RHXI6(_QGHKVQ<6==U,
MM$MFWE+?RFT%6T](5BS+TEENXLA9'7G6K[?=$)>"+5*Q8&*2IP>J.D4DY%NT
M`Y@`W4-B>J<A>O8)6:*..+`SY&ED`;PZIB2-XJ)""))X#9TCL=2\SNFU8[UC
M*T71VXM'(T<I3&1;7^$,F;BQ\@D$,J9`8P.X(*K(3>W`QEX;'&NIZ=W9:K)!
M>$W;.";I]KM]$*;6G>45=W6TL2"L]".AI"=8B-EW)PP7=G;`\!X9L0A"M!3[
MP!.!391UWU)E;GTV<.;JN+>$\5&WA5PG@-PL@YO,:%!9+Z=.KO:[V.GAB^P[
M-!B[S#D)L,F&RA_ASDK($NA'M!(Q;7[7L-KWX=M9O<TG6RJ8I3%*8I3%*8I3
M%*8I4)\A/M:_RAZ6^[/0,K]L_._[*7YIZE3>T^NOW0J;,H*FTQ2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2K3.7G+ZB\0:-!6*Q5B];(N]^L*=)U'J'6-
M>>62^;/O3IJLZ:5Z&;()&9QC4B*)E7;]XHDU9MRF.83"`$-D_2W2N;U5FO!!
M)#CX<$?,GGF8)'#&#8LQ/$F_!54%F/#ZM6?>=ZQ]EQUDD227(D;3'&@U/(_;
M8>0?5)X`54VFV^R]R:&KH\P=.ZTK-ZM':EK=J!@]1V53Z^DUGQEJC&R3Z<CQ
MCYBQ1#5HR<.SI)';(2B9A;G,5,B@T^[-MVT[W)_I7+R),*/NI.1RG:ZZ7("F
MZJQ+!;FY0]X<2*FX(RLW;U^FH(DR'XM&#K4<;J"2+%A8$^0-V=EZN-`.GD#R
M`'D``RP5<Z8I3%*8I3%*PW>/-^;AV3_U`TY]T6#S6?K<_8F?\=#\XM=-_P`(
M?[[\']2S?[M)6B;G)E>M],4IBE,4IBE,4KC//]T=?\.O\Z-D+>U/\E1Q_A%_
MYA_37U&-;_:[H7UEU;_D;'.]\'\RA_%)]R*\!M\_QK,_6I?G&JM,JJM=,4IB
ME,4IBE,4IBE,4IBE,4KYN//K^?)R^_&.VY]F,GG$76'[6;E^O3?=FO</U/?N
MGZ:_\'A_,K5I68[6QZ8I3%*8I3%*8I6V5_9I/XB<N_KXU/\`8W;<Z']1OYIN
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MZ/DW$Y]I-`D&4(SW#JUZU"'N^UU_9>UXUG+S2%;)IBE,4IBE,4IBE,4IBE0G
MR$^UK_*'I;[L]`ROVS\[_LI?FGJ5-[3ZZ_="ILR@J;3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I4*EV/#[EHVS$..6V->2ERKKBR41O;&@M=@UFC[,C6G8
M\RM$1#2['V06@GBZ1W;`':"AB^H$Y!'J%W.WR[3FX[;_`(LZXD@20H;Q/)"3
MVHS*;:@#I;21Y;&J'Q29V/*-LFB,ZEDU>W57`[&`(O;RBXJ4H=D_3BH,MB78
M2UA81S-.2E6C`&39Q,`Q3;RC^.9J*NE(UN]7%02)=Z<2)G[`F-TZC;970RN8
M`RP,QLI-R%O<`GA<@6XV[>-JJT5@B\P@R`"YM;C;B0/)>NXR54=,4IBE,4IB
ME,4K#=X\WYN'9/\`U`TY]T6#S6?K<_8F?\=#\XM=-_PA_OOP?U+-_NTE:)N<
MF5ZWTQ2F*4Q2F*4Q2N,\_P!T=?\`#K_.C9"WM3_)4<?X1?\`F']-?48UO]KN
MA?675O\`D;'.]\'\RA_%)]R*\!M\_P`:S/UJ7YQJK3*JK73%*8I3%*8I3%*8
MI3%*8I3%*^;CSZ_GR<OOQCMN?9C)YQ%UA^UFY?KTWW9KW#]3W[I^FO\`P>'\
MRM6E9CM;'IBE,4IBE,4IBE;97]FD_B)R[^OC4_V-VW.A_4;^:;E^-A^Y>O.G
M^.G_`!?IO]4R_G8:V><WQ7!=,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE:\/^**
M_J>?Z3.*5>;X('YH_P`/W\6RB_.'&*5E1Q2L<'BG[0V[J7BR:QZHM%KURQD-
MG:[K.X]P4.J^W6ZZ7T5.RJS;9.T*S7/,Y`7,G78\$B^<`B<T>DN=V'04.T&9
M>KS;]FW7K+$P=_*?1[1SLJ/)RDGR$A=L;'DE_P"E'-*`&DOV@)8\RU6GJ+)W
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M]=?NA4V905-IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4KBO7:,>S=OW(J`W9-5W
M;@4D57"H(MDCK*BDW0(HNNIW9![)"%,<P^0`$1Z9$BEW"+[8D`>3M^J>`KXS
M!5+'L`O5JFZ=;1W-[CO$5RI[AVOJ"B;*4KL]-6/7B3BC[`LNOC]ZK-415S88
MM&P4UO:VBH(.UT4F\BBF42D,4#&ZY-M&X2=';\^1E8F+E9N/K54EM)$DOV,E
ME.F0H>*@DJ3VU9\[%7?MM$4,\T&/+8ED[CLGE3O#4NKL)%F%2SH[0^HN-NMZ
M_J32%#@M>4"M("E&P4$V%,%5U3"H[DY5\L9:1FYN2<&,JZ>O%5G3E4PG44,8
M>N6O>=ZW3J#<'W3>)GGSI#Q9C[`4=BJ!P"J`H'`"JW`V_#VS&7#P(UCQU'`#
M^DGM)/E)))\M2YEKJLIBE,4IBE,4IBE,4K#=X\WYN'9/_4#3GW18/-9^MS]B
M9_QT/SBUTW_"'^^_!_4LW^[25HFYR97K?3%*8I3%*8I3%*XSS_='7_#K_.C9
M"WM3_)4<?X1?^8?TU]1C6_VNZ%]9=6_Y&QSO?!_,H?Q2?<BO`;?/\:S/UJ7Y
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MB=JB`LF_0@J&13,8^;+]7@@W&8[##T[#O>Z23:N8\T\(AC(`^$:-UCCB72S<
MR0@DDJ-3:5..=4%H,--T?=/HG;\=;22:48.S/W#WPS%A?2%C!)`+6LK$4SX5
M6N?$S2MU[VWS!W):5=`V2"=,=)Z*V;KC4%'W.@=S(P[ICL/:4;J6J0L/4)Q:
M+9N$`A?.G+A(BY?."IJD[`9#ZQ\[U=1;-%LVPX>.>KUE1LC(QI\B;%B4+)KQ
MX7F=N==F0F15"71M!(:L7Z7@ZKRMV&X3Y&0G3"J^F/(ABBR)W]HKM'&H,48`
M+J&;F&Z`J`#?-YFDZV73%*8I6O=SZ\4U[1.8FB^.6EMV:QUU7=;\AM/UKEC*
M62S4E"S3K/8HN#HZ\KL'8C+O6M<K\,)7UCG4TTDV:R[1H1<BPJAFZ_5EZNUW
MS;Y=_P!XP\G)P\J#-APDC20J9L?'9SD2NGM5YP7'QHR09IBY`9%%]?\`K$ZI
M;8<"7;]NGB@WF%<3)F9RH*8\V3$@CB#\'DDB,D\Q`808T99RC.--ZO/[9.]'
ME\XD<:./>XG.@IODU>+VA-[NA:=7+[-UNL:YUY)W@(^KQ-L2>5=9_97S9!)1
M1PBKV60*F3Z&Z&#"NB\';3)O6[;YC>*@V39WRQC,S1K-+XB''5)66SK&O-+-
MILVH*.RX-_ZFW*7"VK`\`ZB;==V@PEE%FY*/#-D/*@]JS%8-$>JZ]\D@VK$N
M7G9SDY$ZEULC1M]HZ*M^H^#^^.5>T+A"ZMJU@+O2Y:'VQ8]71M9<MK2D^CJ_
M2+6TJIWLHK&)I.D7CH2H'(0H$#:V;TQT7T[NNX;_`#[<<S9SN.R8\.&\SJ(4
MW?&&5,2R$2-)#Q3'5FL4L7+$WK%,7,W_`'&;!Z!\:8MZFGW>*3<%C34PVR5(
M(66,@QAI3,CSG3:Z,$50;55NP>??,2\OKCR3HNV2:NUIQ?JO`":M''AOK:`E
M8K>3SE@C6'^P0LMGG`=6V!:0J-A%*`]BEF_>"F`K"<1ZY.VWH3I':MXBZ>W+
M%;-;=^HMXVR*8RLK8<6WI\!+&$LLDS.P:<2`JH4@+PXVN7JC?M[V<Y&#,N%F
M;;TOC[Q*1&&7*ED>4O`0Q)2`IC,JZ3S-4M]?`6V<D%07116`IB`LDFJ!#AT.
M4%"`<"F#]0Q>O0?\N<X2)RW9"02I(X=G"MLXLXR<:/)`*B1%:Q[1J`-C]47X
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MW)9(".\XA-9T+2>TR6JVR2RJ;=I&1R\[3HV*9E.LJ!EEUU0(@B4QQ`W9[(W/
M9^GI-TW*+!R,G$Q()&[TTLL>A`.))TL2>S@`+D\*H]PW#P6(^3%%+/(HX(BG
M4Q[`!<`?RD]@XU!'#S>W(1[7;G?N9CY>$M.PIN/F*1H[7&A]T/(C1%2;,UD$
M:I,7I2B'=7VW21E2+R;H"D:(N""1N'8$<O/5>!TXD\.#TFK/C0(5DR)9H@V2
MY/MUCUVC0=B#BQ'%N-4&R2;PT3Y&^%%FD8%8D5K1+[DO:[L>UCV`]E7B_A`Z
MX_<MC_$ENG[W^8G]'97]5\K%]_5[YR?;>];T5Y_""UQ^Y;(^)+=/WO\`'T=D
M_P!5\K%]_3G)]M[UO13\(+7'[ELCXDMT_>_Q]'9/]5\K%]_3G)]M[UO13\(+
M7'[ELCXDMT_>_P`?1V3_`%7RL7W].<GVWO6]%/P@M<?N6R/B2W3][_'T=D_U
M7RL7W].<GVWO6]%/P@M<?N6R/B2W3][_`!]'9/\`5?*Q??TYR?;>];T4_""U
MQ^Y;(^)+=/WO\?1V3_5?*Q??TYR?;>];T4_""UQ^Y;(^)+=/WO\`'T=D_P!5
M\K%]_3G)]M[UO13\(+7'[ELCXDMT_>_Q]'9/]5\K%]_3G)]M[UO16([QO]MT
MVW^'OL.$AB7(K]>]ZD63&:UGLFL,.PVO\*NKWDM9JG$1*)^[(/9*=8#*&Z%*
M`F$`S6'KAPIX>A<B1^7I$T'9)&QXRKY%8G^;AY:Z=_A!E1O7A@J+W\%F^0_H
MS^6UJTF,Y!KURIBE,4IBE,4IBE<=V'5JY`/FBW6`.H@`>5,WZH]`#(6]J?Y*
MCC_"+_S#^FOI8:]WYKMO0:.@HEL7O$:?64C]WI?<BR?:)",2F["R-"415+U#
MR&*8Q1^:`B&>@N#MV3X&$_!?@D_ZL7N1]O7@#O<R'>LSVWYU-]BWQC?4JL/P
M@M<?N6R/B2W3][_*KZ.R?ZKY6+[^K7SD^V]ZWHI^$%KC]RV1\26Z?O?X^CLG
M^J^5B^_ISD^V]ZWHI^$%KC]RV1\26Z?O?X^CLG^J^5B^_ISD^V]ZWHI^$%KC
M]RV1\26Z?O?X^CLG^J^5B^_ISD^V]ZWHI^$%KC]RV1\26Z?O?X^CLG^J^5B^
M_ISD^V]ZWHI^$%KC]RV1\26Z?O?X^CLG^J^5B^_ISD^V]ZWHI^$%KC]RV1\2
M6Z?O?X^CLG^J^5B^_ISD^V]ZWHI^$%KC]RV1\26Z?O?X^CLG^J^5B^_ISD^V
M]ZWHI^$%KC]RV1\26Z?O?X^CLG^J^5B^_ISD^V]ZWHI^$%KC]RV1\2>Z?>!C
MZ.ROZKY6+[^G.3[;WK>BOGG<YI%K,<TN6$LR!T#.2Y![4?-0>L'T6\!NYMLD
MJEYU&R;=G(L''8-ZM%=)-5,?(8H"`AG"W62E.KMS1K:AGS#@01[<^47!^M7N
M1ZG3?U3=-$=GT'A_,K5K&8W6QZ8I3%*8I3%*8I6TE_9U-B5JBTCE8E8"68QY
M*Z:N5:^U^C7>X$`C>O6I-7SI2H5V<38'[2@=DJXIF.'42@(`(AT?ZAL67(P]
MS,>BPFAOJ=%[5?W3"_UJ\Y_XZW5-XZ;#7XXF7Y"?^K#YA6R-^$%KC]RV1\26
MZ?O?YO[Z.R?ZKY6+[^N".<GVWO6]%/P@M<?N6R/B2W3][_'T=D_U7RL7W].<
MGVWO6]%/P@M<?N6R/B2W3][_`!]'9/\`5?*Q??TYR?;>];T4_""UQ^Y;(^)+
M=/WO\?1V3_5?*Q??TYR?;>];T4#D#KD1`.ZV/Y1Z>72>Z`#R_KB-`Z!CZ.R?
MZKY6+[^G.3[;WK>BIE;KINFZ#E+O.Z<HI+I=\BLW5[M8A5"=ZW<)I.$%.R8.
MT0Y2G*/D,`"`AE$002#VBIM>[/E*8I3%*8I3%*8I3%*UX?\`%%?U//\`29Q2
MKS?!`_-'^'[^+91?G#C%*RHXI6,CE'X2_%?EUOF&Y*;.E]\0>W*W6X^JUNQZ
MOW==-;FKL7'"_$IH`E;<ME89Z\"25!RLV42.X`0`_7IF>]*>L?J+HW:LC9MG
M&(<#+E+RK+`DNLE572Q;VR`*+*;@&Y';5AZ@Z<VWJ5\63<^87PP1$4;3IN^N
M_P#S!N(/:.'F%2;QD\/W5G%6]2VP*1MCE3>Y69K;BL.8O>')7:.XZN@S<R#"
M2.^85NZS4C&,ILJT>0A'A"`L1(ZA`'LG,`RM^Z]W3J';#M65B;7#`95DU08<
M,,ET#`#F(H;0=9U+>S$*3[45)PNF,/"S8\^.?->6+58/.[(=2Z3J0FS6'%;W
MTGB+&KZLP>LDIBE,4JSO=O`7B1R"L57N.Q]'Z^>7"K[(K>TBVV,J%6C+18[+
M5C*&CFURL"4*>6M=?7$X><L'BJB#GNR=L![!>F3[#UEU+TW(K;3F9$<2Q2HL
M?,?E`3(R,PC#!0XU%D<#4CV=3J%ZM&];%M/4&'+A;I!'(LPB#.57FZ8G5U42
M$%@AT!'4&S1EHR-+$5$ES\-;56X:CL"J[HN>UI\UCY&W#D#KVQU#:5^IMRTJ
MYL<<UKZ%5U=<&4\K/5*N#7FRB+B.9JHQO^VKIHH)(B4H5^)UOG[8=OEVV+'7
M(Q-K.%.9(HY%S4>5Y7\4A6TX+,H!EU.>4C,Q84RMFQLV3,$Y;PF0V*T:`E1C
MOB1*D<L%N$4NH.Q9``0]B";D\'9WA*\+]IT+3.N)*I7BJ5[1E.=ZYJ:FN=FW
M*C2\WKN7=DDK)0K]*P4FW<WBI6V7*9[*,WXJIO':AU#^4PY78GK1ZMQ=_P`O
MJ,R8\V9FR122I+#')#KQ[#&=8F&E&QE`2!ELT:\`:MK='[/_`*>AZ<CYT>-!
MS2DJR,,E6R`PR&Y_M]61J+3&_>:QL+"JGV7X87$3:FX*)NBP5"TQD]1&6O([
MVJU2_6FLZTNS'4BJ*VKFNR=?1D@E7+RE0#-TPBO/4CBU`@`&4^T>LGJS9DRE
MQIHWERIIYB\L:2213Y*LF1/`["\,LRL1(R6U<+BH]RZ0V+=,'&VZ:(QX>+"D
M"K&Q37CQNLB8TI!O)`K+?0Q^R87L:R#9@=9-4)\@Q$-:]0'H(;#TMT$/(/VY
MZ!E?MGYW_92_-/4J;VGUU^Z%39E!4VF*4Q2F*4Q2F*4Q2F*4Q2F*5X$0*`F,
M(%*4!$QA$````.HB(CY```Q2K8=1\P]#[WV_M;2^HK2YOMATHA&EV)9*[$/I
M#7,/.23A9O[3V]_03-6Y2X1_<"=XP;+*J-2#_K.A@$H9'NG2F];+M6-N^Z1"
M"#,)Y2.P$K*!?68CWPA^Q8@`^2K3A[UM^X9LV#A.9)(`-;`$H"?L=?M2P\H!
MX5-.OZ<ZHM=]@'ERM][6]EY^5"?O$@UDY[NIR9>RZ,2+MFQCD1BX))X#-D3N
M^VFT13*8QS`)AM&=EKFS\]8HH!H5=,8(7NJ%U6)/%K:FX\6)/#LJOQH#CQ\M
MG>0ZB;L;GB2;=@X"]A]056V4=3Z8I3%*8I3%*8I3%*8I3%*8I6&[QY?S<.R?
M^H&G/NBP6:S];G[$S_CH?G%KIO\`A#_??@_J6;_=I*T3<Y,KUOIBE,4IBE,4
MIBE<9Y_NCK_AU_G1LA;VI_DJ./\`"+_S#^FOJ,:W^UW0OK+JW_(V.=[X/YE#
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M5^V?G?\`92_-/4J;VGUU^Z%39E!4VF*4Q2F*4Q2F*4Q2F*4Q2F*5"Z[5+>M,
MW#KC8NO+C3:K)2%OU4Z+)3+6+>7NG/X5LS<W&IRU2FEI6(AYIO++(M53*M)%
M%5`YNPF(%$;NK'9<O$W#`GBER55)A921'(&)$;JZZ692H)%F4@CB>-4)`W""
M?%R8W2$EH^)L74BVI2IN`;D`\&X>2NSTKI#4_'76]<U)I2BP&N]>U5J#6&K=
M>9E:M4Q-ZIP]>+")W4E*/E>JCAVX.JX74$3'.8?+DO=]XW/?MPDW3=YGGSY3
M=G8W/U`/(`.P*``!V"HL'`P]LQ5P\&-8L9!P4?TGSD^4GB:E7+9593%*8I3%
M*8I3%*8I3%*8I3%*8I6&[QYOS<.R?^H&G/NBP>:S];G[$S_CH?G%KIO^$/\`
M??@_J6;_`':2M$W.3*];Z8I3%*8I3%*8I7&>?[HZ_P"'7^=&R%O:G^2HX_PB
M_P#,/Z:^HQK?[7="^LNK?\C8YWO@_F4/XI/N17@-OG^-9GZU+\XU5IE55KIB
ME,4IBE,4IBE,4IBE,4IBE?-QY]?SY.7WXQVW/LQD\XBZP_:S<OUZ;[LU[A^I
M[]T_37_@\/YE:M*S':V/3%*8I3%*8I3%*VRO[-)_$3EW]?&I_L;MN=#^HW\T
MW+\;#]R]>=/\=/\`B_3?ZIE_.PUL\YOBN"Z8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*UX?\45_4\_TF<4J\WP0/S1_A^_BV47YPXQ2LJ.*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*5"?(3[6O\H>EONST#*_;/SO^RE^:>I4WM/KK]T*FS*"IM,4IBE,
M4IBE:C'BL^)GS;XX<X]IZATSN@:?KRNP.M'D/7PHNO9L&;F?H,%,RRGLE/U>
M3E%O.Y)XHIT46,!.UV2@!0``YR]8/775.R=5Y&V[9E<K"1(BJ\N-K%HU8\60
MGB23VUZ0?P\^HGU5=;^J?;^I.I]K\3O4\V4KR<_(2XCR)$0:8Y50650."B]K
MFYK'7^6E\2SY1YOBPU)[R,PO_=#KG]._^U#^3K=?_J[ZB_\`(_\`]K+_`"]/
MRTOB6?*/-\6&I/>1C_=#KG]._P#M0_DZ?^KOJ+_R/_\`:R_R]?D_C2^)>!#B
M3D:)S@0PD(.LM2$`YP*(D()_:./8`QN@"/ZF3(?6=UHTR+/N!2`NH9A#"Q52
M1J8+H&H@7(%Q<BUZE3_PO^I!('?'V$/D!&**<S+4,P!*J6YQTAFL"UCI!O8V
MJ(8KQ6/$T>;$8[:M?*JR^VB-@I*M1%7B("E-]?QD1*.$EW*CZH(UM*L6"?.9
M`G9D7+,[E$`[*9RE\F;:Z^]>F`-H@Z/]6L3_`$?"RO/NF7%%X[-E`XVB"F/%
MQP2=,2@N0`6:][Z9]6?\'&R_2N5UCZV883GY(98-GPLC(.!@17[M\@R"?+R"
M`"\K,L8)(5+6M,'Y:7Q+/E'F^+#4GO(S4/\`NAUS^G?_`&H?R=;K_P#5WU%_
MY'_^UE_EZ?EI?$L^4>;XL-2>\C'^Z'7/Z=_]J'\G3_U=]1?^1_\`[67^7K([
MX3WB7\V.27.#76H]T;G&XZ]G:ILJ1E(`:-KV$\Z>0-0?2<2M[(P%7C)1+S5\
MB4_9(L4I^G0P"'DS-?5YUSU3O?5<&V[IE<W#>.4E>7&MRJ$CBJ`\#]6M(?Q$
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M4K7A_P`45_4\_P!)G%*O-\$#\T?X?OXME%^<.,4K*CBE,4IBE,4IBE,4IBE,
M4IBE,4IBE0GR$^UK_*'I;[L]`ROVS\[_`+*7YIZE3>T^NOW0J;,H*FTQ2F*4
MQ2F*5H4>.1^<MW=]:^G/N6UG.1?6O^W.5^+A^:6O7S^$[]Q>U?K&;_>I:A#A
M'Q#UER%CMM[.Y`[P0T#H'2L9#FMUQ:L4)FS/[!9G16D##P,(=!\NZ)VA$[@R
M31R<`$I2E#J)@I^END]IW3:YM]ZBSO!;6F1'C1A5U22SRD:=(LUT6]GL";L#
M=5#$9-ZU?69U%T?N&V=,=$;0=YZQW3FR1Q,QCA2"`7D>22Z@,3P0,Z#@>)-E
M,?\`.3BFOPWY`3.H"6U&^5M>`@+Q1K@1H,>XG*5;&RKN$7E&/0$VDNB1$Z;@
MB?\`JA,4#DZ%,!0QGJ/9<OICJ#-Z>W`J<K#FTDKV,I4.C6XV)4V87/>#6-K5
MDGJJ]8$'K/Z&Q.L(8&Q99FDBEA)U<N>$A90K=K1DD,A(#:39N()-^'&;PO="
M;.UAHZ1WERW1U1O#E4A..N/>JZ_!-["W?(QZ'9BT[P_\R>FBGTFY.10$CK,.
MTF?ND3*KD/V=E8?JQVW*AQ]I;<@O6V5@'*3'T@Q*F@NJR.+\0`==FOY$5B+'
M2_6W\075^Q;YN\G373;9_0O3L\<6X9LDAC?4S$2-CIJ74B=FK3(`1KDT(Z7C
M[0/ARZH<0>YKYS2Y*L./.OM5[F<\?(]U58]&TV"T[*8OFS9X[28>92Z[2I)I
M.B=''FI@[1CG452304$;1TOT3LVY;'A[QU'GG"DW+,.-BPJ%=W=6*%G(U`*S
MJZJ3I`T%G(5DO?NM_77U/C[OA=/>JW86WO=I]I&YS&5C%'%BNI**#J37.;7*
M:M7M51'9Q:W;DGP8V#H[F(3B)59!+9EAM$K4BZREHQ$$5+-`WT2J5E_)M2&,
MG&NV[<3B^]5W*0(G5`02$!#'8.C]YFZS?H=%5MVBR^2S`]S3H64RWXE46)@[
MWXJ0PXV!.;=)>MWI_J+U6+ZU,T'#VB/'E>=6-S&\)*R(A^SU.-,5A=RRBVHV
MKOO$6X4Q7!3;-$U3'WF3OSV?U="7.Q2S]BP8M&UA>N%F<DQ@B,2@96#(NW,9
MN=?JN)!#M"(^7)'6.SXW3G5N9T]@R//A8RPLDC@*[B5"UV5>Z.P6`OV]I[:D
M>I3UFY?K8Z1DZHR\2/"(SIH4C5F8A$(TERW_`%+&SZ>[<7``-A._@6?G*-1_
M6/N+[`9+,E]4_P"W&-^*F^;-89_%K^XS<OUO"_O"UOEYUS7D/3%*8I3%*8I3
M%*8I3%*8I3%*PW>/-^;AV3_U`TY]T6#S6?K<_8F?\=#\XM=-_P`(?[[\']2S
M?[M)6B;G)E>M],4IBE,4IBE,4KC//]T=?\.O\Z-D+>U/\E1Q_A%_YA_37U&-
M;_:[H7UEU;_D;'.]\'\RA_%)]R*\!M\_QK,_6I?G&JM,JJM=,4IBE,4IBE,4
MIBE,4IBE,4KYN//K^?)R^_&.VY]F,GG$76'[6;E^O3?=FO</U/?NGZ:_\'A_
M,K5I68[6QZ8I3%*8I3%*8I6V5_9I/XB<N_KXU/\`8W;<Z']1OYIN7XV'[EZ\
MZ?XZ?\7Z;_5,OYV&MGG-\5P73%*8I3%*8I3%*8I3%*8I3%*8I3%*8I6O#_BB
MOZGG^DSBE7F^"!^:/\/W\6RB_.'&*5E1Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2H
M3Y"?:U_E#TM]V>@97[9^=_V4OS3U*F]I]=?NA4V905-IBE,4IBE,4K0H\<C\
MY;N[ZU].?<MK.<B^M?\`;G*_%P_-+7KY_"=^XO:OUC-_O4M1'P,X\;ONTA8>
M3&AZ9K7>5HXQV"O3;[CE:TI28LVPFT\FXCFKZ,JC1H5M.P<:NX$Z_:=H&(HD
M`@!NG09G1&T[_A)'USL6/!N+XV4<=L?O-)&98V43L@L-(5F:-@Q8.FH#N5?/
M7%UETAB+%ZMNL<S/V7#W[&D*;G$4CA@,#J[1F8DE)'TA0-!#*UKB]74^+'H+
M8^R>9U9]'U2OEZW5LKCS3MM;;U/&/5[K+ZKEV[#L35?8F[?>L:M`-.R"*`=$
MT$B@)0$#]1I>O>GY8_6!ON/LO/S,;'5<N=R3*T2NJB1I).SEQ@PJM@`BL@M8
MBL+_`(=NM=FV?U10MO\`-A;?T_C;QD8&%D%1CQY:!R8GT_'2V9FO=F:X8W4U
M77A^\.=EZ0T@T\0EMHR^[WV],$>-.(VIZ3`KSC**EW+608!N?98)F2!I"QA@
M,,8AVA,H8O;Z=I1,4\NV/I_?^C.FUZBVK"ERNLMS@=<;2A=,&"1!?(F'"\TJ
M-\''Q[I`-KN8\=];_K)Z>ZVZSE]3&=NV)LW1^%*IWG)GD$4DYC=6\!B]OE%I
MW[/L>Q2'BW@SP-V%O_8^Z^3O)77&R+C5-'7B<?WO5%5A%'&S]P;P1D$Y=QK5
MI#$['F4<RDGJ:DP;M%!-`P(]0*8XA:?5UTF^W[9_KK)PY\W'Q92N'C1"[Y.4
MC\9'OP2&&0ZG<FQD!`5@C"LC]<OK@VKI[#V_U;=%Y^#@[GN^''ISIGMBX&WN
MC(LX?M>61$*XX\_?/'3>Z+1%R/.\MN7._.<.RJGP<Y22^NF-5X]Q>YXYO'(Z
MPK=TCG5?:6&O5A]+0YIIU7::R%BS6%RF)7"RBP]KM&*-TZ4$9Q>H,WJ3<X=L
M]8FY94<$AD&ETAE6.2;E(65E+Q"*"-]1**(VXM?5@?6NWC%Z*Z3Z/]56U9/5
M?JLPYFGS#A,6&7-C.66.:94<*K9+&>5-!#:0@L%!$8>.AK>DUN8XHVF%W57;
M_8C:'I]'/66#8"R[VJP$,S6B-KF<^RSXYX2Y*JF!`@ICV3`(]\IY>EA]<N'B
MXWK#R<O'E1LC*C3FP*+-B<E`L:OY#S@S%."V$9X$6K)OX1=[W7<.G=ZP,S;9
ML7#CW:>=9V/<DEGE<RXZC2MGQK`.;F^H=U:@/P+/SE&H_K'W%]@,EDCU3_MQ
MC?BIOFS64_Q:_N,W+];PO[PM;Y>=<UY#TQ2F*4Q2F*4Q2F*4Q2F*4Q2L-WCS
M?FX=D_\`4#3GW18/-9^MS]B9_P`=#\XM=-_PA_OOP?U+-_NTE:)N<F5ZWTQ2
MF*4Q2F*4Q2N,\_W1U_PZ_P`Z-D+>U/\`)4<?X1?^8?TU]1C6_P!KNA?675O^
M1L<[WP?S*'\4GW(KP&WS_&LS]:E^<:JTRJJUTQ2F*4Q2F*4Q2F*4Q2F*4Q2O
MFX\^OY\G+[\8[;GV8R><1=8?M9N7Z]-]V:]P_4]^Z?IK_P`'A_,K5I68[6QZ
M8I3%*8I3%*8I6V5_9I/XB<N_KXU/]C=MSH?U&_FFY?C8?N7KSI_CI_Q?IO\`
M5,OYV&MGG-\5P73%*8I3%*8I3%*8I3%*8I3%*8I3%*8I6O#_`(HK^IY_I,XI
M5YO@@?FC_#]_%LHOSAQBE94<4IBE,4IBE,4IBE8QN0WBB:SX][[4TJ^U#N:^
MPE1F-1P.\MQTF%AG6N-#2F]99&'U8SNRDA,L9^5<69RY2-V(AF^%LFH45>P(
M],V#TEZO-PZLP!G0Y6)BG(DR(L-)F8-FSXD1ER(H=*L%,2VNTA1"QT@FQMCW
M4744'3P.N&;)>+$\7.(0&./B\TQ":6Y``)61E2^MDC9E!N*G;EYS!A^*4)KX
MK/56S-\[,VW:7-3UCIO4+*&=7>X/8N%>V6Q/&RMDEH*!CXRNUV/6=.%7+I(!
M`H$(!CF`N8_TWT_)U%G3XYGAQ,+#Q7R<F>8D1P0(RIK?2&9KR.B*J*S$MV6!
M-7#<MSQMLVY=PE);G3QP0(/;332W*1I?@#H1Y&+6"HC$U:-?O&,TU7=<Z<V%
MKW2V]]VCL_4UEWQ:*QKROP03VF-/T.<5JNP[KL@E@G8AH@A3+8T<1Z[5BH[=
MKJME#(IG3`##F4/JJW$;]F[/N6=@X>#AY&+!XJ1F,$LN<HDPDCTJSDY$1$@N
MH"+[<J>%8_\`ZPBDV;'S<?$R9-\R3DJF``HR=>%<9:L"=`Y,FF/5JTR,Z:"0
M;U56R_%FTM0=HUJEPVM-P;'UXK%Z0F=I;[IT'$GU=I"/Y'*,2Z:6OJLI+L+"
MN:W)22"HECF3P6::@"OV!'IDK:?59O6Y-/CY.1B8FX+FY>'CPRN=>7EX*,^5
M!!I#+>,`#6Y5&9@%)KYG];;9B[?!N6''/EPR8,6;*(E[V/A3.$3(F4V('"1C
M&+R!8G.GLOE1`0$`$!`0$`$!#R@(#Y0$!_5`<UB00;'MK,5964,I!4BX/G%0
MIR#\NM>@>7_\0]+?=GH&5^V?G?\`92_-/4N;VGUU^Z%39E!4VF*4Q2F*4Q2M
M"CQR/SEN[OK7TY]RVLYR+ZU_VYROQ</S2UZ^?PG?N+VK]8S?[U+6-?6&W=J:
M3LP733^P[?K.V@R<1HV&ES;N#E#QSOL^<L5EVIR@NU6$@")#@8O4.H=!\N87
MMN\;KL\K3;5D38\KKI8QL5U+<&Q\AX@'SBW"MX]0],=.=68(VSJ?!Q=PV]9`
MXCGC610XN`P![&`)%Q;AP-3SQ[Y8VS4N]+1R$N=EV3=M@2]+OD6212LY?/;7
M9[=$J138FP9:6,X>/J:@=R9TY;-P[Y59NB0G9)VA"NV?>VVF'='4RMG9^WSX
MP[PY;-DV5WR+]Z18Q>6-`03.D)9@BFL3ZV]7F!U1TY@=*8,.#C;+BY^+*5,1
M^"AQFU6Q52RI,UA%K;NB)Y>UB*XE6YY\V*37(2HU'E3NVM5BMQK6(@8"%NKU
MC$Q$8R2*BT81[-(H)MVK=,H%(0/(`94#K;K`*J_2>9I554?"'@JJ%4#ZBJ`!
M]05'N'J@]56ZYTVY[CT]M,VX9$KR2R/`I9Y'8L[L?*S,22?.:X=4YQ\R*(VE
MF=+Y.[FJS2>L$M;)MO!W)ZQ2EK//+@YFY]^5,/\`:965<%`ZZQNICB`=?F!D
MC$ZLZFP,2/`PL_*BPH@P1%<A5#.TC6'DU.[.?.S$^6IFY>J;U8[QD+E;KL&U
MY&2L21!I(%9A'&H2-`3V*B@*H[`*AG9NV-G;IM2MYV[?;1LFY+L648M9[A*+
M3$TK'1P*`P9'>K^K%LS!4P)E^87M#EGR<O*S,M\_+D>3-D8,SL;LS*`H)/E(
M55`^H!65;'T_L?3.W+L_3V)!A;4A8K%"H2,%S=B%'"['B?.:]=^VGLG:KJ"?
M;+O-FO;RKUZ/J5<=6:35DUH.KQ1`3C("-.MY6T6P3#HDD'D*&19^=F;KG2;G
MN4KS[C-;7*YU.^D674?+8&PK[LO3^Q].8SX>P8D&'B22M*R1*$5I'-W<@=K,
M>)/EK)YX%GYRC4?UC[B^P&2S//5/^W&-^*F^;-:$_BU_<9N7ZWA?WA:WR\ZY
MKR'IBE,4IBE,4IBE,4IBE,4IBE8;O'E_-P[)_P"H&G/NBP>:S];G[$S_`(Z'
MYQ:Z<_A#_??@_J6;_=I*T3<Y,KUNIBE,4IBE,4IBE<9Y_NCK_AU_G1LA;VI_
MDJ./\(O_`##^FOJ,:W^UW0OK+JW_`"-CG>^#^90_BD^Y%>`V^?XUF?K4OSC5
M6F556NF*4Q2F*4Q2F*4Q2F*4Q2F*5\W+GU_/DY?_`(QVW/LQE,XBZP_:S<OU
MZ;[LU[A^I[]T_37_`(/#^96K2<QVMCTQ2F*4Q2F*4Q2MLK^S2?Q#Y=_7QJ?[
M&[;G0_J-_--R_&P_<O7G3_'3_B_3?ZIE_.PUL\YOBN"Z8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*UX?\45_4\_TF<4J\WP0/S1_A^_BV47YPXQ2LJ.*4Q2F*4Q
M2F*4Q2L*O+?2GB#;7YFZ]LU6TQQQV9P^U=*TZR0-'O.Z[10I&S;):N(]5WM?
M8E<@=>3K>[O=;(BN%7A7CKV/1>)D>*"*W8!+;70.\=$;+L.4^[Y6=B]69)DB
M2:&!)O"XS!E=<?7*@2;*%A/.!K6(F%+`LS87UGMV];K/!C[7%#-LT<0DFBDD
M,8R\A"7@28JI;PV.VEA%Q5Y1S7#A4C7N-]43FOO:VU#D#JG56HHS;W#KD_N*
MN:BI>RKA=:[1]XZ2LM'3H[BVREB)5!F*I84)&1663*BP>,'!H\2H.%$5B+#;
MMBGZ6V3%;%SLG);"ZAZ=,&88T1I,*8Y0EC,::[2J5@C)1VC<+-W@K+:JW?,3
M<-YTX@1$?:=QPL[&:YTSR^$9,F%C;NJHR65)%U#6@U`'4!:"^\+;F7IO5NLF
M&@7>B;UL*Z<2MO\`%/D6WV%8[95H&KDWAL6;V=+[&UP\C(J95L*U*D+,ZCT(
MUTDS(_2236,JF81+F99'7O1F^;MG[;NWCL?I1\[:<C'DC1'G(VF`8PCDC+*`
M,I+R%@Y,3'3WA5CQ]EZCP1A]7P+C/UO!+N<KP%F&,QW.19RJR6+#P\D42:M-
MI5UL`IL*JK8/A:<G(.>FM+Z>DM03G&C?]<X7P>\KW<)NS0^S]=+<2$Z\S?O*
M)56;"1B+>79+*OD$".'K+V-4.(!W@=!"/;?6;TWF;FN_;^F7%G[=OFZ;GAQQ
M!'2=MP3N8\S'28Q`ZI\(H;F+>Z@U03]%[KMNT^#V1X)<O-Z?@VC*,NI5C2)Y
M->5"!<L6CR)K1,>#*G?L3;8B12(@DDBF`@FBF1(@"/40(F4"%`1'RB/0,T&[
MM(YD;VS$D_RFMF8\$>-CIC17Y4:*HOYE``_F%6R\G:)`SU,2FWZ]F3?(W/3T
M80D7=KE!QHM76X*4V5,I#0L\PB%7@)/#]AR9`7"1P(<ARG3(8MTVG(DCGY:Z
M-.B0\54G\&WE()MP[+V]FODZ!EN;WN/*?.*KWT&47]_;*^.G<7O[RF\?/YHO
MDH_O*CY2?;>^/IIZ#*+^_ME_'3N+W]X\?/YHODH_O*<I/MO?'TT]!E%_?VR_
MCIW%[^\>/G\T7R4?WE.4GVWOCZ:>@RB_O[9?QT[B]_>/'S^:+Y*/[RG*3[;W
MQ]-/091?W]LOXZ=Q>_O'CY_-%\E']Y3E)]M[X^FM&_QJ("/K'B+[FA8Q2459
M-JUJ-1(\S.35DD1,YUG6UU`6E[#(2DLX*"AQ[!5%S%3+T*4`*``''?K;D:7K
MS+D:VHQP=@"C\$GD4`?S5Z__`,)@"^HK:@.SQ&;]7_Y<OGK%;FMZZ/IBE,4I
MBE,4IBE97?!-K\?9_$3U5#2BDJDR<4K;:BAX:=FZW(`9O19%5/NI>NR$7*H$
M$P>J*18I3AY#`(>3-E>J*5H>N\:1-.KE3]H##C&?(P(_FKFO^+=0WJ+W(&]O
M%X782/\`Y">:MX7T&47]_;+^.G<7O[SL+Q\_FB^2C^\KR%Y2?;>^/IIZ#*+^
M_ME_'3N+W]X\?/YHODH_O*<I/MO?'TT]!E%_?VR_CIW%[^\>/G\T7R4?WE.4
MGVWOCZ:>@RB_O[9?QT[B]_>/'S^:+Y*/[RG*3[;WQ]-/091?W]LOXZ=Q>_O'
MCY_-%\E']Y3E)]M[X^FGH,HO[^V7\=.XO?WCQ\_FB^2C^\IRD^V]\?33T&47
M]_;+^.G<7O[QX^?S1?)1_>4Y2?;>^/IIZ#*+^_ME_'3N+W]X\?/YHODH_O*<
MI/MO?'TT]!E%_?VR_CIW%[^\>/G\T7R4?WE.4GVWOCZ:>@RB_O[9?QT[B]_>
M/'S^:+Y*/[RG*3[;WQ]-8C/'#U?5JKX>NQ)B*<W15XC?-1I$)-[*V+9F'9<;
M`A45.\B;):96+5.!#CV3&1$Q#=#%$#``YK#UP9<LO0N1&XCTF:#LC13PE7RJ
MH/\`/73G\(,:KZ\,%A>_@LWRG]&?R7M6DAG(5>N5,4IBE,4IBE,4KCNQZ-7(
M_K-UA\H`(?\`AF^:`]0'(6]J?Y*CC_"+_P`P_IKZ76O=(TA>@498[W8X'5IU
M84,">Y=O(I@8\(Q,/821O":29>H^0I2@4/U``,]!,'/G\##PB_!)_P!*/W(^
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M/GLH],BWMTDFF+N2DG#N0?N!*7U:RZJBJ@^4QA$>N<+]9,7ZNW-VM<YTW8`!
M[<^0<!]:O<CU.BWJFZ:`[/H/#^96K5\QNMCTQ2F*4Q2F*4Q2MI?^SGT*!NE(
MY6JS2]G1-'W35J3<*]>+I4"&*O7;4=072=3GX5-\<!3#LF7!0Q`Z@40`1`>C
MO4/D208>YB,)8S0^V16^Q?W0-OK5YS_QUHK;QTV3?\TR_*1_U8?,:V2_091?
MW]LOXZ=Q>_O-_>/G\T7R4?WE<$\I/MO?'TT]!E%_?VR_CIW%[^\>/G\T7R4?
MWE.4GVWOCZ:>@RB_O[9?QT[B]_>/'S^:+Y*/[RG*3[;WQ]-/091?W]LOXZ=Q
M>_O'CY_-%\E']Y3E)]M[X^FGH,HO[^V5Y!`?MT[B'YGE^8-ZZ#CQ\_FB^2C^
M\IRD^V]\?34N((D;((MTQ4%-NDFBF*RRSA42)$`A!5<.#JKKJ"4OJCG,8YA\
MHB(B(Y1DW-SVU,KVY\I3%*8I3%*8I3%*8I6O#_BBOZGG^DSBE7F^"!^:/\/W
M\6RB_.'&*5E1Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2H3Y"?:U_E#TM]V>@97[9^
M=_V4OS3U*F]I]=?NA4V905-IBE,4IBE,4K0H\<C\Y;N[ZU].?<MK.<B^M?\`
M;G*_%P_-+7KY_"=^XO:OUC-_O4M8D\UU71U,4IBE,4IBE,4K+QX%GYRC4?UC
M[B^P&2S8WJG_`&XQOQ4WS9KFW^+7]QFY?K>%_>%K?+SKFO(>F*4Q2F*4Q2F*
M4Q2F*4Q2F*5AN\>;\W#LG_J!IS[HL'FL_6Y^Q,_XZ'YQ:Z;_`(0_WWX/ZEF_
MW:2M$W.3*];Z8I3%*8I3%*8I7&>?[HZ_X=?YT;(6]J?Y*CC_``B_\P_IKZC&
MM_M=T+ZRZM_R-CG>^#^90_BD^Y%>`V^?XUF?K4OSC56F556NF*4Q2F*4Q2F*
M4Q2F*4Q2F*5\W'GU_/DY??C';<^S&3SB+K#]K-R_7IONS7N'ZGOW3]-?^#P_
MF5JTK,=K8],4IBE,4IBE,4K;*_LTG\1.7?U\:G^QNVYT/ZC?S3<OQL/W+UYT
M_P`=/^+]-_JF7\[#6SSF^*X+IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K7A_Q1
M7]3S_29Q2KS?!`_-'^'[^+91?G#C%*RHXI3%*8I3%*8I3%*8I3%*8I3%*8I4
M)\A/M:_RAZ6^[/0,K]L_._[*7YIZE3>T^NOW0J;,H*FTQ2F*4Q2F*5H4>.1^
M<MW=]:^G/N6UG.1?6O\`MSE?BX?FEKU\_A._<7M7ZQF_WJ6L2>:ZKHZF*4Q2
MF*4Q2F*5EX\"S\Y1J/ZQ]Q?8#)9L;U3_`+<8WXJ;YLUS;_%K^XS<OUO"_O"U
MOEYUS7D/3%*8I3%*8I3%*8I3%*8I3%*PW>/-^;AV3_U`TY]T6#S6?K<_8F?\
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MIBE,4IBE,4IBE,4J$^0GVM?Y0]+?=GH&5^V?G?\`92_-/4J;VGUU^Z%39E!4
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MIBE,4IBE,4IBE,4IBE,4IBE,4K7A_P`45_4\_P!)G%*O-\$#\T?X?OXME%^<
M.,4K*CBE,4IBE,4IBE,4IBE,4IBE,4IBE0GR$^UK_*'I;[L]`ROVS\[_`+*7
MYIZE3>T^NOW0J;,H*FTQ2F*4Q2F*5H4>.1^<MW=]:^G/N6UG.1?6O^W.5^+A
M^:6O7S^$[]Q>U?K&;_>I:Q)YKJNCJ8I3%*8I3%*8I67CP+/SE&H_K'W%]@,E
MFQO5/^W&-^*F^;-<V_Q:_N,W+];PO[PM;Y>=<UY#TQ2F*4Q2F*4Q2F*4Q2F*
M4Q2L-WCS?FX=D_\`4#3GW18/-9^MS]B9_P`=#\XM=-_PA_OOP?U+-_NTE:)N
M<F5ZWTQ2F*4Q2F*4Q2N,\_W1U_PZ_P`Z-D+>U/\`)4<?X1?^8?TU]1C6_P!K
MNA?675O^1L<[WP?S*'\4GW(KP&WS_&LS]:E^<:JTRJJUTQ2F*4Q2F*4Q2F*4
MQ2F*4Q2OFX\^OY\G+[\8[;GV8R><1=8?M9N7Z]-]V:]P_4]^Z?IK_P`'A_,K
M5I68[6QZ8I3%*8I3%*8I6V5_9I/XB<N_KXU/]C=MSH?U&_FFY?C8?N7KSI_C
MI_Q?IO\`5,OYV&MGG-\5P73%*8I3%*8I3%*8I3%*8I3%*8I3%*8I6O#_`(HK
M^IY_I,XI5YO@@?FC_#]_%LHOSAQBE94<4IBE,4IBE,4IBE,4IBE,4IBE,4J$
M^0GVM?Y0]+?=GH&5^V?G?]E+\T]2IO:?77[H5-F4%3:8I3%*8I3%*T*/'(_.
M6[N^M?3GW+:SG(OK7_;G*_%P_-+7KY_"=^XO:OUC-_O4M8D\UU71U,4IBE,4
MIBE,4K+QX%GYRC4?UC[B^P&2S8WJG_;C&_%3?-FN;?XM?W&;E^MX7]X6M\O.
MN:\AZ8I3%*8I3%*8I3%*8I3%*8I6&[QYOS<.R?\`J!IS[HL'FL_6Y^Q,_P".
MA^<6NF_X0_WWX/ZEF_W:2M$W.3*];Z8I3%*8I3%*8I7&>?[HZ_X=?YT;(6]J
M?Y*CC_"+_P`P_IKZC&M_M=T+ZRZM_P`C8YWO@_F4/XI/N17@-OG^-9GZU+\X
MU5IE55KIBE,4IBE,4IBE,4IBE,4IBE?-QY]?SY.7WXQVW/LQD\XBZP_:S<OU
MZ;[LU[A^I[]T_37_`(/#^96K2LQVMCTQ2F*4Q2F*4Q2MLK^S2?Q$Y=_7QJ?[
M&[;G0_J-_--R_&P_<O7G3_'3_B_3?ZIE_.PUL\YOBN"Z8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*UX?\45_4\_TF<4J\WP0/S1_A^_BV47YPXQ2LJ.*4Q2F*4Q
M2F*4Q2F*4Q2J+V-:9:D4.WV^!I5AV/-5JO2LU%T&I'C$[/<'T>T5<MJ[`GFG
MT;$EE955,$4!<N$404,';.4.HY-@C6;)B@=A'')*B%VOI17<*9&M<Z4!+M8$
MZ0;`FPJ)5#7N0+*Q_E*J2%'U6(TCR7(OPJDM#;,M.W]7UR_W/3E^T)8IL'HO
M]6[-5KBUSKGFKU=JB$LI5)B>@C>?(I`NGW+I3_5G#M=#=0"[=0;5B;-N)PL+
M.Q]P@"*W.@UB,EA<K\(J-=3P;A:_82*M.T;AD;EC-/E8LV)(LKH$ETZF"FPD
M&DD:7'%;V:W:`>%3#EDJZ5:SR@L5QCJDA'0VNGUDAU+CJ!VK/H6>M1*",@CM
MZF*MH@6$J[1?F5>N$$D07`@HIBN!C"!2&$+OM$4#3ZGE"OHDX:6/#EMQN!;A
MVV[>%4\[,%L%N+CC<><56/I%W#\GB;^,C7/TWR1X7"_25]X_HJ+7+[@^R*>D
M7</R>)OXR-<_3?'A<+])7WC^BFN7W!]D4](NX?D\3?QD:Y^F^/"X7Z2OO']%
M-<ON#[(IZ1=P_)XF_C(US]-\>%POTE?>/Z*:Y?<'V13TB[A^3Q-_&1KGZ;X\
M+A?I*^\?T4UR^X/LBM<7Q"?"9YF<QN5U_P"0=-KM!J%>N$11HYG`6F^1JTVT
M5JE0B:X[4=*0Z3R/%-TYCS*)=A0P@F8.UT'J&:2ZS]4F3U-U%-O.+N>)%!*L
M8"O%/J&A`IOI4CB1<?4KM_U+_P`5/3'JR]7>'T9NNT;GDYN-+.S20OCB,B:9
MY0`'<-P#`&X[1PX597_=^N>G[?4'NX'UAF+?[#;C_F^!\ED?>5M/_P!Y^B/\
M@WKY3$_*4_N_7/3]OJ#W<#ZPQ_L-N/\`F^!\ED?>4_\`>?HC_(-Z^4Q/RE/[
MOUST_;Z@]W`^L,?[#;C_`)O@?)9'WE/_`'GZ(_R#>OE,3\I3^[]<]/V^H/=P
M/K#'^PVX_P";X'R61]Y3_P!Y^B/\@WKY3$_*4_N_7/3]OJ#W<#ZPQ_L-N/\`
MF^!\ED?>4_\`>?HC_(-Z^4Q/RE/[OUST_;Z@]W`^L,?[#;C_`)O@?)9'WE/_
M`'GZ(_R#>OE,3\I5[?AX>$]S+X:<K*5R!N=;H=PK]7KUYAW4#5;Y&(S;E:UU
MMU"-%FYYE)E'@DU7<`=3M*%,)`]3U'R9E71?JER.F>H8MYRMSQ)8(TD!5(IP
MQUJ5%M2@<">-:I]=7\4_3'K/]7F7T;M6T;GBYN1-`XDF?',8$4HD((1RUR!8
M6';VUL9^D7</R>)OXR-<_3?-V>%POTE?>/Z*XCUR^X/LBGI%W#\GB;^,C7/T
MWQX7"_25]X_HIKE]P?9%/2+N'Y/$W\9&N?IOCPN%^DK[Q_137+[@^R*>D7</
MR>)OXR-<_3?'A<+])7WC^BFN7W!]D4](NX?D\3?QD:Y^F^/"X7Z2OO']%-<O
MN#[(JGZONW9-QADYZ!X_6%>-5?3,:15?86NVZ@NH":D*_)E[HTP8>PG)Q:Q2
M&Z]#E`#!Y!R;-@8L#\N3)4/8'VC^4`CR>8BOBRR,+JAM_**J#TB[A^3Q-_&1
MKGZ;Y*\+A?I*^\?T5]UR^X/LBGI%W#\GB;^,C7/TWQX7"_25]X_HIKE]P?9%
M/2+N'Y/$W\9&N?IOCPN%^DK[Q_137+[@^R*>D7</R>)OXR-<_3?'A<+])7WC
M^BFN7W!]D58OXC.EN1G-/BQ:]!TO4+>G6"P66BSC:=MFQ*<M"MT:I:(Z>=HK
MIPKM\_,LZ;LC)I=E,2@<P"80#KF)];=*1]4=/R;/B9L,4SR1MJ>.4J`CAC[5
M;\;<*VWZD?6/A>JWU@X_6&[8>1E84,$\9CA:,2$S1-&""Y"V!:YN>SLK79_N
M_7/3]OJ#W<#ZPS2O^PVX_P";X'R61]Y7:_\`[S]$?Y!O7RF)^4I_=^N>G[?4
M'NX'UAC_`&&W'_-\#Y+(^\I_[S]$?Y!O7RF)^4I_=^N>G[?4'NX'UAC_`&&W
M'_-\#Y+(^\I_[S]$?Y!O7RF)^4I_=^N>G[?4'NX'UAC_`&&W'_-\#Y+(^\I_
M[S]$?Y!O7RF)^4I_=^N>G[?4'NX'UAC_`&&W'_-\#Y+(^\I_[S]$?Y!O7RF)
M^4I_=^N>G[?4'NX'UAC_`&&W'_-\#Y+(^\I_[S]$?Y!O7RF)^4KU+_V??GJJ
MBLD"FH`%1)1,!&[FZ`)R"4!'HP$>@=<^'U"[B01]+X'R61]Y7U/XZ.AU8-]`
M;UP/QF)^4K;VJUNW-`5BN02_'V776A8&'B5ET=D:[[I96-CV[-15+MRI#]VH
M=$1+U`!Z#Y0#.D<?!PX<>.%LI"R(H/<D\@`\U>;&X9CYF?/EI&P269W`)%P&
M8L`;>47XUWOI%W#\GB;^,C7/TWR=X7"_25]X_HJCUR^X/LBGI%W#\GB;^,C7
M/TWQX7"_25]X_HIKE]P?9%/2+N'Y/$W\9&N?IOCPN%^DK[Q_137+[@^R*>D7
M</R>)OXR-<_3?'A<+])7WC^BFN7W!]D5T3O=&S&-AA*NXX^V`LQ8(^<E(M$N
MP]=&159UQ2'2E3J+^S`%2.D>=;=@O01.!C"'[$<F#!Q6C:49*Z%(![C]K7MY
M/J&OAED#!2AN?JCR5WOI%W#\GB;^,C7/TWR7X7"_25]X_HK[KE]P?9%/2+N'
MY/$W\9&N?IOCPN%^DK[Q_137+[@^R*>D7</R>)OXR-<_3?'A<+])7WC^BFN7
MW!]D4](NX?D\3?QD:Y^F^/"X7Z2OO']%-<ON#[(IZ1=P_)XF_C(US]-\>%PO
MTE?>/Z*:Y?<'V16JWR2\$GG!NWD+N_<<%'ZRA87:>T[M?HF'F+VV4EHN/M$Z
M[E6K"248M%F1WK5%P!%!2.9,3`/9$0SGW?/4KF[KO67N<6ZX219&0\@5HLBX
M#L2`;):XOQM7H1T-_&1TATKT7M/3&9LF[2Y>W[?!CNZ28P1VBC"%E#2!@I(N
M+B]NVH5_N_7/3]OJ#W<#ZPRU_P"PVX_YO@?)9'WE95_[S]$?Y!O7RF)^4I_=
M^N>G[?4'NX'UAC_8;<?\WP/DLC[RG_O/T1_D&]?*8GY2G]WZYZ?M]0>[@?6&
M/]AMQ_S?`^2R/O*?^\_1'^0;U\IB?E*?W?KGI^WU![N!]88_V&W'_-\#Y+(^
M\I_[S]$?Y!O7RF)^4I_=^N>G[?4'NX'UAC_8;<?\WP/DLC[RG_O/T1_D&]?*
M8GY2G]WZYZ?M]0>[@?6&/]AMQ_S?`^2R/O*?^\_1'^0;U\IB?E*S/^%#PQY3
M>'S7-V0NPM<P-^7VC8:9,1:U(V#6D$8Q&LQ4U'N49$+`K'',JY4E"F3[H#E[
M)1[70>G7:'J\Z!/1L.5%G;ACS'(=&'+CF%M(8&^I1VWX6KES^(GUW;1ZYL[:
MLK9-OS,--OAG1Q.\)+F5T8%>6S<!H-[^<6K+<.Q]OEZ=KCU,D`1Z`)ME:X`!
M'H(]`ZR_E'H&;&\+A>3)7WC^BN<.9+[C^<5X]).W?D^R_P`9>N/IOCPN'^DK
M[Q_13F2>X_G%/23MWY/LO\9>N/IOCPN'^DK[Q_13F2>X_G%/23MWY/LO\9>N
M/IOCPN'^DK[Q_13F2>X_G%<.1VOM6+CWTF[X_30-(YFZ?NC)[(URHH5LS0.X
M7,1,)<!.8J28B`?JY$F'B.P1<E;DV]H_E^M7PRR`7T?SBI?K%H86FM5VSM$W
M#9I9(&'GVK=PF/G"#:9CFTB@BOW0'3[]))R!3]D1#M`/0<HY87AE:)K%E8CV
M#:IBNK*&'81>N\\Z0_;&_P#*5_T,EZ6J+4*>=(?MC?\`E*_Z&-+4U"GG2'[8
MW_E*_P"AC2U-0IYTA^V-_P"4K_H8TM34*>=(?MC?^4K_`*&-+4U"GG2'[8W_
M`)2O^AC2U-0IYTA^V-_Y2O\`H8TM34*UY>])_>B.UU'L_D>?F]DWREN\^9TZ
M_L/_`'?-SY8TN.VKT?!`_-'^'[^+91?G#C/E?:RHXI3%*8I3%*8I3%*8I3%*
M8I3%*8I7#?Q["4;^:23)K(-?.&;KS9XW2<H><Q[Q"08..Z6*<G?,GS5-9(W3
MJFJF4Q>A@`<B5F0ZD)!L>SZHL?9'"OA`/`]E<S(:^TQ2F*4Q2F*4SX2`+GLI
M4!UWE5QEMUN:T"J<@]+V6\/9%W$,ZA`[,I\O9'<K'@X,^CFT,PEUY!9\S*T5
M%5(J8G3[LW:`.R/2^'IGJ)<([BV#EC;Q&)#(8I-`C-K/JTVTFXLU[&XX\:M\
MF[;7%DG"ER(%S%DY90NH</?3H*DW#:N&FU[\+7J:9J;AJW$2,_89:-@H*'9K
MR$M,S#UM&Q<8P:D%5R]D'[Q1%JS:-TRB8ZBARD*`=1'+/%')-*D$*EII'554
M"Y9F(554#B68D``<22`.-7$`G@./_P!.)_FKL$U$UDR*I'(HDJ0JB:B9@.11
M,Y0,0Y#%$2F(<H@("'D$,^,K(Q1P0X-B#V@CM!J7%+'-&LT+*\+J&5@0001<
M$$<"".((X$5^\AJ.F*4Q2F*4Q2F*4Q2F*4Q2N%'QT?%-2LHQDTCF9572Y6K)
MNDU;E7>NEGKQ8J*)")@JZ>.%%5#=.IU#F,/41$<B9F<ZG)+?5^IP'\U?``!8
M=E<W(:^TQ2F*4Q2F*4Q2J6<WBEL[A&:]>6VM-;Y-PLC9(:E.)R,0M<M7HARU
M92L[&UY1R66?1$8[?(I.'*21D45%2%.8!,`#4Q8>7-BRYL,4CX<#(LD@4E(V
MDOH#L!92^EM(8@MI-KV-2Y)HH6C29E5IF98P2`795U,J7]L57O$"Y"\3PK]Q
MEUITU9+)3H>UUR5MM-3B%;=5XZ;C7M@JZ=@;*O()2PP[9RI(0Q)EH@=5J+A-
M,'"9!,3M``CGQL3+7#3<&BD&!*[HDFD\MWCMS$5[:69-2ZU!)6XN!<5#XB#Q
M)P]:>+6-9"EQK".657*]H5BC!6M8E6`/`U4V4]3JZ2P66NU..]F+3/0]<B?/
M8V-]DYV29Q,?[(3,@VB8ACYX^60;^>2DH\1;-T^UVUEU2)D`3&`!G8^//ESK
MBXJ/)DO?2B@LS64L;*+DV568V'``GL!J"21(87R)B%@C4L[$V55':S$\`!Y2
M>`KN\DU'3%*8I3%*8I3%*8I7$4CV*SUK)+,VJL@Q1=MV3Y1!([MHW?BV,^1;
M.#%%5!)X9FB*I2B`'[HG7KV0Z1!F"E03I-KCR&W9[%S7RPO?RUR\AK[3%*8I
M3%*8I3%*8I5,6N[4VAQ[66N]LK=.BWTM&0#*2M$W&P+!W.3;HC&'AVSN4<M6
MZ\I*O5"I-T"F%590P%(41\F5&)AY>X9*X6!%)-F.&*I&I=V"*78A5!)THK,U
MAP4$G@#4G)R(,/&DS<MUBPX@"[N0J(&944LQL%!=E4$D79@!Q(JI\IZG5U4U
M.PM<8&E+!+1T)&D<,69Y"5>-V#,KJ3>MXV.;&<N5$T@7?2#I)!$O7M**J%(4
M!,(!DR&*7(E6"!2\[WTJ!<FP+&P'$V52Q^H">P5"[I%&TTA"Q(I9B>`4#M)/
M8`/.:]<#8Z_:HX)>L3D18HH7<@P"2@Y%G*L!?1+YQ%RC,';%9=OYU&R315NN
MGVNVDLF8A@`Q1`/LT$^.5$Z,A=%==0(NCJ&1A?M5E(96'!@002#7Q9(W9T1@
M7C<HX!N5=>U6'D8>4'B/+7<Y*J.F*5Q777_9^GS>_#YTKD:=O'S5"_9]>O'J
M_P!</\^1]VH./GIZO]</\^.[3CYZ>K_7#_/CNTX^>O6LB1PBJW<)I+H+IJ(K
MHJE!1)9%4HD525(8!*=-0AA`P#Y!`>F?00#<7O3CYZ];5J@Q:MF+)!NT9,VZ
M+1HT;)%1;-6K=,J+=LW13*5-%!!(@%(4H`4I0``\F"=1+-<L3<FG$<!V5R/5
M_KA_GSYW:<?/3U?ZX?Y\=VG'ST]7^N'^?'=IQ\]/5_KA_GQW:<?/3U?ZX?Y\
M=VG'ST]7^N'^?'=IQ\]/5_KA_GQW:<?/6O/Y?[T1^IU_(\_TE/\`WY!PO_QY
MZC\G_'FJ]+P0/S1_A^_BV47YPXR"HJRHXI3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I7@W[$?^P?_`&9*G_`/_P`A_HKZ.VL7G"'6V]*_QYK-K;[;
M?R;(*KLQ2J:<F-6T:OMXR><SMG-64'%M3CV]N<ILGX$-VW*@"N13_6=2],V'
MUUN.WLHQ(<4'<?HS``R%FD)N,+'N.4#R[CVEK<"+^VO5CV#%>3?<F?)F*;5]
M/[@7CY:V*'/R-1YEB]FOS`P^HJ]T"L9E'+L*S:-W]+6#>"%EO\YQ!W*'(?4%
M4I/).:V"38GL:B@[7O)=AWRYZ_U_>*I9TY-O%LX.)B238*'!F@LU23[.R-W3
M9<7-PX<#%<=-IO6UG"R>9BK"L?B8VUQ,L2Y,_-A*G(66:0P$!I1&][XUTL^]
M2;SC9.ZRK'U$7RDR(M$ID951P%>,.<>.)6$38TXB170A59^::EZ2;P4RRD:=
MQSNV]K!QYL.P>#<->95Q==N#(H[0GMKR$=MV"A[/*/DK-`.)#7Y(SVVQ[!P@
MQC7*@$%)LH90@48&4V[03=408*9@R]X.,JI#RWPUVQWC)T\)85R]7A)9"SNP
M>SL%6K3@MC0](S?04N1XY=C@&7QDU1Y'B<98^ZUQ%E-&V0)HH0H6$0$HMP6J
M/>^PGNBX/F[HJ.LNTH.V2>W^+:_'.J-9;8]BLCK5AH[1,'/3%(F7#R4E5ZHS
MEXJ92FW1'9BI+%<"[-VE!$]!TMC'J3(Z7W>=,:7E[EN(W%RL,:J3+D2PB=0%
M4!HGB,`*Z2"JH.%AD&_&+8X]WAQS*F*W3D7A5#.S/,L>4DHA+%F,RR%6?CK`
MTMV::MEVYM&_RVW-Q6;7[_9=*=SFM.==*M58:7;?ENV:RLM/KC]"BR]Z.HY:
MZBUH>46A?.Z7#P,8E)H,$TU_9%V"Q@"Z;'MV)'L&-B9?(FQR^R9$;A,9(5YF
MX8QR(E<@Y$\Z++(N:S.(@"T1A`C#52Y$\C]4ID*9(\J')E@<,TA9T^C<G3(L
M:GD)ANT4#8[NK222CF"1'=XQ?-NJM6KCNEI6EZ>D-FI,^9U+B>.2CA]=K]<7
M=*W#-OHZW!L]5]9IV6?P*YM>.;8N]<-SMRIGBVQ2%(($`+%MS874>_[CMNZ+
MCKA[7D_2"Z$CC!P<$O'DXJLB@MK7PBPJQ8NS2%F)8DRL=LK9.D=NZCQ!)+N<
M^(,602&237E[A$APYG4M95CREE$K64*)TXJB6K,O"Q36!AXF#9'=*,X:-8Q3
M0[YVY?O3MHYJDT0.\?O%%G;UT9)$!465.=10_4QA$1$<U+F9,F;ERYDH42RR
M,Y"J%4%B6(55`"J">"@``<`+5G>#BI@X4.$C.Z0Q*@9R6=@BA068\68VNQ/$
MFYKL\IZJJ8I3%*8I3%*8I3%*8I3%*8I3%*8I6&;FPUE:=S5H')6)KTW,..,?
M&64V6]+#1$E(.I>D&VJT@=L5=@#!NJI(2KK7DL\?M6"?:4</H]L/8-V0S9O0
M64B=.[OM$KJL.Z[A@X1#$#C-%DG'?CP58\Q,9I9/L(>8+C5QQWJK%.6FVM&N
MK*Q&S\N(V)TRX\>*2``02TV,V3C(M[%IM0!*BUKII*3J#[F%M*XTZRIN>1L;
MPZM-KD$[+=]5UZO-MG6*^IQ+C8U]JS!6[PFOJ+4EXU*?;QHIOTT@.U!9H"G?
M)Y''CJ<?:^F(IXD.V[MG1@NL<P,\.UX<LY2'4(II9LH2)CW812RK&QU\5-@F
MF&1NNX=3\J1XLOIV`J$8B4XWTKGX^.HE`!14QBDTCA#+#CR,P1F4$^SA+"7G
M:6U=9U&^V#9=GKNN(_F9,5-DE9=]TV@NIBM;XUZ]U(Z[%OM2EQGJLU@I03PJ
M5@DI)16-6$#'62[095=69*;=T[F[OM<4$>^2;9M*CFIB/,LK1[C!D:UCC6%9
MCH5)RD:V(5B`^EZI]JQ8I]QQ-ISI9'V%M]R&DY#SB-H6P<3('*D=S*T/-=WB
M[YC+$J@"=P=!>8S7-_XS)Q+R\;XD>9%IF--M>4-4:V/:\LA7K6/)[6P7)_.U
M=Z24H>N'=:FP<%JZT>C&]J-(!T`70+VPJ-L$V-UEMK;;%BGU=1Y"MBRNL2EU
M^C<FPYW=G>647&:A=BCE@5C.FON7*YV'=SNKRIU@<;<UT(7(T"4B$<JQC\.L
M`A.*[(.8-#!Y&9KY5^)M:=ZTY`<O]/P;FZAJ:G2FEIK7D1;K);[DWAWMQUZ>
M0N9("SW>1FYQVR?3+4JRK<7JZ+9<Q@(5,#=G-:[[FG=^D=KW?,$)WALO/A=D
M2.)FBB>(PATB5%[NMPK%;D<"3;AD>'AIMG43X6&91@OMD$A#.\@YW.R(RP+E
MK,T:1ZP"+V#$7))O_P`P>LEIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE8@^;
M-"V5RYW2OHFF:MA-@:VTOK*=E[@ZM^PY+5D.VW9MN#=PNN)&$EF^N=A^V.5U
ME40>2W=)(MRMG<FU.*PG(!`V)T;E8W3NU9/4\N2^+NLT\>/AO'&)9%&/)'DY
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M%4!QW`R-NCRNF]LPACG9LF?=6EUQQ%Y%BFW88W-=E+@*FC0"0"-%]5DM59L6
M?-!O&7N!E&Y8W3F(8PK,H2:3%4S%%0A3(S@%C9F5@;6XUD)\/MB[CN.*+9ZQ
M=QZX;@Y$K>;/6B[)<$7&^=BKH+=PX324!)PBH51,W3LG(8#%$0$!S">L75\K
M;RI!ML>V`V-[$8,`(/F(/`CM!X&LEVL$;GO)(-FWK*(^J"5XCS@^<<#5[&8C
M5ZIBE<5U_P#J_P#]</G2N1IVG^2H7[/KTZA^N'_?D=C4%>`ZG_8^0OZIQ^9_
ME`H?J_\`LR6\BI_+4:K>O7WG8-V%!^:/0J@!T*;_`"&#R]DW^8<)(DG`<&\U
M&0CCY*]O4/UP_P"_)EC4%<1Z[*S1!7L@?JHFGT[8$`.\-V>T)NR;H4OZODR$
MFQ`\]??(3YJ]"4JV.GVU1[DW864$OJE`[M`_8.<IBD#J`C\P.@#_`),7&G5]
M0'V>%+&^GZI'L5^S238`5[!Q.**?>']0IV"AV0-T.H5,P%'H/S/*.?2;7^H;
M4`O]<5Y))-#G*F"@@81$O42*`F!RI@H8O>&(4G4"#U_[,7']/\W;3_Z?S]E?
MD)5B)3&[[]CV/()#@8W>#V2"0HE[1P,(?J8O_3_]:6KV@^;BH1$#'%0Y2G['
M=*=2E-\P5`[/^KZ]/U>F!Q-AVBAX"]>I20(1WYH`)`<`(/:67!'O.WU'H@`D
M/WHE`/+\SRY\!N;>8_7]BA%A7D9-D`J`*W_AE.8P]@_02IB`*"0>ST/V1'R]
M.N`01?R>GA2QO;RUKV^=H?WH/ONV/=?D>?V?8/TZ?A(][U_8]>SV/U?F=?)\
MW/GV5O\`CSU%Y/\`CS5>UX('YH_P_?Q;*+\X<9!4594<4IBE=)99D:[79VP`
MQ<2?L'#R4N,<T.@DZ?!',UG9FK=1RHDW(LN"/9*)S%*`CY1Z8[2!YV`\_:0+
MV'$V[;#B?(+U$B-(VA.+GL'9<^07/`7/"YX#M)`JU[6^_-O[ET"3:U+T<VHM
MZ/(.$/1QO"YOJBDFPC1*,F\7FJI3;Q*M51#M`V26BDQ7$O:$2)&(H;(]_P!H
MVSIO<N1F9GB=M6!I'DQD#L+!M*A)'C4L=(+#F#1?2W?5E%JVK-RMX:>&'':'
M(3)Y47-8!9`=!60E`Y5"'/$*URMUNC!JMLU_S9Y,[$A>,KJ*T!HYE,<IX>W6
MFDLW_("^#&UVMTRLL[!)#:Y!MQ[6<DFG)WQ$4$&;9R@(`)CK%\A1RK<.B]@V
M[<]TV^3.S&7:,:&69AC1]\SRI&BQ@Y/&VN[%BMK6`-63'W_<Y\*'+&-`#/N$
MF(@YK<'B\3K=CR>"_P#;/IM<G4MP.-I\U;S2U_-0=K0W3*T?4-\H%EVM6K7$
M)W)2PU!WZ'"1;RZ3M/N+^"K)I^(BXN;;++IJ,FK]N<54SM^J1AS'MPZ6G$6-
MG;&)\O;<O&AF0F,)*O.F?&17C5Y!WIHRB,K,C:DX@N!5UQ]T9<Z7:]S$4.='
MD\E=+ETD)QAE@!F1-+B#4[QN`R*C,>[QJ;]F[DAJ%JU/946U-:@G/:PQHD,@
ML:,5M\_>'T?%TZ*16=MS+,B2KV41%0YD3*(H]LW=F,7L#:<39\G(WQ-CFM%D
MF=DD)XB,1ZFF8VN#RT1V[;$K;4+WJJ;<L,;/)OD;&3;TQC,&4$ZEL-&D=IUL
MRJ#Y-6H\`:H*.YE\:'<S9*JYW+14;;1XBZ2EXBD)%ZJT@/1D=PWV6B$LXC6C
M-\I1W3-8'Z28^<MTB`HHD0A@'*P]+;X^,FX8N-,^V3-`(G(`,BY;*F*P4,3:
M=G1$;BNLZ-6H$5`NZ8JYB;7DNB;N;AHKEM,BQ\UX]0&G6L=WTFS%!K"Z:JRX
M\FM!Z_0EG%QVG5H(D&]J49*$=.EU'+>3OD2\G*7&$:-6Z[MU(VF*CUEF*")%
M%7($$"%$P@`TN/T_O64Z1X^-*[R/,BV':V.`9Q]3D@@R$V"CB3:IIW+`$`RC
M,@QS!'-J)L.5-((8GN?L9)2$7SMPJ!K_`.(9QUAM5;3V#K*^57:TUK/6<YM%
M6IQ\L\A`E(&NNV3&;Z3;Z'6:-5H)V_22DDBD6=1JARE<HIF$`R[P=$[^-PQ<
M;<8),?$R-PQL5I2`P0Y3A8W"JUW5EU-&P[DNDA')J1C;UMF9(<?$F5\LX\LJ
M)Q!;E(SE#J`".;#N-9PI+Z=()J5JIS!XXVW7-FVC';6JY:E1BQ)+N_<'DF1Z
MV\FF[9>*;.(^2C6,PZ+,&=%)'J(MCED#>1OWA@$`I=TZ2W[:MQCVV?&E,T\K
MI#8`F0HUB!I+`,HLSH3J12&8!2":?:-_V_=L(9:2(C+BI/(I-A&C@V8LP4%-
M2LBN.ZS*5'>X5W3+E-Q\DIG65=C=IUJ1GMR1"D_K2'8&?O)*U0K=V,>[DVS-
MLR579,X^1`6SH[H$`:N0%)7L*!V<D-TOOZMEJV+(/`Z>>>&F/6AD0EKZ2)$4
MO&5)$BBZ:A4\;YM)@BR1.G*GE>-.V[21R<J1`MM6J.3N2`B\9]O:N7)<F-#1
M&U6&D9+:-79[2DW;2-9U)5PX\Y/+OX]Q+1\$K(%;FAVMBD8QJ=PWCU7!'JZ(
M`9-(P"41DXVP;SF;;+O&+CR/ML*LS.`+:8R!(P%]3+&2-;(&"<=1%C:=F;IM
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MG16Z[WOPVJ&.:/$&6\$DCH`T9179@4U]YU"CF(C-HU`DV(O*FWS`Q=M\?DRQ
M!FPI,A`&)5PD3NO>TC2DC(421U52UP+LI43`\Y3<>HZ<V/6Y';5093>H:\]M
M6RF;A\HFG48&*01<S+^0?&0!@J6#2<IB^(@JJJR[P@+E3$Q0&RIL&\2X<.X1
M8\C863D+!$P`[\KN8HU`O?OR`HC$:6=6522I`KDS<9LI<!G49[0M+R[\0J(L
MC_4ND;+(R^V",KD!6!,6/N?W&7V=U7`5J]I75YM;</H2C#5IA)N"P-P-4I2X
M('LB3ADW<QT6]CV"0-E^P8KD'B2R7;;@HJ2ZQ=$=2.L[3P&!8-MGS;RD*K1P
M.L<B@\;.K,0RD730P<!M(-M/4FRG%?+AG65(YL:,A+DWRG5(F`MWD8$N'%T9
M5(4EK`Q1L3Q"J_4;OI.A0[K3+]WL^F3>QYVZ3^QKS#ZWAJ?#WV#U^B2LV2)U
M!9%;%8IB9F#IMT'J$0V*LV,FHX*)TA/==EZ$GW1\UI%S%BQ&@C")%&V1)-D0
MO.JB)IXU"".,N6#LQ5T*HQUA(-XWQ=LB@Y?*?(GR<J/O,RQQIBAC(\CJCD,"
M`C*%(5M=VTJ"UX\=R!TM+;#M.J&&R:NXV#28M>9M=<!_W:T+'LT6KB16=/ED
MTXLRD2W>HJ/4B+F69$5(9<J8&`1Q`[-N8VH;V87^BBY3F>2X++V7OIU*R![:
M"ZLH8L"*NISL09T>V-(OTA*MU3[)NZ'L/MM#*^CVW+97TZ&!,-ZXYJ:HV[O&
M<U/KB6BK3`5O3WI5FKTS>OVR+,?;<[K18KV&D89FJYCG#1F9XA)HKJ-G"?D3
M`Q?5C=LSI3<-MZ=DW_<U:#1EQPA&`N0\3REF.JZ,FD`QLH87N;6(JG3=L/(S
ML?;\%UFGG:8$*>SE"&S*;6D1S+8.A*`K[8WX=[`\X.)=GA+A98/?-"?5ZA5H
MESM$W[(.&T6QJ)W0,#69J^=M&[>:@F[\Q4%G3$SE%!<Y$U#$.<I1DY'2'4V+
MR.?A3JV3,D48MWFDD%XT*@EE:0<8PP!D`.B]C;Z-XVPY#XO.3G()2P)L!R#:
M;O'NDP_]4`W0<6`%557N4_'RU6JGT>!VE77UMOL(2Q5.`$)%I(2L4LF^7:JB
MD]8MBQ[I^UC7"S5LZ%%TZ01.JBF=,HFR3+TSOT$.3D2XT@@Q"!,>!"$JC&]C
MQTJZ%]-^7J7F:;BH5WO:F$)$\=LARL?&VLZF46OY&9'6,FPD*,(RVDVXT5RT
MXX32.QG$=MZHJM]31Z\OL!PNX=,D(&';NG#`\N19\T;)S$2I(-3MTG3`72"[
M@`23.90Q2C!)TYOD6/C9;XLO(RY8XX2!<O)*`T<>D797=6#*K`,5X@6!-3UW
M'!;<)-J$J>/A1W=2;:4C.F1BQLNF-N$AO:,\'M5MESY2<*[!<ZEM-KO&H3FQ
M:;6+.O0JI9[C=X6H5TZS@\'.V^SU!I`2PT^<;M7"T<68D(HKI%J[,@F($<>J
MR3:NFNKX%FVR'#E&+F20Q32(D;R%&97$$,A8!N8T:.8$D`DDB758H;6O*W/8
M\U89)I_S>1Y8TNZ@RI&Z"22.P+)&':TC*RQARZW.FKB5.7_&E&_OM6*[AJ/I
M!BY&1A).M(KOEUV-AB8P\P^K3AXFQ-'I67V+3%=&-,J#YRD)3))'`Q>N.GIK
M?CM3[W'B3-MB([Z[`:D1BCLJDZF5'!5V4%4(.H@`FKC])X29$>'/+&F9((CI
MOP'/56BNQ`"B4,.67TZR0%[W"HQU#SZT%M?6LMN<+M6:GKB-@:I+N2V)_)M+
MM#.+1-V2O,&-CJYX4B:)YF4KQTH@K!U(+21RJE*F02%[R[[ST/O>S9<6W212
M2Y\TI1.6`T;_``$,Y"L&U%T26\JE`J*`^HJ3ID0;U@Y$LRI(BPXYG$A<E".1
M.T!<:@!RV(&EBP8LRQZ-7"JJ<\\.(+1E`2#G?E%1;65HM(18F<2'?%8M;$O4
MGSR6:!'B[KS6,LK<[)V>0(U*T7Z%6$G:+UIH^B.JYLDX<6%,V0&C6PTD%I4#
MQ!6#:6,JF\84G600MV!`@DZBV6'#\?+D(N->47(:X,(#372VL<I65G)4!496
M-E8$RBWY":7=;6-I!OL*"4VF"*ZI*D`O`<KF:QP2[MFUD#-0AWDJSBA\Y69I
M.#NTD`%0Z8%`1"UQ;%N\VV2;S%`YVV*^M^'=`D6(L5OJTB1E0O;3K8+>YJKF
MW/;\?*APYI47)R-/+'NBR-(H![+O&C.@)!=%+*".-6XW'FS%07+4O&"+;4)$
MT'`426N,[=;;;JS,N9;8SJTH5JHZ[AH_6UAKUIGSH5LJRA7LU%)F*Z*5(RAT
MU0)=L#IB7+Z0S.K'Y[1P-D+%'$B.7.+"DTTDI:5#'"HD"ZE21[JS%-&EFI]S
MW1<#=L+:1RQ)DQ<UWD9E2.,SQP(+JCZG<N2`=*\%4MJ:PZ;1'B':RV-I>8W3
MMI.)T?`QUVA*0T1DY]S9C2LC,ZWINQ"@S*P@6;]=5LVM*J:A$FR@)H,CN#F(
M03`2X[[T'F[9NF-M.VN<S+R(YWL%":5ARIL8DEG*A3R@Q9BH!<+>]B9&-OL4
MN1FQY"\J##=%+$WUL[2*%"@7+'EDA%U,1>PLI-2?R1YJ:4XYT>8L,O;JY-6D
MM&<7FHTU"67*>UL#(@>%$TU&QLTQ@6%D7,5%B[=@1!TJ;LI"H/4`L^Q=*[QO
MF[)MD,,B@9D6/,Q7\"7D5&NK%=3Q@EVC!UV'8+@U7MNVUIC0YDF1&,;)B,D3
M7N'0+J#BU[1G@.:;1BYNW`U*6I]QM=BCL.+EXQO5;1K"R^P5KB32R<BT;Q\C
M"L+55[$C(G;1X^QEAJLJW=E[U),R(B=,_E((C1[MM'T;C8^:DG,P\A90&(TZ
M7@E>&9""3[1T[>QE*L.!J1M&YG=;*(V65H,>90+G4F3"LJ:387*L7A<`$"2-
MU!-J@%'Q`^/S_;#NBQ%VJS^EU[4=XVK>=EJ2[R/B:JUI]KJ56;MO-7T.@E.1
MD^O93BUD&3E9!95MW20*F4#I=(^C=X.SR;I/%*DIR<2&&+3=YGRN=9;`ZD=>
M6O<9;L'OPTFOLF\X`R8L7'D269I9EDL>$:00/.\H;VKHH0ARI*IVL1<`]@X\
M0CBV%GU=7X[8;659;2])Q6=H09R+.`JRNIH1I/VQ"ZKRC-BYK*[:/>%/V'2:
M1B$Z*'`J9R&,7HCJ(0YLT\/+\%C13L"03(DLQ@7E:20YY@864GO*4]OW:A7?
M-MD2%\=^89L],0`!@PEDB,RZ@0"JE-!!/`B16%UU$3?K#D5I7=%:LENU=?XF
MXP504,C9W$<A)HNX13V*2G$BOXA^P9S"'G<.L1RW$4.CE`Y3I"<H@.6C?-BW
MGIM5;><:2#6'*WL=1C8HX!!(U(X*LI(*MP8"IVV;MMN\R-%MDR3.H0D"_9*-
M4;"X%U<<5875K&QX&K5N./B/Z-W75TY^UW'7^NI*:;VNW5JJGL=C?S+35E;?
MR\>2YWQ6<I-3CJFHZ5K[L3%*J[8%$A4TWBRPB0N2]0=!;OLH411S3F..(3LJ
MKRTGE5'$$161VD8++&`"J.Q+%8R@#F@PNH</+SI\5GC1!ER0PW+:Y%B9D>5U
M*`1IJ4DL'=$0J9'1CI$\LN97&"0HDGLMON:I%I<+9HZFRLL[-)1ZS"U335-]
M!P+F&?Q[:<3DIYHL11@F+;J^*<O<=YV@ZV6;I/J/'S(<"3$E\7D*[1J`&UB/
M5S+%21>/2QD!(*`7<`560;UM63%//#/&8<8(9238()&"QL=5NX[$*CBZL;A2
M2#;L=9\M...X[*VIVL=MU>X69W#R$XVB(PS\KA=C#NTV$TFF9XQ:H#*P3Q8B
M;]AV_/F)CE[]%/M!U^;ATKU%M6')GYV)*F)$4#-W2/A%U1L+$ZDD'M)%O&QX
M!K\*AQ]]VG*GCQH)E,\H8JMF![I(*FX&E^!(1K.5[X4KQJWK5'->X;2N3@(W
M5]+>:W9WZUT6SIUG;S.P[WU&WK<K/PC:[;JTR:KQQ*94YB0KB@E\WF'[U!!T
MV5,@)3*=W=LSI;!P-ICS<W*ECFEV]<I)#`?!.6B688Z96N[3<LLOX+1SHWB+
M#@U2'W7*?>'VK!A2:2+-7'>,2`9)U.L1G2'208%=T8LTBL86Y@4\%-RSWD_Q
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ML6^6AW"-HCJFYF>VZ)'`X[*Y"MU#HJ*%ROP.A=_R,R"#-QYL>#(28JQ74=4>
M'-EQ(4!#*9Q$%C+:=0;4NK217S/WS;\+%S'$B-F8D<C<LG2&:*5(Y8]9&D-'
MJ)=1=E`XBQO4P2O,CC%":^KNTI/<=5;4>V2$O%5Z6#V3<.I&1KP.1L;,D`VC
MUK$@O6RM%!DBJM$_8\"]7'=@(=;8O2W4#;E]$KBR>.$2RVNNGEO;1)S+\O0Y
M8!6U:6)L"3PJ<F\[8^(^:DRF".4Q-P.H2#CR]%M9>P+:`I;0"]M(O7@O,GBZ
MK;6U&0W=1W=H>)$5;1[)^L^16[VHM[ZV0)*-&RT0+Q_37)))LAW_`'[IH(G2
M(<"FZ?&Z6ZA3#FSY,29<3'$AD8BVD0RM#,2#9B(I5*26!T&VJP()+O6U//C8
MZ3QM-E\GE`&^OG_@.(X#FV(CU$:R-*W/"I5K.VM;7-[`QU4ND#8'UHH4=M"O
M-HMX5T>6U]+K(MXNW-!3`2GA9!=P0J2HB';$?('D'I;\_:MSVU,ILR"2,X<Y
M@F#"W+FLS<IO,]D8V\PO4[%W+`S8L>?%F22+*1GB(-]:)IU,!VV4NH:]K,0I
MX\*L<B?$FU9+ZXH=C;/==*[+N6_(O2#G3#?;M8<7B%,_W*\U4O/JPZ:`SZZK
M%BT]ECLA8)F[HW8%0I0[W,OBZ`W.7=,?%1<@[9/MHRSDB!S$E]O;-T%O:D:A
MR->L#4;VOW*M&=U)AX&+NLLS1#*VW(DB6)I%5YM$Z0@@'B"X<N%`8V7A<<:N
MH0Y4<=G*NT$4MO4SM:8;N7>S5%)(4&]5:LG2T>]<.7:Z2;5\BRDVYFBQFAW`
M(O.C<_18Q2#C!V#>5Q,;.\-*<7,D6.%@+\QW_!JH%S>3MCN`)`"R:@"1>?'X
M?CWVOFIX^**21TOQ5(K&5CY/@M2\T7O$6`<*2*M[V3XC.C*1`05^KT@386LU
MZ]NZ9M-DKQI)&7K4AI>I0UK=5H]5D(="3/.3J<XW233="R*@59-8XBB?MA?,
M/H?>9<F7!S4./FA<0PJVDK+XK,.'<.&TA8W5RQ&HW1DMJ%JI8=YP,L1-A2+(
MK9BP/[8<O5C290<@KJ(,:*R@#O*X921V]_1.>^EK;MZ7U3+S494'#UAII]K)
M],O)!)QL$-Q5`;3$MC,EH5LVK+Q)?LLFZ;QR!W[D>PD'>>HR=F]!;SBX!R85
M,^3%E9T,R(`1&,(KJ<-J[^I"TA55NB*6;N\:M\'5.V2Q8N5(W*P\O"@R$9[@
MCGRO"$<`$*%=476S!&>0*I/;7OWQRJM>N=RPFD*#4M6RUMD]?IW]H&X-R$T^
ME>5'D^_@(ZA:C3+3[@O>KZ=>*5.Z;G*R;,B.6?>+?[1ZBV[#L,.Y[5E[QE'*
M.+B9"0LF-`,B8:HC*9G0R1A(`H*JY8EY%D4`:"3<MUS_`*/DQ<<-`DN6)2LD
M\G*@7E-$C*T@5SS"9D(4(>X&8GVH:19WEKI.@,-=DW';&6FK=L2"AYMM0;TH
M"5EKH2SEE&"A:2Q024?`M6DZ^(P,^=+(L#N0$I%A\O2&/I7=,_<,K#V%?I"#
M&D*\V(?!OP9DT%])+NJEEB%Y"`;*:D?3F-C;7#N6\`X1E0L8Y.+II]N2%N=$
M?V<EM"@@L5N*Z/5?,#6-WIEDM%PF:_KI_4U-P2\["2$\60/':\U-MNWZH<;!
M=.RL694X23?50RP]"""!E>[[2G9[9H]QZ5W#$;%&(KY"9,6WV(6ULC<,:+)C
MQK7-W^%TKV:K7LM["MAS4ESLK"(`,&1.B&]^8F.D;R2CS!1(NH7-A8W-ZXE`
MYF:JVC;)JK5*:B6*U4WG9]%SX7-U)UMY+V"L4&2OCQ:A(C"O&MB.6/CE5CIN
M%V!$V+5RN*G5---;[D=)[CA;=#N>4K''R-M?,31I8HB9*8Y,UV7EIJ878:B&
M>)=-V8I2C><*7(DQ<9PTD3X8U&X1AF+JB",`=3L#9%M9FX:@+$]@ASGXCN6<
M\_1WS13-*Y(PL7)+&=O4@4=6.2>PU?-#E58D4LC*:EX]9JU=1P.FR[@O=D4$
MYB@,H](=3!86\%/\.&T`+=CHCYK!E!U(PB^$TN%;0"P%E)$;;WM"R3Q-DQ!L
M="\EV%@H=8RP;VK!9&1&*EM+NBM8LH/;2',GC#%TZFW]]N2J(T^_.9)I5YP!
MDUF[Q6&D5(>;,^10CU7<"W@Y9(S5\M()M46;@HIK&(?R9"G274<FYMLZ8DAW
M%4B?1=>*SA3"5;5I;FAUY04DR7[H-0G?=J&WONAF`P8Y)(W:S75X0QE5EMJ4
MQJC,X*C0HU-9>-35='MU0JL@]UI%5*Q6WNFZD+'7*R2M6J[T%%DA6,^L$#6+
MG),TP9F.=,R4<X[9P*4>R41.%BCY$4X\>9$Q%)YA10TB@`^U1F0,VH`69U%K
MF]Q8W,.)(#)CE6=DO'Q[K$VM=A>RD<=0#>2P-8TJCSFY+VVMZ)F&W'W2#5_R
M'VQ=-4T=BMR!O2C2(>:]CMF/[-+VQZGQ[%5LT6]&ZA6*;-%V=7SHHJ]SV!`=
MCR=&=/KF38HSLS3C;.FX2$XT?&.08A2-!XGC)_W:ZM151H-BUQ6,2;WND./D
M3RX\'P&ZK@6$S'5*TK1:^,(M&-)/E;L&GCPEC4>^M:&VSMB;W6VI.H]_0<DV
MT;:%HG9,O;]=6:%UY4G>ZXSVKV&:K].9I/H:LWYXYD6[F.9/T#IJD."B:9#9
M9\[;9DZ<A;8GFR.GLAILPJ\*QS))%*-OD9E5Y2T9:.-4*.RG5Q56#57QSR2;
MTN)NL<4>Y0"*"$I(61QGH)UC.I8RLK''-E=>*JKHQ647NLG]Z:EJ^L(_<T_>
M(B+UE+,(62B;4X*]\VEFUD%`(`(MBFU/+2+N8%TGYNW1;G<*]KU)!\N8\=FW
M0;L=B,+_`$N)&0Q<-09`6<'C8:%5BQ)LH!)(`-7"#.P\K!.Y02*V`%+<R]ET
M@Z;W-N!;NK[HD!;EA>/)[F;Q<K-9IUQG-U4UC6[\A(NZM)BX>N"O64*]3C9R
M0>-FC)=Y!QT#)*E;/W#]-JBQ<#W:YDS@)<N$/2/4F1GOMD.)(V;&L9*]VUI1
M>*S7T-S1QB"L3)8Z-5C:D;?-J3!^DGF48FIEN0VK4@NXT6U]P6+]WN!E+6#*
M3(RF\M0I/7\<?8=8\]C+A3Z`^0)(D5%O<]@1$;/TJO"=(#IGD+-"S#5TS`HB
M55%<A@'H.6_Z&W41+.<>41/'DN"5(NF(7&2;'B.08I!)?BI1AY*J_'8>AI!*
MAC6**4D$$<N=M$+W%P5D;NH1P)JV:]>)%Q&IU#M5]C-I1E]9U`::K*15+0?2
M<LM'76YQ=&CYF,24:((RL0QFI0".W#<ZJ:!TC)&$%Q(F;(-OZ`ZIS]PQ=O;&
M>$Y<_)5Y+!%?E/,`_$E=<:%DN.^O>34+FJ.;?=JA.5&9E,^)C9$SH+DE<;A*
MJFUF=7*QLH/<9AS-(N1/"W(O22^RX?3A-BP9=ERZ*#Z-JBA)!)V\!>'6FDF*
M3Q1B6*":-#`+OS`RY7H-BBH*79#KEIAZ>WE\2?<4QW;"QRXD<%2%T.J.UKW*
M*[HC.H*AF`)O44N[[;&<9)951\L(8@;@MS%9HQQ'=+JCE%:Q;0U@;&H"V=SF
MUGJ?D<MI"ZRM1JE<K6MX2_W^]6V9LT6O&N+C/OJU2ZU5HF/I<M$6&2DY-JGW
M_?R;$2E<ID0*X6[21;GM/2>X;YL$^[X0E><9?AX(HU5VE=(Q-,S7=65(XS<:
M5D9F!NJH-=2=SW:':\[$Q)M`6>.661W8HL<491%-PK`L[L>#F-55>+:F53,!
M.6O&Y:U%I!=PU5.SFB5YGV*6,_;"DU:UT;:Z:+NW#))@WG&E:*+Y6,45+(I-
MP$YD``!RR2])[^F'-GO!(,.`L';ND#2_+9A9KLBN=#2*&0-P+7JNAWG;9<C'
MQ(Y%.3E%!$O$%C(+QJ;CNO(!=$?2S@@J""+TG&\W^),^^C8N)WU2GSV8EH6%
MCVZ?LH`.7-D5(WKKOO#QY4DH*>=*%19R9S%C72Y@337,IZG)[^K[JY20<2<.
M%<]@!!C&IT/>X2*O>,7X33WM%N-23U3L2IK,\9CNHN+D'5V,+`W0?9..XAX.
MRFN#L/=^Y(_?A=":?UKK6V2#34!-MRUAV5L^S4)B@T<6MW5&L'&MZUK'82KM
M<R[,RIUEC-R$((``&R;LNW8,W3^7OV]SSQ0XN9'CA8HDD9R\+3:CKEB50`I7
MM-SQ-A46YY,T&=A86`B22YB3O=V9500M$I]JCLQ8RBP`'8?.*BG67B#ZNODY
M$U_9;BEZ+)(:@BMG(R%^VC58=!Y/DV->]=SU:KZTW[$,K##QLE1C.6\H@H(.
MFKI,QD4A\@WO=NBLW$VW*W/:^=FG'RHD2..%M9CGP8LV-Y%768GM*(VC((#"
MX8@BK9%OJ+F08&XB*`R^+5WYH,:OB9"0$1L0O,635K7VK+I92MP;4X]Y^5Y#
M37'C;Z>OWDHCN\KRR6J/@;&283UYJ=K/-8"R;-5DFL&HG.Q$3)2L:'0B39,Y
M'0F[TI4^HU2^K]VZFR.FI,D1"&"'X1TTZLC(17Q\<J3W6EE)BO>X(OI/$"3/
MU+HV*?>\>'GR1YV3#&B,")8L1I#DS!P"`(L6&3(T\0VGEJQ8@U7^VN4=BK&[
M9G36O*'0+38H"B5^X!&7W;[+6-PVFA9"RRC:MZ"KAJM.DV/86+&#6!R+MU',
MT':[=(RH`<3DM>T]-09NTR[SGR9*0+F&!A!!SVAT*DCS9(UH(8@'[GMG<1RE
M5[O&OW'<SBS8N)C<@S94#2QM-)RHF`81K&C!79I79E[H72`RDGB!7YJN]^0L
M_P`@FVEGNDM2P$<;7E=W,]F)3<MX):(ZAVBQ2561BWM3#2I6:>P8WV,,9VP]
MD08D6'NRO3`':RH?I[IU-HR=R;.R9&Q<TX;<J"-HI)FB,O,BD,ZL<=K=UV17
M((/+\E4;;MNW.PXX<6-/'8[SHLTC))&L)A#),JQNJR@S`%49U!5AJ[*OH]CD
M@1,W[8F2$`(`'1;";L%'J`&-W74P_P"41$?\N885N.-9&#8\*\!&(`9N;M''
MS4"@G^P[?J1$>AE0+W@E$?FEZ]/_`,F?;=[5Y:^>33Y*]R[4CDW^L4$R93%_
MU0%2\@E$#=.\[OOB]1#J(`8,^:03J/D-+\+"O3[&H]VJD!S@DJ"@"4"I=HO>
M#VA[*HIBKT`?F`(CC0+:?(+?S5]U&]_+6OSV`_O0?=^7I^1V['7]7I^$CV?U
MNG7ID-^_?ZO_`/-16[EOJ?\`\5>OX('YH_P_?Q;*+\X<9*J*LJ.*4Q2F*50.
MS+E#42H2,_8RR24"7LL9>681R\FWKC)^51NK8IQ)KVG+6N1(F!1ZZ*0Y6J/5
M50"I$.<MKWG(BQMME:?4(60J6"E@@8$:W`XA%O=B/:CB>`)&6=%=-[EU7U##
MM&S&%MU-WBBDD6-LAX[,,>`M96R);:88B5,KVC0F1E5L-<?JG0$S3>%>O]T/
M4+U5.+=+OU=OL-8-2[!083$C>:RSK>N9QH19D5Q7#W19`5:T#C_:Y0SA-%$J
M;P>Y#,LSUS;.^][]O.!X[%GW7$QX8V",KP<N5'#.P7@,E4M`%[SE@/;<*O4'
M\+?K,.V8N`4VC)1-VFRPJYV)(N0I.6^3'$IDM(VUG(4[DWX+%$+RLS06E,4*
MZ-A'>HZ;QO3OK$FJM%[+LNRN/C4-"W":VJKL]DH\G==:8V(V?Q1H2SVO6SZ8
M?+VAJU6-(3T*@BJY5%(KY0;FGKSV+Z9BZOEASI.L#@QXLX".D,CAU7($:I9D
MR'Q8D^!6R03-)E1\8HRLB?\`A0]8/@LSIR&39XNB\W*;)>=MPQ3)!A/WH\T3
M,Q'T=+ED1XV=,K.\87`92\RALH>XG3O=7'O6^RZF=&[2>L]F:KVU*,J3%3H,
M+0ZUG9V3F[QU283S)G-OVI$2O3,BBD==4Z!2%`ZOJ1MG2F];++U$N=M<C?06
M2,K%62469(\J*3'5WL`-2%U+L`$X,;A0;8/UCT?UATGM^9TKU5C10]7IB1.\
M*2(4YB-%D*MU=PHD6/NHS:K,JGVP-0[(<"IVUU`D.6\5Z/9SECYRVAX^2KTH
MA("RY?-K4G6#BS>>;K%EZ@SL2!9`JX$%;N!(3L^0`R(=7#`Y44<1.3A[7M&*
M@+`Q\[:LG'R':ZW^!FD@:VDW[^JY-62+%CR<^7<FN,;*WA<XKITN(SA-BE"#
MV2V>X)%@!I(KLJAP[W;(7)GL+:]MU+[/DV[QSV`XAZ-&VMS!I0^AZ%9Z:HU:
MNK&5-Z>9GG4VF\1.9,J;3L"3J<2E4&LR>L-DB"Q;7#EB#3NQ/,9-6K<H1&H&
MG@5BMWB;%P38+V58\?8-Q^CDPLN2'5%B;?C(5#6*X.?'F&1K]C2JI30!9&TG
M4P)JG]B^'W>KAJU&B1%^H\7*I,N6J7LD^KLH\BU7O(JXQ-I@W+R.16;J/T8,
M8X2R29U"B\.;U!@`1$*+9>LH-KSL?,DBED7'P]JATZ@+G;YXI6(/'2'6,K'8
M70F]O(;OD;6V1F3SLX$4^[SY9X7.B;`RL,+YBZMD![G@54CRBO;L?A+O'=,#
M?;'L.[ZS@MK/#:&9T&.UDYV14J.E%Z!MDY<8I6T6J)?P^Q64K:Y*T/$S*Q1T
M5(5N1$K91<>],>HP>K=EV7<,>;:H<J3#.9DY$_/,;/?*Q1B,D0L4.B,!]<@/
M.>RR(%1:M,>P[AE;2=JW.3'58]J\%$T2,;@S03M)(KD6NV.BI&IM%JDD5R[6
M$H\:N'$UI#8E0O\`(RU3/[$Z<V!1YB&@W6P)]4ELV-NAQMR:E&-KV38[3:YE
MBHJY,DZ<OG0.7[P!<"B@4_<DIM]ZMQ=SVS)VS'273+-@%'988[186&^,$,4"
M)&@N]XD4,(XP$UN1J-9A[--'D09F04YZ96=,PU22&^5R0/A)279PL/PKD+K9
MB0HXWZN=XC[4?[!LL0PM>N`T5>.2M-Y06%\]BI[TRQ-IJ+RJ37M0KRR`#6#Q
M,E-TED0DHHJB]9QSAPW*DH/8/DO:^IMMP\+"ER(\@[QMF%DXT`4KR)4R5RDU
M3@]\%!ER$JNI92D>K2"U3-WVS-S9<Q,1H1B;E'CQY!=3S(U@$2DPD7#,Z0C0
M7MR)&,BZRJBI7CN.-C9Z3Y1ZM5L\.K);ZM'(:>@90&K_`,PKK?<J<L2(;2B!
MCBX<J0HR)1<BB(%4[(]C+/D[S#/+LD@1A]%X^%&_$?"'%F$C%?,''!;]A[:N
MV#"V)NN5GN=461/'(%':H3'AA(/DN3$3P\A`\E6N7K@OO%[6KAKND7C3YZ5M
MD.-TQL&3N\#;'MIKUFT'&:V@'*-(1CEQC7T)9HK7""K8SU1!6*>+JF*1<JGJ
M,OPNMMF7>,;=<Z'+'@-SS<J!8F2[KFO+(R3%O:M&TA`=`VN.T9"A`3C/T!G0
M;8V#BO`SY&RKM\QD5BHY:SA)44>W!.0=4;%0I42!BQ9:I>1\-*XNYKD*@G=*
MLXK^QH;D4GKF9G;/NB<G(&4Y'NVDK9(^2H;FX%U%7(:)D2*IJ.8J*5>RK8K<
M%.X43.=6#"Z[Q,?;ML@EA?Q.'+MJRA4@"RP;=EG(3X4H<AG=+`1EUC24R2`D
M/H6N?97;?)-RU*<>02/8F0%9&V]<`!45Q$19=;RN"Y4B+1W5>IUG>'FP";K+
MMNIVFCH-DM[Z3V:C7)-E.,TBU?77'VRZ,L4/YS&$4*677+9#/HWHF+8I4025
MZ`83!;$ZKQ)-I.V9J3L9,/=X7D!4M?<LB+(C<!NTH8@LER"VHE3<"J6'I^?'
MV^+&A>+G0X&VP#@0I;!RQD,3;B$=;J@%RK<3PJ-9KP][_)ZRH-#1V/4TG5/T
MO8-8NGBD7-"S>R<QR'UEN9*501(KWB;)*'HBS(Y#=5!<KIG`>P4P9>,/K_!Q
MM^DW=L>4Q/F;=-I#+>V%AY>,ZW[+NV0K+Y`%(/$BKAF[7-DX+8B.%+2[LU^-
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MN7C9.8R,B-R9$:--/>D[S\)&"LR@`J#38=HS,'.VF&=\<X6UH\$;!2)'C?PX
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M*"*/&Q(76\B`+B3RSJRB-E$A8R659++"5UKKULE1W$<`MMA$[5BG>P:/58=^
MI2Y?5>OZL^V;9=5M;GK[<[;=<38Y2H;`FYA36L!9):,1CY&LU=S[#I-EUED0
M%8B67%.NL#&3;IH<>6?<<:9#))-RA((?`O@20I/&BR3D1RL\$V0#)$\<0%QJ
MO\R>GILW/SUDD6#:,S&RXBL1?4S9.0LZ3/&3RED4K><1:1EM)+SCI>PJNV<.
M]\[;=[^MNS;5H^"N6Y-"Q6F(AGKJMVOV)K'L5>9"TFD9FP32J,S;?9)JY2*J
MIYJR,0Z14P3,0A3#3[7U3L.PQX6)ML>;+C8V_8^XN96C!<0HJ\M(UNJ$$,58
MLVHN6.DDBJ_P>Y9>2<O/,"RC;L[%4)J-AE)$JL7:Q('+NR!0%%@I;B:H&@<;
MMX["V/N>%G4Z'3]'%YR!O`\F[K-HC]Q3C[7A:C)P`5]9ZU&IR5=GY>"0(6:!
M4'*#$%6Z29Q*13*J3?=GP]DVK,OD/OL&V9T4:*Z&!?%S9T1YXN)$*QY#2<H`
MK+\'=E5FO9\K:,W)S]RVR'EC;LG'VR*:1E;4>1BXID,!'=:_+6-2Q^!E$C68
MV6O%#\/S=U0A_9!;8&J7EXI$_HN?UBD>*MCNI2RVCYK;JS1O?R.!3E&1;'![
M1Z">.!8T<_:E63!8I0(,W(Z]VN3D\O'R-+KE+D#4@(7*PL/$;D,`>\AQ-8+B
MS*YC(`)85^;LF1GY.8TDB+!,\KQG26(+;E])()%)`(U?!/I/`6D7O#2>6EX>
M6S9F1Y17>UWK6[:^\HM-W.D33*N0T^-3IMKM5D1>`>$4?%0DI"M!!1++SU51
M-%X_D>]6.0I>P`28.MMIV_"VO:<&')?;]KWC"RU9R@DECQI'F=&"DJK<R218
M0"41+'VS-51#@9DVXMN^X<D9;X67CE8P="K-!#!$;L`SM:,M,Q`U!DC4:8P3
M.E=XK;,A.5Y-SL;54ZKKD)B3LL_"4Z9V2B_V9(O]?EI#)I>=;S4Q)ZF8S$0L
M)'8VB)0:S;XK1%NL4J9E>U:X^J-N_P!,3[1D12S9KQR1Q:UB*0<S+3),L4ND
M9"W5&1L?4T):1Y.T*!;#T_F+/@-!)'&N,,3FR*7$DPQL23',;I?E2JS,ACDD
M7FP1((T/V5=OMGBC;-B;T]*["X0<=#^SO&N6"%>,Y)9Z"6CYW<$M,H]\B<&H
M*3B>R4"M1Z=$C-U1/U`Q<MNT[_C[=L,^T21NTTOTI9@18>/V_%PTN#Q^#>!G
M?SJP`X@U>]WP)-REB>-@JIBI$0;\2FX0YA/#R%(BG_,0>RK-(7PO]HU?4E.K
M$=LFIR]VI.SG]P9E1LVWM8UJ8K]CT)4-+6"+D;+J^;A=@,WJ2M:,]1(@OYHZ
M05%NX+T.)R9EF>L+;,_=6GEQI%P)MOR,60,D,[#F[A)G(ZQR@PN!K$;K(./M
ME((%[;]!Y*MDR+(`\FX09<>DNC!H3D=PR+WXRPGX2QW92I&DJYM*%_X%;:0I
M>PM=:>MNGVU6W1H;5.EKX384)>I`::;4E=7K4-*ZY:$FY]T_BY".=&Z,I9^9
M9BY3(X!TX/VR&H8>MMNR=V3<=XCRR,??6W*(QM$)':26&1XYSH1+_`):2-1;
M4R\NUC7S&V7,P<7$7$..<B/;9<*57$C1:)7E?7&&=G.DSR*8G;3(H6[KV"==
M7:@?7N0YDR4^2>K-<WA[%:BA5EHYU"3AX"A:O)J^6N3%N_31=`G*S;A\M'+'
M*4JS5%%0O4I@$<?WC.A^AMN@A9&R_$Y.<PN'5#D3(T,3`>4101M+&;$,[J;5
M7=/PS[7N<)D&M-LP<+##`E1,T',GE9;BX"R3M$&%P>674D&K>7?"SEJ\]BW;
M7:>B:G.ZWXTJ\<=93U9J=H5DI>,2O>N;"2=MRDTD^0KJDM6:.JQ%&.2>'B'K
MP7K18ZA2`3(SUET[)-D961BYDC;ANF/F9,7-"1CE#*UQQ.EI#=\G4K'0VA.6
M;:B]6Z'8\^#%@VZ&6!8,%<H8TO+UR@SPF)&D1B8^X0O,CNZ3>V:V@(U/PO`/
MD]4VDK*5#;VMHRZR>P=WW9C,V1WL_9RM>#=6GZA0E4UYO9+RS3M\D:?/TU%5
MNK,&.B\8K&*HDD*9$LF3=:[!D1Q8>1C3M@1X"8S!%AQRZQ;BV>MEA`6+FAWA
MD=/A%.F52SDU'#M6Z`R2RO%SWR\2=;O++H:#%GQ)"6E)9["2.:).Z@*M"0([
M-5SW#CC#M+05HWM:=CV^!LZ^Z'FO)P$&-KV;>I6!F:A34J9)-'%PVA(/YR8A
MWJ$>@Z:D*5HBR,JH@DW31(GUL'6G4.V=0[%C;-MD3P^%?+TDI%&I3*82`%8N
MUXWU*9&9WD4*SL7O7W9-IW+!W$Y^X21R,^'!$^DN29(9)F+J&LD:2"4'DQHD
M<375!IL:B"#\.^R)ZRV%0I[8=;/(6[0FL=41<^Q@'KSV-GM;;<V3M9![(-)!
MPD9_5)=W;6#9RS*HFHH1NOZH.TF(7:3KZ.+-AS\+';F0[RF=H9@%<)@8F$$;
M3Q#@P2NCV.CF*0"5(,Y]C\1F233O:&7%W2`D"[JNXY!ENM^!Y:FS*2`[#M`-
MQ6Z7$G;]VMSO:FU;'JJ/OTMMSCO;Y*!H$=8W5+1J''X+*JQ(B\L"#28?W&P/
MK6N?OUT2HLD6[=$AC]WVQI8^J-GVV*#!VJ/+;!B^D'8RL@DYN=B#$TKH)41Q
MA$9CP:0L]U%EJER=GW+<<3(@SFQE=L3'QHN6K:=$.;%F.\M^UFT%(T%UB%R&
M;F/:K=<\1[)2+KK"TKVJN+HT;;O*'94H@QC'K=U*M]^R"[V):H*G'N_9*%!4
M//%5>T5<Q>I<MG^I(CM)VW1)J^@8,`&XLKPY$<QD`/8FE"JKV@GS7JYYVW29
M6?-F*RA9=\BSK&]]$>"^(4-NUBS!@>S2+=M4`XX=[6LVXJ%?-BRNCG:VKMD#
M>H??U,ITI4N2-MJK.9=R[765P0@F4?4E(22CW!(N57(Y<IR#1OWOF9%UC"2X
MXG5>T[;MDRXJ9B/-@-!+BEQ)A.[0/"9[.3(&#.^2D84Z)CI6315#G[+F[AD#
M')QWQSE++'.ZZ<J`<Z.7EQ,ME-A&F.)&9;P\9$=AWH8U/P\F]D4#F`1C.N&%
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M+=-MEMG4NZVN)V?$S[9)"`DF\)3"H(-V)EDG<FOYVX,0I")9G^9UCLO3_4.9
MN6WC(R-PS=NCQICK0Q(!M[Q(\#J=32+-(A)<#DHDB)=G)&/Y6RY^][7F[0_*
MBVQMSSYHM:L92SY4X36+:1&4EF<E;F4&`V4*Q:ZX>(>Z*)>#;=U1:=32U^)>
M>4+LE?V3%68E,6H_(^Z5NZ]L7\`1S,LKC5WU/9I*"1%1K(-EG"0F1ZD4##%Z
MCVS,V0=-;I'D+MDNUX&-+)$4,JR8//"LBO9'BD7)DO&Y!#K&]SI(-^R-KR/I
M%MWQ&3Q<>X+E1*UU4_\`91XCJ[K=D;N:TD16('<([Q(IC3_A[RNEJG5J^G>H
M";9U+DIK;?#Z25K\@1]*5ZAZ/8:UDZZ5DW,Y[IZO,(.'#%-/MH-V2A40`3]>
MMTW;U@8VY3^(F@D6`;7N6*4U:KG,R'E20\+L1$468D:I'4D7%JHL?IK)9\DE
MX?&9IP&:RA$$N/E#)D"B]DB+$K"+_!BQ8]M59X>NDI2BL]P;&EY&<D(2X7>4
MJ.BFEEK,M4I:K<=*A.3KZAP*D!8&S&>BP]EK)(%*1RV:'48MF9NZ*``(T/6^
MZ>*VC;]E947=QC"3.=9%D$F5RUQHBS(S(Q7%AA<E78\R:8$AKJ&SXJ2[]N&[
M8VH;+SF3#1D9"BRMXK.8:PLFF7/EF"AU`5(DY?P94G\0W`HL3I'6E`(KK3TA
M4CD=![MD=@(T]-)Y*1,7OI[MIS#(R(-@G"2SJ#=!']^=42"J`B;JF/3(/]8W
MWK'S?^X&VQ;3X-HA):[?1C8!<"^G3S&YMB.P>ZXU/S=B&7M^\XQY7B=RR998
MW*@F,29$<RAC:Y*JA6ZGR\.'"H>IOAV[EUTTVY[1MH4Z)LKRL7JH:9O4Q-;?
MNDPQ@;[MB,V7+Q]BJEOM$OK*@HJ-HWS%4:U"'4.[.202,@J@5$]UEZZVW*P,
M#&S<>5UCDP#E1((8DE7!@D@73.B>*+-S-2:I5Y(UQJ6$FI(9MCG?>\K<XI50
M2OGS1,=;F*?-"VM`6&.R1D'F%E8Y-D,BJ5(;TU_PY]QD9[%3L>S:<HM>@Y$R
M+<ZLSM2_RT7*[ZT%3]0@RDKIL:8EK99V%6E*@FY(Y<K%669J]V5)'L$('S+Z
MWVLXT,.'!)K@BQHU.B"%&&-NS;F"8X%"*7YCQ,1<DA9&+,S5,VS;,Z#<H]QS
M74D9F).P#RR-_P!MBY&,ZAY3?O\`,C=%LJ1C7&JZ50F9T>&&Q91S<9^R6J@-
M;'=[APHM<DG"LIYW'-"\7)*`D;%&(/9%-O(.T;"I$JC&F4(7S<ZW54.O41DR
M=9[9'EXTF+#/X?'R]YG[Q0,WTIBR0)P6X!B+C6?LD4`6[*I,?I_(3I^3:9GB
M.2^PP;?J`.F\&0TH<WXZ64KW>T.";VL:D_D[H/9VX98&\9$\>=JZSF*PE!S&
MJ^1-.>/8^LS[64.^)>J5::S$R,^+V2:J)HNX]QW293L6ZS=RB?O`-C6P;EM^
M!#*F2^=BYYF#Q96(X69%T!.449E1@K7ECDN&5F="&5AIO6YX^5D&-\802Q+&
MR28\Z@PRZFU!RVEV5@/@V72T;H5)4/'>2"9?@SN*O5A[2->;+HEJAMD<:J/Q
MEVY8]PQ-CD[<P@Z8I;6R=SH:T<YD$9*2<0][?D+&2JI42.6K-471NRH0V2R=
M9;3N6;)/NF//#`F]#<X1C,@)E5<<&*4$*+.<6-N<EGC+S:4)8$6?%V7<=KAQ
M9]ND@?<<?#R,;3*K&$)D2F;N<6?EPL2BX[$K+$%1W73QC5WX<6ZJW0Y&CZZV
M5K)RG<-1;YT=;I&\1MN57CJIL_=5MVQ5[)7@B3G-(V6*:V7S&00>&3;K*%%9
M-3R=@URB]86UY6Y19>ZX\ZP0Y>SY8$)2YGVS'C@DC.JP$,W+NA'?3R@WX3X-
MGR=N`^CW1G$F8GPNKA!F001%N[VS1M"7`-HW!TDK[833)\([_8[A-#-W>J-Z
M*]Y`;&V\S5BD)WVX!!;.XTVW1LO"+%=$]B&TM#3%B3?-5DSG15:IF*<I5!#+
M`G56`FV"$12^/&U38?'28[MND&XQ2'B&(M$T<B<+W4J>VIF)MF9B".,-&T<;
M[2]SJ!+;>G+E'F"R*`8V]LK7U`@"J`9<!]RV2U<:YO9-TU`1CQ/1UW4=?H4F
M!LJ*MYI-0M%8G9&6NZ,MT2B;*=K1HT(]@T.[CVCM9TOWO44RA>UZ^VJ#(W/<
M,:#*\;O/.?(5G4I#*^/EQ+X<CBRE\R34[A7$2+&+ZG-6R7IO+FVN/89'QSM>
M*;PMH(DD)FA8\X<551'$P9$)YLS)(Y7E*IY=[X%;;DJK&PU)NU!A;1Z1>1MC
M])+65VK2+S2H3>VUY?8*(UV1H\VUCKNVBX^2(G(UBQ-'$!*OD$UE#`4G8-0[
M1UEMN)F8LN;%,</'V[:\=XPL$J3MMR1JRR1S*5592AY<Z%9\=6;1<GA<=YVF
M?/&XR8PB,^9FY$\9=I$,//PQC!TDA*R+(CJ'<`Z)HQRWL.-9`/;Q8*?$7J5O
ME<>I5:F240QB)V";K3,M.5HS&)3FK?)0+%`BS-I!NW+A=T5J58P,VRATTS&*
M"8ZWWN;!AVPYP+B5S+S(U4N(D+V1@;ZG`0ZGX:E"GVU9?TCT[NN_;[!TKAR8
MYG?&B6&::1(!D9'*<M#<@1QR2.B1PW*QM+,BED6[#$836NBY[77%K7.T;+$W
M"D:&WCM'<=\+8-7W52FV6A;$9;;1I=M37<LQ;,Z=(3>PF249,*BHUD'3<X)%
M`I%3HWJ'UQ[#B[IE;KC>+A>7I^'`20*R\HHF$@RBX'#'E.*ZQLO>8R+:VERN
M?YG\+OK3S,/*V](=OER,O?AEB`9F.TKRI,\N1M0BYFIMRQHF,F5C&Q@C6[&[
MQ+)&DCH&@N-4V3BBVM2D!QD4W-*;9J,$OI.[N]YTZ[/TC6^E:&G%I:-5A9FT
MK[$7"0CQ<KJ2<O4B%9KK%06376K8_7AMHSL#JG)3-?KC`P3C`M$PADE5@L'-
M0`,L[XA=7B0!)90N2"&:YIY/X5.NC]([5@OLPZ0W>02RR)N.*Q3"(*YN=AS:
MV'T?CR)%&,EPW@G,F,$E,1CBR83E8M/)+3.D[51K;07.VM%['JUW24>5^XPF
MII[8-/KLK6+16'\8]CF]HAXQ!M:7:8&017<0TNV\W.45FRZ1:;9.JMB;?,O=
MMI7(?I_+AR<5P_YQ''/H9M+,`IFBD158G@P$L;Z69M.#=4^K_JKI##CZ4ZRC
MAQM\5,;)3DO&\;+#-S,:0B*1@8,A(PZK<!HY(LJ$/&8'>C;MQGY,6!_(WJ,L
M7'@FP-FZ7M6C-KQ#RL7)M1(&MS]KGK''SVOQ04?2\[-L$K,Z2D495-JWFUB(
MK'%MV!(:\XN[],PX[[+(NX?0@R\?*20-'S^;#$(F4K<(D3``Q!6+0$,07UD+
MB_*WSF8^[#P?TUCG("H0YA*3M`PU/[=G0XR%SH`D5REDY:LU(LN"6UJI=8"*
MJ-_H3S3K38O%[9DNYL\?93[./*<<M=U36JD*P*Q.>MJ1]KC*>V>`X54!5HX4
M42[M1,2'+=,KKC`W/%R9-PQY4W-DWE8>6RF*V[\]_A2UFO!+D2<5'PB!+Z6U
M$T'T!E08R86))&87P,2"9F4J0V)E-D!H47NJD@(CT%O@AQ74`!5/S'AV[#-K
M6BU*`OM";3E&XUQNGFZ[F)G6\/(W"+WWK[=19I<60B^;5^4&E*-7(%`SH%G/
M>@!N@@-6OK#PUWB?<O#S&*7=<+)"ZE[L6+B9.*8_->TX,?V(":3:]5XVAAB'
M%U*-7TUQ`_S35H/]F6!D]U;A4T*<7MK&Y60F\D;+2*9433D5:[NPI$YL]&3V
M-*,==O::6MV_7TO*/-2R1F3UX#EO;$FC.Q>:-$&@E!,#B:RX?4FTXO3V3LIC
MGG9DR(X!(L)6(33Q2B=)`.?$X6,K)`CM!([M(>/`46X;3N&;F8>;>"*>,XK3
MR(9-;\A9U>&UPDT3&1>4TR\R!0^CO,"._P!T\6;#M;<:6PVUHK[.$%+C>16`
ME(^0=KKCH_=DSM.6[8IB+(P33"5(V:]H/]4X()S^IZ92=.]10;'B"&2-WE7+
MS)@RD"WB=L.`EK\0R/\`"$CM3@.-5^^[:=XPVQ4*J&P9<<ZA<$R9./.&(':H
M6$J1VW(/8*BFZ\*-I6;VYZY2NNND],V/=U_Y$L)IS&6$NV6=XNC*?=)U1T9N
M`UY6N,;)/G`TFFL60/$D!IW/7JH,_'ZDP4V^"1XIOIK$VD[=&!IY#Q$%!+("
M=8?0Q+(`R22@2$K<@13X4[;G)*C1_1N7EXT\]P>:GAQCC1"1W;OX9-,C6,(9
ME`?2AKNI[A98Y&!M$4RMM1:.IW0?'/3;-?V'D2),G.D[@6SR;XP(E!0D/+)`
M)&:"?0R*INT<.F5\?6$(W1L\Q3&)NI#N974MRA0)RSY#)YV/"W"K3'L<L>W0
MX0D0/%L&9M]P#;7D]D@\H0?9+[8U(6P>'FO-T<D2;EVU5J+L*I1NDVVKXJHV
MF#5E'T=/!<'5C>3Z"J__`*>FR=QZY6QB``JB8G4?4Y9MHZDS-@V7+V[;9)8<
MW*W"+(YB-8!(X6C,;>4DLP8>3AYZNF?ML6Y3;>^2$>##AR%96%]32M"4=?-I
M$;`WX][A7<H\5JDVWW(;.6J^NY"@):'HNFZKK]Q3HMZ-8/4+1<9P7D6B^9+1
M3*)496-!%-!`I#]I`>UU`0RFEZASI>G,W:FFR/I7,W-LII]9!(;%2"SD'4S:
ME+7[`#PXBHFVK$^D-OGACB3`PL2>'E:18F6>*4,HM86"$$^V)-[\35J^L_#-
MB4ZHI6-XW*QV)"*U$ST;2VFH+_L_4T%%:^=.IF:N36P1E9L4$WGUK189@ISH
MO$G+0K:/:D!,!!3M9+O77\V27EV:)8LR:>*>1YXX<CX3&ACAQ602*X5H2DDH
M86;7,PU645;\3IZ./,YV4U\2-\MHTB9XC;,RI)IE=D*EE:+D1:00H"2FQUBW
M96OA_P`AK1K>O:WOT_QRWK7VNMZS2'*VWJ38$YG7L]5&\A#M]D:UL<#'N[#(
M3L[$'9/7;1\X9^:S+03M71$E1*$$G5&R3;G/ND*9^WYLN4T_,Q)%U$RQIS83
M&S+&(TF,Q@8=[E2\N56M>I>)LV?@8,.!&<;+Q(8VA$&4I:-HHYF;'=W"LYE,
M(ACR1;0[Q"2/0>!N+U?QPLFN-NP.P%[R]M\3`<7-<\>P<V,':UYG9JC6&0EW
MUVG9!1=PU5&?2>E,<G>'6!QVQ$PE$!RS[IU)'N>)N<0QU@EW#>SGJL9'+B0P
MF/D@6!)!-P0`-/D!X5686S'"7:8Q*9%V["G@8M>\C3/"X9>+:441%0K,Q`TC
M4UB3=<9%X4H]V=?M].@=M43AT%`HGZ`8_3M=[UZ#\T!^8(!F*GAV=G'V+^BK
MZ+=IKR5%R)3]5'7J45!2`XF2-WW4HD`P=\J8X>3_`.(PAY>F./;Y;C^GC7SZ
MGLU^5$W!>]*F1P`G6.IWA#G,'_AE['9*"Z0``FZ]H1\@=`\@Y\[!8?5_I_HK
M[P_F'_'\M>SHX2;F6.93OP4*;L&.(D,'4H`F!`$2`!NT.?2;6MVW_IX?S>2O
M@^KV`?T5K\]D_P#>@.[[0]Y^1S['>=1Z]O\`"0Z=OK\WKUR'AJ^I_P#6HO)?
M_CLJ]GP0/S1_A^_BV47YPXR74594<4IBE1%R`L$U4M#[KM5;?GB[#6M2[%GX
M&32*B=2.F8>H3$A&/DR.4U6YSM'K<B@`H4Q!$OJ@$.H9'$%;)@C>_+?)A5K=
MI5I45A]=21Y_-53AHLF7'&XNC.`1]0FL/ND-^;/KM:UAN>!OW,#=-,A^.UPV
MGRCAN1&L96FT/S*(U66U1)M56BR:CUFR=6F9NZ/FK9..<2S16-5445`B12*F
MW7U3LVU09NY[1/B;5CP^.CQL`XTROE&:3,C@198A/*W+$#2--S4CLZJ%.LZ#
MK;IO+W#<(=NR<;)SWW>20-*&C(QA$L4C2GF<M0MG$?(:-W);@04+,+F7OB30
M59V#JS6VRM4QU+ME\CM5SEI@S[0@9JQU6-W'95Z_K`\#7DZZRD]B/FKQ(KJP
M%9@W0KS0%%@7==V(#CD'JUESFS1M^3SX\6:>`.(6Y;Y&+"V1*K/JM%#H"K!,
M_&6:2.,1K<LMQGZT.'MF+N4\+QQ96/XE%,JAO"O)%$S`?99`$ID?&6]X8W(D
M9BL9JMOX@U5;V;D!'6'7B,)&Z%A[I/.V9;U`*[8?.:C+Q]=(6;T])1T)8ZNS
MNBTRDI!RJ+B4CGK)4JBJZ'>$(:TP=#Y>7M6WYV&_,S-PR,:*-1&>3S,II45#
MD@LBRQF.T\<BQNER%YFEJN^1U`,7>9MJR;IAP8\TDDC/I/*QXHYWD6)M)E@(
M8B.2-F!DC(94N&JHY_E=NBG+ZJIUGXI.H38VW=A25*K4$TW+4W]01AXK7<IL
MB7MJMS:UT'B)(:.AW+1RS4ADU//R`")UT3@MDENF]EEBS9\3<]6W8&WS9,SC
M'=741SQ0!8T+$-S3,CQ,77RB18R.,L[SN(QDSY\-RT^5CQ0J9`Q8Y`?1SN%X
MRIC(E4<P*K*4=S=1%-=Y[V9&F5MY4-!WS8\)`<:JOR3V/:+%LNJ,IV$H<H_L
M366CF?=UU%M>=AQS*LN7:3,B<4T?)E[(.$3B!1O>X]&X,&?FMN6?!B8\.Z18
M*<N&1@TLT2R(Y37>.`:E$KZG9+E@CVM5/C;ME9$D6!@0-/N<[9Q5&D"@>$R1
M`4YF@CX1W"PC3P``D90"]>ZE<S+=/6RQ/-BP*\)0V7*Y;7>L9.CVADJK)Z^+
MQF>;G1?;$B7M<*Z<HG8I*.!:-E4W!7CA!/O1*U.*\G*Z5Q<#;HR'U;PNSYT^
M4CH2BR8VY+AZ8&#@%P2$5R-)57<K\(H2&/>9=PD,F*A&U2C:&A;4%E)SFXZP
M00J#[-;DE00IN;CM7OB)2->HCW8MQX]62!K]ETL_WUHQ)I?:Y-2VU*3&3%3C
MG4;,LD8YJCKVZ"POL,^(P46DFYD'ARBZ*J@H3'^@&?<?H2',C?>H-QQL++CY
M;!,>3*:1$=9+_#1QR0RQRL%0J54J'5P:FIO^I3FM`Z[*\>4T4MP7=L2-Y61H
MNV,S1QR/`=;!@C:^6UE,F$Y)W&\Z1Y@.75+=:=VIQ\A;S".FS:S1=W9M9D=.
M1NSZC9(6<1B8UL[,6*L[(ZS==F`-WB2B0BL0H*'L.Z[!!@+M.5B9(R<'<90`
M=!C*F+.;#F0JQ-U+1,4>XU(P)5&N!<^F]QEW+=A@[AC&$A<64`N&#PY2:TO8
M*5<6=)$L0"MU=E(-6"63ESR')Q'XXUEC?G+/D4PV/J^&WO>B1D,:0D:/6]B:
MRB9Z:<QPL%(R,6W!7]A1!RG3;D(GY^N1'L'*42[+7IGIR3UDR2^'4=(M%*ZP
M:GTB<KDP<D$G4T<.5C9#>VUZ(XF-U8WPG'W/>#T7DP/.3OY6?ES:>\(4Q7W)
M)5-N7S4QS!`^H:&=IPMV06N>V'XE(:YJ<EM>3T%9WVDI"?V;1-9WIE=Z^$]>
MMAZP+:`>P,E2%8\J]-A[.YHDVE%2*KYX94[)/OV[<'"8AB.V=`ON65C[.N6B
M=1SPXV08#&Q5<;*DQT5^:#9I43*@F>(+;EL^F0M&5.4Y.[R8TN1)R'?:<25H
MIIM0#+*L;-W8NUHC*!C\S4")72\>@EQZGG-C>$UN+4^KHW2L)2'BG(=[J7<C
M28V)'6`S6MR?'B4W94YBI2+*MM0<R1XY1!9Z@=)+S=RS49E.J5<KDDJ7I+:8
M=DSMT?.:2)=CS<F!DB86R<3,3$<,&;C'JN4;AK60.R(8RC4,/4&=/CJRXG+R
M&FVQU#R`AL7/E"$FR@K*I#1M'Q"FSJ[BK=X/G)O%_P`8JC#6*+G:GM&<H>K=
MD57;_LY6IE>]U8O)C6VI;RM-5M&!9MZ<^E$;>0C1$`>E<QZYE>VW5*">9B_1
M.S-UE&\'+;;$S8H9L2S@+XC;,O*AM)JNY#8Q,J]WER64&1;FJ.3><^';L_F(
MW+9=Y\/D:EU*^#*P"F*W!55@(GU/K$9+A2P%9#]5\N8W:%]KNL6]"F(2[J*[
ME3V)"O)F,=JZR3U)<$::V<RYVJ7221OCMXW<QHI`G_LJX'/Y0$,UME=.'&VN
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M'M6U='Y'6>9F96`V-%C19`QT.-'*<<S"`S=[F%7@A,84M-(#\)*BB.Q8I'F;
MRO3FTP3Y2Y+RS)--IG>)9!'$\7,34I*-*HF!BA7VZ(XY@8*'ZS0?*[<,;9K;
M&;AH[Z:U=8N:.]-$T+<?MO@5)".797^SQFOJVKKMA`-'*5,9MX,\8255D3O`
M<D+WC8R9@6&#)Z9VS+V7:CAS"+J)^G8LN2'0Q64JKR3.9M5EF,7?6-4*%4/?
M5N[57E;KDXFY[A*(S)L<.3B*7U!3"N1BX=K1D7=!/,I=BP8&8Z48(;9!F^VM
M8O-B/M1-+[5'&T8V'"??T!&:8GMC.$,"`EE7,(587R3$WG2?102`7U9?+Y0S
M!CMNY-M3[S'#*=L1^690IY8DL;(6[-7U.VKU)EXL.6F!-(BYDBZE0D!F7B;@
M=I%E;C]0^:L+]9Y=<B&7$GD_#RE^6E.03N[;/)Q[N3Z-ARO8^FVZS[&;5:2)
M&-F"+!^RT^A199$ZBB*IC(Q13K]YU,([,W#IW9),SI^;'B,>#X7&^D0I/>,6
M/!ES."2;/DX\T=@-*F5RB:3V6F'+S,??=XQI"LL!RT7"1@UE:>5,%86*V-ER
MSK!-]$<D;2$*;U<[5>>KVGS'%W5U]K$9./\`<%/U#&ENKG:U(;;#L=JNNNE;
M,\L[+34<S7FEJ@VD(Y1N_D%EXXZ3HYA19J(%*H>CW?HZ#)R.H<_;V:&+;)<^
M00I#(\218I#!'R"=,;2`E85^$)"CF%"P%6G#WK(V[:]L&8WB>>L"23.Z1R,\
MF0<8E(@/A62\4LNGEJ%D[FHHPJ9:MM[9G)3B@MM:-\RXGM[O'QMAAKE/V&(N
M4M7=2G=LGUCMZIC1L5`5:TNZDD]]CC.1?M8]8Z+I<%0*9#+'NVR[9TIU+%M^
MXR-GQX\E\B*-3'J?1JCA#DLQ!D,:S:5#6$D<9U%7J^;=G9V\XF5X"%8LC5+#
M`TAU#F1R-#)(R+;NH4=HAKL]D9PJEEJQN-VCOR]4RJTR"WGMNNTV69<L-PZD
MW/(Q]68[:V/K+2,=14=8'MQ9*IC$/JI9[%<WKLZI8UBZEX5HS,44`5$Y\MRL
M+:MM?(WG+P,7Z6PL'!&3A=\X\>1F9,X.I0^M98\3'57C$A$<\S%N\F@6O`ED
MSI4V[!RYY=HSMX&+%E=PR:(\.62=H'TZ'C\6B\F8H=<:R(-2,KU.0;VY)V39
MGANV(]JIM<U%R!A5G%ZJ,)!NEK7:[8^X]6"^J*R<Q(G680]1A)MB"C1FR(#I
M=42F67[!`3&CDZ?Z?Q<WJS:^7*^;@03-B,6&B%(\S'ANPX&28B33<D(%![I9
MKB4^X[K]`[9FI(A+9V-CY+%;/*YFF1^6!W$CD2(,W`N&8JME%S1=RN/(/4>Z
M-Y4EEN';$VWJO'*<Y(Q[S:C"A*0UYL]!MT+*2\'III5(<A(+6HUUVY@YIC,+
MI22#MXS6:]M-,[A23ACI[+Z;@W;)P\98\?=\3%=8VEYRX^0D\4LN46($CDJN
M1C-"+:XG273J$=7')QMQ^G8L#&FGU;E#F!&.@8T<X$<F)%%93(KQ,=,VLVEQ
MN:5+R#4N32=N2LGI29V#7%E&*TAJZ1N,$X.1/OF:KJJ+348L8BH'2[QN<Y!$
M#`)>H>7J&:]WG"EVG-RMNE/PV--)&Q'GC8J;?7'"KYTWEP[S'@YNG_M\H0OI
M/N9-)M[!M6#[3NZ-\S.FM3[/UKN?F!>K3*<>KI>^0;G?&JY.NZ<KK!/1D]84
M;5KBU3>GJ!#/+.TVJ2++#(Q3Z81=1ZBXJ)F;E%8-T=7;3L^V;CNN!DX>TP;5
M#*(\0P3`YAF\5`L4;1<^1]+0&?G\V-`M@0RR:%;!^F,O)W&7!=Y\Z7<I-S"R
M)RSX4P"299=;\M555C5>6R2%^=RTLRLY6XVC<P]N3+GP^O;I2]RZOK=UJ=AL
M>X+]L)OI\E2V0S@..4Y=73Q$U,OUOL+,/99A[+D[<=%E[I(0/V1_U(V??.F-
MDV[=.J6@EQ)HL+&F:#&B\0986&?CQ+8/$J,51VB(YKW+BP;VP;3NN\9VP[2J
MQ9#9V3N>)"TYY0CD63GW7V^H"0JI!Y:V"W)7RTKQ<YM;%W0]Y#T^L[AUG>-F
M;&U!9.1?&N)4E8EU&ZI2=/9JNQ.JKR#-)LFS6K)35Y\X(Z456%5\\%0X)D`I
M?G4W1*;1L6)-+BY*2;?G8V-GR(..2N0D<LDF,6[A*2#+QH6L%(7&)N6)-5M'
M4N+G=5D//']"Y\<YQTN081A2&,/(MN:/%8[19DJD7B;G(MB`HKW0LC=K==;%
MH2[;ZYEZRN<[KHDU*U#>E>H43L[V>KDG6G4E>^/FXJ17I_44[2`3E#,9F+24
ME'C7SA`YBM1$0&EZB3;H-MGW_:<3:LK;\3*!C;':6R1NLZ+%GX\Q69A)H1X9
M5"KS(Y!K?4%$O;Y]S7,Q\3=I,K'S<S'=9!(J&%YM,<E\&6/4D;P_#:XI&+M$
M4(C^#9SS>.4MM:(X$[>W[.;\V_L78SW6&^'\2]V#*4^1C:G*ZWD=D1U;E*U'
M0M+KK=J[%*':F<BY%RFLHB`]DH"(#1=:/MZ[Q@[7B86)C8SC;I',*R!W\5%C
M/*I+2/W;R/I``(!`N;5>NE\:63=LI<G(R)HH=RR<95D92NB*<JA.E%.O2H!:
M_&Y-N/"$-+;^V34X#76Z:[?^8^YJC`<>KCM7DO#<A]92])HH,H76`6F(/JJU
MV34.LF:]PEKRB1JU3CW$JT4C%E5%2D3(14<JZGV?;8<[<=IFQ-JQH3GQ8V`<
M:97RC/)FQ0(LL:Y$K<L8[R/-S$CLZH`VLZ#C73F3G;GB[=D0Y&=)NDK:IU>,
M^&Y0AE>4Z^6JCOB,0&-W8DV(9"S"Y=SXE,56]CZMU=L35\?2K=>&.KI6U01]
MK0<K8:E'[LL#BO:X-7Z\G7F4EL1TDLD5Q8BLRMD()J)U.^=`F(#C\/JXFR_&
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MR%*B==$P+Y2/T]LLJYDN+N>K;L+;YLF:3P[JZ\N>*`*B%B&YO.1XF+C@")%C
M(H-UW"/$3,DPFU394$,*:P=1R!(4YO#X(H8R)5`D"JRLCN;JL0U_GS96],K[
MZHZ"ONQH"M\:J?R1V5:[#LJJLY^%H<TYL"4HP9$3KR+:];$BV%:<NRLR$BFC
MY,O0KA(X@4;]N/1N#!N&:=SS\?$@AW6/!3EPR,&EEB5T<IKU1P#6HE?5(R7)
M"/:U4V+NV5D/#@8$#3[GD>.=4>0*!X3*Y!3F:"+R.P6`:>P`2,HN]>FI\TK?
M*6R=>;,@'$'1&/+*2UQK64H5J8K&D]?L^-TQN--]L2(?5HCMVW-',CKBT;*I
M.//'"!.\[+505X)^D\7"VZ,H^K>1LN;/DI(A*K)C[E'AZ8&#@:]3!%<]PJKN
M5^$4(AWB7<9W?%4C:9!L[0-<+*3GDGOBQ"I[M;DZ00K7-Q43[Q$).N461V#<
M^/-C@86P:8<;YT@V9WZN3<IM.CM)^HPSB-EVR,<T0U]=2M+_``KXK!162;F0
M=G+YT"J)R9`.@#)N0V3'S8WWB'<L?"RTY;!,>3),JHZR7^&B22"6.5@J%2JE
M5=7!J-=_)C.=)CR+LS0Y3Q2W4O(V+&TS1M%_TVFC1W@)=@RHVLQM93*J&Y=J
M;JTURD@8"JO=)[WU$:PU"*0C[)$WUH6UGUO7]D4B4BY@L(P;/6\HSLS)!VW5
M8@9NMWR914`"J&Q_<=NV[8_HS>C.,S8YY.;*-#1L8\7->#*BL6)(98).6X92
MRNI(0W`N.RYD^[9LNTYD)Q<B3&B*-K#Z4S86Y,WM5TR0N6+1L"H:,=YT:]6E
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MTO&0[I&5KQ0<NHTCA`_G(@KVB7;$]6V9M_4.V8&X+SCEY.1C/&ZF%?$)B&50
MDC,!+!KD0+D=Q#)'*I&E-34^=U/'/M^[0X=X\G'V^2:)[AW7DY/(E$D2AC'*
MM@RQG69(YHS'J?4BS%;>96PZCM&EWV;J$HAK&3XQO=H3>LH>TUF=-'0DKOG7
M50C=IN["TCP9N'-;U_9SRD@P;.%$$6X+ID67.F54U#@=(8$N)E[3/-&-U7><
M'#$[(X6*67%S2\`4D,RR9444"R%022LFE$U"JK,WN=]NQ]ZV^)GQ.3G9`34@
M>;'QXL>74?;*DB1&:3EZCQ7EEM1%KFI+E7$J:*Y%;PAH!S[6=+/-G1%?DSND
M'S:^N-;1W</YF+2;@B*$4>VI.8TI3G$YCLU#]2E$.F(OTWF'*VO;%8#<]UY(
M5"-)B.1D&"'63<=]=$P(!'+D4C5>L@P<V#*SLJ&Q.)AVUR>1K8Z9,@4"Y(C1
MPI/:9`Z@=VYL"Y&\S;+Q\N^E:E.\@JO'RVD:=0=I<DX*P/X)C,;B]*-G85Z3
MIE<CO,`<"%.JZ\O/,F[0$U`!&.(JJ<HG[>PNF^E,'?\`<<^3$PI9-GGS#MN(
MP#7A80NRYDECY)1AK(U]!YV6`H*+IP;=-^S<;IG!R9)DAWB;#;=9.("M%&ZG
MP49;@4F!RHP2>:GAH'/X0Z[L=I\Z7^MK7MD6FD)NVZ@T2CJ^0VAM>,NL(V71
MA=J1#"6BY*D4I6-6=7$T"A()J221WT>*;4Y54#+F-W089@=*QY&!'/G92XVY
M9&7DXL,+1L;SXPCNLSW`A61Y%C5],A#WU*%!:LJ?=7FE2/:8CE1G;DS68,$'
M(=YQW-0[\FC'DD5>ZI46+JQ4-45-W'LKD[Q07VQ!@QXK-;W&1]@J]VL%@B;E
M)PFJ57;1Y.W1PF>-B8*KV)Y5$GAH[SD[YNQ440=+@<"G0R/>MBV_I#J>/:]V
MD;-\++_W448,=W"ZD@$A+$WD*)-I4&PDCC))5Z@VC<\OJ#`GGVR$1R/KCQFD
M.H%U=HGD>-;'2A5FC&OO]POI4LM6/1.T-\7VH5&D5_>VW("CV)7E5M+46[)!
MA5F6W-B:OTE7J,;7*]E-(U/V'D*E9[=;WSGOPC&3F6@VC0Q11*KWA\KR\+:]
MN.1O67@8HWC!V[#.1A=_PZ9&7E3J`ZB36DL>)`@>(26CGF8MWD*"W8$S9N0F
MV8.7D2[3F[NN+'E=POI3#EDR#CR:=#Q^*C7DS%2&194&I"CU-9=]<E;+>_#6
MM)[53*YJ;D"P:*;`J<)!NEK9;K5*<?++?'!W\M(G6CX2GP\U'`HU:,R>=KJB
M455N[(!#4QZ?Z>Q=RZLVDQ2OEX&-D/B,6&B%(\K'B!<<&DF(ET@DA`H;NEFN
M)4NX;JNP;=EQRH6.X8V-DN5[\K^(FB<Q@=Q(Y4B#MP+!FT)9>)D/4TWMBC\V
MK)I>T[)VE=*A/:5EMF"YVNUIB<-/6QO=("/%;1*5*C$58"G52.G#LY>/FEP>
M><+-#H$52*=P:TS1;5N'0LNYP8V-#FXF;CPKRVD,ZQO'D:WRRYT/SFB5H6B'
M=(D#Z+JM5^7XS#ZBQ`LD[8N8<HM?3X8:1&\4$0`YBS1J6OK.F2(,P+L.[<U)
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MCQ-:&+&E0`ABT>4ZHIET:N2T!+'+4Z^0L;N#(EF/16WFWL1>5ODK)4M*(TNS
MXT<?=OPLIKO:52F+T6U;.V_+TE^UC9]A"SU4DJ\H$>"97**RR:K1J90H%.\!
M-M7;9T3@\Y,-IBV]CJ/P(6:"1(N5X(9`YL;,L@:YN5X$$A02%UM"_4$\^-C9
MD4:C"FVK<LB0I*KD-B-$J\IU!4\')5C;C(-2*8BK26^YS;'<WQ:E4SC([LK:
M1VUM;25,L,GM^MUMO/7;4+-[,6%_,L3UJ4<UNFNX6-7%N^*+UV9\4K<S(J9@
M<YCN/TOMYVA-USL\0L=N\>T:PM(5QAD'&8*VI0TXDTE8CI0H2QE!72:_*W;)
MQYFAQ\<S1ID8V/JUA29\K%ARH5TV/P>B1A))VJR=V-]7#II7Q((IBKQY=AK"
M,0K_`"`;:H:QGL_N.DPMY1LNUK&SJ"4+6=;IM)2>N4?3+`^3),2!CQB)&XBL
MU(Z`IBA71]`R3Y.XX4.2SS8<<\D92"1HWABPWS4EF>X7'6:-0L:GF.)#I=5%
MF-/F=1/M^W)N.1"BA'D2=><H*2090Q9HX+@')="'E6PB5XD!U*[:!%S?Q)IC
M6.@]8W+>NO:,ELG9%HWVT:UYILJ#J]6&@Z-N4K%2+AG89B`[N4MA62S)G&P:
M#4RLJ]4$P*MR&,)*L=!8.Y;UX#99IFP(=KV^>9N07D#YJ1A%2%7NR%V>1CJ4
M0Q*]]150]3E;_G;><R;+4*4WB;%Q[S!5)6)YM4TI`$198F0-I;5*T2G2K%TJ
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M7+!5TIBE,4KAO/V*'_UP^=*Y&G:?Y*A?L^O7',4#=.HB`AUZ"!A`?+TZ_,']
M7ID=07%>L44Q^;VA_P#OF_\`?D6IA7RR_4K\BU0'YI1'_P"\/_OQK:G=^I7L
M3232`0('3K\WR]?F?]N?"2>VG"O9GROMQ3%+BGDQ2XIBEQ3%+BF*7%,4N*9\
MI<5KU_XH;^IX_I)9!Y?^//4?V-7J^"!^:/\`#]_%LHOSAQD-15E1Q2F*53=R
MJD-?*C::/8T5G%?N5<FZK.H-W"K1PO#V"-<Q,FB@[0,5=JLHR=G`JA!`Q#"`
M@/4,B1BDB2K[>.17'_,C!E_G`X>6HXY&BD65/;J01_**I)UIVCO-,K:$79/C
M:X7UR;52D>$F\+)#3C5WVK"T"8!3S\'GL/ZCSCM][V_5]>UY<N.5N^;F;V>H
M)RIW,YBY5PH"\Y91,#I[+<P`Z>RW#LJDVS%AVC$BPL($00QZ%!.HA;$=IXG@
M>VHYG^*&J[!?ZEL8SB^0LS586HUYU'5>_66MUZ[1%`D?9>CL]A0\2];(VPE5
MEA%=KWXAU$QDU>\1,9,;CB]5;KBQ9,0$$BY4LDIYD2/RY98VBDDAU`B-WB<H
M2!V!2`&16%LGZ?VW(Q<;$82*F+`L",KLKF!61^2S`W*%T5F[&)N-5F(/3!PP
MTJZG[Q.V,EWNZ-WK-TIWM>O%ZL-GKE/K.QI%G+WJ'H,?).E%JJTLLI&MEU@1
M5,*9VR0(BD0A2A`O4^ZQ;='M^,8X3')COS8T5)G;$+G&,DBV+F#6W+)%^-V+
M&JN3;,:?=%W7(UR2IS=,;,3"IFC2*8K'[4&6-`K6X69[`%VO[:7P]U93INIV
MAQ.[5O=KI5BDK)`6?9.SK1<YALXDJ'(:W-'B>3=^:#$-*M*N$TD"HE#OU17.
M)U?5Y,W#JK<=QQLK#,>+#BYF*\$RPPI&'62:.=V.D7#EX8QJ!`"*%4`$WDXF
MS8F&%2-IFCCGADC5W9A%X?7RHXP3W8U,CG3Q+%CJ)L`(#7\.:AO]G$=+SUSA
M=,Q&@:)HV+I=4V3;H1[::Y7;-:)J=JNRD6Y2MK53YII,HI'*=P+E4O?)F$J9
MQ[5[@Z^S4PLI\F."?=\C=(LL&2&-XD:*`1QR(I]K,C@,IL5X`FY%JH\O8$FR
ML<XTDD&+'#GAS&[)*9,Z:.20!QQY9`?A<%&*E+$7%QJ'$C32%N?6\L=/&4>[
M$C]I%KA[%(&IT?<6&LGNH#/(RM=H&#)G(41Z9JZ:E#S=8Q"*"4#E`<Q[_4NZ
M'"."Y1U./D0%V4&0Q94ZY,J%SWB#.O,4]JLS6-C5P.U8?,#QAD15Q%5%)5!X
M)R^.0HX!E)TD_9*`K7`JA8C@-H"*B+)7E$]@S=>FJAZ/8*$L6P[),QVMM?&G
MXVRK4C6"3MT92GUUS*0C#O$DC'4,BP;H]ONDBDRXGKC?C-#EZH1G19,.0\HB
M029$V.&$+Y#6^%,8DDM<<3([-=FO4A=BV])7=`X@>+(18M9Y40RQ;):).Q'E
M`%V'%>Q-()!F\-"ZY*TW@R"/D>XY#JK+;.+[+ONU)'7U]#:Q4&,-WO6%`:E`
MMD@!OV.BQ15_9F$<L$NZYDV+A8DA'(V]W:'@+@ODOEM<_9?#.QX]B]WL%77&
MB3$SAN,/#*$,$5SQ&C'#"(6[+@,;GM;RU%[WA%Q[?RMEFUZS+!*6RK:@ITR[
M2LTTF=2$T?8H6TT4C8A77=,W99>NL3/UTRE5D4VB9%Q.4H!EZCZUW^(C1(FD
M;E-G6T+;Q$\+02$\/:<MFTQ^T5F9@-1)JUC8=M!4A6NNU-MP[[6\,^NZD7L9
M/A'`EMS`#;58`53$]X?7'2S/;$,TQO3RLSKNWR[+71K_`&,NNJ=:+\5R6Y7&
MC50KH&=9M$\$B][UPB82IC(NA2(F*Y^L>#UOOVW)!X9H?%XPA5)C&IGY,$B2
MQ8[2$7:!7BB.@]HBC4G2H%19&RX63E/E2<P+*S.\8=A$\S0O`9VCO8RB-V`;
ML#'7;6`PD:;XG:DF[N&QC)VN+N'I/KVVQEX6V2T<<ULKFM_1*W3,BFJ9N,'(
M4(3,7K+L]RY`YCF#MCVLML74.X1X(VT\M\'PN5CE&0$-%F3>(F#>4GG6D1KW
M0JNG@+5,?:L1TT#6MH\1`0Q!"X4G-@L?.&OJ/V:DJUQ5..N$''YY!5.N+0,_
M[%4F@Q^M:^D2US9%&]4B]DU+:[-JNL5SWCIT2Y4B/6%<XBH9%,R(CV#F`;C'
MUOU!'G2;BLD?BI<F*=CH6QDAQY\5#:U@!#DR@CL)(8\5%)MIPI\8XDBGD,<P
MD7/_`,XDY''[8GN^X^QM7[T3QV"A;GY&\@;+`U>%O^][#7FRC:KSDO8F32FT
M6'2@H!PN^EH:O>:SMF!('LFW;M`026*F0%G`D%4TG<-]YW2V!TKCO(^%CR39
M$FI0OPT^G5&MF<O'%9A&Y*EN8YY:7XR%VUI>ILCJ')5>;X6+#A()+>'A>60.
MW=4*\K2#5&->@1(.:_D:EXOPVO[NG9I-)F[+K^Q[><:5=QDG)MU8:H[WF(>X
M7RO6*#,BG&.'+*V1IO,G!5%Q\V,`]$C"8H_,GJ&67:QB1%AD3X>-CY6H!@ZX
M+/X1D8FX(B<*X`4=P"[#C4;;;S=RDRISJQQFMF1#L*3RP&"<&P`,9%V0&YNY
M+7(!JL=F\9=;[7OM<V/8'=YA[%`QK."D/:7>;#3H^[5N,GDK3$5F^-(%XT]L
MD'$6%,SINB<Q!(=98@F%)90AJ;9NHMPV.&:##$+0S.KVEC60)*J/&)HPX(63
M1(RZK&X"7!*(1-W+:\7=41<G6K(LB!D=D?ERZ#+%J4@Z)#''J`L>X-+#C>BZ
MQPGTI5-D+;)8*;!>+GV7;MSMZ5,[!L<MK6/VW=GDF[G-AQM)>.CQ;2Q]F8<)
M-S%_U#5-0>Z2*?U>52]7;LNU1[4!`%APEPTEY2\]<5;7@$MM6AK7>]V:Y&K2
M;5+RMGQ,S.;-E,G?DBD>,.PBDDA1(XG>/L9D6..WD+(K,"R@U=SF+D!@5/81
M5UJT<>#_`!X,[JCX]8ECO*76-P5&`<&LTT)V\1O%>:7O?G``Z`CUZ;VR2)(]
M=4#*1R;Y<J`D!0W7)%ZJWI(,G'61>3EX^'#(-*\8\$HV.!P[I!C3F%;&32`]
MP*I&P<=\_'W)@?%8N?-F1FY`YTZ*DA90;.A"(0C`JKHKJ`P!JD$_#RX\MK`S
MGX\^S(HK"PZZN36"B]EV9E7"7?5M2B*#5+FI%).0(XL*=*A$8QPHH8Z3AL)^
MTGVSF/E?)UWOLT4D<_AY.8,Q26B0D)G%VRHU-N"2O(SD=H:VD@*`+7+TWMDA
MU#FH3'CHVEV76,6438Y>W:8G`T]@*\&!J4+GQ/U1=^/$1Q@?'N,/JJ#C:E$,
M&M:M\M#3_L92GK"1@V+N?1.=Z_9@ZC$1<HK]XD[(3L+%.0QBC;EZGW0=3+U:
MQB?>%F,H+(I3F%2NK1;3P#77AW6`=;,H(N`VW&&V9.TKJ7$REF62S$-:>1I)
M0K#BNLLRFQ]HQ3L-4E:>$VL[U38&GW6\[PLZE:EK`_B;C([6GDKZC$6Z&-7[
M;2%+1&E8.UJ)9H80;O8PQ115*0A@[)TR&+4P=6YN+GMGX^/A)S(1')&(5,,H
M$JS(TD9)#/'*BNCGO*00.#,#2IL>,F)X3FY!19%DB;F$-`ZQ/"&@(MRSRI98
M^'#3(U@#8B9)G1.M)J1TS(KP:C,=!.GKK6#*+?NXZ-@@?4J1U\HU49-E2)/F
M2-6E%4$DU>T"9NR<OJB@.6L;WN1FS\B237/N<+Q9#,`2ZR2I.YO]BQDC4ZEL
M>T=AJJ3;<./`QMLB73AXDT$L2@GNMCW$5R;E@+FX8G5]E>K<;+PG@8NI[$8:
MTG;/)6W9%1'4'MAVYL*VW4FM]+V6916O=4UR$C[)NXM)Q$&5\T0.<1.\2:F6
M<"F@!1O4/5<V5+B0;ND?T7#EQ9,PABC23*EQ@S0<\@*'&ON/V#ER3$#6P-2!
MM:8DLVX;<7&Y".?PP:1C%CRY!!:6-3J"E&M(HTM?EK"-$;-5S4#K%.,A[O59
M.=D9>GV=NE"PM<,86[6HU1.J,*N>`AUR'%PFDN1LHN)@,`%45$2@7RB./;AG
M?2*AYU!RVDEDDD^RD:5R_>\EE)(7RV/$GA59MV,-JFB.$Q7%@@QXXXS8JA@!
M&L><OW=0[.Z/.:\0VF*)`Z58\?XYD_3UK':W+JAK'*RCU:2+325T:L5F:944
M%^=X$./8\X$_>]OU77M>7(]UW7,WG=I=[SBK9\V1SF(`4&34'N%'`#4.SLK[
MM6)#LT,>/@@K'$Q9;G5Q9RY[>WO$_P!%1I>^(&E-C475VN;)&6(U8T]#'KU)
M0C;5,QCQO#+U(:,\CY*0:.$W,LWD*L<[1P"YC=ZFJ?M?LARY0]5;O!O>5U`K
M1G<<UM4MT4HQY\>2+):PM-%&XMV:0.RJ2+9\*':HMEB##!A8,EF.H$)+&#JO
MJN%F?C>X)![0*K'9?'346W1J!;W5DY9K2HJV5Z(CTG;N/8+UB\55Q3;35Y5L
MQ50+)5Z6@URE.U4'L%5115+V5$B&"WX>];E@3Y&5C2$9&2%UMVG4DZ9$<@/V
M,L<T:O&X[RG58]XWJ'P,5\7'PM-L;&D5XP/)IB>'0;WO&\4C)(A[LBV#@@6J
MG=4<7-?ZFL#6U-+#LV^3\/7W-2J4GM38$W?7-&JCXT<:2KU0-+'_`/2V,H,,
MR!R<W>N5P9H@=4>R/6LW7J3/W?$FQ)DQXDR6#3F&)8VG9=15I2OMM)DD90-*
MAI&-NRU'B['A8<T4D1E,6."((V=FB@#`*>4A[#H58[DLP10H/%M535_C]K6L
MZ5E^/\3'226M9R$N]>D(Y69?KR2D9L)U-O+,FG,JJF?I*N5["Z%(Y3@9$#%`
MG3LAE#G;MF;CG1;AE%3DPKCA2```,58TAN!P-EB2]_;6)/::N>'"F!/+D8_"
M6;)DG:_'X25R[D`]@+$V'8.P5WDAJ"D2>G'6B';-\?73S7A]7+QY9-X21-4%
M*_[63-`ERJ`^*[]B?4><`;O>WZKKUQD;MFY6]_Z@F*G<O&KE7``7G+*)P=/9
M;F`'3V$<.RH-LQ8=HQ(L+"!&/%%RU!.HA=)6USQ/`]M1S/<4M6SVPZILOSN^
MP<Y68BH03R.J]^L=<KEWB]?2!Y:CM=A0L4\;M[86K2:AEFW?B'7MF35[Q$QD
MQN.-U1N>-#DP6@D3)EDE/,C5^7++&T4LD.H'EL\;:"1PL%(`9586V;8=NFQL
M?%(=4QH%@4J[*Y@5E?DLP-RA=`Q[&/$:M+$'I#<,=+/9Z]SEE+=[NG>ZS<J:
M:"N]ZL%EK].J^PI9C/76&H#&0<G6JC.PS44T<J@BJ84E&J((BD1,I0A3J?=(
M=OBV_%,4)CDQWYL:*DSMB:_#&20<7,',?03QX][4:JI-LQYMR7<\@O(Z<W3&
MS$PH9XTBF*Q^U!EC0*]N%B]@-;7Y5)XAZPIDQ6+*O.[4O5JJ,_)6"%M&R=F6
M>YS*#B2H[[79F)E))UYH,4TK$DNFD@5$@=^H*YQ.KZO(MQZGS]R@R,5H\6'&
MR\9X)5AA2,.LDT<[L=(OK+Q1BX("HH50`3>5A[/BX058VF9(YX98P[LPBY`<
M11Q@^UC7F2'3Q)+'4386M]5\.6A/]G'=NIVYQ&F8O0NOM'15)JNR;="NK56:
MM8+/*SE5V:W;E(UM=0F6LPBD8IW`N52=\F82IG$#7V#K[.3#RGR8X)]WR-UC
MS-4D,;QH\4"QQR1J?:31NH92`5X`FY%JHLO8$FRL;PLDL&)'CYZN8W9)6?.G
M260!QQY9`?A<%&*E+$7%Q!>(&E@N#ZXGCK`LJ]V.UVL6MK621-36%S;ZUD]2
M.'L;60,#!FRE*/*J-G34`%NL<I%.P!R`.8^O4VZC!.`Q1D.-D8Y=E!D,.3.F
M3*A<]X_#H)%/ME):QLU7'Z+Q!()(@T:A<0!5)5!X%BV.0HX`I?22/;*`K7`J
MC(C@/H&*A[)7E2;!G8&;J26OH6'LFQ+)-LM<Z^2L49:1H^LRNW1E:C6UI>#8
M"=)(QU#(L&Z7;[I(I<N!ZYWXSP9=X1G19,60THB023S0*ZQ/D,!\*8Q)):XL
M3([-=FO5.NP[>DLC('$#Q9$:Q:VY40R@!D&)+V1I;"[#BMK)I!(-RU1UK5*/
M/;$LE?:ND)7:-FC[;;U'#YR[1=S494Z_2FBS1!<YDF"!8"L-$Q22`I#*$,<0
M[1S".-Y&=D96!C[;/I.)BB41BP[)YI)Y+G[*\DKD7[`0HX`5<EQHDRCF*#SV
M@AA)O]A`K+&+><!C<]I\M6]1'!#C3!ZNK>G&%*=DH52W@CR'@XQ2P3!W+7:#
M:WNKJVE320N@>JQS>5=F1(R,<6Q6!2M>QW!0)E^'6G4*[CC[J)AXW%V[P*-I
M4_\`;F)HBK`@AF(<R%VNQFM+?6`1;9]AVW(Q]RQ9$/)W;+;(R0"1KD:2*1K'
MM56,2(56PY>I/:L:K,G%C5B>VYS<!#W0DI97+F6GJ6E=["CJZ7L[VK'I+VX2
M.OD':<"^LKVI*&8JK+$.FHF(',F*Q2*%H4Z@STV1MA(A;$*.@=HU:5(Y)%F>
M..4C4B-*H>RD$'5I(#,#53[=CS[E'NMW3,C>)R48J)&@5E@,@'MN4K$*."FR
ME@Q5;4K5.$^E:G6W-117V+/5T9^BS41$VS8UHL;&J,=:32T_1ZC5&DB]4:PE
M.@)!RIV&29![U$_=+'43(F4E9D=7[ODSP93B`9<)D8N(D#RO+",>229K7D=H
M@`2>%[O;6S,:7Z!V\+D1J)%@R(C$4#L%C1I>>PB`/<+2]\MQ;@%!"@`4]8.'
M=(J='M#;453:3MI>:KV1IRL5_8U_L[.CQE#VS:BV>RUL56D1:';&`B'QQ-'-
MD6AQ;MDBLTCH)"!R0OU'G[DB[?N<[1X<DF(TLT<:O.&PHGBQYA=H^9,JM=BT
MB&1K.S%AQK<?&BVW(&Y8,2ODP9.1DQ0ES'"9<ED::.ZJ_*AD*WLL;JA9M*6-
MJD*G<7J)4.*,7Q-:D,I26FI5M7/G1^]5=20R,*NPG+$Z.X6477E)B6>+R"QS
MJ"<[A8QA-U'KD/474V?OG5$W52'E9IREFA`L.3R64XZ+86`A5(U6P[$'"J/I
M79X>F=HQ]J7X01JW-/QCREGG8@W_``CNYL;@!K=@KD:GT#%5K7-NKVP6,;8;
M;MMF*6ZI5%_(R;"[/PJS.BJN6YI1!LZC(I[6HM+NH\A018"J=)(3`'>&E]0;
MRNZSJF$&AVR%Y'AC`"F%II6R)+,"2Q69V"2$ZBJH2`181[!MIV1(V+"7+CBA
MAUMQUQ8J<F#6GM`S1`&95`1I&D-K-5M5>\.77Q-B7V1MD[=9354G%Z0KE<UL
MWV3;5*_:ZUING,(6&C]PP3@",[<>*FV0+M#F74,JD4@.!,!0(%\EZ[W"7;-#
MI"V]29V;D-,8DO$^4L2<S&/;%*0CEV`L&*LO>%Q0-TYC<^&.)Y8]MQ]NCQE5
M9&5F"Y.3.Z2$>VBTRQH@N"J\V,61B&N-N'$W4]RXZQG%MX:XP^IXB*K$(S:5
MNWRL-/\`L547S*2AV#FP(',]>,_.H]'SA%7MI.DR]VJ4Z9C%&R?ZGW4]3+U=
M(8WWE9^==D5DYFDKJ*'NDB]QPX,`XLP!%T3;,2+:\C9X@R862DROI8A@L[L\
MH5AQ4,69>[:R,4'`U2=HX3:SO%,@J=<[UO&S*5N7G9&&N<AM>>1O[*+M4(>N
M6JFIVF,+'NQI%E@S^;/8T2BBJ0"CY#D(8M3#U=G8^>V?!CX2\R'ER1<E3#*!
M(LRF6,DAW21%='/>4C@;%@::/9,>/%\()<@HLB/$>80T#I&\(:`K;EGE22)P
MX:7;A>Q$QR^A]9S+O2[E6"49)\?WZK_5S"*?O(Z-@3*4J3U\5JHS;JE2?L6]
M6EUD$DENT4ANR</5%`<M@WW<_$9^7))KR=S@DBR&8`EUEE2:0W^Q9I(U.I;$
M<0.!JI3:\*/;L?:HU*X.++!)&H)NK8U^5<DDL!<WU$ZOLKU2FJ>+VMM0W&2O
M4'(7ZR6)S!K5."=;"OE@O):-3',J2:<TZC^S[ITK!U]U)H(*JI]M593S9$IE
M!*D4H5.?U-N6X[<-MF$"PET>1HXDC>=XU9(WF90-917?3P`N[FQ)O4N+:,2+
M.\<ID+!I61"[&.(SL&E,:$D*7(`OQ*J-":5)!F^T5F"NE:GZA:(UO,UNT0TE
M7Y^)=@86TE#R[-9A(L5P*8I^Z=-%SD'H("`#Y!`<L`9U8/&S+(K!E8&S*RFZ
MLI\C*0"".((!%7>-VB<2)[85;'%\,]<PNOU:%&W[?C949Z(L#2^^FR\+;'BW
M$#!GJ\1'1MG7D%1;P;*L+*,/,A0,W514$ZI3K]%@RC.ZMW#<<]<_,APGLDRO
M'X>/E2\]M<QE0#OL[V?5<%&5=&D"QL>+L.#@XTF)B&6.%TA1`)&^!CQW5X4@
MX_!JA6W"Y=2RR%U-JX;G@IQ^6C&4$A&6N-KS75]7U&XK\7<9IE$2]5IEW6V+
M7%YAJDM_MU@C[<\=.@?"8JQ_/%RF$2GZ!.BZXWZ+-?<`T3939R98+1J>7-'"
M,=>6#[5.0%BT>U*HOE%ZA3I_;H\:/$42<M(LN,G6=4@SM)R3(>UVD=1)J/%7
MXBW94E1G&O541.1%A8Q<J23@]E[%VW'J'G9)5(ETVI'OHRX/%$3K"FJR=M)%
M4$6Q@[IN(@)``0#+(^\9TF'X!F7P_P!'G"MI%^09N>5OVZN9QU>VMPO:K@<+
M'+ER#J.5CY':?PN-`N-$?Y!$B@KV,>\>)J!R>'#QM;/F3R+)LN#09MM7@I$P
MNS;3'1$G+:7F2SNL+-+-$7?5_8:@^`?-ECG[L2'$%$SB/4+_``]=[[$J*WAI
M.4[M'KA1BG-QUQ9@MQP$\"".4&^I;]EZMVX=/X&XK.DQF4944L4VAV3FQRSR
MY.E[>2.>5Y8K6T-;M``JK)/@WIF0KD)6VLOM:O)UFY;"M]<FJMLZRP%F@D-J
MN7;O8%*C)]@X3D&]`LKAX8ZL7VA33.1,Z1B'23,6DQNK=TQIUF*X\@\%%BNL
MD2LDL>.R-`95/!Y(C&@1SQ"@J;JS!JK)VO'RI)II&E$TN7XI6#$&&<Q-"TD/
MDC+QO(K"Q!YCFVH@C];*X,:*VE*.W\YZ0XEA,LZ&TMU8JFR+77JO?#ZO<QKF
M@2%VBFC\?;!*UD(ANBDY54!59!(J:XK%*4`BVSK+>MJF7(@Y#SQY,F1$9(D?
MDS2@B5X01:/F<-0`TW`(4&Y,G(V/!R,=,4F5(%Q/"MID<&7'LX$4K7U.JF21
ME).L,[=X@VJN=.Z9F*>[MERN$P!+[?-H6G8EF:U"4?EJSAJYC&%+I=>=D?,V
MCJ8;5RAUV-`QE$TBC*><+$*!#E*%%G;K%)A8FVXBWQ,;#Y=Y`-1FFE.3DRK8
MV!YSM'$?;>'5`W>O50F&QS)\N0Z2\L0CTGBL&/'RHHV:PN')DG=;=V24H&94
M5C<9EBJX4Q2F*5PWG[%'_P"N'SI7(T[?K5`_M:ZEVHHB9-4JG1,?]6<O0HE`
MP_L#CU\OS?)B4NJ:D[1V_P`E1XRQ/)RY1[;L/F/_`-:]+95RL)>AQ!,/*=0Y
M0$![(@'93ZA_\7^;)433.;GVO_'953DQXL0LHO)Y@>S^6N0Y!0O1PDJ4O=E'
MMIJ#T2.3KU'J/_PF_6'*@W[:MXMV$5^6KHSL14#HFD3H7NQZ=X8XEZB)OVI0
MZ^3]?`-^([*^D6'U:Y"QP*!0[9RB8W0.Z3!4P]`$1#LB!O)T#YN1J"?(/K\*
MAL:]8=3`!@=F`!Z`':(B7J(@`@``)/*/0<B(L;:>/UZAMY;\*_(&$3]@'*PB
M`B`F!!,4P$/*("H!.R`ABW"^D6_EK[8WMQK]>7IU\\\@^0!Z(=.OS/F]GI\W
M/G_]?Z:6/GH'4QC%!V83%'H8O81Z@/3KY/4>4.@X[!?3P^O2WU>->>R;KT\[
M'K^MV4.OE^9_\'ZN/_Z_TTL:\]A3]\F_^1'_`$,^7'N?Z:6->>[4_?)O_D1_
MT,7'N?Z:6/U:U[^R?^]"=.]'K^1X_9=DGRC^GS.ST^;Y?^W_`"9+N-79_P`7
MJ;8Z>W_BU7M>"`'3PD/#]Z^3_P#MLH@_]Z#@0_[PR54RLJ.*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2N&\*8Q4@*4QA!8!$"@(]`[M3RCT_4\N1IP/'S5"
MW97"4;G53.F9,_0Y1#]B;R?K#\SYH#Y<FZE\XJ"QKPDDN"1`.F8#E*!1[)1[
M/D\G4/)Y`$`ZY]++Y"+4L?+VUZG#-5P9$!`X)$/VU$^P;_6=`]2`C^L`Y"2#
MY1:OHN*]OFQ@4[T$SE'L]DP`0>AP\G9Z^3YI>GD_[<^W6][BEC7Y6;*J=CHE
MVNR83"50IP*/4IB_-*`CU#KD2NHOQ\E?""?)7H\Q7`!`"]KJ42^J(?U/4I`[
M9?(/JR]GR?\`MR/FI_Q]>H=)MV<:]@-G`%,D!1%,W;]4)3]X';ZB/D`.@^J'
MYO7YF0ZT)U?95]`8?R5^2LE`'J9+IZDX=/\`6*=3&`H`;U9?4].S^ID1E6W;
MQH%/E%>0:."G`Y"`(AV1]40X"(@EW9@'H4?)^J&.:A!!/#_ZWKYI84*T5(B<
M.[,90>@E$I!`>T4I0+Y1`/)VR_\`=GPR*6''A32;<:Y!$5"$*7L'$0#RCV#>
M4P^4P_,_5$<@+*3>XM7T`@?5K]]VI^YG_P#E-_[L^:E\XK[8UKW=@_\`>A?V
M)OS._7]B/S/PDNQU^9^W\G_;Y,E?97_X[:C\G_'FK61X=_S7])?_`/55_$=C
M_,L_FH?[R[^T!_\`TQ__`'9_^AZ9!457*?II&*4_32,4I^FD8I3]-(Q2GZ:1
MBE/TTC%*?II&*4_32,4I^FD8I3]-(Q2GZ:1BE/TTC%*?II&*4_32,4I^FD8I
M3]-(Q2GZ:1BE/TTC%*?II&*4_32,4I^FD8I3]-(Q2GZ:1BE/TTC%*?II&*4_
M32,4I^FD8I3]-(Q2GZ:1BE/TTC%*?II&*4_32,4I^FD8I3]-(Q2GZ:1BE/TT
MC%*?II&*4_32,4I^FD8I3]-(Q2GZ:1BE/TTC%*?II&*4_32,4I^FD8I3]-(Q
M2GZ:1BE/TTC%*?II&*4_32,4I^FD8I3]-(Q2GZ:1BE/TTC%*?II&*4_32,4I
M^FD8I3]-(Q2GZ:1BE/TTC%*?II&*4_32,4KT+_,)_P#]H7_B!_X_[']B?]A_
M]O\`_-UR)>WR_6KX:]7Z9YD?OJA]BGZ9YCWU/8I^F>8]]3V*?IGF/?4]BGZ9
MYCWU/8I^F>8]]3V*?IGF/?4]BGZ9YCWU/8I^F>8]]3V*?IGF/?4]BGZ9YCWU
M/8I^F>8]]3V*L.__`-DO^)-_FI?UDO\`'G__`!(__B3(?+Y?_P">VHO)Y*__
!V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
